MOLECULAR BIOLOGY INTELLIGENCE UNIT
Marc Symons SYMONS
Rho GTPases
MBIU
Rho GTPases 9/8/03, 4:36 PM
MOLECULAR BIOLOGY INTELLIGENCE UNIT
Rho GTPases Marc Symons, Ph.D. Laboratory of Tumor Cell Biology North Shore-LIJ Research Institute Manhasset, New York, U.S.A.
LANDES BIOSCIENCE / EUREKAH.COM GEORGETOWN, TEXAS U.S.A.
KLUWER ACADEMIC / PLENUM PUBLISHERS NEW YORK, NEW YORK U.S.A.
RHO GTPASES Molecular Biology Intelligence Unit Eurekah.com / Landes Bioscience Kluwer Academic / Plenum Publishers Copyright ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher, with the exception of any material supplied specifically for the purpose of being entered and executed on a computer system; for exclusive use by the Purchaser of the work. Printed in the U.S.A. Kluwer Academic / Plenum Publishers, 233 Spring Street, New York, New York, U.S.A. 10013 http://www.wkap.nl/ Please address all inquiries to the Publishers: Eurekah.com / Landes Bioscience, 810 South Church Street Georgetown, Texas, U.S.A. 78626 Phone: 512/ 863 7762; FAX: 512/ 863 0081 www.Eurekah.com www.landesbioscience.com Rho GTPases edited by Marc Symons, Landes / Kluwer dual imprint / Landes series: Molecular Biology Intelligence Unit ISBN: 0-306-47992-3
While the authors, editors and publisher believe that drug selection and dosage and the specifications and usage of equipment and devices, as set forth in this book, are in accord with current recommendations and practice at the time of publication, they make no warranty, expressed or implied, with respect to material described in this book. In view of the ongoing research, equipment development, changes in governmental regulations and the rapid accumulation of information relating to the biomedical sciences, the reader is urged to carefully review and evaluate the information provided herein.
CONTENTS Preface ................................................................................................... x 1. Signalling Networks of Rho GTPases .................................................... 1 Emmanuel Vignal, Anne Blangy and Philippe Fort Abstract ....................................................................................................... 1 Introduction ................................................................................................ 1 Emergence of the Rho Family ...................................................................... 1 Biological Activities of “Unconventional” Rho Proteins ............................... 3 Signalling Networks Controlled by Rho Proteins in Mammals .................... 8 Concluding Remarks ................................................................................. 10
2. Intracellular Targeting of Rho Family GTPases: Implications of Localization on Function ............................................. 17 David Michaelson, Mark Rush and Mark R. Philips Rho Proteins—Diverse Functions Despite Sequence Homology ................ 17 Targeting Motifs—Location, Location, Location ....................................... 19 C-Terminal Targeting Motifs—The Importance of Being Hypervariable ... 25 TC10 and Cdc42—A Tail of Two GTPases .............................................. 26 RhoGDI—The Catcher in the Cytosol ...................................................... 27 Conclusions—You Are Where You Are ..................................................... 28
3. Regulation of the RhoGTPases by RhoGDI ......................................... 32 Gregory R. Hoffman and Richard A. Cerione Abstract ..................................................................................................... 32 Introduction .............................................................................................. 32 GDIs As Multifunctional Regulators of Signalling through Rho GTPases ........................................................................... 33 Structural Insights into GDI Function ....................................................... 35 Future Directions ...................................................................................... 41 Conclusion ................................................................................................ 43
4. Rho Family Guanine Nucleotide Exchange Factors .............................. 46 Ian P. Whitehead Abstract ..................................................................................................... 46 Introduction .............................................................................................. 46 Structure of RhoGEFs ............................................................................... 49 Regulation of RhoGEFs ............................................................................. 50 Physiological Roles for RhoGEFs ............................................................... 56 RhoGEFs and Human Disease .................................................................. 61 Future Perspectives .................................................................................... 63
5. The Superfamily of Rho GTPase-Activating Proteins .......................... 68 Sarah Jenna and Nathalie Lamarche-Vane Abstract ..................................................................................................... 68 RhoGAPs Are Multimodular Proteins ....................................................... 68 Molecular Basis of the GTPase-Stimulating Activity .................................. 72 RhoGAPs Are Multifunctional Proteins ..................................................... 74 RhoGAPs in Host-Pathogen Interaction .................................................... 81 Conclusion ................................................................................................ 85
6. Rnd Proteins: Intriguing Members of the Rho Family ......................... 96 Pierre Chardin Abstract ..................................................................................................... 96 General Features ........................................................................................ 96 Prenylation ................................................................................................ 96 Chromosomal Localization ........................................................................ 98 Biochemical Properties of Rnds ................................................................. 98 Do Rnd Proteins Need GEFs for Activation .............................................. 99 Rnds As Targets of Bacterial Toxins ........................................................... 99 Expression in Human Tissues .................................................................... 99 Localization of Rnd1 in Swiss 3T3 Fibroblasts and Microinjected MDCK Cells ....................................................................................... 101 Rnd1 or Rnd3 Expression Inhibit the Formation of Actin Stress Fibers ... 101 Rnds Inhibit Smooth Muscle Contraction ............................................... 101 Proteins Interacting with Rnds ................................................................ 102 Effects of Rnd1 in Neurons ..................................................................... 102 Induced Expression of Rnd3 Participates in the Transformation of Epithelial Cells by Raf ..................................................................... 103 Rnds in Development .............................................................................. 104 Perspectives .............................................................................................. 104
7. Rho GTPases in the Organization of the Actin Cytoskeleton ............. 107 Ed Manser Abstract ................................................................................................... 107 Introduction ............................................................................................ 107 Different Actin Networks: Membrane Ruffles, Filopodia and Stress Fibres .................................................................................. 108 Actin–Myosin II Contractility and Stress Fibre Formation ...................... 109 Controlling Actin Treadmilling ............................................................... 110 Arp2/3-Mediated Actin Nucleation and Branching ................................. 111 Stimulating Actin Assembly ..................................................................... 111 Tethering Assembled Actin to Membranes .............................................. 112 The Focal Adhesion Complex-Actin Connection ..................................... 112 Conclusions and Future Directions .......................................................... 112
8. Cell-Cell Adhesion ............................................................................. 115 Vania M.M. Braga and Martha Betson Introduction ............................................................................................ 115 Characteristics of Epithelial Cells ............................................................. 115 Cadherin Receptors ................................................................................. 117 Experimental Models to Investigate Cell-Cell Adhesion Regulation ......... 120 Regulation of Cadherin Function ............................................................ 122 Signalling from Cadherin Receptors ........................................................ 130 Conclusions ............................................................................................. 132
9. Rho GTPases and Cell Motility ......................................................... 141 Alexander Beeser and Jonathan Chernoff Abstract ................................................................................................... 141 Rho GTPases and Cell Polarity ................................................................ 142 Actin Polymerization at the Leading Edge ............................................... 145 Remodeling Focal Contacts ..................................................................... 148 The Generation of Contractile Force ....................................................... 150 Summary ................................................................................................. 152
10. The RhoGTPase in Tumor Invasion .................................................. 155 Arthur M. Mercurio Abstract ................................................................................................... 155 Introduction ............................................................................................ 155 RHO Involvement in Tumor Progression................................................ 156 Mechanisms of Rho Involvement in Invasion .......................................... 157 Conclusions ............................................................................................. 159
11. Rho Family GTPases and Cellular Transformation ............................ 163 Antoine E. Karnoub and Channing J. Der Abstract ................................................................................................... 163 Introduction ............................................................................................ 163 The Rho Family of GTPases Is a Major Branch of the Ras Superfamily ......................................................................... 163 Rho GTPases Function As Membrane-Associated GDP/GTP-Regulated Molecular Switches ........................................... 164 Rho Family GTPases Are Critical Components of Diverse Signalling Pathways ............................................................................. 169 Rho GTPases Promote Oncogenic Transformation ................................. 170 Rho GTPases Mediate Transformation through Multiple Effectors ......... 175 Conclusions and Future Directions.......................................................... 177
12. Rho GTPases in Lipid Metabolism .................................................... 185 Maikel P. Peppelenbosch Abstract ................................................................................................... 185 Introduction ............................................................................................ 185 Rho Family GTPases and Phosphatidylintositol-3-Phosphates ................. 185 Rac-Mediated Arachidonic Acid Release .................................................. 188 Rho A As an Effector of Arachidonic Acid Metabolism............................ 190 Rho Family GTPases and Inositol-1,4,5-Triphosphate Generation .......... 190 Phospholipase D As an Effector of Rho Family GTPases ......................... 191 Final Considerations ................................................................................ 192
13. The Role of Rho GTPases in Vesicle Trafficking ............................... 196 Nicole Rusk and Marc Symons Summary ................................................................................................. 196 Introduction ............................................................................................ 196 Role of Rho GTPases in Clathrin-Mediated Endocytosis ......................... 196 Macropinocytosis ..................................................................................... 199 Phagocytosis ............................................................................................ 199 Exocytosis ................................................................................................ 201 Trafficking in Polarized Epithelial Cells ................................................... 202 Trafficking Controlled by Rho GTPases in the Regulation of Cell Motility and Cell-Cell Junctions .............................................. 203 Conclusion .............................................................................................. 203
14. The Dictyostelium Rho Family of Proteins and Effectors .................. 208 David Seastone and James A. Cardelli Abstract ................................................................................................... 208 Choice of Dictyostelium As an Experimental System ............................... 208 An Overview of the Dictyostelium Rho Family of GTPases ..................... 209 Rho Family GTPase Regulators and Effectors .......................................... 212 Other Proteins that Interact with Rho Family GTPases ........................... 215 Summary ................................................................................................. 216
15. Rho GTPases in Plants ...................................................................... 219 Aline H. Valster, Peter K. Hepler and Jonathan Chernoff Abstract ................................................................................................... 219 Introduction ............................................................................................ 219 Rop Identity ............................................................................................ 219 Regulation of Rop ................................................................................... 221 Rop Localization ...................................................................................... 222 Rop-Regulated Processes .......................................................................... 223 Concluding Remarks ............................................................................... 227
Index .................................................................................................. 231
EDITOR Marc Symons, Ph.D. Laboratory of Tumor Cell Biology North Shore-LIJ Research Institute Manhasset, New York, U.S.A.
[email protected] Chapter 13
CONTRIBUTORS Alexander Beeser Fox Chase Cancer Center Philadelphia, Pennsylvania, U.S.A. Chapter 9
Martha Betson Harvard Medical School Charlestown, Massachusetts, U.S.A.
James A. Cardelli Department of Microbiology and Immunology The Feist-Weiller Cancer Center LSU Health Sciences Center Shreveport, Louisiana, U.S.A.
[email protected] Chapter 14
Chapter 8
Anne Blangy Centre de Recherches en Biochimie des Macromolécules - CNRS UPR1086 Montpellier, France Chapter 1
Vania M.M. Braga Cell and Molecular Biology Section Division of Biomedical Sciences Imperial College School of Medicine London, U.K.
[email protected] Chapter 8
Richard A. Cerione Department of Chemistry and Chemical Biology Baker Laboratory Department of Molecular Medicine Veterinary Medical College Cornell University Veterinary Medical Center Ithaca, New York, U.S.A.
[email protected] Chapter 3
Pierre Chardin Dynamique moléculaire des compartiments cellulaires Institut de Pharmacologie du CNRS Valbonne, France
[email protected] Chapter 6
Jonathan Chernoff Fox Chase Cancer Center Philadelphia, Pennsylvania, U.S.A.
[email protected] Chapters 9, 15
Channing J. Der University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, U.S.A.
[email protected] Chapter 11
Philippe Fort Centre de Recherches en Biochimie des Macromolécules - CNRS UPR1086 Montpellier, France
[email protected] Chapter 1
Peter K. Hepler Department of Biology 221 Morrill Science Center III University of Massachusetts Amherst, Massachusetts, U.S.A. Chapter 15
Gregory R. Hoffman Department of Cell Biology Harvard Medical School Boston, Massachusetts, U.S.A. Chapter 3
Sarah Jenna Department of Surgery Organelle Signaling Laboratory Royal Victoria Hospital McGill University Montreal, Quebec, Canada Chapter 5
Antoine E. Karnoub Department of Biochemistry and Biophysics University of North Carolina Chapel Hill Chapel Hill, North Carolina, U.S.A.
[email protected] Chapter 11
Nathalie Lamarche-Vane Department of Anatomy and Cell Biology McGill University Montreal, Quebec, Canada
[email protected] Chapter 5
Ed Manser Institute of Molecular and Cell Biology Glaxo-IMCB Laboratory Singapore
[email protected] Chapter 7
Arthur M. Mercurio Deptartment of Pathology Beth Israel Deaconess Medical Center Research North Harvard Medical School Boston, Massachusetts, U.S.A.
[email protected] Chapter 10
David Michaelson Department of Cell Biology New York University School of Medicine New York, New York, U.S.A. Chapter 2
Maikel P. Peppelenbosch Laboratory for Experimental Internal Medicine Academic Medical Centre Meibergdreef 9 Amsterdam, The Netherlands
[email protected]
David Seastone Department of Biochemistry Pikeville College of Osteopathic Medicine Pikeville, Kentucky, U.S.A.
Chapter 12
Aline H. Valster Laboratory of Tumor Cell Biology North Shore-LIJ Research Institute Manhasset, New York, U.S.A
[email protected]
Mark R. Philips Medicine and Cell Biology New York University School of Medicine New York, New York, U.S.A.
[email protected] Chapter 2
Mark Rush Department of Biochemistry New York University School of Medicine New York, New York, U.S.A.
Chapter 14
Chapter 15
Emmanuel Vignal Centre de Recherches en Biochimie des Macromolécules - CNRS UPR1086 Universite de Montpellier Montpellier, France Chapter 1
Chapter 2
Nicole Rusk Laboratory of Tumor Cell Biology North Shore-LIJ Research Institute Manhasset, New York, U.S.A.
[email protected]
Ian P. Whitehead Dept. of Microbiology and Molecular Genetics New Jersey Medical School Newark, New Jersey, U.S.A.
[email protected]
Chapter 13
Chapter 4
PREFACE
M
embers of the Rho family of GTP-binding proteins (GTPases) act as molecular switches that mediate a large number of signals, including growth factors, cytokines and adhesion proteins. Accordingly, these GTPases control a vast array of cellular functions, ranging from the organization of the actin cytoskeleton, microtubule dynamics, cell adhesion, cell motility and cell cycle progression. Over the past several years, our knowledge about Rho proteins has rapidly expanded. Over 20 Rho GTPases have been identified in mammals. Of these, RhoA, Rac1 and Cdc42 have been extensively characterized. Chapter 1 gives an overview of other members of the Rho family and also discusses multiple modes of cross-talk between Rho proteins. The nucleotide state of Rho proteins is regulated by three types of regulatory proteins. Guanine nucleotide exchange factors (GEFs, discussed in Chapter 4) activate Rho proteins by catalyzing the exchange of GDP for GTP. GTPase activating proteins (GAPs, Chapter 5) promote the intrinsic GTP hydrolysis of Rho GTPases, causing their inactivation. Lastly, guanine nucleotide dissociation inhibitors (GDIs, Chapter 3) preferentially bind to GDP-bound GTPases and prevent spontaneous and GEF-catalyzed release of nucleotide, thereby maintaining GTPases in the inactive state. The three members of the Rnd subfamily differ from most other Rho proteins in that they lack GTPase activity and therefore are likely to be constitutively active (reviewed in Chapter 6). A requisite for the proper intracellular targeting of most Rho family GTPases is their post-translational modification by the addition of a prenyl group to the C-terminal CAAX motif. The prenyl group serves as a lipid anchor in the localization of Rho GTPases to their respective membrane compartments (reviewed in Chapter 2). As discussed in Chapters 2 through 5, the three classes of regulators in turn are subject to complex regulation. A critical aspect of these regulatory mechanisms is that they are highly localized. This is especially important for Rho family GTPases such as Cdc42 and Rac, which have been implicated in biological processes that involve directionality, including chemotaxis, neurite outgrowth and cell polarization. Over the past several years, dramatic progress has been made in the elucidation of the signaling pathways that mediate some of the functions that are controlled by Rho proteins. The first biological function that was recognized for RhoA, Rac1 and Cdc42, a little more than a decade ago, was their regulation of distinct features of the actin cytoskeleton. In the intervening time, a concerted effort by a large number of laboratories has elucidated several pathways that mediate the organization of the actin cytoskeleton downstream of these GTPases (reviewed in Chapter 7).
The next four contributions review other well-characterized biological functions that are governed by Rho family GTPases. Chapter 8 discusses the role of Rho GTPases in cell-cell adhesion, focusing on adherens junctions in mammalian epithelial cells. Chapter 9 describes how Rho, Rac and Cdc42 direct the sequential steps that lead to cell migration: establishment of cell polarity, induction of cell protrusions, remodeling of cell-substrate contacts and contractile force generation. Two Chapters discuss the multiple roles that are played by Rho family proteins in cancer. Chapter 10 focuses on Rho-mediated tumor cell invasion and Chapter 11 gives a comprehensive overview of the many contributions of Rho proteins to the process of cell transformation, including the stimulation of cell cycle progression and cell survival. The past few years have seen the emergence of additional Rho GTPase-regulated functions. Chapter 12 reviews the impact of Rho GTPases on lipid metabolism, and Chapter 13 discusses recent findings that Rho proteins regulate many steps of vesicular trafficking. In light of the plethora of functions that are regulated by Rho family proteins, it is not surprising that these GTPases also play critical roles during the development of multicellular organisms. A powerful system that is amenable to both genetic and biochemical approaches to study the roles of Rho proteins in development in addition to other biological functions, is provided by Dictyostelium discoideum (reviewed in Chapter 14). In plants, Rho GTPases form a unique group, called Rop GTPases, that appear to be regulated in a manner that is distinct from that of animal Rho proteins. It is therefore expected that the elucidation of the regulatory mechanisms and functions of Rops will shed new light on the core principles that determine the action of Rho GTPases. Rho GTPases have provided students of cell biology and physiology as well as developmental biology with powerful tools to dissect signal transduction pathways. My hope is that this book will serve as a reference point for researchers that are active in these fields and that it will spur the interest in these versatile proteins for new investigators. Marc Symons Laboratory of Tumor Cell Biology North Shore-LIJ Research Institute Manhasset, New York, U.S.A.
CHAPTER 1
Signalling Networks of Rho GTPases Emmanuel Vignal, Anne Blangy and Philippe Fort
Abstract
G
TPases of the Rho family act as molecular switches that convert extracellular signals into multiple cellular effects. Although more than 20 members are known in mammals, only RhoA, Rac1 and Cdc42 have been studied extensively. This chapter gives an overview of the current knowledge on the cellular activities of the other Rho members and describes how multiple Rho activities are coordinated to allow the establishment of complex cellular processes.
Introduction Like other proteins of the Ras-like superfamily, most Rho GTPases are low molecular weight proteins (21-28 kDa) that bind guanine nucleotides GDP or GTP and hydrolyze GTP. These proteins act as signalling gates, which switch on when bound to GTP and switch off when bound to GDP. The first clue of a role of Rho proteins in the control of the actin cytoskeleton came from the correlation between the disappearance of F-actin microfilaments in Vero cells and RhoC ADP-ribosylation upon C. botulinum C3 toxin treatment.1 The causal link between Rho activity and cytoskeletal organization was next concluded from the cellular effects of microinjected recombinant RhoA protein.2 This was followed in 1992 by the demonstration of the pivotal roles of Rac1 and RhoA in remodeling of the cytoskeleton of cells treated by growth factors.3,4 These milestone papers evidenced that Rac1 controls cell spreading through membrane ruffling while RhoA controls cell contraction through F-actin stress fiber assembly. Cdc42 was shown later on to control the formation of filopodia, a third type of F-actin structure also involved in cell motility and spreading.5 Since then, pathways controlled by Rho GTPases have been under intense investigation and have generated over 2000 publications. This wealth of data implicates Rho proteins in a wide variety of fundamental physiological processes, among which cell adhesion and motility, cell proliferation, transformation and apoptosis, cell differentiation or development. Meanwhile, numerous additional Rho proteins have been characterized in mammals and in other eukaryotes. Paradoxically, 95% of the literature has focused only on the cellular activities of RhoA, Rac1 and Cdc42, and the function of most Rho proteins remains poorly known. This review summarizes our current knowledge on "unconventional" Rho members in mammals and emphasizes regulatory crosstalk that coordinate multiple Rho activities in complex physiological processes.
Emergence of the Rho Family The first Rho member identified has been isolated serendipitously in 1985 from a low stringency screen of an Aplysia cDNA library.6 The corresponding mRNA was found to encode a 192 aa protein sharing 35% aminoacid similarity with H-Ras, thus termed Rho, for Ras Homologous. Additional cross hybridization experiments identified human homologues, and also suggested the presence of Rho sequences in the genomes of Drosophila and yeast. This was Rho GTPases, edited by Marc Symons. ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers.
2
Rho GTPases
Figure 1. Clusters of the Rho family. Aminoacid sequences of mammalian Rho members were aligned and a bootstrapped unrooted tree was constructed. Aminoterminal extensions and heterogenous carboxyterminal regions were omitted from the alignment. Although RhoBTB3 is connected to the RhoBTB cluster, it was excluded from the comparison because of its high level of divergence.
confirmed by the cloning of two yeast homologues.7 Human cDNAs encoding two close relatives to Rho8-10 and two more distantly related sequences, termed rac1 and rac2 (for Ras related C3 botulinum toxin substrate,11) were characterized in 1989. These latter turned out to be in fact poor C3 toxin substrates.12 S. cerevisiae CDC42 protein - involved in the establishment of cell polarity - as well as its human counterpart were next identified as Rho members in 1990.13-15 Strategies for directly hunting new Ras-like sequences16 led to the identification of TC10, a CDC42-related Rho member.17 The Rho family grew bigger during the 90’s: RhoG, a growth-regulated gene product,18 TTF/RhoH, whose gene was found translocated in B cell lymphomas,19 RhoD, cloned by a PCR approach,20,21 Rac322,23 and three Rnd proteins,24 isolated from low stringency screenings. Chp (Cdc42 Homologous Protein) was identified through its ability to bind p21 activated kinases (PAK)25 and recently, Wrch1 (Wnt-1 responsive Cdc42 homolog) was identified from a differential screening for downstream targets of Wnt.26 Meanwhile, the development of genomic projects made it possible to screen the whole human and murine genomes for new Rho members. This allowed the discovery of TCL
Signalling Networks of Rho GTPases
3
(TC10-Like)27 and Rif (Rho in filopodia).28 The hunt for new Rho proteins was not quite over since a new subgroup, termed RhoBTB, was characterized recently. In human, it includes three sequences encoding 600-700 aa proteins, whose N-terminal moiety is bona fide Rho sequence and C-terminal moiety contains BTB protein-protein interacting domains.29 Numerous Rho proteins were also identified in other organisms. To date, six Rho proteins are known in yeast (Cdc42, Rho1-5),30 six in C. elegans (Rac1, Rac2, RhoA, Cdc42, Mig-2 and F22E12) and six in D. melanogaster (Rac1, Rac2, Rho1, Mtl-1, RhoL and RhoBTB),29 thirteen in plants (termed Rop for Rho of plants (for a review, see ref 31) and at least 15 in the slime mold D. discoideum.29
Biological Activities of “Unconventional” Rho Proteins Comparison of the 21 mammalian Rho protein sequences shows that they are distributed in four main sub-groups (Fig. 1): The Rho cluster (RhoA, RhoB and RhoC), the Rnd cluster (Rnd1, Rnd2 and Rnd3), the RhoBTB cluster (RhoBTB1, RhoBTB2 and RhoBTB3) and the Rac/Cdc42 constellation, including the Rac cluster (Rac1, Rac2, Rac3), the Cdc42 cluster (Cdc42, TC10, TCL), RhoG, Chp1 and Chp2/Wrch-1. The remaining proteins (RhoD, Rif and RhoH/TTF) delineate distinct stems in the tree. Given that the complete human genome sequence is now available, this represents probably the final picture of the Rho family in mammals. Since attention has focused mostly on RhoA, Rac1 and Cdc42, the structure of the Rho family raises several questions. Do similar Rho proteins exert similar biological functions? Are they expressed differentially? Are similar proteins regulated by the same factors? Do they bind to similar targets?
The Rho Subgroup In addition to RhoA, this sub-group includes RhoB and RhoC. RhoA and RhoC share 95% amino acid similarity, while RhoB shares about 86% similarity with RhoA and RhoC. Homologues of RhoA, RhoB and RhoC are also found in chicken cDNA databases.29 Amino acid changes between the three Rho proteins are concentrated in the C-terminus, involved mainly in plasma and intracellular membranes targeting.32 Due to their high level of similarity, the technical approaches used in most papers cannot discriminate either protein. For instance, the widely used C. botulinum C3 toxin inactivates all three proteins.33 In addition, most RhoA targets identified so far also interact with RhoB and RhoC. Thus for a large part, activities attributed to RhoA must be considered as a combined "Rho" activity. This is true for actin stress fiber assembly, also triggered by RhoB34 and RhoC.35 However, despite their high level of similarity, there are substantial differences between the three GTPases, not only in the regulation of their expression but also in their cellular activities. RhoB gene is an immediate-early response gene inducible by growth factors or UV,36-38 which encodes a protein mainly distributed in endosomes.39 RhoB is an unstable protein (t1/2 = 2 hours) that accumulates during the S phase of the cell cycle40 and is stabilized in response to TGFβ.41 RhoB expression modulates SRE gene transcription like RhoA does,42 but also affects specific transcription pathways.42,43 RhoB also specifically regulates Epidermal Growth Factor (EGF) receptor traffic through its downstream effector PRK1.44,45 A very particular feature that distinguishes RhoB is its ability to be both farnesylated and geranylgeranylated, whereas RhoA and RhoC are only geranylgeranylated.46 Both types of modifications appear to generate functionally distinct properties, since active RhoB shows weak but significant transforming activity42 and an anti-transforming activity when only geranylgeranylated.47 As far as RhoC is concerned, no information is available yet about specific activities, regulators or targets. However, recent evidence suggests that RhoC controls some pathways distinct from those controlled by RhoA. In particular, the level of expression of RhoC but not RhoA correlates positively with the metastatic properties of melanoma cells and seems to be responsible for their invasive properties.48 Similar findings have been observed in pancreatic adenocarcinoma49 and in inflammatory breast cancers.35
4
Rho GTPases
The Rnd Cluster Rnd proteins represent a distinct group of Rho proteins, which are devoid of GTPase activity. The biology of Rnd proteins is described in Chapter 6.
The RhoBTB Cluster Sequences encoding RhoBTB proteins have been detected in mammals, in the fly and in the slime mold.29 RhoBTB members are also present in chicken (AL587471). Human RhoBTB2 is identical to DBC2 mRNA (AY009093), annotated in databases as homozygously deleted in breast cancer cells. No biological activity of RhoBTB members has been reported so far.
The Rac1/Cdc42 Subgroup The Rac Cluster In addition to Rac1, this cluster includes Rac2 and Rac3, which both share 96% amino acid sequence similarity with Rac1. Rac2 has been extensively analyzed in haemopoietic cells where it is exclusively expressed. Human Rac3 and its chicken homologue cRac1B show preferential expression in brain.23,50 Two Rac3/cRac1B homologues are also present in fish brain cDNA libraries (AW281145 and AW305669). Overexpression of cRac1B in primary neurons elicits neurite outgrowth, whereas no such effect is observed when cRac1A (the homologue of the mammalian Rac1) is expressed.51 This differential effect is cell-type specific, since cRac1A and cRac1B elicit similar phenotypes in fibroblasts. This suggests that Rac3/cRac1b controls a specific signalling pathway in the nervous system. Besides, Rac3 was recently reported to be activated in hyperproliferative human breast cancer-derived cell lines and tumor tissues.52 However, it is not known whether Rac3 deregulation correlates with particular breast tumor stages and has a direct impact on cell proliferation. In addition to Rac3, overexpression of Rac1b - a Rac1 splice variant - has been reported to be associated with breast and colon tumors.53,54
The Cdc42 Cluster
This cluster includes two Cdc42 isoforms,14,15 TC1017 and TCL.27 Cdc42 isoforms result from alternative splicing of 3' terminal exons,55 thereby producing proteins with distinct C-terminal ends (10 aminoacids). One isoform (Cdc42u) is ubiquitously expressed, while the second is brain-specific. Both isoforms were shown recently to have slightly different subcellular distributions.32 It is not known if Cdc42 isoforms exert specific cellular activities, since most studies on Cdc42 function did not mention which isoform was used. TC10 shares 68% aminoacid identity with Cdc42 and shows an extension at its N terminus (NH2 extensions are also found in TCL, Chp1, Wrch1, RhoD and Rif ). TC10 homologues are found in other mammals (mouse BF165256, cow BF044629) and also in fish (BF612628) cDNA databases. Expression of a dominant active TC10 in NIH3T3 cells elicits cell rounding, a reduction in actin stress fibers and the formation of peripheral extensions.56,57 The phenotype was similar but more pronounced than the one elicited by active Cdc42. Screens for downstream effectors showed that TC10 and Cdc42 have the ability to bind similar targets, in particular those containing the consensus CRIB (Cdc42/Rac interactive binding) domain, such as (PAK).56 Nevertheless, additional targets have been identified that specifically bind to TC10 or to Cdc42,56,58,59 indicating that these proteins might control specific pathways. This was documented further by the observations that in contrast to mammalian Cdc42, TC10 does not rescue a yeast Cdc42 defective mutant and is not required for neurite extension in PC12 cells.60 Further differences between both proteins reside in their expression pattern. TC10 mRNA is preferentially expressed in heart and skeletal muscle56 and accumulates in axotomized motoneurons61 and in differentiating adipocytes.62 One physiological role of TC10 in adipocytes might be the control of insulin-stimulated glucose uptake.63 Indeed, glucose uptake is controlled by at least two independent pathways: one activates vesicle trafficking through PI3-Kinase
Signalling Networks of Rho GTPases
5
while the other translocates the GLUT4 glucose transporter to the cell surface. This latter pathway appears to be strictly and specifically dependent on TC10 activity. Recently, we identified TCL (closely related to TC10) from human and mouse databases.27 No strict TCL homologue has been deposited yet in other databases. TCL and TC10 mRNAs are distributed in similar tissues, in particular in heart. TCL and TC10 are also very similar at the biochemical level. However, a particular feature that distinguishes TCL is its ability to trigger the formation of highly dynamic ruffles onto the dorsal membrane of fibroblasts, whereas Cdc42 and TC10 activities are restricted to protrusions at the cell periphery.
RhoG
RhoG was first identified as a growth-activated gene.18 The RhoG protein is distantly related to the Rac cluster and to the fly Mtl-1 and the worm Mig-2, which has been implicated in axon guidance.64 RhoG homologues are found in frog and fish databases (BF615856 and BF158461). RhoG mRNA is ubiquitously expressed in mammalian tissues, with preferential expression in haemopoietic tissues, lung and heart.18 Expression of a dominant active RhoG mutant in fibroblasts triggers cellular effects similar to those elicited by active Rac1 and Cdc42: low transforming activity, JNK activation65 and formation of filopodia and membrane ruffling.66 Wild-type RhoG triggers similar effects although to a lower efficiency, whereas dominant negative RhoG has opposite activities. In addition, RhoG is mainly distributed in intracytoplasmic membranes and its activity requires the microtubule network. This feature is probably mediated by kinectin, a protein suspected to bridge cytoplasmic vesicles to the microtubule motor kinesin.67 RhoG was also shown to mediate neurite outgrowth in PC12 cells stimulated by nerve growth factor (NGF).68
Chp and Wrch
Chp has been isolated from a screen for proteins that interact with PAK2,25 while Wrch (Wnt-1 responsive Cdc42 homolog) has been found in a differential screen for Wnt-1 downstream targets.26 Chp and Wrch proteins differ from Rac1 and Cdc42 in that they display N-terminal extensions containing a potential SH3-binding site and in the case of Chp, that it is devoid of CAAX box. Both proteins are preferentially expressed in brain. Sequences homologues to Wrch but not Chp are found in frog (BF611792) and fish (AU167900) cDNA databases. Expression of constitutively active Chp or Wrch activates the JNK pathway, similar to Rac1, Cdc42 and RhoG. Chp however fails to activate the p38 pathway. Active Chp also triggers the formation of lamellipodia, albeit to a much lower efficiency than Rac1 or RhoG, whereas active Wrch elicits the formation of filopodia and promotes G1 to S phase progression of the cell cycle like many Rho GTPases do.69
Other Rho Members RhoH RhoH or TTF (translocation three four) was identified from the analysis of translocation breakpoint between chromosomes 3 and 4, associated with B-diffuse large cell non Hodgkin’s lymphomas.19 As a result of the translocation, the expression of the LAZ3/BCL6 transcription factor is driven by haemopoietic-specific RhoH promoting sequences. A second type of translocation involving RhoH and the immunoglobulin heavy chain locus was shown recently to be associated with multiple myeloma.70 The RhoH amino acid sequence shares 50-60% similarity with other Rho GTPases and is slightly closer to Chp, Wrch and Cdc42. RhoH homologues are only found in mouse databases (BF182503). No information is available on pathways controlled by RhoH.
RhoD and Rif RhoD and Rif are 210-211 aa in length and share 75% sequence similarity. Both proteins show a 15 aa NH2 terminal extension (with respect to e.g., RhoA) and share approximately
6
Rho GTPases
Figure 2. Different types of connections link Rho GTPases activities. Parallel connections: the input signal activates Rho regulators (RhoGEF or RhoGAP) that control several GTPases at once. This allows the simultaneous activation of multiple downstream targets. Series connections: the input signal activates a Rho regulator that controls one GTPase, which in turn initiates a second regulator/RhoGTPase activation. This allows the sequential activation of downstream targets. Redundancy: one particular target is activated by two or more distinct Rho GTPases. Thus, activation of either GTPase elicits identical cellular effects mediated by the common target.
65% similarity with all other Rho GTPases. Homologues of RhoD and Rif are found in pig and cow cDNA databases (BE235803/BE232109 and AW428134/AW652620, respectively). No matches have been hitherto detected in other vertebrate databases. Expression of active RhoD triggers the formation of peripheral extensions and a reduction in actin stress fibers.21 Interestingly, morphological changes are associated with a reduction of early endosome motil-
Signalling Networks of Rho GTPases
7
Table 1. Main biological features of mammalian Rho members mRNA Distribution
Protein Localization
Cytoskeletal Effects
Binding Targets
Downstream Rho req’d.
Activity Opposed with
Ubiq.123
PM, cytosol32,39
SF3
REM-1, RKH124
Rac178
Lung,125 neurons50 RhoC ND
Endosomes39
SF34
ND
PM, cytosol39
SF35
ND
ND
Rac1
Ubiq.11,87
PM, cytosol4
RhoA4
RhoA80,83
Rac2 Rac3
Hemopoietic11 Brain23,50
PM, cytosol 32 ND
lamellipodia, ruffles, SF4 ? filopodia ruffles51 filopodia, lammelipodia, SF5 filopodia56
REM-1, RKH124 REM-1, RKH124 CRIB, coiledcoil116,124 CRIB 124
Rac1, Cdc42, RhoG66,80 ND
ND ND
ND ND
CRIB116
Rac15
RhoA80
CRIB56
ND
ND
CRIB27
Rac1, Cdc4227 Rac1, Cdc4266 ND
ND
RhoA
RhoB
Cdc42 Ubiq.87
TC10
Heart, skeletal muscle56 Heart27
Endomembranes PM32 PM, vesicles56
Chp
Brain, testes25
PM, vesicles27 dorsal ruffles27 PM, ER, lamellipodia vesicles66 filopodia66 PM, Golgi25 lamellipodia25
Wrch RhoH RhoD Rif
Ubiq.26 Hemopoietic19 Ubiq.21 Ubiq.28
ND ND PM, vesicles21 PM28
TCL
RhoG Ubiq.18
filopodia26 ND filopodia21 filopodia28
Not CRIB66 Coiled-coil67 CRIB25 CRIB26 ND ND Not CRIB28
ND ND ND Independent of Rac1 and Cdc4228
RhoA66 ND ND ND RhoA71 ND
Abbreviations: Ubiq : ubiquitously expressed, PM: plasma membrane, ER: endoplasmic reticulum, SF: stress fibers, REM-1: Rho Effector Motif type I, RKH: Rho Kinase Homology, CRIB: Cdc42/Rac Interactive Binding. ND: not determined.
ity. However, no effect on endocytic trafficking was observed when wild-type or dominant negative RhoD were expressed. RhoD activation has also been reported to alter cell migration and cytokinesis.71 Here again, no effect was observed when the dominant negative mutant was expressed. Additional data are clearly needed to confirm RhoD cellular activities and to understand the underlying mechanisms. Like RhoD, Rif triggers the formation of filopodia-like extensions, all around the cell but also on the apical membrane, eliciting a «hairy» phenotype.28 Rif activity is lowered when NH2 tagged, suggesting that the N-terminal extension bears sequence determinants crucial for downstream signalling. Rif appears to shuttle between the plasma membrane, where the GTP bound form preferentially accumulates, and endosomes, when bound to GDP. RhoD and Rif mRNAs are ubiquitously expressed in human tissues, with higher levels in kidney, liver, intestine and lung for RhoD, and in colon, stomach and spleen for Rif.
8
Rho GTPases
Signalling Networks Controlled by Rho Proteins in Mammals As mentioned above, members of the Rho family have been shown to be inserted in a wide range of signalling pathways controlling basic cellular events as diverse as membrane protrusions, actin polymerization, kinase activation, gene transcription or protein targeting. Rho members have partially similar cellular activities, which indicate that i) different Rho GTPases can share one or several pathways in common, ii) several Rho GTPases can be coregulated and iii) Rho GTPases mutually influence their activities. Rho GTPases are therefore thought to be inserted in a global regulatory network in which positive and negative signals are transmitted through multiple parallel and series connections. Parallel connection implies that several GTPases can be controlled by the same regulators, while series connection implies that one GTPase can be controlled by another GTPase (Fig. 2). According to this scheme, different basic cellular events, each controlled by one Rho GTPase, would then be properly coordinated, thus allowing the establishment of more complex physiological processes. For example, the activities of Cdc42, Rac and Rho are coordinated during CSF-1-dependent macrophage chemotaxis (for a review, see ref 72): extensions controlled by Cdc42 are projected towards the CSF-1 gradient. This is associated with the formation of oriented lamellipodia and new adhesions to the extracellular matrix, controlled by Rac. Movement of the whole cell body requires intracellular tension, generated by Rho-dependent actomyosin contractility. Interestingly, in the same cell system, Cdc42, Rac and Rho activities are uncoupled during phagocytosis : only Rac and Cdc42 are necessary to extend membrane projections towards immunoglobulin-coated particles, while uptake of complement C3b-coated particles only requires Rho.73 In addition, Cdc42 but not Rac is necessary for Salmonella invasion of epithelial cells, an endocytic process comparable to phagocytosis.74 Thus, depending on the cell system and the physiological process, activities of Rho proteins can be interconnected according to different branching patterns.
Series Connections Most studies on Rho members have focused mainly on the control of cell morphology. As summarized in (Table 1), Rho GTPases basically elicit the formation of a limited number of cellular structures: stress fiber bundles (RhoA, B and C), lamellipodia and peripheral ruffles (Rac1 and Chp), dorsal ruffles (TCL), microspikes and filopodia - (Rac3, Cdc42, TC10, RhoD, Rif, Wrch, Rnd) or a mixed phenotype (lamellipodia and filopodia (RhoG). This opens the possibility that the cellular effects of a given GTPase are mediated by another GTPase acting downstream.
Positive Signalling Such linear cascades have been identified in fibroblastic cells. For example, Cdc42 elicits the formation of filopodia, followed by the formation of Rac-dependent lamellipodia.5 Similarly, Rnd promotes the formation of Rac-dependent neuritic processes in PC12 cells.75 Despite the high number of Rho GTPases that trigger formation of extensions at the cell periphery, little is known about functional crosstalk. Only Rif activity was shown to be independent of that of Cdc42 and Rac1.28 Another type of cascade is controlled by Rac1, which promotes membrane ruffling and threafter triggers stress fiber assembly through the activation of RhoA.4 Rac1-dependent activation of RhoA might be mediated by Ost, an exchange factor that binds to Rac1 but catalyzes GTP exchange on RhoA.76 The sequential activation of Rac1 and RhoA is also required for PIP5 kinase activation upon G-protein coupled receptor stimulation.77 Interestingly, a reverse cascade has been described in Ras-transformed Rat-1 cells, in which Rac activation by PI3-K requires Rho activity.78 Signalling cascades might also involve more than two GTPases : RhoG was found to activate independently the formation of Rac1-dependent lamellipodia and Cdc42-dependent filopodia and microvilli.66 This is also the case for TCL, whose activity is partially and differently inhibited by dominant negative Rac1 and Cdc42.27
Signalling Networks of Rho GTPases
9
Negative Signalling Although Rac1 or Rif can activate RhoA in particular cell systems, in most situations RhoA is opposed to many other Rho GTPases. In exponentially growing Swiss3T3, REF-52, MDCK or BHK cells, activation of Rac1, Cdc42, RhoG, TCL or Rnd trigger stress fiber disassembly.27,66,79-82 Conversely, RhoA inhibition mimics the cytoskeletal effects of active Rac1 and Cdc42. As shown in NIH3T3 fibroblasts, the antagonistic effects of RhoA and Rac1/Cdc42 correlate with changes in the levels of their GTP-bound forms, suggesting that the balance is mediated through downregulation of GEFs or activation of GAPs.83 A second level of control is potentially mediated by PAK, a target positively activated by at least Rac1 and Cdc42 and shown to inhibit myosin light chain kinase (MLCK) involved in stress fiber bundling and contraction.84 Rac1 and RhoA also have opposed effects in other physiological processes such as macrophage spreading,85 endothelial permeability86 or skeletal muscle differentiation.87 Antagonistic effects have also been evidenced in neuron cells, in which RhoA promotes neurite retraction whereas Rac1 elicits neurite outgrowth.88-90 Recent studies in integrated neuronal systems suggest that differences between RhoA, Rac1 and Cdc42 are not just opposed activities: Rac1 positively controls the level of branching of Xenopus optic tectal neurons and negatively controls axogenesis,91,92 whereas RhoA negatively controls branch extension but has no effect on branch addition or retraction.91 Similar specific activities of Rac1 and RhoA have also been reported in pyramidal neurons of rat hippocampal slice cultures.93 The antagonistic activities of RhoG and RhoA are mediated by at least two mechanisms. First, RhoG might counteract RhoA indirectly through downstream activation of Rac1 and Cdc42. In addition, RhoG and RhoA antagonism might be mediated by kinectin, which binds to RhoG and RhoA via two distinct domains.67 Kinectin overexpression triggers stress fiber disassembly in cells with intact microtubules whereas it triggers a dramatic stress fiber formation when microtubules are disrupted or when RhoG is inhibited. This suggests that kinectin can cooperate with RhoA in stress fiber formation.
Parallel Connections Concomitant activation or inhibition of different Rho activities is also mediated by RhoGEFs, RhoGAPs and RhoGDIs. As far as RhoGEFs are concerned, about 50 proteins can be identified in databases. In brief, RhoGEFs contain a Dbl-Homology (DH) domain usually associated with a Pleckstrin Homology (PH) domain (see Chapter 4). As shown for Dbl, Vav or p115, RhoGEFs are thought to be activated by phosphorylation or translocation upon extracellular stimuli, thereby converting the initial upstream signal into downstream Rho activation.94-100 Only few RhoGEFs have been examined for their exchange specificities and their activities were mostly assayed on RhoA, Rac1 and Cdc42 only. Some RhoGEFs seem to have a narrow specificity (e.g., Lbc, Lfc, GEF-H1, p190, p114 for RhoA, Tiam1 for Rac1, β-PIX for Cdc42), while others have a much broader specificity. This is the case for Dbl and Vav-2, which in vitro promote GTP exchange on at least Rac1, Cdc42, RhoG and RhoA.99,101,102 That Dbl acts on several GTPases was confirmed in vivo using focus formation assays, which showed that Dbl needs activation of at least RhoA, Rac1 and Cdc42 for establishing cell transformation.103 These GTPases are likely to be activated in parallel, since each of them shows low transforming activity whereas they efficiently cooperate in cell transformation.104 Contrarily to RhoGEFs, RhoGAPs downregulate Rho GTPases by enhancing their intrinsic GTPase activity, which favors the inactive GDP-bound form. Also here, at least 50 proteins containing a RhoGAP domain can be identified in databases (see Chapter 5). Most RhoGAPs analyzed so far appear to have a broad specificity, suggesting that RhoGAPs control several Rho-dependent pathways in parallel. Recent reports suggest that like RhoGEFs, the activities of RhoGAPs can be regulated by extracellular signalling.105,106 Parallel Rho regulation can also be achieved by multifunctional regulators such as Trio or Bcr/Abr. Trio contains two GEF domains, one acting on RhoG and Rac1, and the other on RhoA.107,108 Although is not known how the activities of both GEF domains are regulated,
10
Rho GTPases
Trio is crucial for developmental organization of neural tissues, which requires coordinated activities of RhoG, Rac1 and RhoA.109 Bcr/Abr contains a GEF domain, acting on Cdc42, Rac1 and RhoA, and a GAP domain, acting on Rac1 and Cdc42.110 As for Trio, how the activities of both Bcr domains are regulated remains to be characterized. RhoGDI proteins represent a last class of Rho regulators (see Chapter xx). RhoGDIs interfere with the actions of both RhoGEFs and RhoGAPs, and in addition can retrieve Rho GTPases from membranes. Three RhoGDIs have been identified, which act on several Rho GTPases and might therefore represent another regulatory level for controlling simultaneously several Rho-dependent pathways.
Redundancy Different Rho GTPases also elicit similar responses independently, which suggests partially redundant functions. For example, at least Rac1, Cdc42 and TC10 modulate the activity of c-Jun N-terminal Kinase (JNK), p38 or PAK,111,112 as well as the activation of the Serum Response Factor (SRF) and Nuclear Factor κB (NF-κB) transcription factors.60,113,114 A similar situation may hold for focal complexes controlled by Rac1 and Cdc42 and focal adhesions controlled by RhoA. Indeed, these focal structures are very similar in composition and differ mainly in size (for a review, see ref. 115). In most situations, functional redundancy between Rho GTPases is likely to rely on their ability to bind to identical targets. During the last decade, extensive search for Rho targets have allowed identification of numerous effectors of RhoA, Rac1, Cdc42 and TC10. No information is available yet for RhoD, Rif, RhoH, RhoBTBs. Most partners of Rac1 and Cdc42 contain a consensus Rho binding domain, termed CRIB domain.116 CRIB domain-containing proteins are also targets of TC10, TCL, Chp,25,27,56 but not RhoA, Rnd or Rif.28,82,116 CRIB-containing proteins are not targets of all Rac1/Cdc42 members, since RhoG does not bind CRIB motifs,66 and all CRIB proteins do not bind to GTPases with the same affinity. For example, WASP and ACK bind to Cdc42 preferentially,117,118 while PAK1 binds to Rac1, Cdc42 TC10 and TCL with similar apparent affinity. Another group of CRIB proteins termed binders of Rho GTPases (Borg) show preferential binding to Cdc42 and TC10 (and probably to TCL) with the same efficiency but not to Rac1.58 Two types of consensus Rho binding domains have been evidenced among the targets of RhoA : Rho effector motif (REM) and ROK Kinase Homology (RKH).119,120 Although poorly documented, both types of motifs also are likely to bind to RhoB and RhoC: for example, PRK-1 binds to RhoB,44 and p160ROCK binds to RhoB and RhoC (our unpublished results). This might explain the similar effects of RhoA, RhoB and RhoC on actin stress fiber assembly.34,35
Concluding Remarks Although the Rho family contains 21 members in mammals, most of the literature has focused on Rac1, Cdc42 and RhoA. This supported unambiguously the notion that Rho GTPases control many basic aspects of cell physiology (e.g., membrane activity, kinase activation or gene transcription) and cooperate in complex processes (e.g., motility, apoptosis, differentiation). However, we still do not know the full repertoire of basic functions of each of the GTPases. In addition, in many instances the precise relationship between the GTPases that underlies the orchestration of these complex functions remains to be defined. Several reasons account for this ambiguity:
Lack of Accuracy of Tools Used Most conclusions on the cellular functions of Rho GTPases are derived from expression of dominant active or dominant negative mutants. These mutants were first identified from studies on Ras proteins, then extended to Rho proteins. It is not totally clear whether Rho mutants behave as expected and several inconsistencies suggest that some of these might indeed gain new functions (for a review, see ref. 121). In many cases, convergent results using wild-type or
Signalling Networks of Rho GTPases
11
various other mutant proteins could help support the conclusions. Furthermore, given that different Rho members share identical regulators and targets, the expression of a particular mutant is likely to affect pathways controlled by other GTPases. For example, the widely used T17N dominant negative mutants, thought to exert their inhibitory effect by sequestering exchange factors, might inhibit several Rho GTPases simultaneously. This is particularly crucial for closely related GTPases. Indeed, cellular functions attributed for instance to Rac1 or RhoA might be mediated respectively by Rac3 or RhoC.
Fragmentary Data As mentioned above, most data accumulated on pathways controlled by Rho GTPases have focused on RhoA, Rac1 and Cdc42. This represents a clear limitation when specificities of regulators are addressed. Given the high number of potential RhoGEFs and RhoGAPs identified so far (more than fifty of each), high throughput techniques such as the Yeast Exchange Assay we developed recently are clearly needed.122 This is also the case for Rho targets, whose binding specificity remain to be fully analyzed.
Readout Inaccuracy Studies on cellular effects controlled by Rho GTPases have examined mostly changes in cell morphology. These latter fall into three main classes of cell structures : i) ruffles and peripheral lamellipodia, ii) microvilli and peripheral filopodia and iii) stress fibers. In general, these structures are described by low resolution parameters (e.g., presence or absence). It would be certainly valuable to increase the number of parameters which describe these cell structures. For example, the impact of Rho GTPases on the highly dynamic ruffles, lamellipodia and filopodia has been mostly examined on fixed cells. Extending the comparison between Rho GTPases by dynamic studies such as time-lapse videomicroscopy would thus be particularly informative. Many of these limitations will undoubtly be solved in the next few years and completed by gene inactivation studies in mice. This will give a better picture of the cellular functions of each member of the Rho family as well as their crosstalk in more complex processes, in particular cell motility, apoptosis and transformation.
Acknowledgments We wish to thank C. Gauthier-Rouvière for helpful discussions and constant support. This work was supported by institutional grants from the INSERM and the CNRS, and grants from the Ligue Nationale Contre le Cancer («Equipe Labellisée») and the Association pour la Recherche contre le Cancer (n°5284).
References 1. Chardin P, Boquet P, Madaule P et al. The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. Embo J 1989; 8(4):1087-1092. 2. Paterson HF, Self AJ, Garrett MD et al. Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol 1990; 111(3):1001-1007. 3. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70(3):389-399. 4. Ridley AJ, Paterson HF, Johnston CL et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992; 70(3):401-410. 5. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81(1):53-62. 6. Madaule P, Axel R. A novel ras-related gene family. Cell 1985; 41(1):31-40 7. Madaule P, Axel R, Myers AM. Characterization of two members of the rho gene family from the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1987; 84(3):779-783. 8. Chardin P, Madaule P, Tavitian A. Coding sequence of human rho cDNAs clone 6 and clone 9. Nucleic Acids Res 1988; 16(6):2717. 9. Yeramian P, Chardin P, Madaule P et al. Nucleotide sequence of human rho cDNA clone 12. Nucleic Acids Res 1987; 15(4):1869.
12
Rho GTPases
10. Avraham H, Weinberg RA. Characterization and expression of the human rhoH12 gene product. Mol Cell Biol 1989; 9(5):2058-2066. 11. Didsbury J, Weber RF, Bokoch GM et al. Rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem 1989; 264(28):16378-16382. 12. Menard L, Tomhave E, Casey PJ et al. Rac1, a low-molecular-mass GTP-binding-protein with high intrinsic GTPase activity and distinct biochemical properties. Eur J Biochem 1992; 206(2):537-546. 13. Johnson DI, Pringle JR. Molecular characterization of CDC42, a Saccharomyces cerevisiae gene involved in the development of cell polarity. J Cell Biol 1990; 111(1):143-152. 14. Munemitsu S, Innis MA, Clark R et al. Molecular cloning and expression of a G25K cDNA, the human homolog of the yeast cell cycle gene CDC42. Mol Cell Biol 1990; 10(11):5977-5982. 15. Shinjo K, Koland JG, Hart MJ et al. Molecular cloning of the gene for the human placental GTP-binding protein Gp (G25K): Identification of this GTP-binding protein as the human homolog of the yeast cell-division-cycle protein CDC42. Proc Natl Acad Sci USA 1990; 87(24):9853-9857. 16. Touchot N, Chardin P, Tavitian A. Four additional members of the ras gene superfamily isolated by an oligonucleotide strategy: Molecular cloning of YPT-related cDNAs from a rat brain library. Proc Natl Acad Sci USA 1987; 84(23):8210-8214. 17. Drivas GT, Shih A, Coutavas E et al. Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line. Mol Cell Biol 1990; 10(4):1793-1798. 18. Vincent S, Jeanteur P, Fort P. Growth-regulated expression of rhoG, a new member of the ras homolog gene family. Mol Cell Biol 1992; 12(7):3138-3148. 19. Dallery E, Galiegue-Zouitina S, Collyn-d’Hooghe M et al. TTF, a gene encoding a novel small G protein, fuses to the lymphoma- associated LAZ3 gene by t(3;4) chromosomal translocation. Oncogene 1995; 10(11):2171-2178. 20. Chavrier P, Simons K, Zerial M. The complexity of the Rab and Rho GTP-binding protein subfamilies revealed by a PCR cloning approach. Gene 1992; 112(2):261-264. 21. Murphy C, Saffrich R, Grummt M et al. Endosome dynamics regulated by a Rho protein. Nature 1996; 384(6608):427-432. 22. Courjal F, Chuchana P, Theillet C et al. Structure and chromosomal assignment to 22q12 and 17qter of the ras- related Rac2 and Rac3 human genes. Genomics 1997; 44(2):242-246. 23. Haataja L, Groffen J, Heisterkamp N. Characterization of RAC3, a novel member of the Rho family. J Biol Chem 1997; 272(33):20384-20388. 24. Nobes CD, Lauritzen I, Mattei MG et al. A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J Cell Biol 1998; 141(1):187-197. 25. Aronheim A, Broder YC, Cohen A et al. Chp, a homologue of the GTPase Cdc42Hs, activates the JNK pathway and is implicated in reorganizing the actin cytoskeleton. Curr Biol 1998; 8(20):1125-1128. 26. Tao W, Pennica D, Xu L et al. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt- 1. Genes Dev 2001; 15(14):1796-1807. 27. Vignal E, De Toledo M, Comunale F et al. Characterization of TCL, a new GTPase of the rho family related to TC10 andCcdc42. J Biol Chem 2000; 275(46):36457-36464. 28. Ellis S, Mellor H. The novel Rho-family GTPase rif regulates coordinated actin-based membrane rearrangements. Curr Biol 2000; 10(21):1387-1390. 29. Rivero F, Dislich H, Glockner G et al. The Dictyostelium discoideum family of Rho-related proteins. Nucleic Acids Res 2001; 29(5):1068-1079. 30. Gulli MP, Peter M. Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: the yeast perspective. Genes Dev 2001; 15(4):365-379. 31. Valster AH, Hepler PK, Chernoff J. Plant GTPases: The Rhos in bloom. Trends Cell Biol 2000; 10(4):141-146. 32. Michaelson D, Silletti J, Murphy G et al. Differential localization of Rho GTPases in live cells: Regulation by hypervariable regions and RhoGDI binding. J Cell Biol 2001; 152(1):111-126. 33. Aktories K, Mohr C, Koch G. Clostridium botulinum C3 ADP-ribosyltransferase. Curr Top Microbiol Immunol 1992; 175:115-131. 34. Allel C. Personal communication. 35. van Golen KL, Wu ZF, Qiao XT et al. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 2000; 60(20):5832-5838. 36. Jahner D, Hunter T. The ras-related gene rhoB is an immediate-early gene inducible by v- Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts. Mol Cell Biol 1991; 11(7):3682-3690.
Signalling Networks of Rho GTPases
13
37. de Cremoux P, Gauville C, Closson V et al. EGF modulation of the ras-related rhoB gene expression in human breast- cancer cell lines. Int J Cancer 1994; 59(3):408-415. 38. Fritz G, Kaina B, Aktories K. The ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments. J Biol Chem 1995; 270(42):25172-25177. 39. Adamson P, Paterson HF, Hall A. Intracellular localization of the P21rho proteins. J Cell Biol 1992; 119(3):617-627. 40. Zalcman G, Closson V, Linares-Cruz G et al. Regulation of Ras-related RhoB protein expression during the cell cycle. Oncogene 1995; 10(10):1935-1945. 41. Engel ME, Datta PK, Moses HL. RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation. J Biol Chem 1998; 273(16):9921-9926. 42. Lebowitz PF, Du W, Prendergast GC. Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription. J Biol Chem 1997; 272(26):16093-16095. 43. Lebowitz PF, Prendergast GC. Functional interaction between RhoB and the transcription factor DB1. Cell Adhes Commun 1998; 6(4):277-287. 44. Mellor H, Flynn P, Nobes CD et al. PRK1 is targeted to endosomes by the small GTPase, RhoB. J Biol Chem 1998; 273(9):4811-4814. 45. Gampel A, Parker PJ, Mellor H. Regulation of epidermal growth factor receptor traffic by the small GTPase rhoB. Curr Biol 1999; 9(17):955-958. 46. Armstrong SA, Hannah VC, Goldstein JL et al. CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB. J Biol Chem 1995; 270(14):7864-7868. 47. Du W, Lebowitz PF, Prendergast GC. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol Cell Biol 1999; 19(3):1831-1840. 48. Clark EA, Golub TR, Lander ES et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000; 406(6795):532-535. 49. Suwa H, Ohshio G, Imamura T et al. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 1998; 77(1):147-152. 50. Malosio ML, Gilardelli D, Paris S et al. Differential expression of distinct members of Rho family GTP-binding proteins during neuronal development: Identification of Rac1B, a new neural-specific member of the family. J Neurosci 1997; 17(17):6717-6728. 51. Albertinazzi C, Gilardelli D, Paris S et al. Overexpression of a neural-specific rho family GTPase, cRac1B, selectively induces enhanced neuritogenesis and neurite branching in primary neurons. J Cell Biol 1998; 142(3):815-825. 52. Mira JP, Benard V, Groffen J et al. Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci USA 2000; 97(1):185-189. 53. Jordan P, Brazao R, Boavida MG et al. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 1999; 18(48):6835-6839. 54. Schnelzer A, Prechtel D, Knaus U et al. Rac1 in human breast cancer: Overexpression, mutation analysis and characterization of a new isoform, Rac1b. Oncogene 2000; 19(26):3013-3020. 55. Marks PW, Kwiatkowski DJ. Genomic organization and chromosomal location of murine Cdc42. Genomics 1996; 38(1):13-18. 56. Neudauer CL, Joberty G, Tatsis N et al. Distinct cellular effects and interactions of the Rho-family GTPase TC10. Curr Biol 1998; 8(21):1151-1160. 57. Murphy GA, Solski PA, Jillian SA et al. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth. Oncogene 1999; 18(26):3831-3845. 58. Joberty G, Perlungher RR, Macara IG. The Borgs, a new family of Cdc42 and TC10 GTPase-interacting proteins. Mol Cell Biol 1999; 19(10):6585-6597. 59. Neudauer CL, Joberty G, Macara IG. PIST: A novel PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10. Biochem Biophys Res Commun 2001; 280(2):541-547. 60. Murphy GA, Jillian SA, Michaelson D et al. Signalling mediated by the closely related mammalian Rho family GTPases TC10 and Cdc42 suggests distinct functional pathways. Cell Growth Differ 2001; 12(3):157-167. 61. Tanabe K, Tachibana T, Yamashita T et al. The small GTP-binding protein TC10 promotes nerve elongation in neuronal cells, and its expression is induced during nerve regeneration in rats. J Neurosci 2000; 20(11):4138-4144. 62. Imagawa M, Tsuchiya T, Nishihara T. Identification of inducible genes at the early stage of adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 1999; 254(2):299-305. 63. Chiang SH, Baumann CA, Kanzaki M et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001; 410(6831):944-948.
14
Rho GTPases
64. Zipkin ID, Kindt RM, Kenyon CJ. Role of a new Rho family member in cell migration and axon guidance in C. elegans. Cell 1997; 90(5):883-894. 65. Roux P, Gauthier- Rouvière C, Doucet-Brutin S et al. The small GTPases Cdc42Hs, rac1 and RhoG delineate raf-independent pathways that cooperate to transform NIH3T3 cells. Curr Biol 1997; 7(9):629-637. 66. Gauthier-Rouvière C, Vignal E, Mériane M et al. RhoG GTPase controls a pathway that independently activates Rac1 and Cdc42Hs. Mol Biol Cell 1998; 9(6):1379-1394. 67. Vignal E, Blangy A, Martin M et al. Kinectin is a key effector of microtubule-dependent RhoG activity. Mol Cell Biol. In press. 68. Katoh H, Yasui H, Yamaguchi Y et al. Small GTPase RhoG is a key regulator for neurite outgrowth in PC12 cells. Mol Cell Biol 2000; 20(19):7378-7387. 69. Olson MF, Ashworth A, Hall A. An essential role for rho, rac, and cdc42 GTPases in cell cycle progression through G1. Science 1995; 269(5228):1270-1272. 70. Preudhomme C, Roumier C, Hildebrand MP et al. Nonrandom 4p13 rearrangements of the RhoH/ TTF gene, encoding a GTP- binding protein, in nonHodgkin’s lymphoma and multiple myeloma. Oncogene 2000; 19(16):2023-2032. 71. Tsubakimoto K, Matsumoto K, Abe H et al. Small GTPase RhoD suppresses cell migration and cytokinesis. Oncogene 1999; 18(15):2431-2440. 72. Ridley AJ. Rho proteins, PI 3-kinases, and monocyte/macrophage motility. FEBS Lett 2001; 498:168-171. 73. Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998; 282(5394):1717-1721. 74. Chen LM, Hobbie S, Galan JE. Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses. Science 1996; 274(5295):2115-2118. 75. Aoki J, Katoh H, Mori K et al. Rnd1, a novel rho family GTPase, induces the formation of neuritic processes in PC12 cells. Biochem Biophys Res Commun 2000; 278(3):604-608. 76. Horii Y, Beeler JF, Sakaguchi K et al. A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signalling pathways. EMBO J 1994; 13(20):4776-4786. 77. Chatah NE, Abrams CS. G-protein coupled receptor activation induces the membrane translocation and activation of PIP5K Ia by a RAC and RHO-dependent pathway. J Biol Chem 2001; 28:28. 78. Tang Y, Yu J, Field J. Signals from the Ras, Rac and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts. Mol Cell Biol 1999; 19(3):1881-1891. 79. Kozma R, Ahmed S, Best A et al. The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol Cell Biol 1995; 15(4):1942-1952. 80. Moorman JP, Luu D, Wickham J et al. A balance of signalling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival. Oncogene 1999; 18(1):47-57. 81. Zondag GC, Evers EE, ten Klooster JP et al. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J Cell Biol 2000; 149(4):775-782. 82. Chardin P. Rnd proteins: A new family of Rho-related proteins that interfere with the assembly of filamentous actin structures and cell adhesion. Prog Mol Subcell Biol 1999; 22:39-50. 83. Sander EE, ten Klooster JP, van Delft S et al. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 1999; 147(5):1009-1022. 84. Sanders LC, Matsumura F, Bokoch GM et al. Inhibition of myosin light chain kinase by p21-activated kinase. Science 1999; 283(5410):2083-2085. 85. Ory S, Munari-Silem Y, Fort P et al. Rho and Rac exert antagonistic functions on spreading of macrophage- derived multinucleated cells and are not required for actin fiber formation. J Cell Sci 2000; 113(Pt 7):1177-1188. 86. Wojciak-Stothard B, Potempa S, Eichholtz T et al. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 2001; 114(Pt 7):1343-1355. 87. Meriane M, Roux P, Primig M et al. Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: Antagonistic effects of JNK and p38 pathways. Mol Biol Cell 2000; 11(8):2513-2528. 88. Kozma R, Sarner S, Ahmed S et al. Rho family GTPases and neuronal growth cone remodelling: Relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid. Mol Cell Biol 1997; 17(3):1201-1211.
Signalling Networks of Rho GTPases
15
89. Leeuwen FN, Kain HE, Kammen RA et al. The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; Opposing roles for the small GTPases Rac and Rho. J Cell Biol 1997; 139(3):797-807. 90. Yamaguchi Y, Katoh H, Yasui H et al. RhoA Inhibits the Nerve Growth Factor-induced Rac1 Activation through Rho-associated Kinase-dependent Pathway. J Biol Chem 2001; 276(22):18977-18983. 91. Li Z, Van Aelst L, Cline HT. Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo. Nat Neurosci 2000; 3(3):217-225. 92. Ruchhoeft ML, Ohnuma S, McNeill L et al. The neuronal architecture of Xenopus retinal ganglion cells is sculpted by rho-family GTPases in vivo. J Neurosci 1999; 19(19):8454-8463. 93. Nakayama AY, Harms MB, Luo L. Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons. J Neurosci 2000; 20(14):5329-5338. 94. Kozasa T. Regulation of G protein-mediated signal transduction by RGS proteins. Life Sci 2001; 68(19-20):2309-2317. 95. Zhu K, Debreceni B, Bi F et al. Oligomerization of DH domain is essential for Dbl-induced transformation. Mol Cell Biol 2001; 21(2):425-437. 96. Hart MJ, Roscoe W, Bollag G. Activation of Rho GEF activity by G alpha 13. Methods Enzymol 2000; 325:61-71 97. Kato J, Kaziro Y, Satoh T. Activation of the guanine nucleotide exchange factor Dbl following ACK1- dependent tyrosine phosphorylation. Biochem Biophys Res Commun 2000; 268(1):141-147. 98. Majumdar M, Seasholtz TM, Buckmaster C et al. A rho exchange factor mediates thrombin and Galpha(12)-induced cytoskeletal responses. J Biol Chem 1999; 274(38):26815-26821. 99. Schuebel KE, Movilla N, Rosa JL et al. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. Embo J 1998; 17(22):6608-6621. 100. Bustelo XR. Regulatory and Signalling Properties of the Vav Family. Mol Cell Biol 2000; 20:1461-1477. 101. Yaku H, Sasaki T, Takai Y. The Dbl oncogene product as a GDP/GTP exchange protein for the Rho family: Its properties in comparison with those of Smg GDS. Biochem Biophys Res Commun 1994; 198(2):811-817. 102. Abe K, Rossman KL, Liu B et al. Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem 2000; 275(14):10141-10149. 103. Lin R, Cerione RA, Manor D. Specific contributions of the small GTPases Rho, Rac, and Cdc42 to Dbl transformation. J Biol Chem 1999; 274(33):23633-23641. 104. Fort P. Small GTPases of the Rho family and cell transformation. Prog Mol Subcell Biol 1999; 22:159-181. 105. Fincham VJ, Chudleigh A, Frame MC. Regulation of p190 Rho-GAP by v-Src is linked to cytoskeletal disruption during transformation. J Cell Sci 1999; 112(Pt 6):947-956. 106. Ren XR, Du QS, Huang YZ et al. Regulation of CDC42 GTPase by proline-rich tyrosine kinase 2 interacting with PSGAP, a novel pleckstrin homology and Src homology 3 domain containing rhoGAP protein. J Cell Biol 2001; 152(5):971-984. 107. Bellanger JM, Lazaro JB, Diriong S et al. The two guanine nucleotide exchange factor domains of Trio link the Rac1 and the RhoA pathways in vivo. Oncogene 1998; 16(2):147-152. 108. Blangy A, Vignal E, Schmidt S et al. TrioGEF1 controls Rac- and Cdc42-dependent cell structures through the direct activation of RhoG. J Cell Sci 2000; 113:729-739. 109. O’Brien SP, Seipel K, Medley QG et al. Skeletal muscle deformity and neuronal disorder in Trio exchange factor- deficient mouse embryos. Proc Natl Acad Sci USA 2000; 97(22):12074-12078. 110. Chuang TH, Xu X, Kaartinen V et al. Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. Proc Natl Acad Sci USA 1995; 92(22):10282-10286. 111. Manser E, Leung T, Salihuddin H et al. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994; 367(6458):40-46. 112. Minden A, Lin A, McMahon M et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994; 266(5191):1719-1723. 113. Hill CS, Wynne J, Treisman R. The rho family GTPases RhoA, rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 1995; 81(7):1159-1170. 114. Perona R, Montaner S, Saniger L et al. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev 1997; 11(4):463-475. 115. Schwartz MA, Shattil SJ. Signalling networks linking integrins and rho family GTPases. Trends Biochem Sci 2000; 25(8):388-391. 116. Burbelo PD, Drechsel D, Hall A. A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J Biol Chem 1995; 270(49):29071-29074.
16
Rho GTPases
117. Symons M, Derry JM, Karlak B et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 1996; 84(5):723-734. 118. Manser E, Leung T, Salihuddin H et al. A nonreceptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature 1993; 363(6427):364-367. 119. Reid T, Furuyashiki T, Ishizaki T et al. Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J Biol Chem 1996; 71(23):13556-13560. 120. Leung T, Chen XQ, Manser E et al. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 1996; 16(10):5313-5327. 121. Symons M, Settleman J. Rho family GTPases: More than simple switches. Trends Cell Biol 2000; 10(10):415-419. 122. De Toledo M, Colombo K, Nagase T et al. The yeast exchange assay, a new complementary method to screen for Dbl- like protein specificity: Identification of a novel RhoA exchange factor. FEBS Lett 2000; 480(2-3):287-292. 123. Moscow JA, He R, Gnarra JR et al. Examination of human tumors for rhoA mutations. Oncogene 1994; 9(1):189-194. 124. Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J 2000; 348:241-255. 125. Fritz G, Gnad R, Kaina B. Cell and tissue-type specific expression of Ras-related GTPase RhoB. Anticancer Res 1999; 19(3A):1681-1688.
CHAPTER 2
Intracellular Targeting of Rho Family GTPases: Implications of Localization on Function David Michaelson, Mark Rush and Mark R. Philips
Rho Proteins—Diverse Functions Despite Sequence Homology
R
ho proteins are Ras-related GTPases that regulate a wide variety of cellular processes. More than fifteen mammalian Rho proteins have been described including RhoA-E, G and H, Rac1-3, two isoforms of Cdc42hs, and TC10. Originally identified based on their sequence homology to Ras, a great deal of interest in Rho proteins was awakened when Ridley and Hall discovered that RhoA, Rac1 and Cdc42hs differentially regulate the actin cytoskeleton.1-3 Subsequently it was found that Rho family GTPases were also involved in signalling pathways, including the JNK/stress-activated protein kinase4,5 and p38 6 MAP kinase cascades and the serum response factor pathway7 that lead to transcriptional activation. Moreover, Ras-mediated cellular transformation is dependent on Rho GTPases.8 Other cellular processes regulated by Rho GTPases include the phagocyte NADPH oxidase, 9,10 insulin-stimulated recruitment of the GLUT4 glucose transporter to the plasma membrane,11,12 macrophage phagocytosis,13 endocytosis,14-16 epithelial cell polarization,17 and morphogenesis.18 The diversity of functions among Rho proteins belies the extensive sequence homology found among them (Fig. 1). The majority of the amino acid sequences of the Rho proteins are conserved, including those found in the GTP binding domains and the effector loops, giving an overall amino acid identity among family members of 50% or greater with further sequence similarities. Many of the amino acid differences among the Rho proteins occur within the C-terminal 20 amino acids, the so-called hypervariable region. In fact, some Rho proteins are virtually identical except for their hypervariable regions (e.g., Rac 1, 2 and 3; Rho A and B; the two isoforms of Cdc42hs). This region is involved neither in the GTPase activity of Rho proteins nor in the interaction of Rho GTPases with effectors, but it plays a critical role in localization (see below). Of all the various protein-protein interactions in which Rho proteins engage, only the interaction with GDP Dissociation Inhibitors (GDIs) has been found to involve amino acids in the hypervariable region.19 The Guanine nucleotide Exchange Factor (GEF), GTPase Activating Protein (GAP) and effector interactions of Rho proteins depend primarily on sequences outside of the hypervariable region where sequence homology is quite high. As expected, this leads to considerable, though not complete, overlap of affinities shown by Rho proteins for GEFs, GAPs and effectors.20 For example, many Dbl-related GEFs interact with multiple Rho proteins (reviewed in21,22). Similarly, p50RhoGAP has GAP activity for TC10 and Cdc42hs, and somewhat lower activity for RhoA and Rac1.23,24 Among effectors, PAK1-3 interact with Rac1, TC10 and Cdc42hs,24,25 while MLK3 interacts with Rac1 and Cdc42hs, but not TC10.24,26 RhoA and Rac1 also share Rho GTPases, edited by Marc Symons. ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers.
18
Rho GTPases
Figure 1. Alignment of Rho family amino acid sequences. Amino acid sequences of Rho proteins were aligned using the CLUSTAL method with MacVector software. The resulting consensus sequence is shown beneath the protein sequences. Dark grey boxed residues show regions of high sequence identity among Rho proteins. Light grey boxed residues show regions of sequence similarity. The hypervariable region is underscored with a magenta box. The CAAX motif is underscored with a cyan box.
Intracellular Targeting of Rho Family GTPases
19
Figure 2. Posttranslational modifications of the CAAX motif. CAAX motif processing proceeds in three enzymatic steps: 1) addition of the prenyl group by one of two prenyltransferases (geranylgeranylation is shown), 2) proteolysis of the terminal AAX tripeptide, and 3) methyl esterification of the new C-terminal α carboxyl group by prenylcysteine carboxylmethyltransferase (pcCMT).
effectors such as Citron kinase.27 Given their strong sequence homology and the resulting overlap of protein-protein interactions, how does activation of a specific Rho protein regulate a specific pathway? Some explanation for the diverse functions of Rho family proteins may indeed be based on differences in affinities for GEFs, GAPs and effectors due to subtle differences in the amino acid sequences of the GTPases. However, the considerable sequence divergence within the hypervariable region suggests that at least some of the diversity in function is due to diversity of sequence within this region. What effect does the hypervariable region have on Rho family proteins?
Targeting Motifs—Location, Location, Location Like Ras proteins and G protein γ subunits, Rho GTPases are synthesized as cytosolic proteins that acquire the capacity to associate with membranes by virtue of a series of posttranslational modifications. These modifications occur at the C-terminal CAAX motif and include prenylation, proteolysis, and carboxyl methylation (Fig. 2 and ref. 28). These modifications render the otherwise hydrophilic molecule hydrophobic at its C-terminus, allowing interaction with membrane. The CAAX motif signals for prenylation which in turn targets the protein to the ER where it encounters the RCE1 protease29 and the prenylcysteine carboxyl methyltransferase (pcCMT). 30 In the case of Ras proteins, localization beyond the endomembrane requires a second targeting signal that lies adjacent to the CAAX motif and consists of either cysteines that are sites of palmitoylation (N-Ras and H-Ras), or a polybasic region (K-Ras4B). Whereas N-Ras and H-Ras then traffic to the plasma membrane (PM) on
20
Rho GTPases
Figure 3. Classification of Ras and Rho family hypervariable regions. The hypervariable regions of Ras and Rho family proteins are divided into four classes based on their amino acid sequence immediately upstream of the CAAX motif (underlined). Class I proteins have a hypervariable region with 6 or more positively charged residues (bold) adjacent to the CAAX motif. Class II proteins have one or two palmitoylated cysteine residues (outlined). Class I/II proteins also have one or two palmitoylated cysteines adjacent to the CAAX motif as well as several positively charged residues near the palmitoylation sites and thus are hybrids of the Class I and Class II hypervariable regions. Class III proteins have weakly basic hypervariable domains (less than 6 positive residues adjacent to the CAAX motif ) which in the case of Cdc42 isoforms are neutralized by adjacent acidic residues (shown in grey).
Intracellular Targeting of Rho Family GTPases
21
Figure 4. Localization of GFP-tagged full length Ras and Rho proteins in live MDCK cells. The Ras and Rho family proteins are also divided into four classes based on their intracellular localization. The classes defined in (Fig. 3) based on sequence similarity within the hypervariable region match well with the classes shown here based on localization. A.) Class I proteins, with strongly basic hypervariable domains, are expressed almost exclusively on PM. B.) Class II, palmitoylated proteins are found on PM and Golgi. C.) Class I/II proteins, with both palmitoylation and basic residues, localize on PM and on vesicles that colocalize with internalized transferrin. D.) Class III proteins, which have weakly basic or neutral hypervariable domains and no palmitoylation sites, localize like GFP-CAAX, on ER and Golgi. Note the single exception of RhoA. Bars indicate 10 µM.
22
Rho GTPases
Figure 5. Localization of Rac Isoforms: correlation of PM localization with positive charge of hypervariable region. The localization of Rac1, 2 and 3 in living MDCK cells are shown to indicate that as the positive charge of the hypervariable region increases, the proportion of protein found in the PM also increases. This shows the distinction between Class I and Class III GTPases as a continuum. Bars indicate 10 µM.
the cytoplasmic face of secretory granules via the Golgi, K-Ras4B takes an alternative, as yet uncharacterized path that displays faster kinetics and is unaffected by inhibitors of the secretory pathway.31,32 This simple dichotomy of Ras targeting mechanisms is also seen among Rho proteins, though a greater variety of sequence within the hypervariable region leads to a greater diversity of membrane localization patterns. Using subcellular fractionation and indirect immunofluorescence, Rho proteins have been localized in cytosol,9,10,33 PM,34 including cholesterol-rich microdomains,12,35 subplasmalemmal actin mesh,36 Golgi,37 endosomes,33,38 multivesicular bodies,36 and nuclei.39 The membrane localization of many Rho family proteins is further complicated by the ability of GDIs to bind and sequester them in the cytosol prior to activation.40-42 Indeed, upon activation, Rho proteins have been shown to translocate from cytosol to membranes.34,43-46 A comparison of hypervariable region sequences of the Ras and Rho family proteins reveals at least four different classes of hypervariable regions (Fig. 3). K-Ras4B, RhoC and Rac1 all have polybasic domains consisting of six or more positively charged residues in close proximity to the CAAX motif. We refer to this as a Class I hypervariable region. H-Ras, N-Ras (not shown) and RhoB all have one or two palmitoylated Cys residues adjacent to the CAAX. We refer to this as a Class II hypervariable region. TC10 has six basic residues just upstream of two palmitoylated Cys residues that are, in turn, immediately upstream of the CAAX motif. We refer to this as a ClassI/II hybrid hypervariable region. TC10 is the only GTPase yet described that has two second signals adjacent to the ER-targeting CAAX motif. RhoD, however, has four positive residues followed by a single palmitoylated cysteine. We tentatively also classify this as a ClassI/II hypervariable region. Finally, Rac2, Rac3, RhoA and Cdc42hs have weak polybasic domains or no obvious second signal at all. This kind of hypervariable region, which we refer to as Class III, would be predicted to target proteins in a manner similar to a CAAX motif alone, predominantly to ER and Golgi. When a hypervariable domain of a Rho protein is fused to the C-terminus of the normally cytosolic green fluorescent protein (GFP), it is sufficient to direct targeting of the fusion protein to membranes (see below). Interestingly, the four classes of hypervariable regions defined above, when fused to the C-terminus of GFP, result in four distinct patterns of membrane localization.42 Thus, the sequence differences within the hypervariable domains can be used to reliably predict the fusion protein’s ultimate subcellular destination. When GFP is fused to the N-terminus of a full length Rho protein the situation is more complicated due to the affinity of most Rho proteins for RhoGDIα, a unbiquitously expressed
Intracellular Targeting of Rho Family GTPases
23
isoform of GDI. At lower levels of expression there is enough endogenous RhoGDIα present in the cell to sequester the GFP-tagged Rho protein in the cytosol. However, at higher levels of expression, membrane localization is dominant since in many cell types the cellular level of endogenous RhoGDIα is equal to the combined levels of endogenous Rho proteins.42 Thus when GFP fused to a full length Rho protein is expressed in live cells at levels sufficient to overwhelm endogenous RhoGDIα, the pattern of membrane localization is similar to that seen with the hypervariable domains alone (see below). As can be seen in (Fig. 4A), GFP fused to full length GTPases with a Class I hypervariable region has a prominent PM localization. In many cell types, GFP fused to either K-Ras4B or Rac1 give indistinguishable localization patterns with predominantly PM fluorescence. This localization of Rac1 determined by tracking the GFP-fused protein is consistent with earlier studies of Rac1 localization. Endogenous Rac1 has been localized by cell fractionation to both cytosol and crude membranes34,35 and has been shown to translocate from cytosol to membranes in response to PDGF.43 Furthermore, indirect immunofluorescence of myc-tagged Rac1V12, a constitutively active mutant of Rac1, shows expression on PM.47 GFP fused to full length GTPases with a Class II hypervariable region localizes in a manner distinct from the predominantly PM localization seen for Class I hypervariable domains. Figure 4B shows that Class II hypervariable region GTPases localize to both PM and Golgi. The perinuclear fluorescence seen with GFP-H-Ras, -N-Ras (not shown) and -RhoB all colocalize with a variety of Golgi-specific markers.32,42 Endogenous RhoB, as well as RhoD, has been previously localized, using indirect immunoflourescence after Triton X-100 permeablization, to endosomes. Colocalization with endosomal markers was extensive for RhoD38 but only partial for RhoB.33 We found that vesicular localization of endogenous RhoB was highly dependent on fixation and permeablization conditions. When saponin was used instead of Triton X-100 to permeablize cells, endogenous RhoB colocalized precisely with Manosidase II, a Golgi marker. This endogenous localization for RhoB in saponin permeablized cells was identical to that of GFP-RhoB seen in live, unfixed cells.42 Interestingly, in saponin permeablized cells RhoD colocalized precisely with internalized transferrin, an endosomal marker38 while RhoB did not. 42 The stronger colocalization of RhoD with endosomal markers under both permeablization conditions, combined with the Golgi localization of RhoB in saponin permeablized cells and of GFP-RhoB in live cells, together suggest that RhoB, like H- and N-Ras, localizes primarily to PM and Golgi and does not localize strongly to endosomes. In contrast, GFP fused to full length TC10 with a Class I/II hybrid hypervariable region localizes to both PM and distinct cytoplasmic, often perinuclear, vesicles that do not colocalize with Golgi markers (Fig. 4C). Instead, these vesicles colocalize with endosomal markers such as internalized Texas-red conjugated transferrin in live cells and the endosomal/lysosomal marker LAMP in fixed cells.42 Interestingly, RhoD has a similar endosomal localization as TC10 38 and, as shown in (Fig. 3), it also has several basic residues upstream of a palmitoylation site near the CAAX motif. The similarity in localization on endosomes suggests that the Class I/II dual second signal may function in localizing both RhoD and TC10. Finally, as expected if CAAX processing alone directs localization, the full length Class III GTPases Rac2 and both the brain and placental isoforms of Cdc42hs (bCdc42 and pCdc42, respectively) are predominantly localized on ER and Golgi (Fig. 4D). Although some GFP-Rac2 and GFP-Cdc42hs localize on PM in some cells, it is always to a lesser extent than their endomembrane localization. This shows that the Class III hypervariable region is inefficient at localizing proteins to PM. Cell fractionation studies have shown that endogenous Cdc42hs localizes to both the cytosol and membrane pellet34,48,49 while indirect immunofluorescence has localized it to Golgi.37 The localization of GFP-pCdc42hs in live cells to ER and nuclear envelope in addition to Golgi demonstrates the superior sensitivity of imaging in live cells. Golgi localization is consistent with the recent observation that Cdc42hs binds the γ-subunit (γCOP) of a coatomer complex50 since γCOP also localizes to the Golgi.
24
Rho GTPases
Figure 6. Localization of most Rho GTPases is determined by the hypervariable region. A) Comparision between the localizations of GFP fused to the hypervariable regions of Cdc42hs or Rac1, or to the respective full length proteins indicates that the hypervariable region contains all of the membrane targeting signals for these proteins. RhoA is an exception wherein the full length protein has additional information that leads to cytosolic localization. B) Repalcement of the TC10 hypervariable region with that of pCdc42hs (left panel) targets the hybrid protein to the same membranes as pCdc42hs itself, again indicating that the hypervariable domain contains the targeting signals. Localization of full length TC10 is shown in the right panel for comparison. Bars indicate 10 µM.
Intracellular Targeting of Rho Family GTPases
25
In neutrophils Rac2 regulates assembly of the NADPH oxidase that is essential for host defense. In resting cells Rac2 is in the cytosol in a 1:1 complex with RhoGDIα.10 Upon activation in vitro,46 and upon activation of neutroplasts,51 Rac2 translocates to a membrane fraction that has been interpreted as PM. However, a method for separating PM from other light membranes by fractionation of neutrophils has not been developed. Given the predominantly endomembrane localization of GFP-Rac2 expressed in excess of RhoGDIα, this will have to be reevaluated. The NADPH oxidase is thought to be assembled in vivo on phagosome membranes, derived from PM. However, given the diffusing capacity of reactive oxygen species, assembly on endomembrane may be effective. Comparison of the localization of GFP-Rac1, 2 and 3 reveals an interesting trend (Fig. 5 and Chan, et. al., manuscript in press). The hypervariable domains of these proteins vary in terms of their positive charge, from Rac2 (+3) to Rac1 (+6) with Rac3 (+4) being intermediate between the two. GFP-Rac2 localizes almost exclusively on endomembrane, GFP-Rac1 localizes almost exclusively on PM and GFP-Rac3 localizes partly on endomembrane and partly on PM. Thus the Class I and Class III hypervariable regions represent something of a continuum, with the degree of PM localization being largely predictable by the degree of postitve charge. The only full length GTPase whose localization cannot be predicted by its hypervariable region sequence is RhoA. This GTPase is always cytosolic even when overexpressed at a high enough level to overwhelm endogenous GDI (Fig. 4D). This is despite its having a hypervariable region with a +5 charge which would suggest it might localize like Rac3 (Fig. 5). Although RhoA has been reported in both cytosol and membrane pellets34 and has been colocalized with caveolin-1 in PM microdomains by immunogold electron microscopy,35 indirect immunofluorescence analysis, in agreement with live cell GFP fusion protein analysis, has shown RhoA to be cytosolic.33,42,44 We shall address this point in further detail below.
C-Terminal Targeting Motifs—The Importance of Being Hypervariable In order to avoid the influence of RhoGDI and to test if the hypervariable region is sufficient to drive the targeting of Rho proteins to specific membranes, it is helpful to fuse GFP to the hypervariable regions alone. The hypervariable regions of Rac1 and Cdc42hs, as shown in (Fig. 6A), target GFP to the same membranes as the full length proteins. This observation shows that, for many Rho proteins, the hypervariable region contains all the necessary information to dictate membrane targeting.42 This is similar to the situation with Ras proteins.32 However, one protein, RhoA is an exception. GFP fused to full length RhoA is always cytosolic no matter how highly overexpressed while, as seen in (Fig. 6A), the RhoA hypervariable region targets GFP to the same membranes as Rac2, Rac3 and Cdc42hs full length proteins or the Cdc42hs hypervariable region alone. In fact, as might be predicted by its +5 charge, the RhoA hypervariable region localizes similarly to Rac3 full length, whose hypervariable region has a +4 charge (Fig. 5). Since the intracellular levels of RhoGDIα are insufficient to account for the exclusively cytosolic localization of over-expressed full length RhoA, and since the RhoA hypervariable region alone gives GFP a typical Class III localization, sequences upstream of the hypervariable region must give additional targeting information that keeps the protein in the cytosol. Cytosolic binding proteins other than RhoGDIα or intramolecular sequestration of the prenyl group, are possible explanations for the exclusively cytosolic localization of full length RhoA. It has been shown that GFP fused with a truncated version of RhoA lacking amino acids 1-73 of RhoA localizes primarily on endomembrane rather than cytosol, indicating that sequestration in the cytosol depends on the N-terminus of RhoA.42 Another way to demonstrate the importance of the hypervariable region is to make hybrid molecules consisting of hypervariable sequences of one GTPase fused to the bulk of any other GTPase. The localization of such chimeras is usually determined by the hypervariable sequence. For example, fusion of the last 20 amino acids of Cdc42hs with the first 188 amino acids of TC10 yields a protein that has the Class III localization of Cdc42hs rather than the PM and
26
Rho GTPases
endosomal localization of TC10 itself (Fig. 6B and ref. 42). Thus, with the exception of RhoA, sequences upstream of the hypervariable region appear to be irrelevant with regard to the membrane targeting of Rho family GTPases.
TC10 and Cdc42—A Tail of Two GTPases TC10 and CDC42hs are 69% identical and 83% similar, yet they have very different hypervariable regions and correspondingly different localizations. How do these differences affect the function of these two GTPases? To some degree these two proteins have similar, though not identical, functions. Both stimulate filopodia formation and participate in similar signalling pathways.52 Nevertheless, these highly homologous proteins are not functionally identical. TC10 is not able to rescue the growth defect of a Cdc42 mutant in yeast nor does it participate in neurite outgrowth stimulated by nerve growth factor as does Cdc42hs.52 Additionally, as will be discussed below, inactive Cdc42hs can be sequestered in the cytosol by RhoGDIα while TC10 does not interact with RhoGDIα, suggesting that the regulation of these two molecules differs.42 The most interesting difference between TC10 and Cdc42hs so far determined is in their involvement in insulin signalling. Although Cdc42hs plays no apparent role in insulin signalling, TC10 is required along with the PI3K pathway for insulin-stimulated translocation of the glucose tranporter, GLUT4, from an intracellular compartment to the PM.11,12 PI3K activation is necessary but not sufficient for efficient translocation of GLUT4 to the PM. In addition, the insulin receptor recruits the Cbl protooncogene product to the PM via the adaptors APS and CAP. Cbl in turn recruits the CrkII-C3G complex, which then acts as a GEF for TC10 activation. TC10 activation cooperates with the PI3K pathway to bring GLUT4 to the PM11 probably acting through N-WASP to effect necessary actin rearrangements.53 Cdc42 is unaffected by insulin binding and does not participate in GLUT4 translocation. Since GLUT4 localizes to intracellular vesicles in unstimulated cells,54,55 the ER/Golgi localization of Cdc42hs may prevent it from participating in the vesicle-to-PM targeting event. By contrast, TC10 is present on PM and intracellular vesicles12,42 and so may be optimally positioned for participation in GLUT4 transport. Although no function has yet been reported for TC10 localized to internal vesicles, an interesting possibility is that the bridging of the CrkII-C3G complex at the site of the activated insulin receptor and TC10 present on the GLUT4-containing vesicle may be a critical event in insulin signalling. However, it has not yet been determined if the GLUT4-containing vesicles and the TC10 vesicles are the same. Localization of TC10 to particular microdomains of the PM is critical for its ability to be activated by insulin and to function in GLUT4 translocation. TC10, like H-Ras, is a palmitoylated protein, and the combination of prenylation and palmitoylation targets TC10 and H-Ras to cholesterol-rich lipid raft domains of the PM, the same regions where the insulin receptor associated CrkII-C3G complex is localized. Replacement of the TC10 hypervariable region with that of H-Ras does not alter this localization or the ability of the chimera to be activated by insulin, and the chimera has the same effect as overexpressed wild type TC10 on GLUT4 translocation.12 By contrast, replacement of the TC10 hypervariable region with that of nonpalmitoylated K-Ras4B targets the hybrid protein to the nonlipid raft region of the plasma membrane. This hybrid is then unable to be activated by insulin or to affect insulin-stimulated GLUT4 translocation.12 Thus localization of TC10 to particular intracellular vesicles as well as to particular microdomains of the PM may be critical for its function in insulin signalling. Similarly, Cdc42hs, by virtue of its endomembrane localization, may be optimally localized for participation in trafficking of intracellular vesicles (reviewed in ref. 56). As noted previously, Cdc42hs has been found to bind the γ-subunit of the coatomer complex, which is involved in intracellular vesicle trafficking as part of the coat assembled on Golgi membranes.50 Cdc42hs has also been found to be involved in Golgi-to-ER transport57 and sorting of proteins from the Golgi to apical and basolateral membranes.58 Data from experiments using yeast
Intracellular Targeting of Rho Family GTPases
27
Figure 7. GDI binding modifies the localization of some, but not all, Rho proteins. Rac1 and Cdc42hs localize to the cytosol when expressed at low levels in MDCK cells (left column). When expressed at levels that exceed the buffering capacity of endogenous RhoGDIα, these proteins localize to membranes based on their hypervariable region sequence (middle column). When RhoGDIα is coexpressed, cytosolic localization is restored (right column). In contrast, RhoB and TC10 do not bind GDI and thus never localize to the cytosol even when RhoGDIα is coexpressed. Bars indicate 10 µM.
Cdc42 indicate that Cdc42 may participate in the docking of vesicles to target membranes.59 Thus the differential localizations of Cdc42hs and TC10 may be one key factor in their differential activity with Cdc42hs acting within the endomembrane system and TC10 acting to bring vesicles to and from the PM.
RhoGDI—The Catcher in the Cytosol Although Ras protein localization is almost exclusively determined by the nature of its hypervariable domain, Rho family proteins have an additional level of regulation due to their interaction with GDIs. Three main GDIs have been identified. RhoGDIα is ubiquitous and has been found to bind most, but not all, Rho family proteins.42 RhoGDIβ is expressed only in hematopoietic cells and has a 10-fold lower affinity for RhoA, Rac1 and Cdc42hs compared with RhoGDIα.60 RhoGDIγ is expressed mainly in brain and pancreas, binds RhoA with low affinity, and is itself targeted to membranes by virtue of a hydrophobic N-terminal domain.61,62 As mentioned above, GFP-tagged Rho family proteins often localize differently depending on their level of expression.42 This is shown in Figure 7 Low levels of expression of GFP-Rac1, GFP-Rac2 (not shown) and GFP-Cdc42hs result in largely cytosolic localizations. At higher levels of expression, all of these proteins localize to membranes in a fashion identical to the pattern seen when GFP is attached to the hypervariable regions alone. If these GFP tagged
28
Rho GTPases
molecules are coexpressed with RhoGDIα, then the cytosolic localization is restored, indicating that RhoGDIα binding is responsible for the cytosolic localization of these Rho GTPases. In contrast to these molecules, GFP-RhoB and GFP-TC10 are never cytosolic even when coexpressed with RhoGDIα (Fig. 7) due to the inability of these GTPases to bind RhoGDIα.42 RhoB and TC10 are unable to bind RhoGDIα both because they are palmitoylated, sterically hindering GDI binding to the prenyl group of the GTPase,42 and because they lack critical amino acids that form specific hydrogen bonds with RhoGDIα.19 In this sense RhoB and TC10 localization follows the pattern of H- or N-Ras rather than that of other Rho family proteins. The stoichiometry of RhoGDIα in cells is nearly 1:1 with the combined concentrations of RhoA, Rac1 and Cdc42hs.42 This emphasizes the very tight regulation of Rho protein localization. Under normal circumstances, most Rho proteins in the cell will be bound to RhoGDIα and thus kept away from the membranes where they are activated. Yet the system is balanced so closely that slight perturbations may result in release of Rho proteins from RhoGDIα and subsequent translocation to membranes. This balance allows a rapid response to signalling since there is a large pool of available Rho GTPase sequestered in the cytosol poised to respond. No new protein synthesis is required to achieve rapid signalling. Conversely, Rho protein signalling could be rapidly turned off since RhoGDIα is available to bind the GTPase as it becomes inactivated. Thus in addition to their different membrane localizations, determined by their hypervariable regions, Rho proteins are also regulated by GDIs. RhoA, Rac1 and Cdc42hs would not only individually be regulated by RhoGDIα, but, given the tight stoichiometry, they might also affect each other since increased or decreased levels of one GTPase would affect the amount of RhoGDIα available to bind the other GTPases. TC10 and RhoB are unaffected by this system.
Conclusions—You Are Where You Are Rho family proteins look a great deal alike in terms of their amino acid sequences. Despite this, they are capable of considerable specificity of function. The most striking result of the analysis of GFP-tagged Rho proteins in live cells is the diversity of localizations despite their shared pathway of CAAX modification. This diversity of localization is likely to contribute significantly to the functional diversity of these proteins. The diversity in localization is regulated primarily by determinants in the hypervariable region upstream of the CAAX motif and by the capacity to bind RhoGDI. Localization might be critical for function for a number of reasons. Localization to different membrane compartments would allow interaction with different activators and effectors. Furthermore, many GTPases act by targeting binding partners to membranes or by bringing together two different membrane surfaces in preparation for fusion. The activation of Ras proteins, for example, leads to their binding the protein kinase Raf at the plasma membrane where Raf then acts to stimulate the MAP Kinase cascade. In mammalian cells, both RhoA and the Rho-effector Citron kinase relocalize during anaphase to the cleavage furrow, and disruption of RhoA function disrupts the relocalization of Citron-kinase.63 The functional significance of the cell-cycle dependent colocalization of RhoA and Citron kinase has not yet been determined. In budding yeast, the Ras family protein Rsr1, when activated at the site of a previous budding, will bind Cdc24, a GEF for Cdc42, thus activating Cdc42 at a nascent bud site adjacent to a previous bud site.64-66 Cdc42 can then reorganize the actin cytoskeleton to set up appropriate cell polarity. Additionally, Cdc42 also recruits other GTPases such as Rho1 and Sec4 to the new bud site to facilitate bud enlargement and cell wall synthesis.67,68 Cdc42 acts as a key regulator of cell polarity in budding yeast and its subcellular localization is key to this regulation.69 Localization of GTPases to specific membranes allows for specific intracellular localization of effectors and thus for very precise spatial signalling. In some cases localization suggests function. For example, the endosomal and PM localization of TC10 places it in an ideal position to regulate GLUT4 translocation to the PM after
Intracellular Targeting of Rho Family GTPases
29
insulin signalling. Golgi localization of pCdc42hs is consistent with its ability to bind γCOP and to regulate sorting of proteins from the Golgi to apical and basolateral membanes. Rac1 localization primarily to the PM is consistent with its role in assembling the actin cytoskeleton into membrane ruffles. However, the localization of Cdc42hs primarily in the endomembrane and only weakly in the plasma membrane is less consistent with its role in filopodial formation at the PM. Thus not all Rho protein functions are easily predictable from localization. Many of these correlations between function and localization remain speculative and the precise relationship between localization and function remains to be determined. Elucidation of the biology of Rho GTPases will require a more detailed understanding of their intracellular targeting.
References 1. Nobes C, Hall A. Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81:53-62. 2. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70:389-399. 3. Ridley AJ, Paterson HF, Johnston CL et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992; 70:401-410. 4. Coso OA et al. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signalling pathway. Cell 1995; 81:1137-1146. 5. Minden A, Lin A, Claret FX et al. Selective activation of the JNK signalling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995; 81:1147-1157. 6. Minden A, Lin A, Claret FX et al. Selective activation of the JNK signalling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995; 81:1147-57. 7. Hill CS, Wynne J, Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 1995; 81:1159-70. 8. Qiu RG, Chen J, McCormick F et al. A role for Rho in Ras transformation. Proc Natl Acad Sci USA 1995; 92:11781-5. 9. Abo A et al. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 1991; 353:668-670. 10. Knaus UG, Heyworth PG, Evans T et al. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 1991; 254:1512-1515. 11. Chiang SH et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001; 410:944-948. 12. Watson RT et al. Lipid raft microdomain compartmentalization of TC10 is required for insulin signalling and GLUT4 translocation. J Cell Biol 2001; 154:829-840. 13. Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998; 282:1717-1721. 14. Jou TS et al. Selective alterations in biosynthetic and endocytic protein traffic in Madin-Darby canine kidney epithelial cells expressing mutants of the small GTPase Rac1. Mol Biol Cell 2000; 11:287-304. 15. Lamaze C, Chuang TH, Terlecky LJ et al. Regulation of receptor-mediated endocytosis by Rho and Rac. Nature 1996; 382:177-9. 16. Leung SM et al. Modulation of endocytic traffic in polarized Madin-Darby canine kidney cells by the small GTPase RhoA. Mol Biol Cell 1999; 10:4369-84. 17. Kroschewski R, Hall A, Mellman I. Cdc42 controls secretory and endocytic transport to the basolateral plasma membrane of MDCK cells. Nat Cell Biol 1999; 1:8-13. 18. Barrett K, Leptin M, Settleman J. The Rho GTPase and a putative RhoGEF mediate a signalling pathway for the cell shape changes in Drosophila gastrulation. Cell 1997; 91:905-15. 19. Hoffman GR, Nassar N, Cerione RA. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 2000; 100:345-356. 20. Ridley AJ. Rho family proteins: Coordinating cell responses. Trends Cell Biol 2001; 11:471-7. 21. Cerione RA, Zheng Y. The Dbl family of oncogenes. Current Opinion in Cell Biology 1996; 8:216-222. 22. Zheng Y. Dbl family guanine nucleotide exchange factors. Trends Biochem Sci 2001; 26:724-32. 23. Lamarche N, Hall A. GAPs for rho-related GTPases. Trends Genet 1994; 10:436-40. 24. Neudauer CL, Joberty G, Tatsis N et al. Distinct cellular effects and interactions of the Rho-family GTPase TC10. Curr Biol 1998; 8:1151-60. 25. Bagrodia S, Cerione RA. Pak to the future. Trends Cell Biol 1999; 9:350-5.
30
Rho GTPases
26. Teramoto H et al. Signalling from the small GTP-binding proteins Rac1 and Cdc42 to the c- Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/ protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family. J Biol Chem 1996; 271:27225-8. 27. Madaule P et al. A novel partner for the GTP-bound forms of rho and rac. FEBS Lett 1995; 377:243-8. 28. Clarke S. Protein isoprenylation and methylation at carboxyl terminal cysteine residues. Annual Review of Biochemistry 1992; 61:355-386. 29. Schmidt WK, Tam A, Fujimura-Kamada K et al. Endoplasmic reticulum membrane localization of Rce1p and Ste24p, yeast proteases involved in carboxyl-terminal CAAX protein processing and amino-terminal a-factor cleavage. Proc Natl Acad Sci USA 1998; 95:11175-11180. 30. Dai Q et al. Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J Biol Chem 1998; 273:15030-15034. 31. Apolloni A, Prior IA, Lindsay M et al. H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol 2000; 20:2475-87. 32. Choy E et al. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 1999; 98:69-80. 33. Adamson P, Paterson HF, Hall A. Intracellular localization of the P21rho proteins. J Cell Biol 1992; 119:617-627. 34. Boivin D, Beliveau R. Subcellular distribution and membrane association of Rho-related small GFP-binding proteins in kidney cortex. Am J Physiol 1995; 269:F180-F189. 35. Michaely PA, Mineo C, Ying Y et al. Polarized distribution of endogenous Rac1 and RhoA at the cell surface. J Biol Chem 1999; 274:21430-21436. 36. Robertson D, Paterson HF, Adamson P et al. Ultrastructural localization of ras-related proteins using epitope- tagged plasmids. J Histochem Cytochem 1995; 43:471-80. 37. Erickson JW, Zhang C, Kahn RA et al. Mammalian Cdc42 is a Brefeldin A-sensitive component of the Golgi apparatus. J Biol Chem 1996; 271:26850-26854. 38. Murphy C et al. Endosome dynamics regulated by a Rho protein. Nature 1996; 384:427-32. 39. Baldassare JJ, Jarpe MB, Alferes L et al. Nuclear translocation of RhoA mediates the mitogen-induced activation of phospholipase D involved in nuclear envelope signal transduction. J Biol Chem 1997; 272:4911-4. 40. Fukumoto Y et al. Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins. Oncogene 1990; 5:1321-1328. 41. Isomura M, Kikuchi A, Ohga N et al. Regulation of binding of rhoB p20 to membranes by its specific regulatory protein, GDP dissociation inhibitor. Oncogene 1991; 6:119-124. 42. Michaelson D. et al. Differential Localization of Rho GTPases in Live Cells. Regulation by hypervariable regions and rhogdi binding. J Cell Biol 2001; 152:111-126. 43. Fleming IN, Elliott CM, Exton JH. Differential translocation of Rho family GTPases by lysophosphatidic acid, endothelin-1, and platelet-derived growth factor. J Biol Chem 1996; 271:33067-33073. 44. Kranenburg O, Poland M, Gebbink M et al. Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA. J Cell Sci 1997; 110:2417-27. 45. Kraynov VS et al. Localized Rac activation dynamics visualized in living cells. Science 2000; 290:333-7. 46. Philips MR, Feoktistov AS, Pillinger MH et al. Activation Dependent Translocation of p22rac and p22CDC42hs from Neutrophil Cytosol to Plasma Membrane. Clin Res 1993; 40(2):351A. 47. Jou TS et al. Selective alterations in biosynthetic and endocytic protein traffic in Madin-Darby canine kidney epithelial cells expressing mutants of the small GTPase Rac1. Mol Biol Cell 2000; 11:287-304. 48. Bilodeau D, Lamy S, Desrosiers RR et al. Regulation of Rho protein binding to membranes by rhoGDI: Inhibition of releasing activity by physiological ionic conditions. Biochem & Cell Biol 1999; 77:59-69. 49. Bokoch GM, Bohl BP, Chuang T. Guanine nucleotide exchange regulates membrane translocation of rac/rho GTP-binding proteins. J Biol Chem 1994; 269:31674-31679. 50. Wu WJ, Erickson JW, Lin R et al. The g-subunit of the coatomer complex binds Cdc42 to mediate transformation. Nature 2000; 405:800-804. 51. Philips MR, Feoktistov A, Pillinger MH et al. Translocation of p21rac2 from cytosol to plasma membrane is neither necessary nor sufficient for neutrophil nadph oxidase activity. J Biol Chem 1995; 270:11514-11521. 52. Murphy GA et al. Signalling mediated by the closely related mammalian Rho family GTPases TC10 and Cdc42 suggests distinct functional pathways. Cell Growth Differ 2001; 12:157-67.
Intracellular Targeting of Rho Family GTPases
31
53. Jiang ZY, Chawla A, Bose A et al. A phosphatidylinositol 3-kinase-independent insulin signalling pathway to N-WASP/Arp2/3/F-actin required for GLUT4 glucose transporter recycling. J Biol Chem 2002; 277:509-15. 54. Millar CA, Shewan A, Hickson GR et al. Differential regulation of secretory compartments containing the insulin-responsive glucose transporter 4 in 3T3-L1 adipocytes. Mol Biol Cell 1999; 10:3675-88. 55. Simpson F, Whitehead JP, James DE. GLUT4—at the cross roads between membrane trafficking and signal transduction. Traffic 2001; 2:2-11. 56. Ridley AJ. Rho proteins: Linking signalling with membrane trafficking. Traffic 2001; 2:303-10. 57. Luna A et al. Regulation of Protein Transport from the Golgi Complex to the Endoplasmic Reticulum by CDC42 and N-WASP. Mol Biol Cell 2002; 13:866-79. 58. Musch A, Cohen D, Kreitzer G et al. cdc42 regulates the exit of apical and basolateral proteins from the trans-Golgi network. Embo J 2001; 20:2171-9. 59. Muller O, Johnson DI, Mayer A. Cdc42p functions at the docking stage of yeast vacuole membrane fusion. Embo J 2001; 20:5657-65. 60. Gorvel JP, Chang TC, Boretto J et al. Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity. FEBS Lett 1998; 422:269-73. 61. Adra CN et al. RhoGDIgamma: A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc Natl Acad Sci USA 1997; 94:4279-84. 62. Zalcman G et al. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a noncytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG. J Biol Chem 1996; 271:30366-74. 63. Eda M et al. Rho-dependent transfer of Citron-kinase to the cleavage furrow of dividing cells. J Cell Sci 2001; 114:3273-84. 64. Bender A, Pringle JR. Multicopy suppression of the cdc24 budding defect in yeast by CDC42 and three newly identified genes including the ras-related gene RSR1. Proc Natl Acad Sci USA 1989; 86:9976-80. 65. Chant J, Herskowitz I. Genetic control of bud site selection in yeast by a set of gene products that constitute a morphogenetic pathway. Cell 1991; 65:1203-12. 66. Zheng Y, Bender A, Cerione RA et al. Interactions among proteins involved in bud-site selection and bud-site assembly in Saccharomyces cerevisiae. J Biol Chem 1995; 270:626-30. 67. Drgonova J et al. Rho1p, a yeast protein at the interface between cell polarization and morphogenesis. Science 1996; 272:277-9. 68. Cabib E, Drgonova J, Drgon T. Role of small G proteins in yeast cell polarization and wall biosynthesis. Annu Rev Biochem 1998; 67:307-33. 69. Drees BL et al. A protein interaction map for cell polarity development. J Cell Biol 2001; 154:549-71.
32
Rho GTPases
CHAPTER 3
Regulation of the RhoGTPases by RhoGDI Gregory R. Hoffman and Richard A. Cerione
Abstract
S
ignal transduction pathways mediated by the Rho-family GTPases require tight temporal and spatial control. The GDI proteins are key components of the regulatory machinery controlling both the timing and the localization of Rho GTPase activity. Recent structural work has provided significant insight into the mechanisms by which the GDI proteins control Rho-family signalling. In this review, the basis of the three distinct biochemical activities of the GDI toward the Rho GTPases, namely (1) inhibition of nucleotide dissociation, (2) inhibition of GTP hydrolysis, and (3) membrane release, are described in the context of this structural information. Understanding the biochemistry of the GDI provides a starting point for exploring the cell biology of this important class of regulatory molecules and recent progress in understanding the roll of the GDI in the cell is also discussed.
Introduction Members of the Rho family of GTPases are remarkable in their ability to regulate an enormous range of cellular responses (described in reviews of this series and in references 1, 2). The ability to bind and hydrolyze GTP lies at the heart of the biological activity of the Rho GTPases, allowing them to function as molecular switches cycling between an active, GTP-bound conformation and an inactive, GDP-bound conformation. In the GTP-bound state, Rho GTPases are able to specifically couple to downstream effector proteins and activate their biological activities, giving rise to signals that control important cellular processes including organization of the actin cytoskeleton, maintenance of cell polarity, lipid signalling, membrane trafficking, gene expression, and oncogenic transformation. Given the complex signalling networks governed by Rho-family proteins, it is clear that both the timing and the localization of the GTP binding and hydrolytic cycle must be tightly controlled. To this end, the cell has evolved a series of regulatory factors responsible for controlling signalling events mediated by the Rho GTPases. Guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs) catalyze activation via GDP/GTP exchange and inactivation via GTP hydrolysis, respectively (reviewed in this series and in refs. 3-5). Guanine nucleotide dissociation inhibitors (GDIs) represent a third class of regulatory proteins that are critical to the control of signalling events mediated by the Rho GTPases. The GDIs are unique among regulatory proteins in that they exhibit multiple effects on their Rho-family substrates, controlling both the nucleotide state of the GTP-binding proteins as well as their cellular location. Recently, significant progress has been made toward understanding the structural basis of the interaction of the Rho GTPases with GDIs. As described in the following review, this structural information provides important insights into the signalling events mediated by the Rho GTPases and provides a context for understanding the cellular function of the GDIs.
Rho GTPases, edited by Marc Symons. ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers.
Regulation of the RhoGTPases by RhoGDI
33
Figure 1. Biochemical activities of the GDI. The GDI serves as a multi-functional regulator of signalling by Rho GTPases. The three distinct biochemical activities of the GDI (1) inhibition of nucleotide dissociation, (2) inhibition of GTP hydrolysis, and (3) membrane release, are illustrated in relation to the GTP-binding and hydrolytic cycle of the Rho proteins.
GDIs As Multifunctional Regulators of Signalling through Rho GTPases The GDI proteins comprise a family of regulatory factors that control signalling by the Rho proteins (previously reviewed in ref. 6) and exhibit three distinct biochemical activities toward these GTPases (Fig. 1). The GDI proteins were initially identified based on their ability to bind to the inactive, GDP-bound form of Rho proteins and block nucleotide dissociation.7-9 In this capacity, the GDI acts as a negative regulator of Rho-family signalling, blocking GEF-mediated
Figure 2. The RhoGDI family. Three Rho family-specific GDI proteins have been identified, each exhibiting a high degree of primary sequence conservation (indicated as percent identity). The domain architecture of the GDIs described in the text is illustrated in relation to the primary sequence, with the amino-terminal regulatory arm shown in orange and the immunoglobulin-like domain in blue (residue 74 marks the beginning of the first β-strand in the immunoglobulin like domain of RhoGDI and is marked by the arrow). The approximate locations of important residues described in the text are indicated. The unique helical region at the amino-terminus of GDI3 is shown in pink.
34
Rho GTPases
Figure 3. Structure of the GTPase/GDI complex. (A) A ribbon diagram of the Cdc42/GDI complex is shown with Cdc42 in yellow, with the switch I in red and switch II in orange, and GDI in blue. The Mg2+ ion and GDP are shown in the nucleotide-binding pocket of Cdc42 as a ball and stick model. A transparent molecular surface of the GDI is shown to emphasize the domain architecture of the GDI. (B) A similar depiction of the complex is shown with the molecular surface colored by electrostatic potential with regions of net negative potential shaded red and regions with net positive potential shown in blue.
Regulation of the RhoGTPases by RhoGDI
35
exchange and maintaining the GTPase in an inactive GDP-bound state. Subsequently, it was shown that RhoGDI is also able to bind with high affinity to the GTP-bound form of the Rho family member Cdc42 to act as a GTPase inhibitory protein (GIP),10 blocking both intrinsic and GAP-catalyzed GTP-hydrolysis and thus maintaining Cdc42 in a GTP-bound conformation. The third, and perhaps the most important cellular activity of the GDI, is its ability to solubilize Cdc42 from cellular membranes.11,12 In the absence of a GDI, Rho proteins are stably associated with cellular membranes by virtue of a series of post-translational modifications directed toward their carboxy-terminal CAAX motif13 (see also Chapter 2). The most significant of these modifications is the covalent attachment of a prenyl moiety to the CAAX box cysteine. In most cases this lipid group is a 20-carbon geranylgeranyl group attached by geranylgeranyl transferase I14 (RhoB, RhoD and RhoE are modified with the smaller 15-carbon farnesyl group). Following prenylation, a specific protease cleaves the last three residues of the CAAX motif, and the new carboxyl-terminal prenylated cysteine is carboxy-methylated. The hydrophobic prenyl moiety, along with a polybasic region proximal to the modified cysteine, directs the Rho family proteins to specific membrane-bound locations where they carry out their cellular function.15 RhoGDI binds only to the prenylated form of Rho proteins, and GDI binding sequesters the lipid moiety from the membrane, creating a soluble cytosolic GDI/GTPase complex. Appropriate localization of Rho proteins is critical for their biological function, and regulation of this localization by RhoGDI is likely to play an important role in signalling through Rho GTPases (see also Chapter 2). A GDI activity acting on Rho and Cdc42 was independently purified from bovine brain cytosol by two groups.7-9 The sequencing and cloning of the protein responsible for this activity lead to the identification of RhoGDI (also known as GDI1 or αGDI ), the first Rho family specific GDI protein. In addition to RhoGDI, two related proteins have been described (Fig. 2). The Ly- or D4-GDI (also referred to as GDI2 and βGDI) was found as a GDI protein preferentially expressed in hematopoietic cells16-18 with 74% sequence identity to RhoGDI. In spite of the high degree of conservation at the level of primary sequence, GDI2 interacts with a 20-fold lower affinity toward Cdc42. This decreased binding affinity has been attributed to a single amino-acid change from Ile177 in RhoGDI to an asparagine at the corresponding position in GDI2.19 Two groups have recently described a third member of the GDI-family, referred to as GDI3 (also called γGDI).20,21 This protein is enriched in brain and appears to have a high degree of specificity to RhoB and RhoG and also binds more weakly to Cdc42 and RhoA but not Rac. GDI3 has a unique, extended amino-terminal region comprised of an amphipathic α-helix. Unlike the other members of this family, which are entirely cytosolic, GDI3 is associated with a Triton-X insoluble fraction and appears to localize to vesicular structures in the vicinity of the ER. While the conserved nature of the primary sequence of GDI3 suggests a common mode of interaction with Rho-family substrates, the distinctive noncytosolic localization and substrate specificity point to a specialized role, possibly in the regulation of RhoB signalling.6
Structural Insights into GDI Function
We have recently described the structure of the Cdc42/RhoGDI complex22 which, along with the structure of the Rac1/GDI2 complex,23 the recently described Rac2/RhoGDI structure,24,25 and a low resolution structure of the RhoA/RhoGDI complex,26 provides a consistent mechanistic picture of the regulation of Rho GTPases by the GDIs. In addition, these structures reveal important differences between the RhoGDI and GDI2 proteins and provide important insights into the cellular function of these regulatory proteins. The structure of the post-translationally modified form of Cdc42 bound to RhoGDI is shown in (Fig. 3). The molecular surface of the GDI is drawn to emphasize the domain architecture of the GDI, which is comprised of two distinct domains, a well-ordered carboxy-terminal domain and a more flexible amino-terminal region.
36
Rho GTPases
Earlier structural work on the carboxy-terminal domain of the GDI27,28 showed that this region adopts an immunoglobulin-like fold, comprised of two anti-parallel β-sheets that pack against one another to form a β-sandwich. The most striking feature of the GDI immunoglobulin-like domain is the presence of a unique hydrophobic cavity between the two sheets of the β-sandwich, which provides a binding site for the geranylgeranyl moiety. In the absence of Cdc42 binding, the hydrophobic pocket of the GDI is too small to accommodate the lipid. Upon complex formation, the base of the pocket dramatically expands to allow insertion of the geranylgeranyl group. In the structure of the Cdc42/GDI complex, the geranylgeranyl moiety of Cdc42 is completely sequestered from the solvent, and the binding of the lipid group within this hydrophobic cavity provides a mechanism for release of the GTPase from cellular membranes. In contrast, the geranylgeranyl moiety was not visible in the electron density map of the Rac1/GDI2 structure.23 The lack of an ordered geranylgeranyl group in the Rac1/GDI2 complex reflects a weak affinity of the GDI2 for binding to the lipid moiety. As noted above, a single amino acid change from isoleucine at position 177 of RhoGDI to an asparagine at the corresponding position in GDI2 accounts for a 20-fold difference in binding affinity for Cdc42.19 Isoleucine 177 in RhoGDI forms hydrophobic contacts with the geranylgeranyl group important in stabilizing the lipid in the binding pocket. The introduction of a polar asparagine residue at this position is likely to disrupt geranylgeranyl binding as seen by the disordered nature of the lipid in the Rac1/GDI2 complex. Importantly, the structure of Rac2 bound to RhoGDI24 clearly shows the presence of the geranyl-geranyl group in the hydrophobic pocket with a conformation nearly identical to that seen for the Cdc42/RhoGDI complex. This structure confirms that lack of a well ordered geranylgeranyl moiety in the Rac2/GDI2 structure is due to the differences in lipid binding between the two GDI proteins, rather than differences in the GTPases, and may reflect functional differences between these GDIs. In each of these structures, the amino-terminal region of the GDI folds into a well-ordered helix-loop-helix, and this ‘regulatory-arm’ of the GDI interacts with the switch I and switch II regions of the Rho protein to influence the nucleotide state of the GTPase. Importantly, NMR spectroscopy of the full-length GDI shows that the amino-terminal region of the GDI is disordered in the absence of Cdc42 binding.27-29 As predicted by these NMR studies, the structure of the complex clearly shows that this flexible region adopts an ordered structure upon binding to the GTPase. The amino-terminal region of the GDI is essential for its function, and biochemical studies show that while deletion of the first 22 residues from the GDI has only slight affects on its interaction with Rho proteins, deletions of 45 or 60 residues completely abrogates binding and blocks GDI activity.30 The amino-terminal region of the GDI contributes a significant portion of the protein-protein interactions at the complex interface, and the structural data demonstrates that this region is responsible for blocking guanine nucleotide dissociation and inhibition of GTP hydrolysis (described in detail below). A number of recent NMR studies have investigated the functional importance of the disordered amino-terminal region of the GDI. These studies show that the free GDI is in equilibrium between two conformations, one in which the amino-terminus is in a random coil and a second in which the amino-terminal domain transiently adopts a helical structure similar to that seen in complex with Rho GTPases.29,31 Mutations in the amino-terminal domain that favor the random coil structure dramatically interfere with GDI binding to Rac1.32 The structure of the Cdc42/GDI complex shows that the extreme amino-terminal region of RhoGDI (residues 10-15) forms a short helical region that caps the geranylgeranyl binding pocket, further sequestering the lipid moiety from the solvent. In the Rac1/GDI2 structure this region is disordered, consistent with NMR data showing that this region of RhoGDI exhibits transient helical structure while GDI2 does not. These differences in the helical nature of the amino-terminal region may also contribute to the disparity in lipid binding and the divergent function of these two GDIs.
Regulation of the RhoGTPases by RhoGDI
37
Figure 4. The involvement of threonine 35 in the regulation of nucleotide binding. Threonine 35 provides an important site for the regulation of nucleotide binding through the action of GEFs and GDIs. The Cdc42/GDI complex and the Rac/Tiam1 complex are shown oriented relative to the GTPase to illustrate that both regulatory proteins engage the switch residues of the GTPase. The contacts surrounding Thr35 in each structure are shown in detail below the ribbon diagram. In the more detailed description of the Rac/ Tiam1 nucleotide binding pocket, the approximate position of the GDP in the Cdc42/GDI complex is indicated by the pink oval and the position of the Mg2+ ion in the Cdc42/GDI is indicated by the X.
As emphasized by these NMR studies, a critical aspect of complex formation is stabilization of the flexible amino-terminal region of the GDI. A universally conserved arginine residue in switch II (Arg66 in Cdc42) is crucial to the GTPase/GDI interaction and is involved in a series of interactions that buttress the flexible regulatory arm of the GDI against the stable immunoglobulin like domain.22 In the absence of these bridging interactions, the amino-terminal region of the GDI will not adopt the stable fold required for interacting with the switch regions of the GTPase. Based on the central importance of the conserved arginine in switch II, we predicted from the structural data that mutation of this residue would render Rho GTPases unable to interact with the GDI. The importance of this arginine in the Cdc42/GDI interaction was recently demonstrated biochemically by Gibson and Wilson-Delfosse, showing that the Cdc42(R66A) mutant is unable to couple to the GDI and, thus, localizes exclusively to the membrane fraction.33 Importantly, this mutation appears to be specific to the GDI interaction, as other known effectors and regulatory factors do not rely on this arginine residue for binding. As described in the following sections, the structural data provides a mechanistic understanding of the three biochemical functions of the GDI; however, the cellular role of these regulatory
38
Rho GTPases
interactions remains less clear. GDI-insensitive mutants, such as the Cdc42(R66A) mentioned above, will be a valuable reagent in unraveling the role of the GDI in signalling events mediated by the Rho GTPases.
Mechanism of the GDI Activity A primary function of the GDI is to block the dissociation of the bound nucleotide and inhibit the exchange activity of Dbl-family GEFs. Recently the structure of Rac in complex with its specific GEF Tiam1 was determined,34 and comparison of this structure with that of the Cdc42/GDI complex provides important insight into the antagonistic activities of these two proteins. On a basic level, both the GDI and Tiam1 form extensive contacts with the switch regions of the Rho protein (Fig. 4), and the binding of GDI will clearly be competitive with that of exchange factors. More fundamentally, these proteins engage a similar set of residues to exert opposing biochemical effects. All GTP-binding proteins require a Mg2+ ion for high affinity nucleotide binding. This Mg2+ ion offsets the negative charge of the phosphate groups to stabilize the bound nucleotide. Rho proteins exhibit unique coordination of this critical Mg2+ ion in the GDP-bound state,35 with the main-chain carbonyl of Thr35 directly coordinating the Mg2+ ion, replacing a water molecule found in the corresponding position of Ras. Importantly, the unique coordination of the Mg2+ ion by the main chain carbonyl of Thr35 provides access to the bound Mg2+ ion, allowing GDIs and GEFs to control nucleotide binding by influencing Mg2+ ion coordination. Specifically, the GDI interacts directly with the Thr35 side chain to stabilize the interaction of this residue with the Mg2+ ion and lock the nucleotide in the binding pocket, contacts mediated by a conserved aspartic acid and serine residues in the regulatory arm of the GDI (T47 and S47 in RhoGDI). As shown in (Fig. 4), Tiam1 forms main chain hydrogen bonding contacts on either side of this threonine residue, ratcheting switch I laterally along the nucleotide binding cleft, to pull the main chain carbonyl of Thr35 away from its position in the Cdc42/GDI complex. Disruption of the favorable interactions between Thr35 and the Mg2+ ion contributes to release of the bound nucleotide. In addition, Tiam1 disrupts the structure of the switch II domain of Rac such that the side chain of Ala59 protrudes into the Mg2+ ion binding site to assist in its ejection from the binding-pocket. Again, the GDI engages a similar set of residues in the switch II region to achieve the opposite effect, specifically fixing a conformation of switch II consistent with Mg2+ ion binding and stabilization of the associated GDP.
Mechanism of GIP Activity The GDI is unique among effectors and regulatory proteins in its ability to associate with both nucleotide states of Rho-family proteins. In the case of Cdc42, the affinity of the GDI for the GTP- and GDP-bound forms of the GTPase is identical.30 This ability to bind both conformations of the GTPase with equal affinity relies in part on the extensive contacts between the regulatory arm of the GDI and switch II. Relative to other members of the Ras superfamily, the nucleotide-dependent conformational changes in switch II are relatively subtle, thus allowing the GDI to bind to Cdc42 and presumably other Rho proteins in both nucleotide states.22 In the GTP-bound complex, the GDI is able to inhibit GTP hydrolysis. All of the GTPase/ GDI structures solved to date involve a GDP-bound Rho protein, and while definitive proof of the mechanism of the GDI’s GIP activity awaits a GTP-bound complex, some clues to the ability of the GDI to block GTP hydrolysis can be gleaned from comparison with GTPase/ GAP complexes. Structures of Rho proteins in complex with their specific GAP proteins have been solved in both the ground state (GTP-bound)36 and transition state (aluminum fluoride-bound) conformations.37,38 These data demonstrate that GAP-catalyzed GTP hydrolysis proceeds by a two-pronged attack. First, the GAP introduces a catalytic arginine, the so-called ‘arginine-finger’, into the active site. Second, the interaction of the GAP protein stabilizes a catalytically active conformation of the conserved glutamine residue in switch II (Gln61 in Cdc42). This glutamine residue is universally conserved in all GTP binding proteins and is
Regulation of the RhoGTPases by RhoGDI
39
Figure 5. Structural model for membrane release. A) A model, which accounts for the available structural and kinetic data,12 for GDI-mediated release of Rho family GTPases from cellular membranes is shown. The GTPase is localized to membranes by the insertion of the geranylgeranyl group into the bilayer as well as interactions between the poly-basic tail and the acidic phospholipid head groups. The GDI first binds rapidly to the GTPase at the membrane where specific interactions with the polybasic tail and the geranylgeranyl group subsequently cause release of the GTPase/GDI complex into the cytosol. B) The structure shown in Figure 3B is rotated 90º showing a view looking directly into the geranylgeranyl binding pocket. The polybasic tail of Cdc42 (shown in magenta) interacts with an acidic patch on the surface of the GDI and may provide some of the driving force for membrane release.
40
Rho GTPases
absolutely required for GTP hydrolysis. In the Cdc42/GDI complex, GDI-binding rotates the side chain of the catalytic glutamine residue out of the nucleotide-binding pocket into an orientation that can no longer stabilize the transition state for GTP-hydrolysis. Thus, the binding of the GDI has essentially the same effect as mutating this critical catalytic residue. By subtly perturbing the structure of switch II, the GDI removes the catalytic glutamine from the active site into a position where it can no longer stabilize the transition state for GTP hydrolysis. Without this glutamine residue, hydrolysis can no longer proceed, allowing the GDI to maintain Rho-family proteins in a GTP-bound conformation. These structural rearrangements block intrinsic GTP-hydrolysis in the Cdc42/GDI complex. In addition, the GDI will clearly be competitive with GAP binding due to the extensive interface both proteins form with the switch regions of the Rho proteins, particularly switch II.
Structural Model for Membrane Release The structure of the Cdc42/GDI complex represents the only structural data available for a fully processed, post-translationally modified GTP-binding protein, providing insight into the ability of these proteins to associate with biological membranes and the regulation of this process by the GDI. Upon complex formation, the geranylgeranyl-binding pocket in the immunoglobulin-like domain of the GDI expands to conform to the shape of the bound geranylgeranyl group. This complimentarity in shape is likely to provide specificity for binding to the geranylgeranyl group over other hydrophobic ligands. In addition, interactions between the polybasic tail of Cdc42 and an acidic patch on the surface of the GDI further ensure the specificity of the interaction. Kinetic data on the release of Cdc42 from cell membranes by the GDI suggests that this interaction proceeds by a two-step mechanism. On the basis of this biochemical work and the structural data, we propose the model for membrane release shown in (Fig. 5). In the absence of GDI binding, the geranylgeranyl group is inserted into the bilayer and the polybasic tail of Cdc42 interacts with the acidic head groups of the phospholipids. The interaction of the GDI with Cdc42 at the membrane surface corresponds to the initial rapid phase in the kinetic mechanism. Subsequently, a slower isomerization event occurs involving transfer of the geranylgeranyl group out of the bilayer and into the hydrophobic binding pocket of the GDI. This isomerization may be driven in part by competition between an acidic patch on the GDI and the acidic phospolipid headgroups for binding to the polybasic tail of Cdc42. The importance of the GDI in regulating the cellular localization of Rho proteins makes the identification of small molecule inhibitors of the Cdc42/GDI interaction an attractive area of research. The geranylgeranyl-binding pocket is an obvious starting point for identifying such inhibitors and some progress has been made in isolating small molecules that bind in this hydrophobic pocket. Most of these analogs are geranylgeranyl cysteine analogs, which interact with relatively low (micromolar) affinity.39 The Cdc42/GDI complex has an affinity of 20 nM and, as such, the currently available small molecules will not act as efficient inhibitors of the Cdc42/GDI interaction. A recent finding highlighted the potential importance of carboxy-methylation demonstrating that carboxymethylated geranylgeranyl cysteine analogs bind to the GDI with much greater affinity than a corresponding unmethylated analog.39 The importance of methylation can be rationalized from the available structural data, which shows that the opening of the geranylgeranyl-binding pocket on the GDI is adjacent to a large acidic patch involved in interactions of the GDI with the polybasic tail of Cdc42. As described above, these interactions are thought to provide some of the driving force for extraction of Cdc42 from the membrane by competing for interactions of the polybasic tail with acidic phospholipid head groups. In an unmethylated situation, the acidic carboxy terminus would be directly adjacent to the acidic patch on the surface of the GDI, generating unfavorable electrostatic interactions between these two negatively charged regions. Methylation of the carboxyl group protects against such unfavorable electrostatic contacts and leads to a higher affinity interaction. Methylation presumably protects against similarly unfavorable interactions with the acidic head groups of phospholipids when the Rho proteins are inserted into the
Regulation of the RhoGTPases by RhoGDI
41
bilayer. The structural features of the geranylgeranyl-binding pocket seen in the Cdc42/GDI complex could provide an important starting point for designing higher affinity geranylgeranyl analogues for use as GDI inhibitors
Future Directions Regulation of the GTPase/GDI Complex In the resting cell, a large fraction of Rho proteins are found in a cytosolic pool associated with the GDI.40,41 In this role, RhoGDI is primarily considered a negative regulator of signalling through Rho GTPases, and over-expression or microinjection of the GDI can be shown to block many signalling events mediated by Rho-family proteins.42-46 In order for Rho proteins to respond to activating signals, they must first be displaced from the GDI and inserted into cellular membranes. This event has been observed most dramatically in the case of RhoA activation in neuronal cells where stimulation with LPA causes its redistribution from the cytosol to the plasma membrane.47 The actin based morphology changes induced by RhoA activation in these cells depends on its membrane localization and can be blocked by GDI over-expression, emphasizing the importance of regulating the RhoA/GDI interaction in this process. Translocation to specific membrane-bound locations can also be demonstrated upon activation of Rho GTPases in other systems.48-51 While it is possible that simple mass action by Dbl-family GEFs is sufficient to displace the GDI and drive the association of Rho proteins with cellular membranes, the high affinity and 1:1 stoichiometry of the complex argues for the existence of a specific GDI displacement factor (GDF). A GDF would be capable of displacing the GDI and provides an appealing means for regulating the GTPase/GDI interaction. A GDF activity has recently been described for the regulation of the Rab/RabGDI interaction,52 and the identification of similar activities acting on Rho-family proteins is an important area of study. The Ezrin-Radixin-Moeisin (ERM) family of proteins has been proposed to act as a GDF for the Rho proteins, regulating the Rho/GDI complex through direct interactions with the GDI.53 Binding of the amino-terminal domain of ERM proteins to RhoGDI causes the release of the GTPase from the complex allowing for its activation by GEFs (reviewed in ref. 54). The ERM proteins are actin-binding proteins involved in connecting the cytoskeleton with the plasma membrane and may play a role in the effects of Rho proteins on the actin cytoskeleton.55 In vivo, it appears that the ERM proteins are involved in Rho-mediated actin rearrangements, but many of these effects appear to be downstream of Rho activation. While the ERMs are candidates for GDI displacement factors involved in Rho signalling to the cytoskeleton, activated Rho proteins localize to a variety of cellular membranes and participate in signalling processes that do not involve ERM proteins, suggesting that there may be other GDFs acting in these pathways. The Vav proto-oncogene was recently identified as specific GDI-binding partner, and may act as a GDF in certain Rac-dependent signalling pathways. Originally identified as a Dbl-family GEF specific for Rac, Vav was recently shown to interact directly with both RhoGDI and GDI2 through a calponin homology domain at its amino-terminus, a portion of the protein that is lost upon oncogenic activation.56 While the ability of Vav to regulate the Rac/GDI interaction has not been directly demonstrated, the coupling of a DH domain responsible for GEF activity with a GDI-binding domain raises the potential for coordinated down-regulation of the GDI binding and activation of nucleotide exchange. Phosphorylation of the RhoGDI downstream of phorbol ester stimulation of PKCα has also been shown to correlate with Rho activation, providing yet another potential mechanism for control of the GTPase/GDI interaction.57 Finally, the involvement of specific lipid products in controlling GDI release has been proposed.58 While ERM proteins remain the only proteins shown biochemically to dissociate Rho GTPases from a complex with the GDI, there is emerging evidence demonstrating that
42
Rho GTPases
Figure 6. Model for the GDI as a shuttle in Cdc42 signalling. The GDI protein, by virtue of its GIP activity, may act to deliver the activated form of Cdc42 to membrane locations distant from the site of activation. Similarly, the GDI can then act to recycle Cdc42 back to the original membrane compartment for another round of activation. Such a shuttling mechanism may be important in establishing the proper localization of Cdc42 and other Rho-family GTP-binding proteins.
other signalling events impact directly on the GDI to modulate its interaction with Rho-family GTPases.
Positive Signalling Roles for the GDI The cell maintains a careful balance in GDI expression, ensuring that there are nearly equal concentrations of the GDI and Rho proteins in the cell,15 and over-expression of the GDI may
Regulation of the RhoGTPases by RhoGDI
43
mask the more subtle regulatory features of its interaction with Rho GTPases. Recent work has pointed to a more complex role for GTPase/GDI complexes in directly mediating signalling events. Specifically, the Cdc42/GDI complex is able to block MAP-kinase activation downstream of Ras-GRF, suggesting a model in which Cdc42 and RhoGDI act to control signalling through the Ras/MAPK pathway.59 Disruption of the Cdc42/GDI complex and activation of Cdc42 releases the inhibition of Ras-GRF and is a prerequisite for Ras activation. In another study, the GDP-bound Rac/GDI complex can associate in the cytosol with a complex of the type I PIP-5 kinase and diacylglycerol kinase forming a preassembled signalling complex that translocates to the membrane upon GDI release,44 while the Rac/GDI complex is also able to effectively stimulate the NADPH-oxidase.25 Additional evidence for a positive signalling role for the GDI comes from the isolation of a Rac/GDI complex as a factor required for maintaining stimulated secretion in permeabilized mast cells.60 Interestingly, the GDI alone inhibited secretion, emphasizing the fact that over-expression of the GDI may mask its positive effects.
Conclusion While structural studies on the GDI provide a mechanistic understanding of the regulation of the membrane association of Rho GTPases by the GDI, the signalling pathways that modulate this interaction are only now becoming clear. As described above, the importance of membrane localization in signalling by Rho GTPases, and the ability of GDIs to regulate this activity, point to an important role for the GDI in signalling through Rho family proteins. Further, the involvement of the GTPase/GDI complex in ‘positive’ signals suggests that this complex represents an additional signalling state of the GTPase, in addition to the membrane associated GTP-bound form. The ability of the GDI to interact with both nucleotide states of the Rho GTPases suggests a mechanism in which the GDI may not only be involved in delivering the GDP-bound form of Rho proteins to the site of activation, but also in delivering the GTP-bound form to membrane compartments distant from the site of activation (Fig. 6). Interestingly, the membrane localization of certain Rho-family proteins in response to activating signals appears to be distinct from the ‘default’ membrane localization seen in over-expression studies,15 suggesting that shuttling by the GDI may be important to accessing specific membrane bound locations in response to extracellular stimuli. The structural studies described here provide a mechanistic understanding of the biochemical activities of the GDI. Even more valuable will be the tools provided by the structure, particularly the ability to specifically disrupt formation of the GTPase/GDI complex and assess the role of the GDI in the varied signalling events mediated by Rho-family GTPases.
References 1. Symons M. Rho family GTPases: The cytoskeleton and beyond. Trends Biochem Sci 1996; 21(5):178-81. 2. Ridley AJ. Rho proteins: Linking signalling with membrane trafficking. Traffic 2001; 2(5):303-10. 3. Geyer M, Wittinghofer A. GEFs, GAPs, GDIs and effectors: Taking a closer (3D) look at the regulation of Ras-related GTP-binding proteins. Curr Opin Struct Biol 1997; 7(6):786-92. 4. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature 1993; 366(6456):643-54. 5. Cerione RA, Zheng Y. The Dbl family of oncogenes. Curr Opin Cell Biol 1996; 8(2):216-22. 6. Olofsson B. Rho guanine dissociation inhibitors: Pivotal molecules in cellular signalling. Cell Signal 1999; 11(8):545-54. 7. Ueda T, Kikuchi A, Ohga N et al. Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein. J Biol Chem 1990; 265(16):9373-80. 8. Leonard D, Hart MJ, Platko JV et al. The identification and characterization of a GDP-dissociation inhibitor (GDI) for the CDC42Hs protein. J Biol Chem 1992; 267(32):22860-8. 9. Fukumoto Y, Kaibuchi K, Hori Y et al. Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins. Oncogene 1990; 5(9):1321-8. 10. Hart MJ, Maru Y, Leonard D et al. A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs. Science 1992; 258(5083):812-5.
44
Rho GTPases
11. Isomura M, Kikuchi A, Ohga N et al. Regulation of binding of rhoB p20 to membranes by its specific regulatory protein, GDP dissociation inhibitor. Oncogene 1991; 6(1):119-24. 12. Nomanbhoy TK, Erickson JW, Cerione RA. Kinetics of Cdc42 membrane extraction by Rho-GDI monitored by real-time fluorescence resonance energy transfer. Biochemistry 1999; 38(6):1744-50. 13. Clarke S. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu Rev Biochem 1992; 61:355-86. 14. Casey PJ, Seabra MC. Protein prenyltransferases. J Biol Chem 1996; 271(10):5289-92. 15. Michaelson D, Silletti J, Murphy G et al. Differential localization of Rho GTPases in live cells: Regulation by hypervariable regions and RhoGDI binding. J Cell Biol 2001; 152(1):111-26. 16. Adra CN, Ko J, Leonard D et al. Identification of a novel protein with GDP dissociation inhibitor activity for the ras-like proteins CDC42Hs and rac I. Genes Chromosomes Cancer 1993; 8(4):253-61. 17. Lelias JM, Adra CN, Wulf GM et al. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP- binding proteins. Proc Natl Acad Sci USA 1993; 90(4):1479-83. 18. Scherle P, Behrens T, Staudt LM. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci USA 1993; 90(16):7568-72. 19. Platko JV, Leonard DA, Adra CN et al. A single residue can modify target-binding affinity and activity of the functional domain of the Rho-subfamily GDP dissociation inhibitors. Proc Natl Acad Sci USA 1995; 92(7):2974-8. 20. Adra CN, Manor D, Ko JL et al. RhoGDIgamma: A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc Natl Acad Sci USA 1997; 94(9):4279-84. 21. Zalcman G, Closson V, Camonis J et al. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a noncytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG. J Biol Chem 1996; 271(48):30366-74. 22. Hoffman GR, Nassar N, Cerione RA. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 2000; 100(3):345-56. 23. Scheffzek K, Stephan I, Jensen ON et al. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat Struct Biol 2000; 7(2):122-6. 24. Grizot S, Faure J, Fieschi F et al. Crystal structure of the Rac1-RhoGDI complex involved in nadph oxidase activation. Biochemistry 2001; 40(34):10007-13. 25. Di-Poi N, Faure J, Grizot S et al. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex. Biochemistry 2001; 40(34):10014-22. 26. Longenecker K, Read P, Derewenda U et al. How RhoGDI binds Rho. Acta Crystallogr D Biol Crystallogr 1999; 55(Pt 9):1503-15. 27. Gosser YQ, Nomanbhoy TK, Aghazadeh B et al. C-terminal binding domain of Rho GDP-dissociation inhibitor directs N- terminal inhibitory peptide to GTPases. Nature 1997; 387(6635):814-9. 28. Keep NH, Barnes M, Barsukov I et al. A modulator of rho family G proteins, rhoGDI, binds these G proteins via an immunoglobulin-like domain and a flexible N-terminal arm. Structure 1997; 5(5):623-33. 29. Lian LY, Barsukov I, Golovanov AP et al. Mapping the binding site for the GTP-binding protein Rac-1 on its inhibitor RhoGDI-1. Structure Fold Des 2000; 8(1):47-55. 30. Nomanbhoy TK, Cerione R. Characterization of the interaction between RhoGDI and Cdc42Hs using fluorescence spectroscopy. J Biol Chem 1996; 271(17):10004-9. 31. Golovanov AP, Chuang TH, DerMardirossian C et al. Structure activity relationships in flexible protein domains: Regulation of rho GTPases by RhoGDI and D4 GDI. J Mol Biol 2001; 305(1):121-35. 32. Golovanov AP, Hawkins D, Barsukov I et al. Structural consequences of site-directed mutagenesis in flexible protein domains: NMR characterization of the L(55,56)S mutant of RhoGDI. Eur J Biochem 2001; 268(8):2253-60. 33. Gibson RM, Wilson-Delfosse AL. RhoGDI-binding-defective mutant of Cdc42Hs targets to membranes and activates filopodia formation but does not cycle with the cytosol of mammalian cells. Biochem J 2001; 359(Pt 2):285-94. 34. Worthylake DK, Rossman KL, Sondek J. Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1. Nature 2000; 408(6813):682-8. 35. Wei Y, Zhang Y, Derewenda U et al. Crystal structure of RhoA-GDP and its functional implications. Nat Struct Biol 1997; 4(9):699-703. 36. Rittinger K, Walker PA, Eccleston JF et al. Crystal structure of a small G protein in complex with the GTPase- activating protein rhoGAP. Nature 1997; 388(6643):693-7.
Regulation of the RhoGTPases by RhoGDI
45
37. Nassar N, Hoffman GR, Manor D et al. Structures of Cdc42 bound to the active and catalytically compromised forms of Cdc42GAP. Nat Struct Biol 1998; 5(12):1047-52. 38. Rittinger K, Walker PA, Eccleston JF et al. Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature 1997; 389(6652):758-62. 39. Mondal MS, Wang Z, Seeds AM et al. The specific binding of small molecule isoprenoids to rhoGDP dissociation inhibitor (rhoGDI). Biochemistry 2000; 39:406-412. 40. Regazzi R, Kikuchi A, Takai Y et al. The small GTP-binding proteins in the cytosol of insulin-secreting cells are complexed to GDP dissociation inhibitor proteins. J Biol Chem 1992; 267(25):17512-9. 41. Bourmeyster N, Stasia MJ, Garin J et al. Copurification of rho protein and the rho-GDP dissociation inhibitor from bovine neutrophil cytosol. Effect of phosphoinositides on rho ADP- ribosylation by the C3 exoenzyme of Clostridium botulinum. Biochemistry 1992; 31(51):12863-9. 42. Miura Y, Kikuchi A, Musha T et al. Regulation of morphology by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in Swiss 3T3 cells. J Biol Chem 1993; 268(1):510-5. 43. Nishiyama T, Sasaki T, Takaishi K et al. rac p21 is involved in insulin-induced membrane ruffling and rho p21 is involved in hepatocyte growth factor- and 12-O-tetradecanoylphorbol-13- acetate (TPA)-induced membrane ruffling in KB cells. Mol Cell Biol 1994; 14(4):2447-56. 44. Takaishi K, Kikuchi A, Kuroda S et al. Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility. Mol Cell Biol 1993; 13(1):72-9. 45. Coso OA, Chiariello M, Yu JC et al. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signalling pathway. Cell 1995; 81(7):1137-46. 46. Lu W, Mayer BJ. Mechanism of activation of Pak1 kinase by membrane localization. Oncogene 1999; 18(3):797-806. 47. Kranenburg O, Poland M, Gebbink M et al. Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA. J Cell Sci 1997; 110(Pt 19):2417-27. 48. Takaishi K, Sasaki T, Kameyama T et al. Translocation of activated Rho from the cytoplasm to membrane ruffling area, cell-cell adhesion sites and cleavage furrows. Oncogene 1995; 11(1):39-48. 49. Dash D, Aepfelbacher M, Siess W. Integrin alpha IIb beta 3-mediated translocation of CDC42Hs to the cytoskeleton in stimulated human platelets. J Biol Chem 1995; 270(29):17321-6. 50. Mizuno T, Kaibuchi K, Ando S et al. Regulation of the superoxide-generating NADPH oxidase by a small GTP- binding protein and its stimulatory and inhibitory GDP/GTP exchange proteins. J Biol Chem 1992; 267(15):10215-8. 51. Fleming IN, Elliott CM, Exton JH. Differential translocation of rho family GTPases by lysophosphatidic acid, endothelin-1, and platelet-derived growth factor. J Biol Chem 1996; 271(51): 33067-73. 52. Dirac-Svejstrup AB, Sumizawa T, Pfeffer SR. Identification of a GDI displacement factor that releases endosomal Rab GTPases from Rab-GDI. Embo J 1997; 16(3):465-72. 53. Hirao M, Sato N, Kondo T et al. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/ plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signalling pathway. J Cell Biol 1996; 135(1):37-51. 54. Sasaki T, Takai Y. The Rho small G protein family-Rho GDI system as a temporal and spatial determinant for cytoskeletal control. Biochem Biophys Res Commun 1998; 245(3):641-5. 55. Tsukita S, Yonemura S. ERM (ezrin/radixin/moesin) family: From cytoskeleton to signal transduction. Curr Opin Cell Biol 1997; 9(1):70-5. 56. Groysman M, Russek CS, Katzav S. Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation. FEBS Lett 2000; 467(1):75-80. 57. Mehta D, Rahman A, Malik AB. Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem 2001; 276(25):22614-20. 58. Chuang TH, Bohl BP, Bokoch GM. Biologically active lipids are regulators of Rac.GDI complexation. J Biol Chem 1993; 268(35):26206-11. 59. Arozarena I, Matallanas D, Crespo P. Maintenance of CDC42 GDP-bound state by Rho-GDI inhibits MAP kinase activation by the exchange factor Ras-GRF. evidence for Ras-GRF function being inhibited by Cdc42-GDP but unaffected by CDC42-GTP. J Biol Chem 2001; 276(24):21878-84. 60. O’Sullivan AJ, Brown AM, Freeman HN et al. Purification and identification of FOAD-II, a cytosolic protein that regulates secretion in streptolysin-O permeabilized mast cells, as a rac/rhoGDI complex. Mol Biol Cell 1996; 7(3):397-408.
46
Rho GTPases
CHAPTER 4
Rho Family Guanine Nucleotide Exchange Factors Ian P. Whitehead
Abstract
T
he guanine nucleotide exchange factors for the Rho GTPases (RhoGEFs) are a large family of proteins that share a dual structural motif designated the DH/PH domain. The interaction of Rho with residues within the DH domain enhances the exchange of GDP for GTP, thus converting Rho into the biologically active form. Outside of the core DH/ PH domain structure, RhoGEFs are structurally unrelated to one another suggesting that they may be involved in the regulation of a multitude of physiological processes. These sequences often contain additional structural and functional domains that provide valuable clues to the identity of these native functions. RhoGEFs are themselves subject to regulation, either through autoinhibition, or by external signals. The recent determination of the structures of RhoGEFs in complex with their substrates, coupled with the identification and analysis of RhoGEFs in model genetic systems, has provided important insights into the temporal and spatial regulation of RhoGEF function. The common theme that emerges is that RhoGEFs are often used as molecular sensors that can directly convert intra- or extra-cellular signals into localized modifications to actin-based cytoskeletal structures.
Introduction The Rho-specific guanine nucleotide exchange factors (RhoGEFs) are a large, structurally related family of enzymes that share a common ability to catalyze the exchange of GDP for GTP on members of the Rho subfamily of small GTPases (Table 1). Since Rho proteins will only bind with their effector targets when in the GTP-bound state, the RhoGEFs can be considered a family of Rho activators. Through the combined, and extensive, efforts of expression and database cloning strategies, the number of proteins that have been assigned to this family has risen at an alarming rate within the past several years. Based on the recent compilation of the complete genome sequences for a variety of organisms it has been estimated that there may be as many as 46 RhoGEFs in H. sapiens, 19 in D. melanogaster, 20 in C. elegans, 9 in S. cerevisiae, and 8 in A. thaliana.1 As an increasing number of RhoGEFs have been described and characterized, the number of cellular activities or behaviors that are known to be regulated by these proteins has also increased. Through their interactions with Rho-type GTPases, RhoGEFs have been implicated in the regulation of processes as diverse as chemotaxis, growth cone migration, bacterial invasion, cytokinesis, motility, cell polarity and oncogenic transformation. Most of these activities are presumed to occur as a consequence of the important regulatory role that RhoGEFs and their substrates play in the remodeling of the actin cytoskeleton. RhoGEFs also share a common ability to regulate signals to the nucleus, which stimulate transcriptional pathways or the cell cycle machinery. It should come as no surprise that such a large family of proteins that Rho GTPases, edited by Marc Symons. ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers.
Rho Family Guanine Nucleotide Exchange Factors
47
Table 1. Properties of RhoGEFs Organism
Designation
Specificity1
Comments
Mammals
Dbl
Cdc42, RhoA
Lbc Lfc
RhoA RhoA
Lsc/p115 -RhoGEF Dbs/Ost Tiam1
RhoA Cdc42, RhoA Rac1
Vav1
Rac1,Cdc42
Vav2
FGD1
Rac1, Cdc42, RhoA Rac1, RhoA, RhoG Cdc42
Trio
Rac1, RhoA
Abr
Tim NET1 Sos
Cdc42, RhoA, Rac1 Cdc42, RhoA, Rac1 Cdc42, RhoA, Rac1 NR RhoA Rac1
RasGRF1
Rac1
RasGRF2
Rac1
ARHGEF3 ARHGEF4
NR NR
Brx
NR
CDEP Collybist in/ hPEM-2 Ephexin
NR Cdc42
Frabin GEF337
Cdc42 RhoA
Oncogene;activated by truncation Oncogene Oncogene; binds microtubules Oncogene; RGS domain GAPs on Gα13 Oncogene Invasive phenotype in T lymphoma cells Oncogene; activated by phosphorylation Oncogene; ubiquitously expressed May regulate GTPhydrolases Disrupted in faciogenital dysplasia Encodes two DH/PH domain modules Similar to Bcr but lacks kinase domain Rearrangements associated with CML Oncogene; may regulate cytokinesis Oncogene Oncogene Contains a RasGEF domain Contains a RasGEF domain Contains a RasGEF domain Widely expressed Expression restrictcted to brain Modulates estrogen receptor Expressed in chondrocytes Induces clustering of gephryin Regulates growth cone dynamics Binds actin filaments Promotes actin stress fiber formation
Vav3
Bcr Ect-2
RhoA, Cdc42
continued on next page
Rho GTPases
48
Table 1. Continued Designation
Specificity1
Comments
GEF-H1 Intersectin
Rac1, RhoA NR
KIAA0380
RhoA
LARG
RhoA
Ngef
NR
p114-RhoGEF p116-RIP
RhoA RhoA
p190-RhoGEF PDZ-RhoGEF
RhoA NR
Pix/Cool /ARHGEF6 Kalirin
Rac1
Duet
NR
Stef
Rac1
Cdc24p/ Scd1p Rom1p, Rom2p DRG
Cdc42p
Binds microtubules Component of the endocytic machinery Contains PDZ and RGS domains Rearrangement associated with MLL Oncogene; expressed in brain Widely expressed Promotes neurite outgrowth Binds microtubules Binds Gα subunits through RGS domain Mutated in X-linked mental retardation Regulates dendritic morphogenesis Contains serine/ threonine kinase activity Closely related to Drosophila Sif Regulate cell polarity
Rac1A
MyoM
NR
DrtGEF
NR
DRhoGEF2 Pebble Sos
NR Rho1 NR
SIF
NR
C. Elegans
UNC-89 UNC-73
NR Rac1
Salmonella
SopE
Cdc42
SopE2
Cdc42
Organism
Yeast
Dictyostelium
Drosophila
Rac1
Rho1p
Implicated in bud emergence Encodes both GAP and GEF activity Unconventional myosin protein Highly expressed in morphogenic tissues Regulator of gastrulation Regulator of cytokinesis Regulates eye development Expressed in synaptic terminals Muscle protein Required for growth cone migration Bacterial toxin Contains no DH/PH domain Bacterial toxin Contains no DH/PH domain
1 Exchange specificities are for DH domain related activities only.NR = none reported.
Rho Family Guanine Nucleotide Exchange Factors
49
participates in such a diverse array of fundamental biological processes would be linked to an increasing number of clinical disorders in humans.
Structure of RhoGEFs All members of the RhoGEF family share an ≈ 300 amino acid region of similarity with Dbl, a transforming protein that was originally isolated from a diffuse B-cell lymphoma. This region can be further sub-divided into two recognizable domains, an ≈200 amino acid Dbl homology (DH) domain and an ≈100 amino acid pleckstrin homology domain. The DH domain is a unique feature of the RhoGEFs, while PH domains have been identified in numerous other signalling molecules.2 The DH and PH domains are almost always found in a tandem array in RhoGEFs with the PH domain located immediately carboxyl-terminal to the DH domain. The only exceptions to this conserved topography are DRG which contains two DH domains which flank a single PH domain,3 and a splice variant of βPIX, which contains no PH domain at all.4
DH Domains It has now been demonstrated through a number of cell-based, biochemical, and structural studies that the DH domain represents the core catalytic domain of RhoGEFs. In any instance where the biological activity of a RhoGEF is mediated via its interaction with a Rho GTPase substrate, this activity is dependent upon the structural integrity of the DH domain. For example, a subset of the RhoGEFs has been isolated based on their transforming activity in NIH 3T3 focus-formation assays.5 This activity is presumed to occur through their interaction with Rho family GTPases since mutants of Rho proteins that are constitutively activated exhibit a similar oncogenic activity. Although fragments of RhoGEFs that contain the isolated, intact DH/PH domain module retain all of their transforming activity, this activity is abrogated by deletions or point mutations that disrupt the DH domain.6-10 Biochemical studies also suggest that isolated DH domains can contain all the residues that are necessary to catalyze guanine nucleotide exchange.11-15 However, in virtually all cases, the associated PH domain is required for full biological activity in vivo. Early predictions that the DH domain structure would be all α-helical5 have been confirmed by the recent determinations of DH domain structures from Vav, Tiam1, Sos1, Trio, βPIX and Dbs.13,14,16,17 In each case the DH domain was shown to be a flat, elongated bundle of α-helices. Three conserved regions, designated CR1, CR2 and CR3,5 pack together to form the central core suggesting that other DH domains may have similar structures. In the cases of Tiam1 and Dbs, the DH domain structures have been resolved in complex with their GTPase substrates (Rac1 and Cdc42 respectively), and in both instances the interface between GTPase and GEF is extensive and is mediated primarily by residues within the CRI and CR2 domains.16 Consistent with the biochemical characterization of RhoGEFs, Tiam1 binds to the Switch I and II domains of Rac1 causing them to assume a conformation that blocks Mg++ binding and favoring the release of GDP. Interestingly, the extent of the interface between GEF and substrate precludes the possibility that the GTPase can simultaneously bind to both a GDI and GEF suggesting that both families of regulatory proteins may compete for access to the substrate. A search of the relevant databases suggests that the structure of the DH domain is unique, bearing no resemblance to other families of GEFs. Despite the fact that small GTPases are highly conserved in their structure, each subfamily is associated with a structurally distinct and highly specific family of exchange factors. For example, the RasGEF region of Sos1 and the ArfGEF domain of Gea2 are structurally unrelated to one another, and to the DH domain.18,19
PH Domains With respect to the full biological activity of RhoGEFs in vivo, the PH domain is as indispensable as the DH domain. Point mutations in conserved residues of either domain are often
50
Rho GTPases
associated with a complete loss of cellular activity.6-8 Although generally considered to be noncatalytic in nature, PH domains are thought to perform several tasks within the context of a RhoGEF. These include contributing to the correct folding of the DH domain, direct modulation of catalytic activity, and recruitment of RhoGEFs to cellular membranes. These latter two functions may be mediated by the association of PH domains with phosphoinositide second messengers and will be discussed in detail in subsequent sections of this chapter. Although there have also been numerous reports of nonRhoGEF associated PH domains mediating protein-protein interactions, such reports have been rare for RhoGEFs, one exception being the PH domain of Lfc which has been shown to bind directly to tubulin.20 The PH domain structures are known for the RhoGEF domains of Sos1, Dbs and Tiam1.16,17 Typical of other PH domains, the PH domains of RhoGEFs form antiparallel β-sandwiches composed of two β-sheets that are capped at one end by the carboxyl-terminal α-helix. Mutational analysis has identified clusters of positively charged residues contained within the highly variable loops that connect the β-strands that are the likely sites of phosphoinositide binding. In the proximity of the hinge region that connects the DH and PH domains are additional secondary structural elements that may be unique to the PH domains of RhoGEFs.
Additional Structural and Regulatory Motifs Outside of the well conserved DH/PH domain module, RhoGEFs exhibit relatively little similarity to one another. Nonetheless, a large and diverse array of motifs that are commonly found in other families of signalling molecules have also been described in RhoGEFs.5 These include consensus sites for protein phosphorylation, C2 domains that are thought to bind diacylglycerol in a calcium dependent manner, and SH2, SH3 and PDZ domains that are likely to mediate binding to other proteins. Additional catalytic domains have also been described that would allow for the coordinate regulation of multiple substrates. These include kinase domains, RhoGAP domains, RasGEF domains, additional RhoGEF domains, and domains that can bind and regulate membrane-bound heterotrimeric G proteins. The diversity of these signalling motifs suggests that the regulation of RhoGEFs will be equally diverse reflecting the multitude of biological activities in which they are known to participate.
Regulation of RhoGEFs It is generally thought that, in the absence of activating signals, RhoGEFs exist in the cell in a quiescent, catalytically inactive state. This state is maintained by autoinhibitory interactions between the DH domain and either the adjacent PH domain, or more distal regulatory sequences. In response to activating signals these constraints are relieved, exposing the catalytic interface and allowing access to the GTPase substrates. The large array of recognizable signalling motifs that have been identified within RhoGEFs provide ample opportunities for upstream signalling events to impinge upon catalytic function. The diversity of these motifs suggests that the signals that regulate RhoGEFs are likely to be equally diverse, and in some cases unique to a particular family member. Not surprisingly, there are an increasing number of distinct classes of signalling molecules that have been shown to interact directly with RhoGEFs and stimulate their catalytic activity. These include phosphoinositides, protein tyrosine or serine/ threonine kinases, heterotrimeric G protein Gα subunits and other regulators of small GTPases.
Regulation by PH Domains The invariable pairing of the DH domain with the PH domain suggests that the RhoGEF PH domains may play a specific role in regulating GEF activity. Although there is some structural and in vivo data to suggest that this may be the case, the picture that is emerging is complex, with PH domains having positive, negative or no effect at all on catalytic activity. For example, whereas the isolated DH domain of Trio is competent to catalyze guanine nucleotide exchange on its substrates in vitro, addition of the PH domain dramatically increases exchange proficiency.13 Structural studies of the DH/PH domain module of Tiam1 in complex with Rac1 provide some clues as to a potential mechanism for such positive regulation. In Tiam1 the
Rho Family Guanine Nucleotide Exchange Factors
51
carboxyl-terminus of the DH domain interacts with both Rac1 and the PH domain suggesting that the structural stabilization of Rac1 is dependent on both the DH and PH domains. In addition, the DH/PH domain of Tiam1, which is catalytically active in vitro, assumes a conformation that is favorable for Rac1 binding. However, the structural data for Tiam1 are in direct contrast to what has been observed for Sos1 and βPIX. The DH/PH domain of Sos1 is catalytically inactive in vitro, and assumes a configuration that would deny access to the substrate,17 while the DH and PH domains of β-PIX seem to act as independent units in solution.4 There is also some biological data to suggest that functional interdependence between the DH and PH domains may not be a characteristic of all RhoGEFs. For example, the DH domain of Lbc, when expressed alone, retains most of its biological activity in vivo,21 and the PH domains of Lfc and Dbs can be functionally replaced by plasma membrane targeting signals.7,15 Thus, while it is clear from the structural data that the PH domain is ideally situated and competent to directly regulate catalytic activity, there is also evidence to suggest that such regulation may not always occur.
Regulation by Distal Autoinhibitory Domains In addition to regulation by the adjacent PH domain, there is evidence that several RhoGEFs are regulated by additional autoinhibitory domains located outside of the DH/PH domain motif. Many of the RhoGEFs that were isolated in transformation assays require truncation of specific amino- or carboxyl-terminal sequences to expose their oncogenic activity. Such sequences are likely to impose intramolecular blocks on catalytic activity. For example, both Dbl and Vav contain amino-terminal sequences that can bind directly to the DH/PH domain module and block access to the binding surface of the GTPase.14,22 In the case of Vav, this autoinhibition is a consequence of an interaction between an amino-terminal α-helix and the GTPase binding site of the DH domain.14 These inhibitory contacts are relieved by phosphorylation of tyr-174 which is contained within the amino-terminal regulatory domain (discussed later in this chapter). In contrast, a structurally distinct domain within the amino-terminus of Dbl blocks access to substrates by forming contacts with the PH domain.22 Although the mechanism by which this constraint is relieved in vivo is not known, it may also involve phosphorylation on tyrosine residues. The large number of RhoGEFs that exhibit enhanced biological activity when expressed in a truncated form suggests that autoinhibition may be a common regulatory mechanism employed by RhoGEFs.
Regulation by Self-Association Recent studies suggest that oligomerization may also contribute to the regulation of at least a subset of the RhoGEFs. The crystal structure of Tiam1 in complex with Rac1 consists of heterotetramers whose formation are mediated by residues within the DH domain,16 and RasGRF1, RasGRF223 and an oncogenic derivative of Dbl24 are thought to undergo oligomerization in a DH domain-dependent manner. In the case of RasGRF1, RasGRF2 and Dbl, the association seems to be homophilic in nature since binding can be detected with closely related DH domains but not with those that are more distantly related. It is unclear what the function of oligomerization will be in vivo. The introduction of point mutations into the DH domain of Dbl that block oligomerization have no effect on GTPase binding and GEF activity in vitro, but exhibit reduced GEF activity in vivo.24 This reduction in activity is accompanied by selective loss of some biological responses that are normally associated with overexpression of oncogenic derivative of Dbl (e.g., anchorage independent growth) and an overall reduction in transforming activity. Based on these observations, it has been argued that oligomerization favors localized augmentation of Rho GTPase activation, which may be necessary for full oncogenic transformation. However, it has not been determined whether full-length Dbl also undergoes oligomerization and if so, what such an event contributes to its normal biological function. Although it will be of interest to see which other RhoGEFs undergo oligomerization, it may not be a universal phenomenon since the crystal structure of Dbs/Cdc42 does not consist of heterotetramers (John Sondek, personal communication).
Rho GTPases
52
Table 2. Binding of RhoGEFs to phosphoinositides GEF
Binds
Comments
Sos1
PtdIns(3,4,5)P3 PtdIns(4,5)P2 PtdIns(1,4,5)P3 PtdIns(4,5)P2
Stabilizes the DH/PH interface Destabilizes the DH/PH interface Function unknown Stabilizes the DH/PH interface; Inhibits exchange Destabilizes the DH/PH interface; Promotes exchange Promotes exchange Promotes exchange Weak interaction; Promotes exchange Weak interaction; No effect on exchange Function unknown Function unknown Blocks Cdc42 binding; Inhibits exchange Blocks Cdc42 binding; Inhibits exchange
Vav
PtdIns(3,4,5)P3 Tiam11
Trio1 Dbl
PtdIns(3,4)P2 PtdIns(3,4,5)P3 PtdIns(3,4)P2 PtdIns(4,5)P2 PtdIns(4,5)P2 PtdIns(4)P PtdIns(3,4,5)P3 PtdIns(4,5)P2
1 Binding properties for Tiam1 and Trio are for their amino-terminal PH domains.
Regulation by Phosphoinositides RhoGEFs are generally thought to require membrane localization in order to interact with their membrane-bound GTPase substrates. There is now substantial evidence that the association of RhoGEFs with membranes is mediated by interactions between PH domains and phosphoinositides. Not only are phosphoinositides thought to direct RhoGEFs to membranes, but it also thought that they can contribute directly to catalytic activation. Although PH domains will preferentially bind to phosphoinositides relative to other membrane lipids, they can differ in their ability to interact with specific members of the phosphoinositide family (Table 2). For example, the PH domains of Dbl, Sos1 and the amino-terminal PH domain of Tiam1 show their highest affinity for phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3),25-27 suggesting that they may be regulated by phosphoinositide 3-kinase (PI3K), while Dbs and Intersectin bind preferentially to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), and the carboxyl-terminal PH domain of Tiam1 binds with greatest affinity to phosphatidylinositol 3-phosphate (PtdIns(3)P) (John Sondek, personal communication). The possibility that RhoGEF PH domains may exhibit specificity with respect to phosphoinositide binding may provide a mechanism through which RhoGEFs may be targeted to specific membrane locations. Since the PH domains of RhoGEFs bind with phosphoinositides, and phosphoinositides such as PtdIns(3,4,5)P3 are involved in the recruitment of signalling proteins to the plasma membrane, it is tempting to speculate that the sole function of phosphoinositide binding with respect to RhoGEFs is to mediate membrane association. However, there is evidence that in at least one case binding to phosphoinositides is not associated with, or sufficient for membrane association. Although the amino-terminal PH domain of Tiam1 binds with high affinity to PtdIns(3,4,5)P3, this isolated PH domain is not localized to the membrane and the PI3K inhibitor Wortmannin has no effect on the subcellular localization of Tiam1.28 What then is the function of phosphoinositides with respect to the regulation of Tiam1? There is in fact
Rho Family Guanine Nucleotide Exchange Factors
53
Figure 1. A model for the sequential activation of Vav by phosphoinositides and phosphorylation. In the basal state the PH domain of Vav is bound to PtdIns(4,5)P2 which favors binding of the PH domain to the DH domain. This conformation would hinder access of tyrosine kinases to tyr-174. Vav activation is initiated by the conversion of PtdIns(4,5)P2 to PtdIns(3,4,5)P3 by PI3K which would disrupt the DH/PH interface, allowing access by Lck. Subsequent phosphorylation on tyr-174 causes the autoinhibitory domain to lose its structure allowing access of the DH domain to the GTPase substrate.
evidence that a number of PH domains, within the context of RhoGEFs, can directly regulate GEF activity via their interaction with phosphoinositides. This includes Tiam1 for which it has been demonstrated that two products of PI3K, PtdIns(3,4,5)P3 and PtdIns(3,4)P2, enhance Tiam1 guanine nucleotide exchange activity in vitro.26 Interestingly, the carboxyl-terminal DH-associated PH domain of Tiam1 binds a different phosphoinositide (PtdIns(3)P), yet this binding is not associated with altered GEF activity in vitro (J. Sondek, personal communication). Therefore, the two PH domains of Tiam1 are likely to have discrete functions with respect to both membrane localization and catalytic regulation. Tiam1 is not the only RhoGEF whose catalytic activity is regulated by phosphoinositide binding. Studies on the PH domain of the Vav oncoprotein have determined that binding to the product of PI3K, PtdIns(3,4,5)P3, enhances GEF activity, whereas binding to the PI3K substrate PtdIns(4,5)P2 decreases GEF activity.29 Interestingly, the full-length Vav protein lacks GEF activity in vitro, yet Vav without the PH domain exhibits biological activity in vivo. This supports a model in which the PH domain of Vav, through its interaction with discrete pools of phosphoinositides, directly regulates exchange activity. In further support of this model, it has been demonstrated that PtdIns(4,5)P2 increases the affinity of the Vav DH domain for the PH domain, interfering with its ability to bind Rac1. In contrast, binding of the Vav PH domain to PtdIns(3,4,5)P3 reduces the affinity of the DH domain for the PH domain, and is permissive for Rac1 binding.30 Although it is still unclear what the consequences of phosphoinositide binding to RhoGEFs is in vivo, it seems clear that the tight coupling of DH domain/GTPase and PH domain/phosphoinositide complexes at the membrane should have a profound effect on catalytic activity.
Regulation by Phosphorylation Several RhoGEFs are known to become phosphorylated in response to extracellular stimuli and this event is generally accompanied by activation of an associated GTPase. Consistent with this, in virtually all cases that have been examined, RhoGEF phosphorylation has been shown to directly regulate exchange activity in vitro. For example, the activation of Rac1 by RasGRF1 is significantly enhanced following phosphorylation of RasGRF1 by the nonreceptor tyrosine kinase Src.31 Dbl and Vav also exhibit enhanced exchange activity when they are phosphorylated on tyrosines by the nonreceptor tyrosine kinases ACK1 and Lck respectively.32,33 Activation of RhoGEFs by phosphorylation is not just restricted to the tyrosine kinases. Membrane localization and enhanced nucleotide exchange toward Rac1 have also been reported for Tiam1 in response to phosphorylation on threonine by the serine/threonine kinase CamKII.34 Ect2 is phosphorylated during G2 and M phases by an unidentified kinase, and this phosphorylation is required for its exchange activity.35 Although relatively little is known about the mechanism through which phosphorylation can directly regulate the exchange activities of Tiam1, Dbl, Ect2 and RasGRF1, the mechanism through which tyrosine phosphorylation contributes to the activation of Vav has been extensively studied.
54
Rho GTPases
Figure 2. A model for RhoA activation by the Gα13 subunit of heterotrimeric G proteins. When the GPCR engages its ligand it becomes catalytically active, converting its associated Gα13 subunit to the GTP-bound state. Gα-GTP uncouples from the Gβγ dimer and interacts with the RGS domain in the amino-terminus of p115 RhoGEF, thus stimulating the GEF activity of p115 RhoGEF for RhoA.
Vav expression has been observed primarily in hematopoeitic tissues and it is known to be rapidly phosphorylated in response to antigen stimulation of the B- and T-cell receptors.36-38 Phosphorylation is mediated through the actions of Syk and Src-family nonreceptor tyrosine kinases.32,39 Phosphorylation of Vav invariably results in the stimulation of nucleotide exchange activity directed towards Rac1. In the absence of phosphorylation, exchange activity is not detectable, even in in vitro assays. The best characterized site of phosphorylation on Vav is tyr-174 which has been shown to be a substrate for both Syk and Lck.32 Phosphorylation of this residue by Lck enhances GEF activity of Vav in vitro, and amino-terminal truncations that remove this residue eliminate the catalytic requirement for phosphorylation.32 Interestingly, phosphorylation on tyr-174 of Vav is facilitated by the presence of PtdIns(3,4,5)P3 and hindered by the presence of PtdIns(4,5)P2.29 This correlates with phosphoinositide-mediated binding of the PH domain to the DH domain construct with PtdIns(4,5)P2 enhancing and PtdIns(3,4,5)P3 decreasing the binding affinity.30 This suggests that phospholipid binding to the PH domain may contribute to the structural coupling between tyr-174 and the DH domain. The structure of Vav in solution lends some support to such a mechanism. The amino-terminal inhibitory domain forms an α-helix that interacts with conserved residues in the DH domain, effectively blocking access by the substrate.14 At the center of this inhibitory complex is tyr-174 and phosphorylation of tyr-174 causes the α-helix to lose its structure and release from the catalytic interface. Based on the NMR structure of autoinhibited Vav, a model has been proposed for Vav regulation (Fig. 1). In its inactive state, the PH domain of Vav would be bound to PtdIns(4,5)P2, which would favor binding of the PH domain to the DH domain, which in turn would sterically hinder access of tyrosine kinases to tyr-174. Vav activation would be initiated by the conversion of PtdIns(4,5)P2 to PtdIns(3,4,5)P3 by PI3K, which would disrupt the DH/PH domain interface. This would allow access by tyrosine kinases to tyr-174. Subsequent phosphorylation would cause the autoinhibitory domain to lose its structure and expose the catalytic activity. Ect2, Dbl and Tiam1 are also regulated by amino-terminal sequences that lie outside of the DH domain. Like Vav, the regulatory sequences of Dbl have been localized and have been shown to form intramolecular contacts with the DH/PH domain module.22 Whether or not this inhibition is dependent upon phosphoinositide binding, or is released by phosphorylation, remains to be determined. The observation that Dbl GEF activity is regulated by the tyrosine kinase ACK1 suggests that Vav and Dbl may be subject to similar regulatory mechanisms.33 Although evidence for direct roles of phosphorylation in the regulation of RhoGEF activity remains scarce, it seems likely that such evidence will be forthcoming and that this will represent a relatively common mechanism of RhoGEF activation.
Rho Family Guanine Nucleotide Exchange Factors
55
Figure 3. A model for the coordinate regulation of Ras and Rac1 by Sos1. Activation of a receptor tyrosine kinase by its ligand recruits the Grb/Sos1 complex to the plasma membrane. The RasGRF domain of Sos1 activates membrane-bound Ras, which in turn can interact with and activate its effector protein PI3K. PI3K then phosphorylates PtdIns(4,5)P2, which is bound to the PH domain of Sos1, converting it into PtdIns(3,4,5)P3. This would modify the interface between the DH and PH domains allowing access to Rac1.
Regulation by Gα Subunits The heterotrimeric G proteins are a large family of membrane associated GTPases that coordinate the conversion of extracellular stimuli into intracellular signalling events. They are anchored to the intracellular surface of the plasma membrane where they are activated by an associated family of transmembrane receptors (G protein coupled receptors or GPCRs). Typically, a heterotrimeric G protein consists of a Gα subunit that contains the guanine nucleotide binding site, and a dimer that consists of tightly associated β and γ subunits (Gβγ). GPCRs contain GEF activity and can activate heterotrimeric G proteins by catalyzing the exchange of GDP for GTP on the Gα subunit. When a GPCR is engaged by its ligand it will become catalytically activated, converting Gα to the GTP-bound state. The Gα subunit will then become dissociated from the dimer allowing both components to function independently to stimulate distinct signalling events. Inactivation of heterotrimeric G proteins is regulated by a family of GAPs, which share a common catalytic domain referred to as the regulator of G protein signalling (RGS) domain. It has now been established that a distinct subset of the cellular changes that accompany the activation of heterotrimeric G proteins occur in a Rho-dependent manner.40 In cases where the heterotrimeric and the Rho GTPases are known to regulate similar cellular processes, they often appear to function within the context of the same signalling pathway. At least one mechanism has now been identified through which these two families of signalling molecules are coupled, and this mechanism involves a RhoGEF. p115 RhoGEF is a RhoA specific exchange factor that also contains an RGS domain within its amino-terminus.41,42 The RGS domain of p115 RhoGEF is specific for a subset of the Gα subunits, which includes Gα12 and Gα13.43 Importantly, binding of Gα13 to the RGS domain of p115 RhoGEF stimulates its catalytic activity for RhoA in vitro, and in vivo.44,45 Thus, a surprisingly simple model emerges (Fig. 2) in which activation of Gα13 causes the recruitment and activation of p115 RhoGEF which in turn causes activation of RhoA. Since p115 RhoGEF can also function as a GAP for Gα13, this would allow for rapid cycling of the complex. p115 is not the only RhoGEF that may be regulated by direct interactions with heterotrimeric G proteins. PDZ-RhoGEF and LARG also have RGS domains, and may also link heterotrimeric G proteins with Rho GTPases.46,47 PDZ-RhoGEF has been shown to bind to Gα subunits, but whether the RGS domains of PDZ-RhoGEF, or LARG, can function as GAPs for Gα subunits, or whether Gα binding stimulates their exchange activity, remains to be determined. Nonetheless, p115 RhoGEF, PDZ-RhoGEF and LARG are likely to represent an important subgroup of the RhoGEFs that can functionally link extracellular signalling via GPCRs to Rho-mediated effector responses.
56
Rho GTPases
Regulation by Small GTPases There is also evidence that members of the RhoGEF family may have the capacity to coordinately regulate the activity of more than one small GTPase. GEFs such as Sos1 and RasGRF1 contain GEF domains for both Ras and Rho proteins and there is evidence that Sos1 can activate Rac in a Ras-dependent manner.48 Trio and DRG each contain two distinct DH domains and proteins such as BCR contain both DH and GAP domains. Although the mechanisms through which BCR, Trio and DRG may coordinately regulate multiple Rho family GTPases remain largely unknown, recent studies have suggested a mechanism through which Sos1 may coordinately regulate the activation of both Ras and Rac1.48 Sos1 is a member of the RhoGEF family that is probably better known as an activator of Ras.49 In addition to its DH domain, which contains GEF activity for Rac1, Sos1 also contains a structurally distinct domain through which it can catalyze guanine nucleotide exchange on members of the Ras subfamily. Since several studies have positioned Rac1 downstream of Ras, there has been keen interest in the role that Sos1 may play in linking these two GTPases. In a manner very similar to Vav, the binding of phosphoinositides to the adjacent PH domain regulates the DH domain of Sos1.30 As is the case with Vav, PtdIns(4,5)P2 promotes the binding of the DH and PH domains of Sos1, interfering with substrate binding, while PtdIns(3,4,5)P3 supports a conformation that favors substrate binding. Expression of the Sos1 DH domain alone in COS-7 cells can activate Rac1, while the DH/PH domain module can only activate Rac1 if it is coexpressed with a derivative of Ras that is competent to activate PI3K.48 PI3K is an effector protein for Ras that will bind and become activated when Ras is in the GTP-bound state. These observations are consistent with the phosphoinositide binding studies and suggest that one of the products of PI3K may be necessary to activate the DH domain of Sos1 in vivo. It also provides the framework for a model that would explain the coordinate regulation of Ras and Rac1 by Sos1 (Fig. 3). This model proposes that recruitment of Sos1 to the cellular membrane results initially in the activation of Ras by the Sos1 encoded RasGRF domain. Activated Ras would then interact with and activate its effector protein PI3K. PI3K could then, in turn, phosphorylate PtdIns(4,5)P2 which is bound to the PH domain of Sos1, converting it into PtdIns(3,4,5)P3. This would convert the DH domain of Sos1 into an active state and support exchange on Rac1. Although many aspects of this model must be confirmed by additional in vivo studies, it provides another mechanism through which RhoGEFs may play a critical role in converting extracellular signals into specific intracellular responses. As more is learned about the coordinate regulation of multiple GTPases by RhoGEFs the number of distinct regulatory mechanisms that they employ are likely to increase.
Physiological Roles for RhoGEFs Although RhoGEFs and their substrates have well documented roles in the regulation of cell morphology, the mechanisms that ensure that they are able to perform complex morphogenetic alterations in a spatially and temporally precise manner are not well understood. With the generation of mouse strains that are homozygous null for specific RhoGEFs, and the identification of RhoGEFs in species that are more amenable to genetic manipulation, the role that some of these RhoGEFs may play in the regulation of specific morphogenetic changes can now be examined in more detail. Since several chapters in this volume are devoted to the analysis of Rho function in model systems, we will confine the discussion here to some specific examples of biological processes in which the regulatory role of the RhoGEF has been more clearly defined. These include regulation of neuronal development, cytokinesis, bud emergence, and cellular transformation. The picture that emerges from these studies is that local activation or recruitment of RhoGEFs is an important strategy that is used by many organisms to link global changes in cell behavior to the local reorganization of the actin cytoskeleton.
Rho Family Guanine Nucleotide Exchange Factors
57
Figure 4. Activation of Pak by Trio in the growth cones of developing photoreceptors. Localized activation of Trio in the growth cone of a photoreceptor causes activation of Rac1 by the GEF1 domain. The adapter protein Dock recruits Pak to the same location and the two events converge. Rac-GTP binds to the CRIB domain of Pak, stimulating its kinase activity.
RhoGEFs and Neuronal Development During development of the nervous system intricate patterns of neuronal connections are formed as axons are directed towards their targets by guidance clues. This targeting system relies on the local reorganization of the actin cytoskeleton within the growth cone which can direct axonal growth away from, or towards, these extracellular markers. However, the mechanism by which guidance clues are able to convert positional information, via cellular receptors, into appropriate cytoskeletal changes is not fully understood. There is now mounting evidence that a subfamily of the RhoGEFs that includes proteins such as Trio, UNC-73 and Ephexin, may function within the context of growth cones to regulate these processes. Genetic studies have shown that UNC-73 is necessary for axon guidance in C. elegans,50 and a loss-of-function mutation in murine trio causes aberrant neuronal organization that would be consistent with a defect in axon pathfinding.51 However, the most compelling evidence linking RhoGEFs to the regulation of axon guidance comes Drosophila where a series of elegant genetic studies have identified a crucial role for Drosophila Trio in regulating multiple axon guidance pathways.52-54 These studies revealed that loss-of-function mutations in Trio were associated with defective guidance of photoreceptors, motor axons, and neurons of the embryonic central nervous system. Importantly, in each of these studies Trio expression was observed along the length of axons and at particularly high levels within the growth cone. With respect to photoreceptor guidance in Drosophila, Trio mutants exhibit phenotypes that are indistinguishable from those of Dock and Pak.54 Dock is an SH2-SH3 adaptor protein that binds to the amino-terminus of Pak, while Pak is a serine/threonine kinase that is an effector for Rac1. The recruitment of Pak to the plasma membrane by Dock is required for correct pathfinding by photoreceptors. What emerges from these studies is a model in which Trio is activated at the cell membrane and in turn activates Rac1 (Fig. 4). In response to a second signal, Dock recruits Pak to the cellular membrane where the two events can converge culminating in Pak activation. How extracellular guidance clues are able to cause localized activation of Trio remains an important question. Recent studies looking at the regulation of repulsive signals for axon guidance in mice may provide some answers.
58
Rho GTPases
Figure 5. Ect2 may link cell cycle progression to cytokinesis in mammalian cells. During interphase Ect2 is localized primarily in the nucleus. It becomes phosphorylated during the G2-M phases of the cell cycle, which stimulates its catalytic activity. Phosphorylated Ect2 enters the cytoplasm at the beginning of mitosis where it accumulates at the midbody prior to cytokinesis. Ect2 may activate RhoA at the midbody which in turn could stimulate the assembly of actin structures. Thus, ect2 may provide an important molecular link between cell cycle progression and the initiation of cytokinesis.
The ephrins are a family of extracellular guidance molecules that exert a repulsive effect on axons during the development of the central nervous system of mice. The binding of ephrins to their receptors, the Eph receptor tyrosine kinases, results in growth cone collapse via activation of RhoA.55 Ephexin is a member of the RhoGEF family that was isolated as a binding partner for Eph receptors.56 Ephexin shows greatest activity for RhoA in vitro, and ligand engagement by the receptor stimulates the catalytic activity of Ephexin and is associated with increased GTP levels on RhoA in vivo. Expression of a dominant-inhibitory version of Ephexin blocks ephrin-induced growth cone collapse in primary neurons. It is clear that the direct association between the receptor and the RhoGEF may provide an important molecular link that couples positional clues to localized alterations in the actin cytoskeleton. It remains to be determined whether Trio is also sequestered by transmembrane receptors during photoreceptor growth.
RhoGEFs and Cytokinesis The process of cytokinesis is responsible for the accurate partitioning of cellular material between daughter cells during division. This involves the assembly and contraction of the actomyosin ring which drives the formation of a cleavage furrow. In addition to the structural components of the ring, which include actin, an assortment of actin-associated proteins, and the regulatory light chain of nonmuscle myosin, members of the Rho family have also been localized to the cleavage furrow in Xenopus embryos and mammalian cells.57,58 Not surprisingly, any cellular process that is driven by the action of Rho proteins is influenced by RhoGEFs, and cytokinesis is no exception. Recent studies in both Drosophila and mammalian systems point to an important role for RhoGEFs in this process.35,59 Pebble is a RhoGEF in Drosophila that is required for cytokinesis.59 During mitosis, Pebble accumulates at the cleavage furrow, and mutations in Pebble do not form a contractile ring and fail to undergo cytokinesis. The most likely target for Pebble is Rho1, since Rho1 mutations are also defective in cytokinesis, and the two proteins interact in a yeast 2-hybrid assay.59 What emerges from a large body of genetic data is a linear pathway that is responsible for the assembly of the contractile ring. The first step in this pathway is the activation of Rho1 by Pebble. In
Rho Family Guanine Nucleotide Exchange Factors
59
Figure 6. Cdc24p links cell cycle progression to bud emergence in Saccharomyces cerevisiae. At the beginning of G1 Cdc24p is sequestered in the nucleus by the adapter protein Far1p. Once the cell reaches a critical size, the G1-specific CDK, Cdc28p, phosphorylates Far1p. Once phosphorylated, Far1p dissociates from Cdc24p and is targeted for ubiquitin-mediated degradation. Cdc24p is then free to leave the nucleus where it is targeted to the incipient bud site via a Cdc28p-dependent mechanism. At the bud site, the Ras-like GTPase Rsr1 can directly activate Cdc24p in a GTP-dependent manner. Catalytic activation of Cdc24p could then trigger Cdc42p-dependent actin assembly. Rsr1 is activated by its own GEF, Bud5p, which is specifically localized to the budding landmark through its binding to Axl2p/Bud10p.
its GTP-bound form, Rho1 will interact with the formin-related protein Dia,60 which in turn will bind and activate profilin. Profilin is required for the polymerization of actin and is likely to be responsible for the assembly of the contractile ring. What then is the nature of the signal that coordinates cytokinesis with progression through the cell cycle, and how could such a signal direct the localized activation of Pebble? Studies on a mammalian relative of Pebble, Ect2,may provide an answer to this question. Ect2 is a RhoA specific RhoGEF that was identified as a transforming protein in NIH 3T3 focus-formation assays.10 Ect2 is closely related to Pebble, and has a pattern of expression that suggests that it may also be involved in the regulation of cytokinesis. During interphase Ect2 is localized primarily in the nucleus, but then enters the cytoplasm during the beginning of mitosis where it accumulates at the midbody prior to the onset of cytokinesis.35 Genetic inhibitors that block Ect2 function cause large multinucleate cells further supporting an important role for Ect2 in the regulation of cell division. In addition to the canonical DH/PH tandem structure, Ect2 also contains several motifs that suggest that it may be directly regulated by components of the cell cycle machinery. These include a region of homology to the yeast cyclin Clb6, two copies of the BRCA1-COOH-terminal repeat (BRCT) which is found in many checkpoint and repair proteins, and two consensus Cdc2 phosphorylation sites. Importantly, Ect2 becomes phosphorylated during the G2-M phases of the cell cycle and this phosphorylation is required for its catalytic activity.35 Thus, it is possible that Ect2 is directly phosphorylated by components of the cell cycle machinery, and that this phosphorylation may be required for its catalytic activation, as well as correct localization to the cleavage furrow. Thus, Ect2 may function as a nuclear sensor that provides a molecular link between cell cycle progression and the initiation of cytokinesis (Fig. 5). It remains to be determined whether Pebble would perform a similar function in Drosophila and whether it is also catalytically regulated by phosphorylation.
RhoGEFs and Bud Emergence in Yeast The budding yeast Saccharomyces cerevisiae exhibits polarized growth at several points during its life cycle. For example, during vegetative growth, and through a mechanism that is
60
Rho GTPases
tightly linked to the cell cycle machinery, a bud will begin to emerge during late G1.61 This process is initiated by the cyclin-dependent kinase (CDK) Cdc28p which triggers a complex program of actin polarization.62 At the cell cortex, both the position and the timing of bud emergence are specified by a group of regulatory proteins that act through localized modifications to the actin cytoskeleton. Central to this regulatory complex is the Rho family GTPase Cdc42p, and its GEF Cdc24p, which become localized at the site of bud emergence.61 Mutant alleles of both CDC42 and CDC24 exhibit similar budding defects suggesting that activation of Cdc42p by Cdc24p is required for bud assembly. Although relatively little is known about the localized recruitment of Cdc42p, considerably more progress has been made in understanding the relationship between the cell cycle machinery, and the activation and recruitment of Cdc24p to the incipient bud site. At the beginning of G1 Cdc24p is sequestered in the nucleus by the adapter protein FarIp (Fig. 6).63-65 Once the cell reaches a critical size Cdc28p phosphorylates FarIp causing it to be released from Cdc24p and targeting it for ubiquitin-mediated degradation.64-66 Cdc24p is now free to exit the nucleus where it is targeted to the bud site through a Cdc28p-dependent mechanism.67 Once Cdc24p reaches the bud site it probably interacts with the Ras-related small GTPase RsrI/BudI. RsrI/BudI, which is also present at the bud site, will interact with the amino-terminal regulatory domain of Cdc24p in a GTP-dependent manner.68 Binding to GTP-bound RsrI/BudI may stimulate the catalytic activity of Cdc24p, which in turn, could trigger Cdc42-dependent actin assembly. RsrI/BudI is activated by its own GEF, Bud5p69 which colocalizes with Axl2p/Bud10p, a component of the early budding landmark.70 Thus, similar to the case with Ect2, Cdc24p may function as a nuclear sensor that can actively participate in the conversion of temporal information from the cell cycle machinery, into the assembly of a spatially regulated actin structure at a distant cellular location.
Transforming Activity of RhoGEFs Although recent studies have begun to reveal the broad assortment of normal biological activities that are regulated by members of the RhoGEF family, historically the family has attracted the most attention for its potential role in oncogenesis. A large subset of the RhoGEFs has been isolated in screens for proteins whose expression cause deregulated growth in NIH 3T3 mouse fibroblasts.5,71 Typically, NIH 3T3 cells that are transiently transfected with oncogenic RhoGEFs fail to undergo contact inhibition when confluence has been reached, forming large dense foci that are morphologically distinct from those that have been reported for oncogenes such as Ras or Src. Cell lines that stably express these oncogenic RhoGEFs also exhibit transformation as measured by a variety of parameters including growth in low serum, anchorage independence and tumorigenicity in nude mice. The transforming activity of RhoGEFs is often associated with truncated derivatives.5,71 Such truncations are presumed to relieve intramolecular structural constraints that normally mask the catalytic activity of the GEF when it is in its quiescent state. Since equivalent truncations activate both GEF and transforming activity, it is presumed that transforming activity is a consequence of the chronic stimulation of Rho GTPase targets. There are in fact several lines of evidence to suggest that this is the case. First, there is an absolute requirement for an intact DH domain for transformation.6-10,72 Second, activated derivatives of Rho GTPases, such as RhoA, exhibit a similar transforming activity to RhoGEFs when expressed in NIH 3T3 cells.73 Finally, dominant-inhibitory derivatives of Rho GTPases block RhoGEF transforming activity.15,74 Although the expression of constitutively activated derivatives of several Rho family GTPases have been shown to exhibit a transformed phenotype under a variety of conditions, the oncogenic potential is often very weak compared to the more potent RhoGEFs.75-81 There are several possible explanations for such a discrepancy. First, RhoGEFs may transform NIH 3T3 cells through activation of a common Rho GTPase target that has not yet been characterized for its transforming activity. The Rho family has grown rapidly in the past few years and many
Rho Family Guanine Nucleotide Exchange Factors
61
family members have not yet been tested in focus-formation assays. Second, mutations that lock GTPases into a constitutively activated GTP-bound form may not mimic the actions of a RhoGEF on a GTPase in vivo. For example, it may be necessary for GTPases to retain the ability to cycle, albeit at an accelerated rate, in order to mimic RhoGEF activation. However, mutants of RhoA, Rac1 and Cdc42 have been constructed that exhibit accelerated cycling, and none have transforming activity that is equivalent to the more strongly transforming RhoGEFs.82 Finally, transformation may be attributable to the promiscuous stimulation of several GTPases by a single RhoGEF. For example, it has been shown that the simultaneous activation of Cdc42, RhoA and Rac1 in NIH 3T3 cells could collectively account for the full complement of cellular effects that are associated with the overexpression of oncogenic Dbl.82 Although it is clear that RhoGEFs utilize Rho GTPases as their substrates for transformation, expression of the catalytic activity is not sufficient for full transforming activity. For example, the isolated DH domain of the Dbl protein retains GEF activity in vitro, yet has no transforming activity in vivo.12,72 Removal of the PH domains from Lfc and Dbs also eliminates their transforming activity, yet this can be restored by the addition of a prenylation site.7,15 Interestingly, the version of Dbs that lacks a PH domain is primarily found in the soluble fraction, whereas the wild-type and prenylated versions are found in membrane fractions. Since it is unlikely that an isoprenyl group can contribute to the structure of the DH domain in the same way that a PH domain does, then the PH domain-mediated membrane association must be required for full transformation. Thus, transformation by RhoGEFs seems to require both catalytic activity, and correct subcellular localization of this activity. Further support for this comes from the recent observation that Dbl mutants that are defective in phosphoinositide binding show much reduced transforming activity.25 Although these mutants are no longer able to associate with the plasma membrane, they exhibit enhanced levels of GEF activity in vivo. What then are the signalling events that are triggered when oncogenic RhoGEFs interact with membranes that contribute to cellular transformation. Oncogenic RhoGEFs can regulate many of the biological activities that are associated with their GTPase substrates including cytoskeletal rearrangements, transcriptional activation, and regulation of cell cycle progression.73 Many effector proteins have now been identified for various Rho family members and it would seem that at least some would have the potential to contribute to a phenotype of deregulated growth. In recent years particular attention has been focused on effectors for RhoA, since this is the GTPase that can most closely mimic the transforming activity of RhoGEFs in NIH 3T3 cells. There are now at least two RhoA effectors, PKN and ROCK, which have been strongly implicated in RhoA mediated transformation, and would presumably also be important for transformation by RhoA exchange factors such as Dbl, Dbs and Lfc.83-85 A detailed discussion of these effector proteins and their potential role in Rho and RhoGEF transformation can be found in Chapter 11 of this volume.
RhoGEFs and Human Disease It should come as no surprise that a family of proteins that is as large as the RhoGEFs, and which participates in such a broad spectrum of fundamental biological processes, would be linked to an increasing number of clinical disorders in humans. Chromosomal rearrangements that either disrupt or cause deregulated expression of RhoGEFs are associated with leukemias as well as human developmental disorders. It is anticipated that linkage and positional cloning studies will continue to add to the roster of human disorders that can be traced to dysfunctions within Rho-mediated signalling pathways.
Faciogenital Dysplasia (Aarskog-Scott Syndrome) Faciogenital dysplasia (FGDY) is an X-linked developmental disorder that was first described in the early 1970’s.86 Symptomology typically includes a specific pattern of skeletal defects which is generally accompanied by mental retardation. Loss-of-function mutations in
62
Rho GTPases
the FGDY locus (FGD1) alter the shape and size of a number of small bones and cartilages, while leaving others unaffected. FGD1 was determined by positional cloning to be the gene responsible for FGDY and sequence analysis revealed that it is a member of the RhoGEF family.87 Both biochemical and cell-based studies have confirmed that FGD1 has catalytic, signalling and oncogenic activity that are reminiscent of Cdc42-like GTPases.88,89 A recent analysis of the expression of FGD1 during murine development revealed a pattern of expression that is consistent with the observed pattern of skeletal defects in humans.90 Murine FGD1 is expressed at a variety of sites where endochondral and intramembranous ossifications occur. Although it is still unclear what role FGD1 plays in the ossification of skeletal elements, it remains an important reminder of the critical role that members of the RhoGEF family are likely to play during normal human development.
Nonspecific X-Linked Mental Retardation Mental retardation is generally diagnosed during early childhood development and thus, by definition, is considered to be a developmental brain disorder. Almost nothing is known about the underlying biological defects that are responsible for mental retardation since informative studies are relatively scarce. However, since abnormalities in dendritic spine morphology have been observed in several developmental disabilities that are associated with mental retardation,91 this may be a common feature of the disorder. This possibility is supported by the recent cloning and biochemical characterization of a large group of proteins associated with X-linked mental retardation (MRX). Positional cloning and linkage studies have made possible the identification of nine genes that are associated with MRX.92 Of these nine genes, four encode proteins that have been previously linked to Rho-mediated signalling pathways. These include a RhoGAP,93 a member of the Pak family,94 FGD1,87 and ARHGEF6 which is a RhoGEF for Rac1.95 Interestingly, studies in mammalian cell lines had shown previously that ARHGEF6 is a binding partner for Pak, and that Pak binding may be necessary for ARHGEF6 activation.96,97 Thus both Pak and ARHGEF6 may be participants in a common signalling pathway that participates in the establishment of neuronal connections during human development. If so, this would be similar to the situation in Drosophila (discussed earlier in this chapter) in which members of the RhoGEF, Rho and Pak families form a signalling complex within the growth cones of developing photoreceptors that is required for the establishment of neural connections during Drosophila development.
Philadelphia Chromosome Associated Leukemias Virtually all cases of chronic myelogenous leukemia (CML) and a subset of the acute myelogenous leukemias (AML) are associated with a reciprocal translocation commonly referred to as the Philadelphia chromosome (Ph1). The product of the translocation is a fusion protein that contains amino-terminal sequences from the product of the breakpoint cluster region gene (Bcr) attached, in frame, to carboxyl-terminal sequences from the nonreceptor tyrosine kinase Abl. Animal models suggest that the expression of this chimeric molecule is sufficient to produce a full range of CML and AML like symptoms, and also suggest that elevated levels of Abl tyrosine kinase activity contribute to Bcr-Abl mediated leukemogenesis.98-100 However, the sequences that distinguish the chimeric protein that is commonly associated with CML (p210 Bcr-Abl) from the chimeric protein associated with AML (p185 Bcr-Abl) lie within the Bcr protein, suggesting that Bcr may also contribute to the outcome of the disorder. Bcr is a 160 KD protein that encodes three major structural domains. Contained within the amino-terminus of Bcr is a structurally unique serine/threonine kinase domain that has both trans- and auto-phosphorylation activity.101 However, the physiologically relevant substrates for this activity have not yet been identified, and its contribution to the disorder remains unclear. The carboxyl-terminus of Bcr encodes a catalytically active GAP domain that shows specificity for Rac-related GTPases in in vitro assays.102 In fact, mice that are null for the bcr locus exhibit several phenotypes that are consistent with increased Rac activity suggesting that
Rho Family Guanine Nucleotide Exchange Factors
63
Bcr can also function as a RacGAP in vivo.103 The central portion of Bcr, which is also the region that distinguishes p210 Bcr-Abl from p185 Bcr-Abl, contains a DH/PH domain module. The biochemical analysis of this domain revealed catalytic activity for Cdc42, RhoA and Rac1, suggesting that Bcr can coordinately regulate the activity of several distinct Rho family GTPases.102 Although the function of this domain in vivo, or within the context of p210 Bcr-Abl is not known, the observation that other DH/PH modules can stimulate growth regulatory pathways suggests that these Bcr encoded sequences may play an important role in the clinical outcome of Ph1 positive leukemias.
Mixed Lineage Leukemias Leukemia associated Rho guanine nucleotide exchange factor (LARG) is a second RhoGEF family member that has been implicated in the pathogenesis of human leukemia. LARG was originally identified as a fusion partner with the product of the mixed lineage leukemia gene (MLL) in a patient with acute myeloid leukemia.104 Typically, the mixed lineage leukemias are a treatment complication associated with the use of DNA topoisomerase II inhibitors as anti-cancer drugs. Although rearrangements involving MLL are quite common in these leukemias, MLL can be quite promiscuous in terms of its choice of translocation partners. Over 20 distinct partners have now been isolated from more than 30 independent chromosomal rearrangements. In virtually every case, the molecular mechanism through which these fusion products contribute to the progression of the disorder is unknown. In addition to its tandem DH/PH domain module, LARG also contains PDZ and RGS domains in the amino-terminus. Whereas the function of the PDZ domain is unknown, the RGS domain can mediate direct interactions between LARG and Gα12 and Gα13.47 However, it has not yet been determined whether LARG can function as a GAP for either Gα subunit. The DH/PH domain of LARG exhibits specificity for RhoA in both in vitro and in vivo assays, and exhibits signalling and transformation profiles in NIH 3T3 cells that are consistent with RhoA activation.105 The fusion of MLL with LARG occurs as the result of an interstitial deletion that joins amino-terminal sequences of MLL with carboxyl terminal sequences from LARG.104 Thus, both the DH/PH and RGS domains are retained, while the PDZ domain is lost. However, removal of the PDZ domain from LARG, independent of the MLL fusion, does not appear to activate its exchange or transforming activity.105 Thus, although it is intriguing that LARG harbors oncogenic potential, and is associated with a human leukemia, there is no obvious mechanism through which it may contribute to the outcome of the disorder.
Future Perspectives Tremendous progress has been made in the past few years towards an understanding of how the catalytic activity of RhoGEFs is regulated. Most are thought to exist in a basal state that is maintained by intramolecular interactions that block access to the substrate. A surprisingly diverse array of regulators have now been identified that can relieve this inhibition and it is likely that many more will be described. However, in many cases it has not yet been determined whether these regulatory mechanisms can be recapitulated in live cells. For example, although many RhoGEFs share a common ability to bind phosphoinositides in cell free systems, there is still little evidence to suggest that such binding is occurring in vivo. The identification of RhoGEFs in systems that are more amenable to genetic manipulation has provided some exciting glimpses into the dynamic and central role that many of these molecules will play in the regulation of some very fundamental cellular processes. The theme that continues to emerge is that RhoGEFs function as intracellular sensors that are able to actively convert signals coming from within or outside the cell into localized rearrangements of the actin cytoskeleton. It is anticipated that new experimental approaches that allow for the visualization of activated GTPases in live cells will contribute dramatically to our understanding of how these localized alterations in actin polymerization are initiated.106 Such techniques will be particularly useful in mammalian cells where multiple RhoGEFs with broad and overlapping specificities are often expressed simultaneously making it difficult to identify their primary substrates.
64
Rho GTPases
References 1. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001; 291:1304-51. 2. Rebecchi MJ, Scarlata S. Pleckstrin homology domains: A common fold a with diverse functions. Annu Rev Biophys Biomol Struct 1998; 27:503-28. 3. Knetsch ML, Schafers N, Horstmann H et al. The Dictyostelium Bcr/Abr-related protein DRG regulates both Rac- and Rab-dependent pathways. Embo J 2001; 20:1620-9. 4. Aghazadeh B, Zhu K, Kubiseski TJ et al. Structure and mutagenesis of the Dbl homology domain. Nat Struct Biol 1998; 5:1098-107. 5. Whitehead IP, Campbell S, Rossman KL et al. Dbl family proteins. Biochim Biophys Acta 1997; 1332:F1-23. 6. Whitehead I, Kirk H, Kay R. Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor. Oncogene 1995; 10:713-21. 7. Whitehead I, Kirk H, Tognon C et al. Expression cloning of lfc, a novel oncogene with structural similarities to guanine nucleotide exchange factors and to the regulatory region of protein kinase C. J Biol Chem 1995; 270:18388-95. 8. Whitehead IP, Khosravi-Far R, Kirk H et al. Expression cloning of lsc, a novel oncogene with structural similarities to the Dbl family of guanine nucleotide exchange factors. J Biol Chem 196; 271:18643-50. 9. Horii Y, Beeler JF, Sakaguchi K et al. A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signalling pathways. Embo J 1994; 13:4776-86. 10. Miki T, Smith CL, Long JE et al. Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 1993; 362:462-5. 11. Abe K, Rossman KL, Liu B et al. Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem 2000; 275:10141-9. 12. Hart MJ, Eva A, Zangrilli D et al. Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. J Biol Chem 1994; 269:62-5. 13. Liu X, Wang H, Eberstadt M et al. NMR structure and mutagenesis of the N-terminal Dbl homology domain of the nucleotide exchange factor. Trio Cell 1998; 95:269-77. 14. Aghazadeh B, Lowry WE, Huang XY et al. Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 2000; 102:625-33. 15. Whitehead IP, Lambert QT, Glaven JA et al. Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation. Mol Cell Biol 1999; 19:7759-70. 16. Worthylake DK, Rossman KL, Sondek J. Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1. Nature 2000; 408:682-8. 17. Soisson SM, Nimnual AS, Uy M et al. Crystal structure of the Dbl and pleckstrin homology domains from the human Son of sevenless protein. Cell 1998; 95:259-68. 18. Goldberg J. Structural basis for activation of ARF GTPase: Mechanisms of guanine nucleotide exchange and GTP-myristoyl switching. Cell 1998; 95:237-48. 19. Boriack-Sjodin PA, Margarit SM, Bar-Sagi D et al. The structural basis of the activation of Ras by Sos. Nature 1998; 394:337-43. 20. Glaven JA, Whitehead I, Bagrodia S et al. The Dbl-related protein, Lfc, localizes to microtubules and mediates the activation of Rac signalling pathways in cells. J Biol Chem 1999; 274:2279-85. 21. Olson MF, Sterpetti P, Nagate et al. Distinct roles for DH and PH domains in the Lbc oncogene. Oncogene 1997; 15:2827-31. 22. Bi F, Debreceni B, Zhu K et al. Autoinhibition mechanism of proto-Dbl. Mol Cell Biol 2001; 21:1463-74. 23. Anborgh PH, Qian X, PapaGeorge AG et al. Ras-specific exchange factor GRF: Oligomerization through its Dbl homology domain and calcium-dependent activation of Raf. Mol Cell Biol 1999; 19:4611-22. 24. Zhu K, Debreceni B, Bi F et al. Oligomerization of DH domain is essential for Dbl-induced transformation. Mol Cell Biol 2001; 21:425-37. 25. Russo C, Gao Y, Mancini P et al. Modulation of oncogenic DBL activity by phosphoinositol phosphate binding to pleckstrin homology domain. J Biol Chem 2001; 276:19524-31. 26. Fleming IN, Gray A, Downes CP. Regulation of the Rac1-specific exchange factor Tiam1 involves both phosphoinositide 3-kinase-dependent and -independent components. Biochem J 2000; 351:173-82. 27. Rameh LE, Arvidsson AK, Carraway KL et al. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem 1997; 272:22059-66.
Rho Family Guanine Nucleotide Exchange Factors
65
28. Stam JC, Sander EE, Michiels F et al. Targeting of Tiam1 to the plasma membrane requires the cooperative function of the N-terminal pleckstrin homology domain and an adjacent protein interaction domain. J Biol Chem 1997; 272:28447-54. 29. Han J, Luby-Phelps K, Das B et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 1998; 279:558-60. 30. Das B, Shu X, Day GJ et al. Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding. J Biol Chem 2000; 275:15074-81. 31. Kiyono M, Kaziro Y, Satoh T et al. Induction of rac-guanine nucleotide exchange activity of RasGRF1/CDC25(Mm) following phosphorylation by the nonreceptor tyrosine kinase Src. J Biol Chem 2000; 275:5441-6. 32. Han J, Das B, Wei W et al. Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol 1997; 17:1346-53. 33. Kato J, Kaziro Y, Satoh T. Activation of the guanine nucleotide exchange factor Dbl following ACK1- dependent tyrosine phosphorylation. Biochem Biophys Res Commun 2000; 268:141-7. 34. Fleming IN, Elliott CM, Exton JH. Phospholipase C-gamma, protein kinase C and Ca2+/ calmodulin-dependent protein kinase II are involved in platelet-derived growth factor- induced phosphorylation of Tiam1. FEBS Lett 1998; 429:229-33. 35. Tatsumoto T, Xie X, Blumenthal R et al. Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol 1999; 147:921-8. 36. Bustelo XR, Barbacid M. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 1992; 256:1196-9. 37. Bustelo XR, Ledbetter JA, Barbacid M. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 1992; 356:68-71. 38. Margolis B, Hu P, Katzav S et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 1992; 356:71-4. 39. Deckert M, TartareDeckert S, Couture C et al. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 1996; 5:591-604. 40. Whitehead IP, Zohn IE, Der CJ. Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene 2001; 20:1547-55. 41. Glaven JA, Whitehead IP, Nomanbhoy T et al. Lfc and Lsc oncoproteins represent two new guanine nucleotide exchange factors for the Rho GTP-binding protein. J Biol Chem 1996; 271:27374-81. 42. Hart MJ, Sharma S, elMasry N et al. Identification of a novel guanine nucleotide exchange factor for the Rho GTPase. J Biol Chem 1996; 271:25452-8. 43. Kozasa T, Jiang X, Hart MJ et al. p115 RhoGEF, a GTPase activating protein for Gα 12 and Gα13. Science 1998; 280:2109-11. 44. Hart MJ, Jiang X, Kozasa T et al. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Gα 13. Science 1998; 280:2112-4. 45. Mao J, Yuan H, Xie W et al. Guanine nucleotide exchange factor GEF115 specifically mediates activation of Rho and serum response factor by the G protein alpha subunit Gα13. Proc Natl Acad Sci USA 1998; 95:12973-6. 46. Fukuhara S, Murga C, Zohar M et al. A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J Biol Chem 1999; 274:5868-79. 47. Fukuhara S, Chikumi H, Gutkind JS. Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links heterotrimeric G proteins of the G(12) family to Rho. FEBS Lett 2000; 485:183-8. 48. Nimnual AS, Yatsula BA, Bar-Sagi D. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 1998; 279:560-3. 49. Chardin P, Camonis JH, Gale NW et al. Human Sos1: A guanine nucleotide exchange factor for Ras that binds to GRB2. Science 1993; 260:1338-43. 50. Steven R, Kubiseski TJ, Zheng H et al. UNC-73 activates the Rac GTPase and is required for cell and growth cone migrations in C. elegans. Cell 1998; 92:785-95. 51. O’Brien SP, Seipel K, Medley QG et al. Skeletal muscle deformity and neuronal disorder in Trio exchange factor- deficient mouse embryos. Proc Natl Acad Sci USA 2000; 97:12074-8. 52. Awasaki T, Saito M, Sone M et al. The Drosophila trio plays an essential role in patterning of axons by regulating their directional extension. Neuron 2000; 26:119-31. 53. Bateman J, Shu H, Van Vactor D. The guanine nucleotide exchange factor trio mediates axonal development in the Drosophila embryo. Neuron 2000; 26:93-106. 54. Newsome TP, Schmidt S, Dietzl G et al. Trio combines with dock to regulate Pak activity during photoreceptor axon pathfinding in Drosophila. Cell 2000; 101:283-94.
66
Rho GTPases
55. Wahl S, Barth H, Ciossek T et al. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J Cell Biol 2000; 149:263-70. 56. Shamah SM, Lin MZ, Goldberg JL et al. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 2001; 105:233-44. 57. Takaishi K, Sasaki T, Kameyama T et al. Translocation of activated Rho from the cytoplasm to membrane ruffling area, cell-cell adhesion sites and cleavage furrows. Oncogene 1995; 11:39-48. 58. Kishi K, Sasaki T, Kuroda S et al. Regulation of cytoplasmic division of Xenopus embryo by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI). J Cell Biol 1993; 120:1187-95. 59. Prokopenko SN, Brumby A, O’Keefe L et al. A putative exchange factor for Rho1 GTPase is required for initiation of cytokinesis in Drosophila. Genes Dev 1999; 13:2301-14. 60. Wasserman S. FH proteins as cytoskeletal organizers. Trends Cell Biol 1998; 8:111-5. 61. Pruyne D, Bretscher A. Polarization of cell growth in yeast. I. Establishment and maintenance of polarity states. J Cell Sci 2000; 113:365-75. 62. Lew DJ, Reed SI. Cell cycle control of morphogenesis in budding yeast. Curr Opin Genet Dev 1995; 5:17-23. 63. Toenjes KA, Sawyer MM, Johnson DI. The guanine-nucleotide-exchange factor Cdc24p is targeted to the nucleus and polarized growth sites. Curr Biol 1999; 9:1183-6. 64. Nern A, Arkowitz RA. Nucleocytoplasmic shuttling of the Cdc42p exchange factor Cdc24p. J Cell Biol 2000; 148:1115-22. 65. Shimada Y, Gulli MP, Peter M. Nuclear sequestration of the exchange factor Cdc24 by Far1 regulates cell polarity during yeast mating. Nat Cell Biol 2000; 2:117-24. 66. Henchoz S, Chi Y, Catarin B et al. Phosphorylation- and ubiquitin-dependent degradation of the cyclin- dependent kinase inhibitor Far1p in budding yeast. Genes Dev 1997; 11:3046-60. 67. Gulli M, Jaquenoud M, Shimada Y et al. Phosphorylation of the cdc42 exchange factor cdc24 by the PAK-like kinase cla4 may regulate polarized growth in yeast. Mol Cell 2000; 6:1155-67. 68. Park HO, Bi E, Pringle JR et al. Two active states of the Ras-related Bud1/Rsr1 protein bind to different effectors to determine yeast cell polarity. Proc Natl Acad Sci USA 1997; 94:4463-8. 69. Park HO, Sanson A, Herskowitz I. Localization of bud2p, a GTPase-activating protein necessary for programming cell polarity in yeast to the presumptive bud site. Genes Dev 1999; 13:1912-7. 70. Gulli MP, Peter M. Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: The yeast perspective. Genes Dev 2001; 15:365-79. 71. Cerione RA, Zheng Y. The Dbl family of oncogenes. Curr Opin Cell Biol 1996; 8:216-22. 72. Ron D, Zannini M, Lewis M et al. A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr. New Biol 1991; 3:372-9. 73. Westwick JK, Lee RJ, Lambert QT et al. Transforming potential of Dbl family proteins correlates with transcription from the cyclin D1 promoter but not with activation of Jun NH2-terminal kinase, p38/Mpk2, serum response factor, or c-Jun. J Biol Chem 1998; 273:16739-47. 74. Khosravi-Far R, Chrzanowska-Wodnicka M, Solski PA et al. Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol Cell Biol 1994; 14:6848-57. 75. Khosravi-Far R, Solski PA, Clark GJ et al. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol 1995; 15:6443-53. 76. Lin R, Bagrodia S, Cerione R et al. A novel Cdc42Hs mutant induces cellular transformation. Curr Biol 1997; 7:794-7. 77. Murphy GA, Solski PA, Jillian SA et al. Cellular functions of TC10, a Rho family GTPase: Regulation of morphology, signal transduction and cell growth. Oncogene 1999; 18:3831-45. 78. Prendergast GC, Khosravi-Far R, Solski PA et al. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 1995; 10:2289-96. 79. Qiu RG, Chen J, McCormick F et al. A role for Rho in Ras transformation. Proc Natl Acad Sci USA 1995; 92:11781-5. 80. Qiu RG, Chen J, Kirn D et al. An essential role for Rac in Ras transformation. Nature 1995; 374:457-9. 81. Qiu RG, Abo A, McCormick F et al. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol Cell Biol 1997; 17:3449-58. 82. Lin R, Cerione RA, Manor D. Specific contributions of the small GTPases Rho, Rac, and Cdc42 to Dbl transformation. J Biol Chem 1999; 274:23633-41. 83. Marinissen MJ, Chiariello M, Gutkind JS. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev 2001; 15:535-53. 84. Sahai E, Ishizaki T, Narumiya S et al. Transformation mediated by RhoA requires activity of ROCK kinases. Curr Biol 1999; 9:136-45.
Rho Family Guanine Nucleotide Exchange Factors
67
85. Tran Quang C, Gautreau A, Arpin M et al. Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. Embo J 2000; 19:4565-76. 86. Aarskog D. A familial syndrome of short stature associated with facial dysplasia and genital anomalies. J Pediatr 1970; 77:856-61. 87. Pasteris NG, Cadle A, Logie LJ et al. Isolation and characterization of the faciogenital dysplasia (Aarskog- Scott syndrome) gene: A putative Rho/Rac guanine nucleotide exchange factor. Cell 1994; 79:669-78. 88. Whitehead IP, Abe K, Gorski JL et al. CDC42 and FGD1 cause distinct signalling and transforming activities. Mol Cell Biol 1998; 18:4689-97. 89. Zheng Y, Fischer DJ, Santos MF et al. The faciogenital dysplasia gene product FGD1 functions as a Cdc42Hs- specific guanine-nucleotide exchange factor. J Biol Chem 1996; 271:33169-72. 90. Gorski JL, Estrada L, Hu C et al. Skeletal-specific expression of Fgd1 during bone formation and skeletal defects in faciogenital dysplasia (FGDY; Aarskog syndrome). Dev Dyn 2000; 218:573-86. 91. Williams RS, Hauser SL, Purpura DP et al. Autism and mental retardation: Neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol 1980; 37:749-53. 92. Chelly J. Breakthroughs in molecular and cellular mechanisms underlying X-linked mental retardation. Hum Mol Genet 1999; 8:1833-8. 93. Billuart P, Bienvenu T, Ronce N et al. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998; 392:923-6. 94. Allen KM, Gleeson JG, Bagrodia S et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 1998; 20:25-30. 95. Kutsche, Yntema H, Brandt A et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat Genet 2000; 26:247-50. 96. Manser E, Loo TH, Koh CG et al. PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell 1998; 1:183-92. 97. Bagrodia S, Taylor SJ, Jordon KA et al. A novel regulator of p21-activated kinases. J Biol Chem 1998; 273:23633-6. 98. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 1990; 247:824-30. 99. Gross AW, Zhang X, Ren R. Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy. Mol Cell Biol 1999; 19:6918-28. 100. Huettner CS, Zhang P, Van Etten RA et al. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 2000; 24:57-60. 101. Maru Y, Witte ON. The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell 1991; 67:459-68. 102. Chuang TH, Xu X, Kaartinen V et al. Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. Proc Natl Acad Sci USA 1995; 92:10282-6. 103. Voncken JW, Kaartinen V, Pattengale PK et al. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 1995; 86:4603-11. 104. Kourlas PJ, Strout MP, Becknell B et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: Evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000; 97:2145-50. 105. Reuther GW, Lambert QT, Booden MA et al. LARG, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA. J Biol Chem 2001; 276:27145-51. 106. Kraynov VS, Chamberlain C, Bokoch GM et al. Localized Rac activation dynamics visualized in living cells. Science 2000; 290:333-7.
68
Rho GTPases
CHAPTER 5
The Superfamily of Rho GTPase-Activating Proteins Sarah Jenna and Nathalie Lamarche-Vane
Abstract
G
TP hydrolysis is a key step in many intracellular processes. GTPases are the molecular machines that catalyze this reaction but their intrinsic GTPase activity is very slow in the case of the Ras superfamily of GTPases. This hydrolysis can be accelerated by orders of magnitude upon interaction with GTPase-activating proteins (GAPs), which are specific for their respective GTP-binding proteins. To date, around 42 distinct RhoGAP-containing proteins from various species have been reported in the literature. They are generally large and multifunctional. A consensus RhoGAP domain has been used to identify 220 potential RhoGAPs from the nonredundant protein database. On the basis of their multimodular structure, we have divided these proteins into 15 subfamilies. In this chapter, we will discuss the molecular basis of the RhoGAP activity and we will focus on studies that begin to address the multifunctional role of the RhoGAP subfamilies.
RhoGAPs Are Multimodular Proteins RhoGAPs appear to play a critical role in many biological functions and pathological processes. They are thought to be implicated in the regulation of cell cycle progression, cytokinesis, cell adhesion and migration, actin and microtubule cytoskeleton reorganization, membrane trafficking, host-pathogen interactions, development, and in cross-talk between the small GTPases Rho, Ras and Ral (Tables 2, 3). To date, around 42 distinct proteins containing a closely related RhoGAP domain have been reported in mammals, avian, worm, yeast and pathogenic bacteria (Fig. 1). RhoGAP domains show about 20 to 40% amino acid identity and the proteins in which they are contained are generally large and multifunctional. Based on amino acid sequence analysis of eucaryotic RhoGAPs, a consensus RhoGAP domain has been used to identify potential RhoGAPs from the nonredundant protein database using the SMART (Simple Modular Architecture Research Tool) interface.3,4 To date, around 220 potential RhoGAPs have been identified: 90 in human, 28 in mouse (Mus musculus), 24 in fruit fly (Drosophila melanogaster), 22 in Caenorabditis elegans, 8 in Arabidopsis thalia and 12 in Saccharomyces cerevisiae (supplemental data). On the basis of their multimodular structure, we have divided these proteins into 15 subfamilies (Fig. 1, Table 1 and supplemental data). In addition to their RhoGAP domain, enzymatic activities have been found in the Bcr, OCRL, Myosin-IX and p190-RhoGAP subfamilies as well as in D. discoideum DdRacGAP, the S. cerevisiae Bem2p and bacterial RhoGAPs. Bcr, GRAF and CeGAP subfamilies as well as the yeast Bem2p and Bem3p, and DdRacGAP proteins also contain the lipid-binding module, Pleckstrin homology (PH) domain. Other putative lipid-binding modules such as the protein kinase C conserved region 1 and 2 (C1 and C2, respectively) homology domains, the Sec14 and star-related lipid-transfer (START) Rho GTPases, edited by Marc Symons. ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers.
The Superfamily of Rho GTPase-Activating Proteins
69
Table 1. Protein modules identified within RhoGAP sequences Symbols
Names of Protein Modules
References
GTPase-activating protein for Rho GTPases (RhoGAP)
14-18,121,190
Dbl-homology (DH) domain. Catalytic domain of guanine-nucleotide exchange factor for RhoGTPases
29,191-194
GTP-binding domain of the Ras superfamily.
195-197
Ras Guanine nucleotide exchange factor domain.
190,198
Inositol polyphosphate phosphatase
199-201
Myosin ATPase domain. Actin-binding domain.
202,203
Pleckstrin homology (PH) domain. Can bind inositol phosphates or proteins.
204-207
Protein kinase C conserved region 1 (C1) (Cysteine-rich domain). Can bind phorbol esters, diacylglycerol, RasGTP or Zinc.
87,91,208,209
Protein kinase C conserved region 2 (C2). Can bind Ca2+, phospholipids, inositol polyphosphates, and intracellular proteins
210-214
Sec14 homology domains (SEC14)Lipid binding domain 215-218 presenting homology with the S. cerevisiae phosphatidylinositol transfer protein (Sec14p). Star-related lipid-transfer (START) domain. putative lipid-binding domain in Star and phosphatidylcholine transfer protein
219,220
Src homology 2 (SH2) domain. binds phosphotyrosine-containing polypeptides.
221-227
Src homology 3 (SH3) domain. Binds generally to poly-proline sequences (PXXP)
228-230
Ras interactive binding domain. known also as RalGDS/AF-6 domains LIM domain. Zinc-binding domain family. Cdc42/Rac interactive binding (CRIB) domain. Present in Cdc42 and Rac1 effectors
231-235 236-238 239,240
PhoX homologous (PX) domain. SH3-binding motif FF domain. Contains two conserved F residues. A novel motif that often accompanies WW domains
241,242 243
Sterile alpha motif (SAM). In EPH-related tyrosine kinases, binds SH2-containing proteins to a conserved phosphorylated tyrosine.
244-249
IQ domain. calmodulin-binding motif. FCH domain. Fes/CIP4 homology domain. Non-kinase domain of the FER and Fes/Fps family of tyrosine kinases, also present in Cdc42 effector CIP4
251-255 250
Protein modules were identified using the SMART interface.3,4 Symbol corresponding to these domains refers to those used in (Fig. 1). Enzymatic domains: dashed symbols; lipid-binding modules: empty symbols; protein-binding modules: black-filled symbols; uncharacterized domains: grey-filled symbols.
70
Rho GTPases
Figure 1. Organization of RhoGAPs into subfamilies based on their multi-modular structures. A) Proteins that have consensus RhoGAP domains were identified using the nonredundant database and the SMART interface in Homo sapiens, Ratus norvegicus, Mus musculus, Drosophila melanogaster and Caenorabditis elegans. Nonredundancy was verified using National Center for Biotechnology Information (NCBI, http:// www.ncbi.nlm.nih.gov) Basic Local Alignment Search Tool (BLAST®). Continued on next page.
homology domains have been found in members of the Bcr, chimaerin, Myosin-IX, p122-RhoGAP and p50-RhoGAP subfamilies. In addition, calmodulin-binding (IQ) domains have been found in the myosin-IX subfamily members. Furthermore, the majority of RhoGAP
The Superfamily of Rho GTPase-Activating Proteins
71
Figure 1 (cont’d). Continued on next page.
proteins contains various protein-binding modules. Src homology 2 (SH2) domains are found in members of the chimaerin and p85 subfamilies; Src homology 3 (SH3) domains in the GRAF, p85, C1 subfamilies and in dCdGAPr proteins and yeast Bem3p proteins; GTPase interactive binding domains in the Myosin-IX and RLIP subfamilies and in most of the A. talia RhoGAPs; LIM domains in yeast Dbm1p and Lrg1p and an actin-binding domain in the Myosin-IX subfamily. Proline-rich domains containing the SH3-binding motif (PXXP) have also been found in a large majority of RhoGAPs.5
72
Rho GTPases
Figure 1 (cont’d). B) Proteins with a RhoGAP domain were identified in Saccharomyces cerevisiae, Arabidopsis thalia and Dictyostelium discoideum as described above. The protein modules identified with RhoGAP proteins are represented by symbols referring to Table 1.
To date, the precise role of these functional domains has remained elusive in most cases. It has been proposed however that these domains may serve to recruit RhoGAP-containing proteins to specific protein complexes. Then, RhoGAPs could act in a localized fashion to downregulate Rho GTPases or mediate downstream signals.5 Lipid- and protein-binding modules also have been described to regulate the RhoGAP activity of α-chimaerin, p190-RhoGAP, PSGAP and CdGAP. This regulation can be either direct by induction of a change of protein conformation or indirect through subcellular relocalization of the RhoGAP proteins.6-11 In this chapter, we will discuss the molecular basis of the RhoGAP activity and we will focus on studies that begin to address the multifunctional role of the RhoGAP subfamilies.
Molecular Basis of the GTPase-Stimulating Activity The Eucaryotic RhoGAP Domain The RhoGAP domain extends over approximately 180 amino acids. Analysis of its primary structure allowed the identification of three blocks of sequence conservation (Fig. 2A).12,13 Crystallographic analysis of the human p50-RhoGAP and of the p85-α subunit of Phosphatidylinositol-3 Kinase revealed that RhoGAP domains consist of 8 or 9 α-helices, respectively and present protein cores constituted by a four–helix bundle (Fig. 2A, filled rectangles), one face of which contains most of the conserved residues.14,15 Insight into the three-dimensional interaction between Rho GTPases and their specific GAPs came from the crystal structures of RhoA and p50-RhoGAP complexed with GDP.AlF -4 (transition state-mimicking complex) and from Cdc42 and p50-RhoGAP complexed with a nonhydrolysable GTP analogue (ground state).16,17 These studies revealed that p50-RhoGAP actively participates in the process of GTP hydrolysis by contributing an arginine residue (Arg85) to the catalytic domain of the GTPase. This residue has been shown to contact GDP.AlF4- and a critical glutamine at position 63 of RhoA (Gln63) during the transition state.16 It is thought that this “Arginine finger” acts to stabilize the transition state of the GTPase reaction. Additional residues of the RhoGAP domain also contribute to stabilize this interaction (Fig. 2A, indicated by an asterisk). The ‘Arginine finger’ model is highly supported by site-directed mutagenesis analysis of numerous RhoGAPs in which replacement of the ‘Arginine finger’ drastically impairs their
The Superfamily of Rho GTPase-Activating Proteins
73
Figure 2. Sequence alignment of a subset of RhoGAP domains. The sequences used are identified by their GenBank accession number: Human breakpoint cluster region (Bcr) (P11274); Rat p190 (A38218); Rat α1-chimaerin (Q03070); Human p85-α (P27986); human p50-RhoGAP (Z23024); Salmonella SptP (AAC44349); Pseudomonas aeruginosa ExoS (AAK39624); Yersinia YopE (P08008). Three blocks of sequence conservation are indicated by gray boxes (A). Numbering above and below the sequences respectively corresponds to the full-length human p50-RhoGAP and human p85-α (A) and to full-length SptP (B). Helical fragments are represented by open rectangles above the sequences. Helices implicated in the four-helix bundle GAP domain are represented by filled rectangles. Residues that are conserved in at least 14 sequences out of 22 aligned eucaryotic RhoGAPs14,15 and in all 3 bacterial RhoGAPs are shown in bold. Residues of p50-RhoGAP and SptP that are part of the proposed ligand-binding site during the transition state are indicated by an asterisk and the ‘arginine finger’ by an arrow.
GAP activity.12,18 Interestingly, these amino acid substitutions do not alter the ability of GAPs to bind to their specific Rho GTPases, indicating that these two functions are independent.12 This latter hypothesis is also supported by the identification and characterization of p85-α that
74
Rho GTPases
has no GAP activity but can still bind its specific GTPase.5,14,15 Comparison of the p85-α sequence and structure with those of active GAPs14,15 as well as mutagenesis analysis12 has facilitated the identification of residues implicated in the GTPase-acceleration activity to those implicated in GTPase recognition and binding.
Bacterial RhoGAPs Three bacterial cytotoxins with RhoGAP activities have been isolated: the Salmonella typhimurium SptP,19 the Yersinia spp. YOPE 20,21 and the Pseudomonas aeruginosa ExoS.22 As observed for eucaryotic RhoGAPs, the crystal structures of SptP and ExoS complexed with Rac1.GDP.AlF4 showed that the cytotoxins bind Rac1 exclusively through a four-helix bundle domain (Fig. 2B, filled rectangles). This bundle inserts a conserved arginine (Fig. 2B, arrow) into the active site of Rac1, catalyzing GTP hydrolysis through stabilization of the transition state.23,25 Despite the high degree of homology between the amino acid sequences of bacterial and eucaryotic RhoGAPs, the residues shown to be implicated in GTPase-interaction during the transition-state are different from those identified in eucaryotic RhoGAPs (compare residues indicated by an asterisk in (Fig. 2A and B). Moreover, several important differences between the SptP and p50-RhoGAP secondary and ternary structures have been observed.23 Although the cytotoxins are much smaller in size, they make more extensive contacts with the GTPase and its nucleotide than observed in most eucaryotic GTPase/GAP complexes (compare the number of residues indicated by an asterisk in Fig. 2A and B). In addition, the catalytic arginine in SptP extends from a bundle helix,23 whereas in eucaryotic RhoGAPs it is distal from the bundle and contained in a loop.
RhoGAPs Are Multifunctional Proteins The Bcr Subfamily The Bcr subfamily includes the human Bcr (Breakpoint Cluster Region) which has been the first RhoGAP activity to be described,26 Abr (Active Bcr-Related), and a putative Drosophila melanogaster 80 kDa protein whose GAP activity has not been established yet (Fig. 1 and supplemental data). Bcr is a 160 kDa phosphoprotein mainly present in brain and hematopoietic cells26,27 while Abr is a 92 kDa protein predominantly expressed in brain.28,29 These two proteins display a RhoGAP domain at their C-terminus. The recombinant Bcr-GAP domain has GAP activity towards Rac1, Rac2, Cdc42 but not RhoA in vitro.26,28-30 Consistent with its Rac1-specific GAP activity, the Bcr-GAP domain has also been shown to inhibit Rac1-mediated membrane ruffling, but not RhoA-mediated stress fibre formation into Swiss 3T3 fibroblasts.31 These proteins also contain Dbl-homology (DH) domains (Fig. 1, Table 1) that has GEF activity towards Cdc42, RhoA, Rac1 and Rac2 but not Rap1 or Ha-Ras in vitro.30 DH domains are usually found together with pleckstrin-homology (PH) domains thought to be involved in the regulation of the GEF activity.32-35 However, such a regulatory role in Bcr and Abr has not been established yet. Interestingly, GAP and GEF domains of both proteins bind in vitro to the GTPases in a noncompetitive manner suggesting that these two domains may interact simultaneously with two members of the Rho GTPase family of proteins30 and may act in a coordinated manner to regulate Rho GTPases. Bcr, but not Abr, also contains an amino-terminal Ser/Thr kinase domain that displays in vitro activity towards Bcr itself27 and towards members of the 14-3-3 protein subfamily: 14-3-3β and BAP-1 (Bcr-associated protein 1).36,37 The role of the Ser/Thr kinase activity of Bcr, in vivo, remains to be determined. Bcr was first identified as part of the Bcr-Abl fusion oncogene, which is generated by a translocation event between the coding sequence of the Abl tyrosine kinase on chromosome 9 and the Bcr sequence on chromosome 22 in human leukemias positive for the philadelphia chromosome.38-40 Two distinct translocations result in the generation of chimeric proteins p210Bcr-Abl and p185Bcr-Abl, which are characteristic of chronic myelogenous leukaemia (CML) and acute lymphocytic leukemia (ALL), respectively. Interestingly, both proteins lack
The Superfamily of Rho GTPase-Activating Proteins
75
the Bcr-GAP domain and p185Bcr-Abl lacks the DH domain. Moreover, neutrophils from Bcr-null mice show a pronounced increase in reactive oxygen metabolite production upon activation as well as a significant increase in Rac2 membrane translocation compared to control mice.41 Taken together, these data suggest that Bcr may act to regulate Rac-mediated superoxide production in leukocytes, pointing to a role for the Bcr-GAP activity in Bcr-Abl-mediated leukemia development. However, misregulation of Rac is not the only pathological mechanism responsible for leukemia development. Constitutive activation of Bcr-Abl tyrosine kinase activity results in deregulated activation of signalling pathways mediated by Ras, p120-RasGAP and p62(dok)42-47 and is thought to play a key role in the development of this pathology. In addition, association of Bcr and Bcr-Abl with 14-3-3β and tyrosine phosphorylation of BAP-1 by Bcr-Abl36 have been proposed to participate into mitogenic signalling by Bcr and Bcr-Abl.36,37 c-Fes, a nonreceptor tyrosine kinase involved in myeloid cell growth and differentiation has also been shown to phosphorylate Bcr on tyrosine residues48 leading to its association with multiple signalling molecules,48,49 and to abolish its serine/threonine kinase activity.49-50 Interestingly, c-FES has been shown to suppress cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.51 Together, these data suggest a link between Bcr and the regulation of cell cycle progression in hematopoietic cells and suggest a regulatory role for Bcr sequences in Bcr-Abl oncogenicity. In addition to hematopoietic cells, Bcr is strongly expressed in brain. Moreover, mice lacking the Bcr product show an abnormal stress response and increased fighting behavior, suggesting a role of Bcr in brain functions.52
The p190-RhoGAP Subfamily The p190-RhoGAP subfamily consists of two isoforms, p190-A (originally named p190) and p190-B. These two proteins have been identified in rat,53,54 mouse55 and human (Fig. 1).56,57 Both p190-A and -B contain a RhoGAP domain at their C-terminus and a GTP-binding domain at their N-terminus. The central domain of these proteins also contains a repetition of four FF domains (Table 1) whose role remains unknown. In vitro, both rat p190-A and human p190-B display GAP activity towards Rac1, Cdc42 and RhoA, with a preference for RhoA.31,57,59 When expressed in Swiss 3T3 cells however, p190-A exclusively acts on RhoA.31,60 p190-A was first isolated from mitogenically stimulated and tyrosine kinase-transformed cells as a p120-RasGAP-associated protein.53,61,62 It is phosphorylated on tyrosine and to a larger extent on serine residues.61 It is the first RhoGAP whose activity has been shown to be regulated. The molecular mechanisms implicated in this regulation are not fully understood yet, but may involve both the GTP-binding domain, association with p120-RasGAP and tyrosine phosphorylation. The guanine nucleotide binding domain of the p190 proteins is similar to those of monomeric small GTPases.53 This domain has GTPase activity and appears to play a role in the regulation of p190-RhoGAP activity in vivo.63,64 p190-A interacts with p120-RasGAP in both a phosphotyrosine-dependent and independent manner.65 Phosphorylation of Tyr1105 appears to be mainly responsible for the phosphotyrosine-dependent association of these proteins.65 p190-A appears to interact with the two SH2 domains of p120-RasGAP, 62,66 resulting in a conformational change of p120-RasGAP.67 In addition to regulating the potential scaffolding activity of p120-RasGAP, this association may control the p190-A RhoGAP activity towards RhoA. The N-terminus of p120-RasGAP (GAP-N), containing the SH2 and SH3 domains but lacking the RasGAP domain, when overexpressed in Rat-2 fibroblasts, constitutively interacts with p190-A9 and induces changes in the actin cytoskeleton and cell adhesion that are consistent with the stimulation of p190-A activity towards RhoA.9 This stimulation however is likely to be indirect, since the GAP activity of p190-A is not increased by GAP-N in vitro.9,60 Phosphorylation on tyrosine residues has been shown to play a major regulatory role on p190-RhoGAP and GTP-binding activities. p190-A is a preferred substrate of the non recep-
76
Rho GTPases
tor tyrosine kinase c-Src.68,69 Roof and coworkers have shown that phosphorylation of p190-A by Src in vitro results in a dramatic loss of p190 GTP-binding activity,69 suggesting a first level of regulation of p190 RhoGAP activity by Src. c-Src has been shown to phosphorylate p190-A on Tyr1105 both in vivo and in vitro, resulting in the association of p190-A with p120-RasGAP.70 Since this association regulates p190-RhoGAP activity, these data suggest a second level of regulation of p190-A activity by Src. Moreover, p120-RasGAP has been proposed to modulate the tyrosine phosphorylation of p190-A since this phosphorylation is abnormal in p120-RasGAP null fibroblasts.71 Regulation of p190-A tyrosine phosphorylation and GAP activity has been recently proposed to involve novel p190-A protein partners. In breast cancer cells, p190-A tyrosine phosphorylation by Src upon heregulin (HRG) stimulation seems to be regulated by the related adhesion focal tyrosine kinase (RAFTK), a kinase that associates in these conditions with both p190-A and Src.72 In NIH 3T3 cells, p190-A tyrosine phosphorylation as well as its GAP activity are regulated by a low molecular weight protein-tyrosine phosphatase (LMW-PTP) upon integrin engagement or platelet derived growth factor (PDGF) stimulation.73 It should be pointed out however that the regulatory role of p190-A tyrosine phosphorylation on its RhoGAP activity may be cell type specific, since p190-A activation correlates with its tyrosine phosphorylation in some cell types and conditions72-75 but not others.60,76 A role for p190-A has also been proposed in fibroblast migration74,77 as well as in melanoma and breast cancer cell invasion.72,75 It has been shown that RhoA is transiently inhibited prior to its activation during integrin-mediated adhesion to fibronectin and that integrin stimulates p190-A RhoGAP activity as well as its c-Src-dependent-tyrosine-phosphorylation.74,77 Thus, it has been postulated that initial localized suppression of RhoA activity by integrin via c-Src and p190-A may be a critical step to allow cells to migrate and may also contribute to focal adhesion disassembly at the rear of the motile cell.74 Recently, a role for p190-A in neuronal development has been proposed.78,80 p190-A is expressed widely throughout the nervous system at all stages of development and is highly phosphorylated in all regions of the brain.78,79 p190-A is coenriched with F-actin at the distal tip of axons and its overexpression promotes Src-dependent, integrin-mediated neurite outgrowth in neuroblastoma cells.79 Moreover, p190-A null mice exhibit several defects in neuronal development that are reminiscent of those described in mice lacking certain mediators of neuronal cell adhesion.78
The Chimaerin Subfamily Members of the chimaerin subfamily present both a RhoGAP domain located at their C-terminus and a cysteine-rich (C1) domain in their amino-terminal extremity (Fig. 1, Table 1). This subfamily consists of α1- ( or n-), α2-, β1- and β2-chimaerin variants, rotund-like, and PARG1-like proteins. α1-, α2, β1 and β2-chimaerin are 34 to 46 kDa proteins and are alternative spliced variants from the α- and β-chimaerin genes.81-84 α2 and β2-chimaerin variants contain an additional Src homology 2 (SH2) domain at their N-terminus whose role remains undefined.81,83 The expression of these four isozymes appears to be spatially and temporally regulated in vivo and some of the molecular mechanisms of their tissue-specific expression have been described.85,86 For instance, the brain-specific α1-chimaerin expression is detected at day 15 and appears to increase postnatally from birth to 20 days, a time of extensive cellular differentiation and synaptogenesis.84 It has been also proposed that α1-chimaerin expression might be regulated by neuronal/synaptic activity.88 The cerebellar β2-chimaerin is expressed predominantly in granule cells and exhibits post-natal developmental increase.83 Moreover, human β2-chimaerin is differently expressed in normal brain and low-grade astrocytoma compared to malignant gliomas where its expression is drastically reduced.89 Thus, it was proposed that down regulation of β2-chimaerin expression might be implicated in the development of malignant glioma.89
The Superfamily of Rho GTPase-Activating Proteins
77
Both α- and β-chimaerin variants show in vitro GAP activity towards Rac1 and to a lesser extent Cdc42, but not RhoA.26,82 This activity has been also confirmed in vivo, since the expression of the α1-chimaerin GAP domain inhibits Rac1-induced lamellipodia formation in Swiss 3T3 cells.90 Surprisingly, the expression of the full-length protein seems to cooperate with Rac1 and Cdc42 to induce the formation of lamellipodia and filopodia in a GAP activity-independent but GTPase-binding dependent manner.90 This suggests a putative role for α1-chimaerin as a Rac1 and/or Cdc42 effector. In addition to their GAP domain, chimaerins contain a cysteine-rich (C1) domain homologous to the protein Kinase C (PKC) regulatory domain. The C1 domain of PKC is responsible for phospholipid–dependent phorbol ester binding.91 Similar to PKC, α1- and β2-chimaerins bind phorbol ester in a phospholipid- and zinc-dependent manner.6,7 Moreover, it has been shown that the α1-chimaerin GAP activity towards Rac1 is stimulated in vitro through its C1 domain by phosphatidylserine and phosphatidic acid in a synergistic manner with phorbol esters, whereas lysophosphatidic acid (LPA) inhibits this GAP activity.8 Therefore, this suggests a potential regulation of chimaerin GAP activity by lipid binding that may orchestrate the dual function of chimaerin as negative regulators or effectors of Rac and/or Cdc42. Rotund proteins constitute a second subgroup within the chimaerin subfamily. Drosophila rotund, a 41 kDa protein, has been isolated as a male sterility mutant.94,95 Rotund transcripts have been localized in germ line cells of testis and primary spermatocytes.94,95 Very homologous to rotund, the human MgcRacGAP and the C. elegans CYK-4, are predominantly expressed in testis and in spermatocytes or in gonads and oocytes respectively.96,258 Both proteins have GAP activity towards Rac1 and Cdc42 but not RhoA in vitro.96,258 In contrast to other RhoGAPs that are mainly cytosolic, MgcRacGAP and CYK-4 are localized to the nucleus during interphase, accumulates at the mitotic spindle during metaphase, and are concentrated in the midbody during cytokinesis.97,258 Experiments using a GAP-inactive mutant or embryonic stem cells defective in MgcRacGAP expression and RNA interference for CYK-4 support the idea that these proteins are required for normal mitosis and cytokinesis.98,258 MgcRacGAP has also been shown to interact with a sulfate transporter specifically expressed in male germ cell line, suggesting that MgcRacGAP may link sulfate transport to Rho GTPases in male germ cells.99 Additional roles for MgcRacGAP have been also proposed in the control of growth and differentiation of hematopoietic cells100 and in neuronal development.101 Finally, a 150 kDa protein PARG1 (PTPL1-associated RhoGAP1) has been isolated from its ability to bind to the five PDZ domains present in the protein-tyrosine phosphatase PTPL1.102 PARG1 has GAP activity in vitro towards both Rac1, Cdc42 and RhoA with a clear preference for RhoA.102 To date, the in vivo function of PARG1 is still unknown.
The GRAF Subfamily The GRAF subfamily contains the human proteins GRAF (GAP for Rho associated with focal adhesion kinase), oligophrenin-1, the murine PSGAP-S and PSGAP-M. Most of them are constituted from their N- to C-terminus of a PH domain, a RhoGAP domain and a SH3 domain (Fig. 1, Table 1). Chicken GRAF was the first protein of this subfamily to be identified as a focal adhesion tyrosine kinase (FAK)-interacting protein through its SH3 domain and was subsequently shown also to interact with cell adhesion kinase β (CAKβ), a tyrosine kinase that is closely related to FAK.103,104 GRAF has GAP activity towards RhoA and Cdc42 in vitro.103 However, when expressed in Swiss 3T3 cells, it inhibits RhoA-induced stress fibers formation but not Cdc42-induced filopodia.106 In chicken embryo cells, GRAF colocalizes with actin stress fibers, cortical actin and focal adhesion complexes.103 Human GRAF localizes to the gene locus 5q31,107 which is disrupted in some cases of myelodysplastic syndrome and acute myeloid leukemia, suggesting that deletions and mutations of the GRAF gene may be instrumental in the development and progression of hematopoietic disorders.107 Mutations resulting in oligophrenin-1 loss of function are related to nonspecific X-linked mental retardation (MRX), a pathology affecting 0.15 to 0.3% of men.108 Oligophrenin-1
78
Rho GTPases
mRNA is present in various adult and fetal tissues and appears largely expressed in fetal brain. Oligophrenin-1 displays in vitro GAP activity towards both RhoA, Cdc42 and to a lower extent Rac1.108 To date, the specificity of this GAP activity in vivo and the molecular mechanisms linking mental retardation to loss of oligophrenin-1 activity are still unknown. There is two splice variants of PSGAP: PSGAP-S, a 683 amino acid protein (85 kDa) and PSGAP-M, a 786 amino acid protein (95 kDa). Three mRNAs have been detected in a variety of mouse tissues.10 Generation of specific anti-PSGAP antibodies revealed that these two protein variants were expressed in different cell types: PSGAP-M was expressed in fibroblastic cells whereas PSGAP-S appeared to be expressed ubiquitously. PSGAP has GAP activity towards RhoA and Cdc42 both in vitro and in vivo10 and interacts through its SH3 domain with PYK2, a FAK homologous tyrosine kinase. PSGAP colocalizes with PYK2 to focal adhesion complexes through its PH domain and is also phosphorylated by PYK2. In addition, PYK2 has been shown to inhibit PSGAP activity towards Cdc42 in vivo.10 These results suggest that PSGAP may be an important mediator for PYK2 to regulate cytoskeletal dynamics via Cdc42.
The Myosin-IX Subfamily Members of the unconventional myosin-IX subfamily are large multimodular proteins. They are constituted from their N- to C-terminus of a Ras interactive binding domain, whose biological relevance has not been reported, a myosin ATPase domain, four to six short calmodulin binding motifs (IQ), a cysteine-rich domain (C1), and a RhoGAP domain (Fig. 1, Table 1). Rat Myr 5 and its human ortholog myosin-IXB are detected as 225-229 kDa proteins in several rat and human tissues.109,110 Human myosin-IXB is more abundant in cells of myeloid origin.111 Its expression increases upon differentiation of human leukocytes into macrophage-like cells,111 concomitantly with relocation of myosin-IXB from actin-rich structures at the cell periphery to a more cytosolic and perinuclear location.111 Isolated from rat brain, Myr 7 is expressed at high levels in developing and adult brain, while Myr 5 is expressed at moderate levels in this tissue at all developmental stages.112 These proteins display specific GAP activities towards RhoA but not Rac1 or Cdc42 in vitro.110,112,113 Cloning of the mouse ortholog of the rat myr 5 and the human myosin-IXB genes has allowed the identification of two alternatively spliced exons that have still no equivalent in the human or Rat genes.115 Mouse myosin-IXB coding sequence has been mapped to chromosome 8 and is a candidate target for the mouse mutation myodystrophy and quinky.115 Recently, myosin-IXA has been identified in human as a candidate gene involved in the Bardet-Bield syndrome (BBS), an heterogenous autosomal recessive disorder partially characterized by mental retardation, obesity, short stature and hypogenitalism.116 The biological role of these unconventional myosins remains to be determined. The presence of the actin-binding myosin domain suggests that they may act as effectors of RhoA by regulating the organization of actin filaments. However, no evidence for such an effector role of unconventional myosins was obtained. In the case of myr 5, it seems plausible that the myosin domain participates in controlling the subcellular localisation of myr 5, thereby contributing to the spatial and temporal regulation of RhoA.113
The RLIP Subfamily The RLIP proteins consist of a central RhoGAP domain and a C-terminal Ral- binding domain. The human Ral-interacting protein of 76 kDa (RLIP76), the mouse Ral-interacting protein 1 (RLIP1) and the rat Ral-binding protein 1 (RalBP1) bind to activated GTP-bound RalA. RLIP76 and RLIP1 show GAP activity towards Cdc42 and Rac1 but not RhoA in vitro,117,118 while RalBP1 GAP activity seems specific towards Cdc42. The GAP activities and Ral-effector properties of the rat cytocentrin and the D. melanogaster member of this subfamily (supplemental data) are so far unknown, although the high degree of identity (98.4%) between cytocentrin and RalBP1 amino acid sequences suggest that they have similar properties.119 The RhoGAP domain appears not to be required for RLIP1 binding to RalA-GTP117 and the
The Superfamily of Rho GTPase-Activating Proteins
79
RalA-binding domain does not affect RLIP1 GAP activity in vitro,118 suggesting that these two domains may function independently. The biological relevance of these activities in vivo has not been established yet. In mouse and rat, RLIP1 and cytocentrin appear to be ubiquitously expressed.118,119 Interestingly, the localization of cytocentrin can cycle between the cytosol and the mitotic poles.120 Moreover, overexpression of this protein inhibits the assembly of mitotic spindles whereas loss of cytocentrin expression leads to the formation of monopolar spindle, suggesting that cytocentrin may play a regulatory role in mitosis.119
The p85 Subfamily p85-α and -β are the regulatory subunits of the phosphatidylinositol-3 kinase (PI-3K). They are constituted from their N- to C-terminus by a SH3 domain, a RhoGAP domain, and two SH2 domains that mediate interaction with activated protein tyrosine kinases121-123 (Fig. 1, Table 1). The RhoGAP domain of p85 is similar to p50-RhoGAP (45% homology) but has no GAP activity.124 However, p85-α is able through its RhoGAP domain to bind specifically to Cdc42 and Rac1 but not RhoA and this interaction has been shown to modulate PI-3 Kinase activity in vitro.124,125 The association between PI-3K and Rac1 induced upon PDGF stimulation of Swiss 3T3 cells suggests a potential role of this interaction in PDGF-mediated actin reorganization.125,126 However, more recently, Rac1 has been shown to inhibit apoptosis in epithelial cells in anchorage-dependent conditions and PI-3K appears to mediate the effects of Rac1 on cell survival.257 Therefore, PI-3K may act both upstream and downstream of Rac1, suggesting the possibility of a positive feedback loop.257
The p50-RhoGAP Subfamily p50-RhoGAP isoforms have been found in human, mouse, D. melanogaster, and C. elegans. They present a RhoGAP domain at their C-terminus and a putative lipid-binding domain (Sec14 domain) whose function has not yet been established (Fig. 1, Table 1 and supplemental data). p50-RhoGAP (named also Cdc42Hs-GAP) displays GAP activity towards Cdc42, RhoA and Rac1 with notable preference for Cdc42 in vitro.31,127-129 Although p50-RhoGAP activity has not been tested in vivo towards Cdc42, it has been shown to inhibit RhoA- but not Rac1-induced cytoskeleton reorganization when expressed in Swiss 3T3 cells.31 p50-RhoGAP has also been shown to interact in vitro with the SH3 domains of p85-α and of c-Src through a proline-rich domain.127 To date, the biological function of these interactions remains to be established.
The OCRL Subfamily The Lowe syndrome, also known as oculocerebrorenal syndrome, is caused by mutations in the X chromosome-encoded OCRL gene.130-132 The OCRL protein is 51% identical to inositol polyphosphate 5-phosphatase II (5-phosphatase II) from human platelets and contains a RhoGAP domain at its C-terminus. OCRL is expressed in a number of tissues and functions as a phosphatidylinositol 4,5-bisphosphate 5-phosphatase both in vitro and in vivo133 but does not present any GAP activity towards Cdc42, Rac1 or RhoA (Lamarche-Vane, unpublished data). OCRL is associated with lysosomal membranes suggesting that OCRL may regulate a specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes.134
The p122-RhoGAP Subfamily In addition to their RhoGAP domain, members of this subfamily display a star-related lipid transfer (START) domain (Fig. 1, Table 1 and supplemental data). p122-RhoGAP displays GAP activity in vitro and in vivo towards RhoA but not Rac1. In addition, it interacts with phospholipase C-δ1 and can activate its phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysing activity.135,136 PIP2 modulates the function of numerous actin-binding protein, including gelsolin and profilin, and p122-RhoGAP therefore may be involved in remodeling the actin cytoskeleton through the control of the intracellular levels of PIP2.
80
Rho GTPases
The C1 Subfamily Members of the C1 subfamily are constituted by a N-terminal Fes/CIP4 homology domain, a RhoGAP domain, and a C-terminal SH3 domain (Fig. 1, Table 1 and supplemental data). To date, the function of these RhoGAPs is poorly described. Human C1 protein, also named p115, is synthesized predominantly in cells of hematopoietic origin (spleen, thymus and leukocytes) and localized within the cell just below the plasma membrane.137 Overexpression of this protein into fibroblasts disrupts stress fibers suggesting that this protein may have GAP activity towards RhoA in vivo.137 Whether this protein has GAP activity towards Rac1 and Cdc42 has not been investigated.
The CeGAP Subfamily Members of C. elegans GAP (CeGAP) subfamily contain a PH and a RhoGAP domain (Fig. 1, Table 1 and supplemental data). CeGAP presents GAP activity towards human and C. elegans Rac1, Cdc42 and RhoA as well as the C. elegans and human Ras protein (let-60 and Ras) and Rab3A.138 The biological relevance of this cross reactivity in vivo has not been established yet.
The 3BP-1 Subfamily 3BP-1 contains a RhoGAP and a SH3-binding domain. It is mainly expressed in brain and spleen and displays GAP activity towards Rac1 and Cdc42 but not RhoA in vitro.139 Its Rac1-specific GAP activity has been also confirmed in vivo.139 Moreover, this protein is able to bind to the SH3 domain of the protooncogene c-Abl.140 It will therefore be interesting to see whether this interaction can regulate the transforming potential of c-Abl. Nadrin is another member of the 3BP-1 subfamily that has been first identified in rat. Nadrin is a neuronal protein whose expression correlates well with differentiation of neurons. It has GAP activity towards RhoA, Rac1 and Cdc42 in vitro and its expression in NIH 3T3 cells disrupts stress fibers and membrane ruffles formation.141 Since overexpression of a GAP-inactive mutant inhibited Ca2+-dependent exocytosis in PC12 cells, it has been postulated that nadrin may play a regulatory role in this process.141
The CdGAP Subfamily Mouse CdGAP consists of a N-terminal RhoGAP domain and five potential SH3-binding motifs localized within a large C-terminal proline rich domain. CdGAP mRNA is detected in a number of mouse tissues but seems more abundant in brain, heart and lung. CdGAP has GAP activity towards Rac1 and Cdc42 but not RhoA, both in vitro and in vivo.142 Moreover, this activity has been shown to be directly regulated through its interaction with the scaffolding protein intersectin both in vitro and in vivo.11 Since intersectin has been implicated in clathrin-dependent endocytosis and mitogenic signalling, the CdGAP-intersectin interaction may play a role in the regulation of these cellular processes. However, to date such a function has not been established. d-CdGAPr is a D. melanogaster CdGAP related protein that contains an additional SH3 domain at the N-terminus of the GAP domain. This protein has not been characterized functionally yet, but its mRNA has been detected throughout development as well as in adult and presents a highly dynamic spatio-temporal pattern.143
The ARHGAP6 Subfamily
ARHGAP6 proteins display GAP activity towards RhoA both in vivo and in vitro.144,145 ARHGAP6 localizes to the X chromosome in a critical region deleted in patients suffering of microphthalmia with linear skin defects (MLS),144,145 but whether alteration of this gene contributes to MLS remains to be shown.
The Superfamily of Rho GTPase-Activating Proteins
81
The Saccharomyces Cerevisiae GAPs Bem2p consists of a RasGEF, a PH, and a RhoGAP domain (Fig. 1 and Table 1). Bem2 mutations cause cells to become large and multinucleate, suggesting that Bem2p is involved in bud emergence.146,147 Bem2p has GAP activity towards Rho1p in vitro.148 In addition, increasing the gene dosage of rho1 or rho2 can partially suppress bem2 mutant phenotypes. Thus, it appears that Rho1p and Rho2p GTPases might be the targets of Bem2p in vivo.149 Since bem2 mutations have abnormal microtubule arrays, Bem2p has been also proposed to be involved directly or indirectly in regulating microtubule function.150 Bem3p is a suppressor of the temperature-sensitive lethality caused by mutations in bem2.151 In addition to its C-terminal RhoGAP domain, it has PX and PH domains (Fig. 1, Table 1). The recombinant GAP domain of Bem3p has GAP activity towards human Cdc42 in vitro.13,151 Dbm1p (named also Rga1p) has two LIM domains at its N-terminus and a RhoGAP domain at its C-terminus (Fig. 1, Table 1). It has been identified as a negative regulator of the pheromone response pathway152 and has been implicated in bud site selection.153 Mutations within the LIM domains result in mutant forms of Dbm1p that can no longer function in bud site selection.153 Using the yeast two-hybrid system, this protein has been shown to interact with Cdc42p, suggesting that the latter protein may be a specific target for Dbm1p GAP activity.152 Like Dbm1p, Lrg1p consists of three LIM domains and a RhoGAP domain at its C-terminus. Lrg1p has been shown to be expressed during sporulation and is thought to play a role during mating.154 To date, nothing is known about its GAP activity. The sac7 gene was identified as a genomic suppressor of actin mutations.155 Its protein product has GAP activity towards Rho1p in vitro.156 Signal transduction mediated by the mitogen-activated protein kinase (MAPK) Slt2 pathway is essential to maintain the cell wall integrity in Saccharomyces cerevisiae. Disruption of the Rho1-GTPase-activating protein genes sac7 and bem2 leads to constitutive Slt2 activation, indicating their involvement as negative regulators of the MAPK pathway and a putative role in the maintenance of cell wall.157,158
The Arabidopsis Thalia GAPs Recently, RhoGAP-like proteins have been identified in plants: the RopGAPs. They all present a consensus RhoGAP domain and most of them contain a Cdc42/Rac-interactive binding (CRIB) motif as well (Fig. 1, Table 1, supplemental data). Interestingly, the CRIB domain has been shown to regulate the in vitro GAP activity of the RopGAPs towards a Rho GTPase closely related to the mammalian Rac protein.159
The Dictyostelium Discoidum GAP Dictyostelium discoideum DdRacGap1 (DRG) contains from its N- to C-terminus a RhoGAP domain, a SH3 domain, and a PH domain surrounded by two DH domains (Fig. 1, Table 1, see also Chapter 14). Its GAP domain is active towards DdRac1A, DdRacC, DdRacE, HsRhoA and HsRac1 in vitro, but not HsN-Ras.160,161 Disruption of DRG stimulates membrane ruffling, similar to overexpression of a constitutively active DdRac1 mutant, suggesting that DdRacGAP is a Rac1-specific GAP in vivo.161,162 DRG also has GEF activity towards Rac1, but not DdRacE. Interestingly, DRG has a high GAP but not GEF activity towards DdRabd, the dictyostelium homolog of Rab4. Moreover, DRG-GAP activity appears to be required for RabD-dependent regulation of the contractile vacuole, suggesting that the RabD-specific GAP activity of DRG may have some biological relevance in vivo.161
RhoGAPs in Host-Pathogen Interaction Multiple studies indicate that Rho GTPases are the preferred eucaryotic substrates of various bacterial protein toxins and exoenzymes.163 ExoS, YopE and SptP are cytotoxins secreted via a type III secretion pathway by the opportunistic bacteria Pseudomonas aeruginosa, Yersinia spp. and Salmonella typhimurium respectively.164-168 All proteins present a RhoGAP domain.
82
Table 2. Specific GAP activities, tissue distributions and putative cellular and pathological functions of characterized RhoGAPs Subfamily
Name
GAP Activity
Tissue Distribution
Role In
References
Bcr
Bcr Abr
Rac1, Rac2, Cdc42 Rac1, Cdc42
Brain, hematopoietic cells Brain
•cell cycle progression •mediation of glucocorticoid effects
26-31, 52
p190-RhoGAP
p190-A
Rac1,Cdc42, RhoA*
Most tissues
•Ras-RhoA cross-talk
31, 57, 59, 60, 72, 74, 75, 77-79, 188, 189
p190-B
Rac1,Cdc42, RhoA*
Most tissues
•fibroblast migration •melanoma and breast cancer cell invasion •neurogenesis •Shigella flexneri entry
Alpha 1 Alpha 2 Beta 1 Beta 2 MgcRac-GAP
Rac1, Cdc42 Rac1, Cdc42 Rac1, Cdc42 Rac1, Cdc42 Rac1,Cdc42
Brain Brain, testis Testis, germs cells Brain, pancreas Testis,Thymus, CNS
•Rac1, Cdc42 effector?
Rotund CYK-4 PARG1
ND Rac1,Cdc42 Rac1, Cdc42, RhoA*
testis gonad, oocytes Most tissues
Chimaerin
26, 81-83, 87, 90, 94-97, 100-102, 258
continued on next page
Rho GTPases
•malignant glioma? •mitosis, cytokinesis •hematopoiesis spermatogenesis? •neurogenesis? •spermatogenesis •cytokinesis
Subfamily
Name
GAP Activity
Tissue Distribution
Role In
References
GRAF
GRAF Oligophrenin1 PSGAP
RhoA,Cdc42 RhoA,Cdc42, Rac1 RhoA,Cdc42
Most tissues Most tissues, fetal brain* Most tissues
•hematopoietic disorders? •X-linked mental retardation
10, 103, 106-108
Myosin-IX
Myosin-IXB
RhoA
Most tissues, cells of myeloid origin*
Myosin-IXA Myr 5 Myr 7
ND RhoA, RhoB, RhoC RhoA
Most tissues Most tissues, brain*
RLIP
RLIP76 RIP1 RalBP1 Cytocentrin
Cdc42,Rac1 Cdc42,Rac1 Cdc42 ND
Most tissues Most tissues Most tissues Most tissues
Ral-Rho crosstalk Ral-Rho crosstalk Ral-Rho crosstalk Ral-Rho crosstalk •mitosis
117-119
p85
P85-alpha P85-beta p50-RhoGAP (Cdc42Hs-GAP)
(-)
Most tissues Most tissues
•actin reorganization
124, 125
p50-RhoGAP
109-111, 112, 113, 114,116 •Bardet-Bield sydrome?
Rac1,Cdc42*,RhoA
OCRL
OCRL1
(-)
p122-RhoGAP
P122-RhoGAP
RhoA
The Superfamily of Rho GTPase-Activating Proteins
Table 2. Cont.
31, 127-129
Most tissues
•Lowe syndrome
130-133
RhoA effector? activates PLC-δ1
135,136,256
83
continued on next page
84
Table 2. Cont. Subfamily
Name
GAP Activity
Tissue Distribution
C1
Hs C1
RhoA
spleen,thymus, leukocytes
CeGAP
CeGAP
Rac1,Cdc42, RhoA,Ras, let60,Rab3A
3BP1
3BP1 Nadrin
Rac1, Cdc42 Rac1, Cdc42,RhoA
Brain,spleen neurons
•Abl signalling? •exocytosis in PC12
139, 141
CdGAP
CdGAP
Rac1, Cdc42
Most tissues
•endocytosis? •mitogenic-signalling?
142
ARHGAP6
ARHGAP6
RhoA
Most tissues
•Microphthalmia with Linear Skin defects?
144, 145
Role In
References
137 138
Rho GTPases experimentally identified as in vitro and/or in vivo RhoGAP substrates are indicated respectively in italic and/or bold. Organs in which the RhoGAP transcript or protein has been detected and the proposed cellular and/or pathological roles are indicated. Asterisks indicate the preferred substrates or tissues. ND indicates noncharacterized activity.(-) indicates that the protein does not present any GAP activity in vitro.
Rho GTPases
The Superfamily of Rho GTPase-Activating Proteins
85
Table 3. Specific GAP activity and potential cellular function of S. cerevisiae, D. discoideum and pathogen RhoGAPs Species
Name
GAP Activity
Role In
References
S. cerevisiae
BEM2
Rho1p,Rho2p
13, 146, 147 149, 151, 152, 154, 156-158
BEM3 DBM1 LRG1
HsCdc42 Cdc42p ND
SAC7
Rho1p
-bud emergence - microtubule regulation? -cell wall -bud emergence -pheromone response -sporulation, mating -cell wall
D. discoideum
Yersinia spp.
P. aeruginosa S. typhimurium
DdRacGAP DdRac1A, DdRacC,DdRacE, HsRhoA, HsRac1, DdRabd YopE Rac1,Cdc42, RhoA ExoS SptP
Rac1,Cdc42, RhoA, Rac1,Cdc42
160-162
-inhibition of phagocytosis -cell rounding -antagonizes SOPE, SOPB
175, 180-183
Rho GTPases experimentally identified as in vitro and/or in vivo RhoGAP substrates are indicated respectively in italic and/or bold. Cellular roles proposed for these proteins are indicated. ND indicates noncharacterized activity.
In addition to its RhoGAP domain, ExoS has a C-terminal ADP-ribosyltransferase domain. Intracellular delivery of ExoS is cytotoxic for eucaryotic cells and has been shown to ADP-ribosylate Ras in vivo and uncouple Ras-mediated signal transduction pathways.169-174 ExoS displays a GAP activity towards RhoA, Rac1, and Cdc42 in vitro.175 In addition, intracellular expression of the RhoGAP domain of ExoS elicits the rounding of Chinese hamster ovary (CHO) cells and the disruption of actin filaments in a dose-dependent manner.176 The functional role of ExoS GAP activity in microbial pathogenesis is not fully understood, however it may play a role in microbial entry since both Rac1, RhoA and Cdc42 have been implicated in phagocytosis.178,179 Similar to ExoS, YopE exhibits in vitro GAP activity towards RhoA, Rac1 and Cdc42.180,181 Infection assays carried out with a Yersinia pseudotuberculosis strain producing a YopE GAP-deficient mutant (R144A) demonstrated that the GAP function is essential for the disruption of actin filaments, cell rounding and inhibition of phagocytosis by YopE.180-183 SptP consists of a RhoGAP domain and a protein tyrosine phosphatase domain.184 Microinjection of purified GST-SptP into cultured cells results in the disruption of the actin cytoskeleton.185 SptP has GAP activity towards Rac1 and Cdc42 but not RhoA in vitro and antagonizes the Rac1/Cdc42 GEF activity of SopE in vivo.19,186,187
Conclusion Analysis of the various subfamilies of RhoGAP proteins points out the high degree of redundancy of RhoGAPs within higher eucaryotic organisms such as human and mouse in com-
86
Rho GTPases
parison with C. elegans that in most cases has only one member of each subfamily (supplemental data). This analysis also highlights that within a same family of proteins, RhoGAPs are not clearly homogenous when considering their Rho GTPase targets and tissue distribution (Table 2). The hypothesis considering RhoGAPs as spatio-temporal regulators of Rho GTPases gives a reasonable explanation to such an abundance of RhoGAP proteins. This hypothesis is nicely illustrated in the case of p190-A thought to be implicated in the temporally and spatially restricted inactivation of RhoA in fibroblasts upon integrin engagement allowing cell movement.74 This also implies that RhoGAP activities may be submitted to a spatio-temporal regulation that could be at the level of their subcellular localization and/or GAP activity. In this study, 24 and 22 potential RhoGAPs have been identified in D. melanogaster and C. elegans, respectively. However, little is known about the in vivo characterization of most of these putative GAPs encoded genes. Clearly, disruption of the GAP genes in fruit fly and worm will be of great interest and will provide novel insights into the biological functions of RhoGAPs. Future studies of RhoGAP proteins and their cellular partners will help to elucidate how the regulation of GAP activities and the integration of inputs from a number of different signalling pathways are translated into a specific pattern of Rho GTPase activities.
Acknowledgments Nathalie Lamarche-Vane and Sarah Jenna hold a junior scholarship and a fellowship, respectively, from the Fonds de la Recherche en Sante du Quebec and the Canadian Institute of Health Research
References 1. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: A conserved switch for diverse cell functions. Nature 1990; 348:125-132. 2. Zhang B, Zheng Y. Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr and 3BP-1. Biochemistry 1998; 37:5249-5257. 3. Ponting CP, Schultz J, Milpetz F et al. SMART: Identification and annotation of domains from signalling and extracellular protein sequences. Nucleic Acids Res 1999; 27:229-232. 4. Schultz J, Milpetz F, Bork P et al. SMART, a simple modular architecture research tool: Identification of signalling domains. Proc Natl Acad Sci USA 1998; 95:5857-5864. 5. Lamarche N, Hall A. GAPs for rho-related GTPases. Trends Genet 1994; 10:436-440. 6. Ahmed S, Kozma R, Monfries C et al. Human brain n-chimaerin cDNA encodes a novel phorbol ester receptor. Biochem J 1990; 272:767-773. 7. Ahmed S, Kozma R, Lee J et al. The cysteine-rich domain of human proteins, neuronal chimaerin, protein kinase C and diacylglycerol kinase binds zinc. Evidence for the involvement of a zinc-dependent structure in phorbol ester binding. Biochem J 1991; 280:233-241. 8. Ahmed S, Lee J, Kozma R et al. A novel functional target for tumor-promoting phorbol esters and lysophosphatidic acid. The p21rac-GTPase activating protein n-chimaerin. J Biol Chem 1993; 268:10709-10712. 9. McGlade J, Brunkhorst B, Anderson D et al. The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. Embo J 1993; 12:3073-3081. 10. Ren XR, Du QS, Huang YZ et al. Regulation of CDC42 GTPase by proline-rich tyrosine kinase 2 interacting with PSGAP, a novel pleckstrin homology and Src homology 3 domain containing rhoGAP protein. J Cell Biol 2001; 152:971-984. 11. Jenna S, Hussain NK, Danek E et al. The activity of the GTPase activating protein CdGAP, is regulated by the endocytic protein, intersectin. J Biol Chem 2002; 277:6366-6373. 12. Ahmed S, Lee J, Wen LP et al. Breakpoint cluster region gene product-related domain of n-chimaerin. Discrimination between Rac-binding and GTPase-activating residues by mutational analysis. J Biol Chem 1994; 269:17642-17648. 13. Zheng Y, Hart MJ, Shinjo K et al. Biochemical comparisons of the Saccharomyces cerevisiae Bem2 and Bem3 proteins. Delineation of a limit Cdc42 GTPase-activating protein domain. J Biol Chem 1993; 268:24629-24634. 14. Musacchio A, Cantley LC, Harrison SC. Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 alpha subunit. Proc Natl Acad Sci USA 1996; 93:14373-14378.
The Superfamily of Rho GTPase-Activating Proteins
87
15. Barrett T, Xiao B, Dodson EJ et al. The structure of the GTPase-activating domain from p50rhoGAP. Nature 1997; 385:458-461. 16. Rittinger K, Walker PA, Eccleston JF et al. Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP. Nature 1997; 388:693-697. 17. Rittinger K, Walker PA, Eccleston JF et al. Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature 1997; 389:758-762. 18. Li R, Zhang B, Zheng Y. Structural determinants required for the interaction between Rho GTPase and the GTPase-activating domain of p190. J Biol Chem 1997; 272:32830-32835. 19. Fu Y, Galan JE. A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 1999; 401:293-297. 20. Forsberg A, Wolf-Watz H. Genetic analysis of the yopE region of Yersinia spp.: Identification of a novel conserved locus, yerA, regulating yopE expression. J Bacteriol 1990; 172:1547-1555. 21. Michiels T, Wattiau P, Brasseur R et al. Secretion of Yop proteins by Yersiniae Genetic analysis of the yopE region of Yersinia spp.: Identification of a novel conserved locus, yerA, regulating yopE expression. Infect Immun 1990; 58:2840-2849. 22. Kulich SM, Yahr TL, Mende-Mueller LM et al. Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388. J Biol Chem 1994; 269:10431-10437. 23. Stebbins CE, Galan JE. Modulation of host signalling by a bacterial mimic: Structure of the Salmonella effector SptP bound to Rac1. Mol Cell 2000; 6:1449-1460. 24. Wurtele M, Renault L, Barbieri JT et al. Structure of the ExoS GTPase activating domain. FEBS Lett 2001; 491:26-29. 25. Wurtele M, Wolf E, Pederson KJ et al. How the Pseudomonas aeruginosa ExoS toxin downregulates Rac. Nat Struct Biol 2001; 8:23-26. 26. Diekmann D, Brill S, Garrett MD et al. Bcr encodes a GTPase-activating protein for p21rac. Nature 1991; 351:400-402. 27. Maru Y, Witte ON. The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell 1991; 67:459-468. 28. Heisterkamp N, Kaartinen V, van Soest S et al. Human ABR encodes a protein with GAPrac activity and homology to the DBL nucleotide exchange factor domain. J Biol Chem 1993; 268:16903-16906. 29. Tan EC, Leung T, Manser E et al. The human active breakpoint cluster region-related gene encodes a brain protein with homology to guanine nucleotide exchange proteins and GTPase-activating proteins. J Biol Chem 1993; 268:27291-27298. 30. Chuang TH, Xu X, Kaartinen V et al. Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. Proc Natl Acad Sci USA 1995; 92:10282-10286. 31. Ridley AJ, Self AJ, Kasmi F et al. rho family GTPase activating proteins p190, bcr and rhoGAP show distinct specificities in vitro and in vivo. Embo J 1993; 12:5151-5160. 32. Soisson SM, Nimnual AS, Uy M et al. Crystal structure of the Dbl and pleckstrin homology domains from the human Son of sevenless protein. Cell 1998; 95:259-268. 33. Liu X, Wang H, Eberstadt M et al. NMR structure and mutagenesis of the N-terminal Dbl homology domain of the nucleotide exchange factor Trio. Cell 1998; 95:269-277. 34. Han J, Luby-Phelps K, Das B et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 1998; 279:558-560. 35. Hussain NK, Jenna S, Glogauer M et al. The endocytic scaffolding protein intersectin-l regulates actin dynamics via Cdc42 and N-WASP. Nat Cell Biol 2001; 3:927-932. 36. Reuther GW, Fu H, Cripe LD et al. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. Science 1994; 266:129-133. 37. Braselmann S, McCormick F. Bcr and Raf form a complex in vivo via 14-3-3 proteins. Embo J 1995; 14:4839-4848. 38. Bartram CR, Kleihauer E, de Klein A et al. C-abl and bcr are rearranged in a Ph1-negative CML patient. Embo J 1985; 4:683-686. 39. Heisterkamp N, Stam K, Groffen J et al. Structural organization of the bcr gene and its role in the Ph’ translocation. Nature 1985; 315:758-761. 40. Hariharan IK, Adams JM. cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia. Embo J 1987; 6:115-119. 41. Voncken JW, van Schaick H, Kaartinen V et al. Increased neutrophil respiratory burst in bcr-null mutants. Cell 1995; 80:719-728. 42. Carpino N, Wisniewski D, Strife A et al. p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997; 88:197-204. 43. Gotoh A, Miyazawa K, Ohyashiki K et al. Potential molecules implicated in downstream signalling pathways of p185BCR-ABL in Ph+ ALL involve GTPase-activating protein, phospholipase C-gamma 1, and phosphatidylinositol 3'-kinase. Leukemia 1994; 8:115-120.
88
Rho GTPases
44. Sawyers CL, McLaughlin J, Witte ON. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp Med 1995; 181:307-313. 45. Skorski T, Kanakaraj P, Ku DH et al. Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: Implication for RAS-dependent Philadelphia chromosome positive cell growth. J Exp Med 1994; 179:1855-1865. 46. Bhat A, Kolibaba K, Oda T et al. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells. J Biol Chem 1997; 272:16170-16175. 47. Kashige N, Carpino N, Kobayashi R. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. Proc Natl Acad Sci USA 2000; 97:2093-2098. 48. Maru Y, Peters KL, Afar DE et al. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol Cell Biol 1995; 15:835-842. 49. Peters KL, Smithgall TE. Tyrosine phosphorylation enhances the SH2 domain-binding activity of Bcr and inhibits Bcr interaction with 14-3-3 proteins. Cell Signal 1999; 11:507-514. 50. Li J, Smithgall TE. Coexpression with BCR induces activation of the FES tyrosine kinase and phosphorylation of specific N-terminal BCR tyrosine residues. J Biol Chem 1996; 271:32930-32936. 51. Lionberger JM, Smithgall TE. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl. Cancer Res 2000; 60:1097-1103. 52. Voncken JW, Baram TZ, Gonzales-Gomez II et al. Abnormal stress response and increased fighting behavior in mice lacking the bcr gene product. Int J Mol Med 1998; 2:577-583. 53. Settleman J, Narasimhan V, Foster LC et al. Molecular cloning of cDNAs encoding the GAP-associated protein p190: Implications for a signalling pathway from ras to the nucleus. Cell 1992; 69:539-549. 54. Chakravarty G, Roy D, Gonzales M et al. P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer. Cell Growth Differ 2000; 11:343-354. 55. Burbelo PD, Finegold AA, Kozak CA et al. Cloning, genomic organization and chromosomal assignment of the mouse p190-B gene. Biochim Biophys Acta 1998; 1443:203-210. 56. Tikoo A, Czekay S, Viars C et al. p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas. Gene 2000; 257:23-31. 57. Burbelo PD, Miyamoto S, Utani A et al. p190-B, a new member of the Rho GAP family and Rho are induced to cluster after integrin cross-linking. J Biol Chem 1995; 270:30919-30926. 58. Nagase T, Kikuno R, Hattori A et al. Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 2000; 7:347-355. 59. Settleman J, Albright CF, Foster LC et al. Association between GTPase activators for Rho and Ras families. Nature 1992; 359:153-154. 60. Haskell MD, Nickles AL, Agati JM et al. Phosphorylation of p190 on Tyr1105 by c-Src is necessary but not sufficient for EGF-induced actin disassembly in C3H10T1/2 fibroblasts. J Cell Sci 2001; 114:1699-1708. 61. Ellis C, Moran M, McCormick F et al. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 1990; 343:377-381. 62. Moran MF, Polakis P, McCormick F et al. Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution and activity of p21ras GTPase-activating protein. Mol Cell Biol 1991; 11:1804-1812. 63. Tatsis N, Lannigan DA, Macara IG. The function of the p190 Rho GTPase-activating protein is controlled by its N-terminal GTP binding domain. J Biol Chem 1998; 273:34631-34638. 64. Foster R, Hu KQ, Shaywitz DA et al. p190 RhoGAP, the major RasGAP-associated protein, binds GTP directly. Mol Cell Biol 1994; 14:7173-7181. 65. Roof RW, Haskell MD, Dukes BD et al. Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation. Mol Cell Biol 1998; 18:7052-7063. 66. Koch CA, Moran MF, Anderson D et al. Multiple SH2-mediated interactions in v-src-transformed cells. Mol Cell Biol 1992; 12:1366-1374. 67. Hu KQ, Settleman J. Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: A conformational mechanism for SH3 domain regulation. Embo J 1997; 16:473-483. 68. Chang JH, Gill S, Settleman J et al. c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation. J Cell Biol 1995; 130:355-368. 69. Roof RW, Dukes BD, Chang JH et al. Phosphorylation of the p190 RhoGAP N-terminal domain by c-Src results in a loss of GTP binding activity. FEBS Lett 2000; 472:117-121. 70. Fincham VJ, Chudleigh A, Frame MC. Regulation of p190 Rho-GAP by v-Src is linked to cytoskeletal disruption during transformation. J Cell Sci 1999; 112:947-956.
The Superfamily of Rho GTPase-Activating Proteins
89
71. van der Geer P, Henkemeyer M, Jacks T et al. Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap. Mol Cell Biol 1997; 17:1840-1847. 72. Zrihan-Licht S, Fu Y, Settleman J et al. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 2000; 19:1318-1328. 73. Chiarugi P, Cirri P, Taddei L et al. The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem 2000; 275:4640-4646. 74. Arthur WT, Petch LA, Burridge K. Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Curr Biol 2000; 10:719-722. 75. Nakahara H, Mueller SC, Nomizu M et al. Activation of beta1 integrin signalling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia. J Biol Chem 1998; 273:9-12. 76. Dib K, Melander F, Andersson T. Role of p190RhoGAP in beta(2) Integrin Regulation of RhoA in Human Neutrophils. J Immunol 2001; 166:6311-6322. 77. Ren XD, Kiosses WB, Schwartz MA. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. Embo J 1999; 18:578-585. 78. Brouns MR, Matheson SF, Hu KQ et al. The adhesion signalling molecule p190 RhoGAP is required for morphogenetic processes in neural development. Development 2000; 127:4891-4903. 79. Brouns MR, Matheson SF, Settleman J. p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation. Nat Cell Biol 2001; 3:361-367. 80. Threadgill R, Bobb K, Ghosh A. Regulation of dendritic growth and remodeling by Rho, Rac and Cdc42. Neuron 1997; 19:625-634. 81. Hall C, Sin WC, Teo M et al. Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes. Mol Cell Biol 1993; 13:4986-4998. 82. Leung T, How BE, Manser E et al. Germ cell beta-chimaerin, a new GTPase-activating protein for p21rac, is specifically expressed during the acrosomal assembly stage in rat testis. J Biol Chem 1993; 268:3813-3816. 83. Leung T, How BE, Manser E et al. Cerebellar beta 2-chimaerin, a GTPase-activating protein for p21 ras-related rac is specifically expressed in granule cells and has a unique N-terminal SH2 domain. J Biol Chem 1994; 269:12888-12892. 84. Lim HH, Michael GJ, Smith P et al. Developmental regulation and neuronal expression of the mRNA of rat n-chimaerin, a p21rac GAP:cDNA sequence. Biochem J 1992; 287:415-422. 85. Dong JM, Smith P, Hall C et al. Promoter region of the transcriptional unit for human alpha 1-chimaerin, a neuron-specific GTPase-activating protein for p21rac. Eur J Biochem 1995; 227:636-646. 86. Dong JM, Lim L. The human neuronal alpha 1-chimaerin gene contains a position-dependent negative regulatory element in the first exon. Neurochem Res 1996; 21:1023-1030. 87. Hall C, Monfries C, Smith P et al. Novel human brain cDNA encoding a 34,000 Mr protein n-chimaerin, related to both the regulatory domain of protein kinase C and BCR, the product of the breakpoint cluster region gene. J Mol Biol 1990; 211:11-16. 88. Dong JM, Lim L. Selective up-regulation of alpha 1-chimaerin mRNA in SK-N-SH neuroblastoma cells by K+/-induced depolarisation. Eur J Biochem 1996; 236:820-826. 89. Yuan S, Miller DW, Barnett GH et al. Identification and characterization of human beta 2-chimaerin: Association with malignant transformation in astrocytoma. Cancer Res 1995; 55:3456-3461. 90. Kozma R, Ahmed S, Best A et al. The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia. Mol Cell Biol 1996; 16:5069-5080. 91. Ono Y, Fujii T, Igarashi K et al. Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proc Natl Acad Sci USA 1989; 86:4868-4871. 92. Caloca MJ, Fernandez N, Lewin NE et al. Beta2-chimaerin is a high affinity receptor for the phorbol ester tumor promoters. J Biol Chem 1997; 272:26488-26496. 93. Caloca MJ, Wang H, Delemos A et al. Phorbol esters and related analogs regulate the subcellular localization of beta 2-chimaerin, a nonprotein kinase C phorbol ester receptor. J Biol Chem 2001; 276:18303-18312. 94. Agnel M, Roder L, Vola C et al. A Drosophila rotund transcript expressed during spermatogenesis and imaginal disc morphogenesis encodes a protein which is similar to human Rac GTPase-activating (racGAP) proteins. Mol Cell Biol 1992; 12:5111-5122.
90
Rho GTPases
95. Agnel M, Kerridge S, Vola C et al. Two transcripts from the rotund region of Drosophila show similar positional specificities in imaginal disc tissues. Genes Dev 1989; 3:85-95. 96. Toure A, Dorseuil O, Morin L et al. MgcRacGAP, a new human GTPase-activating protein for Rac and Cdc42 similar to Drosophila rotundRacGAP gene product, is expressed in male germ cells. J Biol Chem 1998; 273:6019-6023. 97. Hirose K, Kawashima T, Iwamoto I et al. MgcRacGAP is involved in cytokinesis through associating with mitotic spindle and midbody. J Biol Chem 2001; 276:5821-5828. 98. Van de Putte T, Zwijsen A, Lonnoy O et al. Mice with a homozygous gene trap vector insertion in mgcRacGAP die during preimplantation development. Mech Dev 2001; 102:33-44. 99. Toure A, Morin L, Pineau C et al. Tat1, a novel sulfate transporter specifically expressed in human male germ cells and potentially linked to RhoGTPase signalling. J Biol Chem 2001; 276:20309-20315. 100. Kawashima T, Hirose K, Satoh T et al. MgcRacGAP is involved in the control of growth and differentiation of hematopoietic cells. Blood 2000; 96:2116-2124. 101. Arar C, Ott MO, Toure A et al. Structure and expression of murine mgcRacGAP: Its developmental regulation suggests a role for the Rac/MgcRacGAP signalling pathway in neurogenesis. Biochem J 1999; 343 Pt1:225-230. 102. Saras J, Franzen P, Aspenstrom P et al. A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1. J Biol Chem 1997; 272:24333-24338. 103. Hildebrand JD, Taylor JM, Parsons JT. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol 1996; 16:3169-3178. 104. Ohba T, Ishino M, Aoto H et al. Interaction of two proline-rich sequences of cell adhesion kinase beta with SH3 domains of p130Cas-related proteins and a GTPase-activating protein, Graf. Biochem J 1998; 330:1249-1254. 105. Taylor JM, Hildebrand JD, Mack CP et al. Characterization of graf, the GTPase-activating protein for rho associated with focal adhesion kinase. Phosphorylation and possible regulation by mitogen-activated protein kinase. J Biol Chem 1998; 273:8063-8070. 106. Taylor JM, Macklem MM, Parsons JT. Cytoskeletal changes induced by GRAF, the GTPase regulator associated with focal adhesion kinase, are mediated by Rho. J Cell Sci 1999; 112:231-242. 107. Borkhardt A, Bojesen S, Haas OA et al. The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. Proc Natl Acad Sci USA 2000; 97:9168-9173. 108. Billuart P, Bienvenu T, Ronce N et al. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998; 392:923-926. 109. Reinhard J, Scheel AA, Diekmann D et al. A novel type of myosin implicated in signalling by rho family GTPases. Embo J 1995; 14:697-704. 110. Post PL, Bokoch GM, Mooseker MS. Human myosin-IXb is a mechanochemically active motor and a GAP for rho. J Cell Sci 1998; 111:941-950. 111. Wirth JA, Jensen KA, Post PL et al. Human myosin-IXb, an unconventional myosin with a chimerin-like rho/rac GTPase-activating protein domain in its tail. J Cell Sci 1996; 109:653-661. 112. Chieregatti E, Gartner A, Stoffler HE et al. Myr 7 is a novel myosin IX-RhoGAP expressed in rat brain. J Cell Sci 1998; 111:3597-3608. 113. Muller RT, Honnert U, Reinhard J et al. The rat myosin myr 5 is a GTPase-activating protein for Rho in vivo: Essential role of arginine 1695. Mol Biol Cell 1997; 8:2039-2053. 114. Graf B, Bahler M, Hilpela P et al. Functional role for the class IX myosin myr5 in epithelial cell infection by Shigella flexneri. Cell Microbiol 2000; 2:601-616. 115. Grewal PK, Jones AM, Maconochie M et al. Cloning of the murine unconventional myosin gene Myo9b and identification of alternative splicing. Gene 1999; 240:389-398. 116. Gorman SW, Haider NB, Grieshammer U et al. The cloning and developmental expression of unconventional myosin IXA (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome 15q22-q23. Genomics 1999; 59:150-160. 117. Jullien-Flores V, Dorseuil O, Romero F et al. Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem 1995; 270:22473-22477. 118. Park SH, Weinberg RA. A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene 1995; 11:2349-2355. 119. Quaroni A, Paul EC. Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus. J Cell Sci 1999; 112:707-718. 120. Paul EC, Quaroni A. Identification of a 102 kDa protein (cytocentrin) immunologically related to keratin 19, which is a cytoplasmically derived component of the mitotic spindle pole. J Cell Sci 1993; 106:967-981.
The Superfamily of Rho GTPase-Activating Proteins
91
121. Otsu M, Hiles I, Gout I et al. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell 1991; 65:91-104. 122. Skolnik EY, Margolis B, Mohammadi M et al. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 1991; 65:83-90. 123. Escobedo JA, Navankasattusas S, Kavanaugh WM et al. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor. Cell 1991; 65:75-82. 124. Zheng Y, Bagrodia S, Cerione RA. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. J Biol Chem 1994; 269:18727-18730. 125. Bokoch GM, Vlahos CJ, Wang Y et al. Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem J 1996; 315:775-779. 126. Tolias KF, Cantley LC, Carpenter CL. Rho family GTPases bind to phosphoinositide kinases. J Biol Chem 1995; 270:17656-17659. 127. Barfod ET, Zheng Y, Kuang WJ et al. Cloning and expression of a human CDC42 GTPase-activating protein reveals a functional SH3-binding domain. J Biol Chem 1993; 268:26059-26062. 128. Lancaster CA, Taylor-Harris PM, Self AJ et al. Characterization of rhoGAP. A GTPase-activating protein for rho-related small GTPases. J Biol Chem 1994; 269:1137-1142. 129. Hart MJ, Shinjo K, Hall A et al. Identification of the human platelet GTPase activating protein for the CDC42Hs protein. J Biol Chem 1991; 266:20840-20848. 130. Attree O, Olivos IM, Okabe I et al. The Lowe’s oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 1992; 358:239-242. 131. Nussbaum RL, Orrison BM, Janne PA et al. Physical mapping and genomic structure of the Lowe syndrome gene OCRL1. Hum Genet 1997; 99:145-150. 132. Leahey AM, Charnas LR, Nussbaum RL. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. Hum Mol Genet 1993; 2:461-463. 133. Zhang X, Jefferson AB, Auethavekiat V et al. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc Natl Acad Sci USA 1995; 92:4853-4856. 134. Zhang X, Hartz PA, Philip E et al. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. J Biol Chem 1998; 273:1574-1582. 135. Homma Y, Emori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities. Embo J 1995; 14:286-291. 136. Sekimata M, Kabuyama Y, Emori Y et al. Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J Biol Chem 1999; 274:17757-17762. 137. Tribioli C, Droetto S, Bione S et al. An X chromosome-linked gene encoding a protein with characteristics of a rhoGAP predominantly expressed in hematopoietic cells. Proc Natl Acad Sci USA 1996; 93:695-699. 138. Chen W, Blanc J, Lim L. Characterization of a promiscuous GTPase-activating protein that has a Bcr-related domain from Caenorhabditis elegans. J Biol Chem 1994; 269:820-823. 139. Cicchetti P, Ridley AJ, Zheng Y et al. 3BP-1, an SH3 domain binding protein, has GAP activity for Rac and inhibits growth factor-induced membrane ruffling in fibroblasts. Embo J 1995; 14:3127-3135. 140. Cicchetti P, Mayer BJ, Thiel G et al. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 1992; 257:803-806. 141. Harada A, Furuta B, Takeuchi K et al. Nadrin, a novel neuron-specific GTPase-activating protein involved in regulated exocytosis. J Biol Chem 2000; 275:36885-36891. 142. Lamarche-Vane N, Hall A. CdGAP, a novel proline-rich GTPase-activating protein for Cdc42 and Rac. J Biol Chem 1998; 273:29172-29177. 143. Sagnier T, Grienenberger A, Mariol M et al. Dynamic expression of d-CdGAPr, a novel Drosophila melanogaster gene encoding a GTPase activating protein. Mech Dev 2000; 94:267-270. 144. Prakash SK, Paylor R, Jenna S et al. Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA. Hum Mol Genet 2000; 9:477-488. 145. Schaefer L, Prakash S, Zoghbi HY. Cloning and characterization of a novel rho-type GTPase-activating protein gene (ARHGAP6) from the critical region for microphthalmia with linear skin defects. Genomics 1997; 46:268-277. 146. Bender A, Pringle JR. Use of a screen for synthetic lethal and multicopy suppressee mutants to identify two new genes involved in morphogenesis in Saccharomyces cerevisiae. Mol Cell Biol 1991; 11:1295-1305.
92
Rho GTPases
147. Chant J, Corrado K, Pringle JR et al. Yeast BUD5, encoding a putative GDP-GTP exchange factor, is necessary for bud site selection and interacts with bud formation gene BEM1. Cell 1991; 65:1213-1224. 148. Peterson J, Zheng Y, Bender L et al. Interactions between the bud emergence proteins Bem1p and Bem2p and Rho-type GTPases in yeast. J Cell Biol 1994; 127:1395-1406. 149. Kim YJ, Francisco L, Chen GC et al. Control of cellular morphogenesis by the Ip12/Bem2 GTPase-activating protein: Possible role of protein phosphorylation. J Cell Biol 1994; 127:1381-1394. 150. Wang T, Bretscher A. The rho-GAP encoded by BEM2 regulates cytoskeletal structure in budding yeast. Mol Biol Cell 1995; 6:1011-1024. 151. Zheng Y, Cerione R, Bender A. Control of the yeast bud-site assembly GTPase Cdc42. Catalysis of guanine nucleotide exchange by Cdc24 and stimulation of GTPase activity by Bem3. J Biol Chem 1994; 269:2369-2372. 152. Stevenson BJ, Ferguson B, De Virgilio C et al. Mutation of RGA1, which encodes a putative GTPase-activating protein for the polarity-establishment protein Cdc42p, activates the pheromone-response pathway in the yeast Saccharomyces cerevisiae. Genes Dev 1995; 9:2949-2963. 153. Chen GC, Zheng L, Chan CS. The LIM domain-containing Dbm1 GTPase-activating protein is required for normal cellular morphogenesis in Saccharomyces cerevisiae. Mol Cell Biol 1996; 16:1376-1390. 154. Muller L, Xu G, Wells R et al. LRG1 is expressed during sporulation in Saccharomyces cerevisiae and contains motifs similar to LIM and rho/racGAP domains. Nucleic Acids Res 1994; 22:3151-3154. 155. Dunn TM, Shortle D. Null alleles of SAC7 suppress temperaturesensitive actin mutations in Saccharomyces cerevisiae. Mol Cell Biol 1990; 10:2308-2314. 156. Schmidt A, Bickle M, Beck T et al. The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 1997; 88:531-542. 157. Cid VJ, Cenamor R, Sanchez M et al. A mutation in the Rho1-GAP-encoding gene BEM2 of Saccharomyces cerevisiae affects morphogenesis and cell wall functionality. Microbiology 1998; 144:25-36. 158. Martin H, Rodriguez-Pachon JM, Ruiz C et al. Regulatory mechanisms for modulation of signalling through the cell integrity Slt2-mediated pathway in Saccharomyces cerevisiae. J Biol Chem 2000; 275:1511-1519. 159. Wu G, Li H, Yang Z. Arabidopsis RopGAPs are a novel family of rho GTPase-activating proteins that require the Cdc42/Rac-interactive binding motif for rop-specific GTPase stimulation. Plant Physiol 2000; 124:1625-1636. 160. Ludbrook SB, Eccleston JF, Strom M. Cloning and characterization of a rhoGAP homolog from Dictyostelium discoideum. J Biol Chem 1997; 272:15682-15686. 161. Knetsch ML, Schafers N, Horstmann H et al. The Dictyostelium Bcr/Abr-related protein DRG regulates both Rac- and Rab-dependent pathways. Embo J 2001; 20:1620-1629. 162. Chung CY, Lee S, Briscoe C et al. Role of Rac in controlling the actin cytoskeleton and chemotaxis in motile cells. Proc Natl Acad Sci USA 2000; 97:5225-5230. 163. Aktories K. Rho proteins: Targets for bacterial toxins. Trends Microbiol 1997; 5:282-288. 164. Barbieri JT. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin. Int J Med Microbiol 2000; 290:381-387. 165. Frithz-Lindsten E, Du Y, Rosqvist R et al. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol Microbiol 1997; 25:1125-1139. 166. Yahr TL, Goranson J, Frank DW. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol Microbiol 1996; 22:991-1003. 167. Cheng LW, Schneewind O. Yersinia enterocolitica type III secretion. On the role of SycE in targeting YopE into HeLa cells. J Biol Chem 1999; 274:22102-22108. 168. Lee VT, Schneewind O. Type III machines of pathogenic yersiniae secrete virulence factors into the extracellular milieu. Mol Microbiol 1999; 31:1619-1629. 169. Ganesan AK, Mende-Mueller L, Selzer J et al. Pseudomonas aeruginosa exoenzyme S, a double ADP-ribosyltransferase, resembles vertebrate mono-ADP-ribosyltransferases. J Biol Chem 1999; 274:9503-9508. 170. Henriksson ML, Rosqvist R, Telepnev M et al. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras. Biochem J 2000; 347 Pt 1:217-222. 171. McGuffie EM, Frank DW, Vincent TS et al. Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S. Infect Immun 1998; 66:2607-2613.
The Superfamily of Rho GTPase-Activating Proteins
93
172. Radke J, Pederson KJ, Barbieri JT. Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase. Infect Immun 1999; 67:1508-1510. 173. Vincent TS, Fraylick JE, McGuffie EM et al. ADP-ribosylation of oncogenic Ras proteins by pseudomonas aeruginosa exoenzyme S in vivo. Mol Microbiol 1999; 32:1054-1064. 174. Ganesan AK, Frank DW, Misra RP et al. Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. J Biol Chem 1998; 273:7332-7337. 175. Goehring UM, Schmidt G, Pederson KJ et al. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem 1999; 274:36369-36372. 176. Pederson KJ, Vallis AJ, Aktories K et al. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins. Mol Microbiol 1999; 32:393-401. 177. Pederson KJ, Pal S, Vallis AJ et al. Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells. Mol Microbiol 2000; 37:287-299. 178. Massol P, Montcourrier P, Guillemot JC et al. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. Embo J 1998; 17:6219-6229. 179. Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998; 282:1717-1721. 180. Black DS, Bliska JB. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol Microbiol 2000; 37:515-527. 181. Von Pawel-Rammingen U, Telepnev MV, Schmidt G et al. GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: A mechanism for disruption of actin microfilament structure. Mol Microbiol 2000; 36:737-748. 182. Rosqvist R, Forsberg A, Rimpilainen M et al. The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol Microbiol 1990; 4:657-667. 183. Rosqvist R, Forsberg A, Wolf-Watz H. Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun 1991; 59:4562-4569. 184. Kaniga K, Uralil J, Bliska JB et al. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol Microbiol 1996; 21:633-641. 185. Fu Y, Galan JE. The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton. Mol Microbiol 1998; 27:359-368. 186. Hardt WD, Chen LM, Schuebel KE et al. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 1998; 93:815-826. 187. Galan JE, Zhou D. Striking a balance: Modulation of the actin cytoskeleton by Salmonella. Proc Natl Acad Sci USA 2000; 97:8754-8761. 188. Dumenil G, Sansonetti P, Tran Van Nhieu G. Src tyrosine kinase activity down-regulates Rho-dependent responses during Shigella entry into epithelial cells and stress fibre formation. J Cell Sci 2000; 113:71-80. 189. Dumenil G, Olivo JC, Pellegrini S et al. Interferon alpha inhibits a Src-mediated pathway necessary for Shigella-induced cytoskeletal rearrangements in epithelial cells. J Cell Biol 1998; 143:1003-1012. 190. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature 1993; 366:643-654. 191. Hart MJ, Eva A, Evans T et al. Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product. Nature 1991; 354:311-314. 192. Shou C, Farnsworth CL, Neel BG et al. Molecular cloning of cDNAs encoding a guanine -nucleotide-releasing factor for Ras p21. Nature 1992; 358:351-354. 193. Cerione RA, Zheng Y. The Dbl family of oncogenes. Curr Opin Cell Biol 1996; 8:216-222. 194. Crespo P, Schuebel KE, Ostrom AA et al. Phosphotyrosine-dependent activation of Rac-1 GDP/ GTP exchange by the vav proto-oncogene product. Nature 1997; 385:169-172. 195. Sprang SR. G proteins, effectors and GAPs: Structure and mechanism. Curr Opin Struct Biol 1997; 7:849-856. 196. Geyer M, Wittinghofer A. GEFs, GAPs, GDIs and effectors: Taking a closer (3D) look at the regulation of Ras-related GTP-binding proteins. Curr Opin Struct Biol 1997; 7:786-792. 197. Bos JL. Ras-like GTPases. Biochim Biophys Acta 1997; 1333:M19-31. 198. Nimnual AS, Yatsula BA, Bar-Sagi D. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 1998; 279:560-563. 199. York JD, Majerus PW. Isolation and heterologous expression of a cDNA encoding bovine inositol polyphosphate 1-phosphatase. Proc Natl Acad Sci USA 1990; 87:9548-9552. 200. Neuwald AF, York JD, Majerus PW. Diverse proteins homologous to inositol monophosphatase. FEBS Lett 1991; 294:16-18. 201. York JD, Ponder JW, Chen ZW et al. Crystal structure of inositol polyphosphate 1-phosphatase at 2.3-A resolution. Biochemistry 1994; 33:13164-13171.
94
Rho GTPases
202. Rayment I, Holden HM, Whittaker M et al. Structure of the actin-myosin complex and its implications for muscle contraction. Science 1993; 261:58-65. 203. Rayment I, Rypniewski WR, Schmidt-Base K et al. Three-dimensional structure of myosin subfragment-1: A molecular motor. Science 1993; 261:50-58. 204. Musacchio A, Gibson T, Rice P et al. The PH domain: A common piece in the structural patchwork of signalling proteins. Trends Biochem Sci 1993; 18:343-348. 205. Mayer BJ, Ren R, Clark KL et al. A putative modular domain present in diverse signalling proteins. Cell 1993; 73:629-630. 206. Haslam RJ, Koide HB, Hemmings BA. Pleckstrin domain homology. Nature 1993; 363:309-310. 207. Yoon HS, Hajduk PJ, Petros AM et al. Solution structure of a pleckstrin-homology domain. Nature 1994; 369:672-675. 208. Hommel U, Zurini M, Luyten M. Solution structure of a cysteine rich domain of rat protein kinase C. Nat Struct Biol 1994; 1:383-387. 209. Hurley JH, Newton AC, Parker PJ et al. Taxonomy and function of C1 protein kinase C homology domains. Protein Sci 1997; 6:477-480. 210. Perin MS, Fried VA, Mignery GA et al. Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C. Nature 1990; 345:260-263. 211. Brose N, Petrenko AG, Sudhof TC et al. Synaptotagmin: A calcium sensor on the synaptic vesicle surface. Science 1992; 256:1021-1025. 212. Sutton RB, Davletov BA, Berghuis AM et al. Structure of the first C2 domain of synaptotagmin I: A novel Ca2+/phospholipid-binding fold. Cell 1995; 80:929-938. 213. Li C, Ullrich B, Zhang JZ et al. Ca(2+)-dependent and -independent activities of neural and nonneural synaptotagmins. Nature 1995; 375:594-599. 214. Shao X, Davletov BA, Sutton RB et al. Bipartite Ca2+-binding motif in C2 domains of synaptotagmin and protein kinase C. Science 1996; 273:248-251. 215. Bankaitis VA, Aitken JR, Cleves AE et al. An essential role for a phospholipid transfer protein in yeast Golgi function. Nature 1990; 347:561-562. 216. Gu M, Warshawsky I, Majerus PW. Cloning and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to retinaldehyde-binding protein and yeast SEC14p. Proc Natl Acad Sci USA 1992; 89:2980-2984. 217. Del Vecchio RL, Tonks NK. Characterization of two structurally related Xenopus laevis protein tyrosine phosphatases with homology to lipid-binding proteins. J Biol Chem 1994; 269:19639-19645. 218. Aravind L, Neuwald AF, Ponting CP. Sec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signalling. Curr Biol 1999; 9:R195-197. 219. Iyer LM, Koonin EV, Aravind L. Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins 2001; 43:134-144. 220. Tsujishita Y, Hurley JH. Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol 2000; 7:408-414. 221. Sadowski I, Stone JC, Pawson T. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 1986; 6:4396-4408. 222. Stahl ML, Ferenz CR, Kelleher KL et al. Sequence similarity of phospholipase C with the noncatalytic region of src. Nature 1988; 332:269-272. 223. Mayer BJ, Hamaguchi M, Hanafusa H. A novel viral oncogene with structural similarity to phospholipase C. Nature 1988; 332:272-275. 224. Waksman G, Kominos D, Robertson SC et al. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 1992; 358:646-653. 225. Overduin M, Rios CB, Mayer BJ et al. Three-dimensional solution structure of the src homology 2 domain of c-abl. Cell 1992; 70:697-704. 226. Booker GW, Breeze AL, Downing AK et al. Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase. Nature 1992; 358:684-687. 227. Waksman G, Shoelson SE, Pant N et al. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell 1993; 72:779-790. 228. Yu H, Rosen MK, Shin TB et al. Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science 1992; 258:1665-1668. 229. Musacchio A, Noble M, Pauptit R et al. Crystal structure of a Src-homology 3 (SH3) domain. Nature 1992; 359:851-855. 230. Ren R, Mayer BJ, Cicchetti P et al. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993; 259:1157-1161.
The Superfamily of Rho GTPase-Activating Proteins
95
231. Hofer F, Fields S, Schneider C et al. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA 1994; 91:11089-11093. 232. Ponting CP, Benjamin DR. A novel family of Ras-binding domains. Trends Biochem Sci 1996; 21:422-425. 233. Kuriyama M, Harada N, Kuroda S et al. Identification of AF-6 and canoe as putative targets for Ras. J Biol Chem 1996; 271:607-610. 234. Huang L, Weng X, Hofer F et al. Three-dimensional structure of the Ras-interacting domain of RalGDS. Nat Struct Biol 1997; 4:609-615. 235. Vetter IR, Linnemann T, Wohlgemuth S et al. Structural and biochemical analysis of Ras-effector signalling via RalGDS. FEBS Lett 1999; 451:175-180. 236. Breen JJ, Agulnick AD, Westphal H et al. Interactions between LIM domains and the LIM domain-binding protein Ldb1. J Biol Chem 1998; 273:4712-4717. 237. Schmeichel KL, Beckerle MC. Molecular dissection of a LIM domain. Mol Biol Cell 1997; 8:219-230. 238. Wu R, Durick K, Songyang Z et al. Specificity of LIM domain interactions with receptor tyrosine kinases. J Biol Chem 1996; 271:15934-15941. 239. Thompson G, Owen D, Chalk PA et al. Delineation of the Cdc42/Rac-binding domain of p21-activated kinase. Biochemistry 1998; 37:7885-7891. 240. Zhang B, Wang ZX, Zheng Y. Characterization of the interactions between the small GTPase Cdc42 and its GTPase-activating proteins and putative effectors. Comparison of kinetic properties of Cdc42 binding to the Cdc42-interactive domains. J Biol Chem 1997; 272:21999-22007. 241. Hiroaki H, Ago T, Ito T et al. Solution structure of the PX domain, a target of the SH3 domain. Nat Struct Biol 2001; 8:526-530. 242. Ponting CP. Novel domains in NADPH oxidase subunits, sorting nexins, and PtdIns 3-kinases: Binding partners of SH3 domains? Protein Sci 1996; 5:2353-2357. 243. Bedford MT, Leder P. The FF domain: A novel motif that often accompanies WW domains. Trends Biochem Sci 1999; 24:264-265. 244. Smalla M, Schmieder P, Kelly M et al. Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites. Protein Sci 1999; 8:1954-1961. 245. Stapleton D, Balan I, Pawson T et al. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat Struct Biol 1999; 6:44-49. 246. Thanos CD, Goodwill KE, Bowie JU. Oligomeric structure of the human EphB2 receptor SAM domain. Science 1999; 283:833-836. 247. Kyba M, Brock HW. The SAM domain of polyhomeotic, RAE28, and scm mediates specific interactions through conserved residues. Dev Genet 1998; 22:74-84. 248. Schultz J, Ponting CP, Hofmann K et al. SAM as a protein interaction domain involved in developmental regulation. Protein Sci 1997; 6:249-253. 249. Ponting CP. SAM: A novel motif in yeast sterile and Drosophila polyhomeotic proteins. Protein Sci 1995; 4:1928-1930. 250. Aspenstrom P. A Cdc42 target protein with homology to the nonkinase domain of FER has a potential role in regulating the actin cytoskeleton. Curr Biol 1997; 7:479-487. 251. Mercer JA, Seperack PK, Strobel MC et al. Novel myosin heavy chain encoded by murine dilute coat colour locus. Nature 1991; 349:709-713. 252. Xie X, Harrison DH, Schlichting I et al. Structure of the regulatory domain of scallop myosin at 2.8 A resolution. Nature 1994; 368:306-312. 253. Houdusse A, Silver M, Cohen C. A model of Ca(2+)-free calmodulin binding to unconventional myosins reveals how calmodulin acts as a regulatory switch. Structure 1996; 4:1475-1490. 254. Rhoads AR, Friedberg F. Sequence motifs for calmodulin recognition. Faseb J 1997; 11:331-340. 255. Deloulme JC, Prichard L, Delattre O et al. The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain. J Biol Chem 1997; 272:27369-27377. 256. Yuan BZ, Miller MJ, Keck CL et al. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 1998; 58:2196-2199. 257. Coniglio SJ, Jou T-S, Symons M. Rac1 protects epithelial cells against anoikis. J Biol Chem 2001; 276:28113-28120 258. Jantsch-Plunger V, Gonczy P, Romano A et al. CYK-4: A Rho family gtpase activating protein (GAP) required for central spindle formation and cytokinesis. J Cell Biol 2000; 149:1391-1404
96
Rho GTPases
CHAPTER 6
Rnd Proteins: Intriguing Members of the Rho Family Pierre Chardin
Abstract
T
he three Rnd proteins form a distinct sub-branch of the Rho family. They appear to differ from most other Rho family proteins in their basic functional cycle (see Preface). Rnd1 and Rnd3 exchange GTP rapidly, have a reduced affinity for GDP and have no GTPase activity suggesting that they might be constitutively in the GTP-bound form. However, compared to active Rho, they have opposite effects on the actin cytoskeleton and cell adhesion. Rnd1 or Rnd3 expression in fibroblasts inhibits the formation of actin stress fibers and focal adhesions. Rnd1 is expressed mostly in brain and liver, the highest level of Rnd2 expression is in testis and Rnd3 is present at very low levels in most tissues, but can be induced by a variety of signals.
General Features Rnd proteins share 54-63% identity pairwise, 45-49% identity with RhoA, B or C and about 40% identity with Rac or Cdc42 (ref. 1, for a detailed phylogenic analysis, see Guasch et al2). The first member of this group, RhoE, was discovered by Foster et al3 in 1996, mouse RhoE was also cloned independently.2 RhoE is identical to Rnd3, except that it is missing 15 N-terminal residues. The first cloned RhoE cDNAs had shorter 5’ends, but there are now at least 4 mouse cDNAs (for instance GB: BC009002) and 1 pig cDNA (GB:AF078839) encoding full length proteins. Rnd proteins display striking differences from other members of the Rho family in their size, charge and biochemical properties.1 Their expected molecular weights are higher due to N-terminal extensions of 10-20 a.a. for Rnd1 and Rnd3/RhoE, and C-terminal extensions of about 30 a.a. for all three. Calculated molecular weights predict that Rnd1 is a 26 kD protein, Rnd2 is 25 kD and Rnd3 is 27 kD. Their apparent molecular mass on SDS-PAGE is about 3032 kD, whereas other Rho proteins have apparent mobilities of about 24 kD. They also have very different isoelectric points: whereas most Rho family proteins are negatively charged at neutral pH (pI 5.5 to 6.8, ref. 4), Rnd proteins are positively charged with pIs of 8.1-8.7.
Prenylation As other Rho family members, Rnd proteins end with a “CAAX box” that serves as a recognition signal for prenylation (see Chapter 2). However, unlike Rho, Rac or Cdc42, which have a C-terminal leucine specifying geranyl-geranylation, Rnd proteins end with a methionine residue, suggesting that they are farnesylated. Indeed, it has been shown that in-vivo, RhoE/ Rnd3 is farnesylated.3 Interestingly, the farnesyltransferase inhibitor L-739,749 developed to inhibit Ras farnesylation, induces cell flattening, actin stress fiber formation and inhibition of anchorage-independant growth after only 18 hours of treatment,5 too fast to be explained by Rho GTPases, edited by Marc Symons. ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers.
Rnd Proteins: Intriguing Members of the Rho Family 97
Figure 1. Alignment of Human Rnd1, 2 and 3 with RhoA, RhoD, Rac1 and H-Ras. Top, Stars over the sequence indicate the positions corresponding to Ras activating mutations, “effector”: region considered as the main target binding site including the asparagine (FENY) ADP-ribosylated by the C3 transferase in Rho. Bottom, P1-3: regions involved in binding phosphate, G1-3: regions binding the guanine moiety of GTP, below, α-helices and β-sheets (based on Ras, Rac and Rho structures). The “Rho insert” (α3b) is a 14 amino acids helical insertion found only in Rho family proteins. The C-terminal parts are poorly conserved, except for the presence of basic residues. The cysteines of the CAAX sequences for prenylation are aligned. Accession numbers for human nucleotide and protein sequences: Rnd1: Y07923, Q92730 Rnd2: X95456, P52198, Rnd3: X95282, P52199. Xenopus laevis Rnd1: AF151014, AAD40670. Pig Rnd3: AF078839, O77683.
98
Rho GTPases
the loss of farnesylated Ras which is stable (half-life of 24 h). Since Rnd1 or 3, that have shorter half-lives, induce a loss of stress fibers and cell rounding, (see next paragraphs) the inhibition of Rnd farnesylation would presumably induce opposite effects, namely stress fiber formation and cell spreading, as seen with L737-749. Rnd proteins are thus interesting candidate targets for this class of drugs.
Chromosomal Localization Rnd1: 12q13, Rnd2: 17q21, Rnd3: 2q22. Sequencing of the BRCA1 region and now the human genome sequence indicate that the Rnd2 gene is one of the closest to BRCA1 (ref. 6). Rnd2 maps to a region frequently rearranged in breast and ovarian tumors. Breast cancer is one of the most frequent malignancies in women and rearrangements of chromosome 17 are the most frequent genetic alterations observed in breast and ovarian tumors. Mutations in BRCA1 increase susceptibility to breast and ovarian cancers, but other genetic rearrangements of this region are also frequent. Although Rnd2 is located very close to BRCA1, no implication of Rnd2 in breast cancer could be detected at present.
Biochemical Properties of Rnds Although Rnds are related to Rho in terms of sequence, they possess strikingly different biochemical properties.
GTP Binding The three motifs for guanine binding (noted G1-3 on Fig. 1) are conserved in Rnd proteins, the two loops and a conserved threonine involved in phosphate binding (noted P1-3 on Fig. 1) can also be recognized. The three major residues that coordinate magnesium in the GTP bound form of Ras: T17, T35 (noted P2 on Fig. 1) and D57 (ref. 6) are strictly conserved. Compared to most other small GTP-binding proteins they have a weaker affinity for GTP: in a physiological buffer (with 1 mM magnesium) it takes only 1 or 2 minutes to dissociate half of the GTP (for Rnd1 t1/2=1.4 min at 37°C), but most strikingly they have a 100 fold weaker affinity for GDP, suggesting that they are constitutively in a GTP-bound form.
GTP Hydrolysis Three residues of the phosphate binding site that are important for the intrinsic GTPase activity differ in Rnd. The equivalent of Ras glycine 12 is replaced by valine, alanine or serine in Rnd proteins, Ras glycine 13 is replaced by glutamine or glutamic acid and Ras alanine 59 and glutamine 61 are both replaced by serine. Any of these substitutions in Ras decreases the GTPase rate and leads to constitutively active, oncogenic proteins. Based on the effects of these substitutions on Ras, the prediction was that Rnd proteins will have little or no intrinsic GTPase activity. Indeed, Rnd1 has no detectable GTPase activity, even in the presence of RhoGAP.1 Foster et al 3 also reported that p190 and another RhoGAP do not stimulate GTP-hydrolysis on RhoE, but if the three residues residues of the phosphate binding site that differ in RhoE are mutated to those found in RhoA, then the intrinsic GTPase activity is restored. The activity is even higher than in RhoA, indicating that the presence of a proline immediately after Glutamine 61 (ras numbering) does not impair the proper positioning of this glutamine relative to the γPhosphate. In addition, Foster et al3 showed that a tagged version of RhoE expressed in COS cells, was constitutively GTP-bound. Taken together these results strongly suggest that in-vivo, Rnd proteins are constitutively GTP bound. This would be the first example of a GTPase that does not switch between GDP- and GTP-bound forms. This raises to question as to why do they bind nucleotide? In fact, it seems that these proteins have appeared rather recently in evolution. Rnd1 is present in Xenopus, but there are no obvious homologs in the fly or nematode. One possible explanation is that Rnds may have retained GTP binding mostly for reasons of stability, since it is well known that nucleotide-free small G proteins are very unstable.
Rnd Proteins: Intriguing Members of the Rho Family
99
Do Rnd Proteins Need GEFs for Activation The observation that Rnd1 exchanges GTP rapidly, binds GDP with a very low affinity and has no GTPase activity already suggests that it is constitutively GTP bound in the cell. A feature of the primary structure of Rnds further supports this idea. Glutamate 62 from Ras (DTAGQE) is conserved in almost all proteins of the Ras family (Ras, Rho, Rab, Ran), although examination of the structure of isolated proteins either bound to GDP or GTP does not suggest any obvious reason for the conservation of this residue. However, in the nucleotide free complex of Ras or Rac, with their GEFs, this glutamate contacts the strictly conserved Lysine 16. In the GDP or GTP forms, Lys16 contacts the phosphates, but when GDP leaves, the positive charge of Lys16 needs to interact with a negative charge, provided by Glu62. The fact that this glutamate is not conserved in Rnd proteins suggests that they may never form a nucleotide free complex with GEFs. Their biochemical properties suggest that they may not need GEFs to accelerate GTP binding and therefore, they may never see GEFs. Another intriguing possibility would be that Rnd-GTP forms a complex with GEFs and inhibits them, behaving as endogenous “dominant negatives”. Rnds in their GTP form would mimic the nucleotide free form of Rho to bind its GEFs and inhibit endogenous Rho activation. At present there is no experimental data to support this hypothesis. It is also possible that GTP binding plays a regulatory role through a completely new mechanism that we currently do not understand.
Rnds As Targets of Bacterial Toxins The Clostridium botulinum C3 transferase is an exo-enzyme that specifically ADP-ribosylates Rho proteins on asparagine 41 (ref. 7,8). Rnd proteins are almost identical to Rho proteins in the region surrounding the ADP-ribosylated Asn41, but surprisingly Rnd1, Rnd2 and Rnd3 proteins, either expressed and purified from bacteria, or in intact tissues, are not ADP-ribosylated by C3 (ref. 1). Positions Val43 and Glu54 of Rho are involved in C3 interaction (P. Chardin, unpublished). These positions, as well as Arg5, Lys6, and Glu47 were recently shown to participate in C3 binding.9 Lys 6 and V43 are not conserved in Rnd proteins, explaining why they are not C3 substrates. Recently, a novel C3-like ADP-ribosyltransferase from Staphylococcus aureus was shown to ADP-ribosylate Rnd3, although less efficiently than RhoA.10 At present the functional relevance of this observation is not clear since this novel C3-like ADPribosyltransferase from Staphylococcus aureus causes the same cytoskeletal changes on NIH/ 3T3 cells as C3 from Clostridium botulinum. It is possible however, that in other cell types expressing high levels of Rnd3 and less Rho, this novel C3-like toxin might have different effects on the cytoskeleton.
Expression in Human Tissues Northern blots show that Rnd1 is expressed as a major 1.9 kb mRNA, mostly in brain and liver. In the brain, Rnd1 is mostly expressed in different types of neurons (see Nobes et al,1 for a detailed description of the brain regions expressing Rnd1). The Rnd2 mRNA of 1.5 kb is abundant in testis, and is expressed at lower levels in brain and liver. Rnd3/RhoE is expressed at low levels in all tissues studied, as a 3.1 kb mRNA. Rnd3/RhoE expression is specially low in brain, pancreas, thymus, testis, and peripheral bloods leukocytes.1 The expression of Rnd1 in rat brain and liver could also be detected at the protein level, with antibodies raised against the bacterially expressed Rnd1. In post-nuclear supernatants Rnd proteins are mostly found in the pellet (P100) fraction, whereas most Rho appears in the supernatant (S100) fraction. In rat liver, Rnd1 expression is mostly found in hepatocytes. Nishi et al,11 have cloned the rat and mouse homologs of Rnd2 and named them RhoN. In rats, they found expression of RhoN in neurons from the brain and spinal cord (see Nishi et al,11 for a detailed description of the brain regions expressing RhoN/Rnd2) and in stellate cells of the liver. Surprisingly, they find only a faint expression in rat testis, whereas in human this was the place where Rnd2 was expressed at the highest levels and expression of the Rnd2 protein has been observed in rat testis.1
100
Rho GTPases
Figure 2. Rnd1 or Rnd3 expression in fibroblasts inhibit actin stress fibers formation. Serum-starved confluent Swiss 3T3 fibroblasts micro-injected with expression vectors for: w.t. Rnd1 (A, B), T27N Rnd1 (C, D), N-terminal truncated Rnd1 (E, F) or Myc-tagged Rnd3 (G, H) and then stimulated with LPA for 30 minutes, 2 hours after injection. Cells were fixed, permeabilised, and stained with Anti-Rnd1 antibodies (A, C, E) or Anti-Myc-tag antibodies (G) and phalloidin to decorate actin filaments (right: B, D, F, H).
Rnd Proteins: Intriguing Members of the Rho Family
101
Localization of Rnd1 in Swiss 3T3 Fibroblasts and Microinjected MDCK Cells In Swiss 3T3 fibroblasts, the anti-Rnd1 antibody gives a dotted staining of the plasma membrane at points of cell-cell contacts, but no staining at places where there is no neighboring cell. The peripheral staining co-localizes with an anti-pan-cadherin antibody, indicating that Rnd1 is localized in adherens junctions. In MDCK epithelial cells, microinjection of wild type Rnd1 does not cause cell rounding and Rnd1 localises at the cell periphery. The staining pattern closely resembles E cadherin staining in these cells. Interestingly, a truncated form, in which the N-terminal 6 amino acids are deleted, no longer localizes to adherens junctions, instead the expressed protein is present in the cytoplasm and cell nucleus. Deletion of the CAAX motif for prenylation leads to a predominant nuclear localization. Thus, the integrity of the N-terminus and the CAAX box are required for normal localization of Rnd1 to adherens junctions.
Rnd1 or Rnd3 Expression Inhibit the Formation of Actin Stress Fibers Microinjection of Rnd1 expression vectors in quiescent serum-starved Swiss 3T3 fibroblasts does not induce the formation of actin stress fibers. In contrast, Rnd1 expression inhibits actin stress fibers formation in cells stimulated with LPA (Fig. 2A,B). After longer times, Rnd 1 expressing cells round up and detach from the glass coverslips. In cells expressing T27NRnd1 (equivalent of a dominant negative S17N mutation in Ras) (Fig. 2C and D) or T45ARnd1 (equivalent of a T35A, effector site mutation in Ras), LPA-induced stress fiber formation was not inhibited. Thus the binding of GTP and a functional effector domain are both required for Rnd1 to block stress fiber formation.1 In Ras the substitution of glutamine 61 by leucine gives a higher transforming potential because it impairs GAP stimulation of GTP hydrolysis. Rap proteins that have a threonine at this position do possess an intrinsic GTPase activity, that is stimulated by RapGAP. However, Rnd1 with a leucine instead of serine at position 71 (equivalent to codon 61 in Ras) has the same activity as wild-type Rnd1 in blocking LPA-induced stress fiber formation, suggesting that fibroblasts do not contain a RndGAP. Interestingly, a mutant Rnd1 deleted of its first 6 amino-acids was unable to block stress fiber formation (Fig. 2E and F). Thus, the six N-terminal amino-acids of Rnd1 (strictly conserved in Rnd3/RhoE) are also required. This could explain the lack of effects on the cytoskeleton reported for RhoE, a N-terminal truncated version of Rnd3 (ref.3). Expression of fulllength Rnd3/RhoE also blocks LPA induced stress fibers formation (Fig. 2G, H), similar to wild-type Rnd1 (Fig. 2B). This N-terminal sequence is highly polar (MKERRA) and mostly basic, there are no other proteins in the database with a very similar N-terminus, it might be that the positive charges interact with the negative charges of phospholipid head groups and stabilize membrane binding. At high levels of expression a Rnd1 mutant deleted of its CAAX box also blocked stress fiber formation, but was less potent than wild type Rnd1. Thus, it seems that the N-terminal motif is even more important than the prenylation for the effects of Rnd1 or Rnd3 on actin structures. In this respect, it is interesting to note that expression of Rnd2 has no obvious effects on the cytoskeleton, and that Rnd2 does not possess this N-terminal motif. Furthermore, N or Cterminal truncations that impair the proper localization of Rnd1 also abolish or decrease the effects of Rnd1 on actin stress fibers, indicating that both GTP binding and localization are essential for these biological effects.
Rnds Inhibit Smooth Muscle Contraction Smooth muscle contraction is regulated by the level of phosphorylation of Myosin Light Chain (MLC). Calcium increase activates a calcium/calmodulin dependent MLC kinase.
102
Rho GTPases
Smooth muscle contraction can also occur at constant calcium (this is called ”calcium sensitization”) when Rho is activated.12,13 One of the Rho-stimulated kinases (p160ROKα, or ROCK) can phosphorylate a regulatory subunit of myosin light chain phosphatase, leading to its inhibition.14,15 In physiological conditions, calcium increase and Rho activation are both required and cooperate in MLC phosphorylation, calcium activating the kinase and Rho inhibiting the phosphatase. Consistently, the Rho-kinase inhibitor Y27632 inhibits agonist induced contraction.14 Thus, activation of Rho increases the phosphorylation of MLC and leads to the bundling of actin into stress fibers.15 Loirand et al16 found that Rnd1 inhibits agonist induced calcium sensitization, by acting on the Rho-dependent pathway. Furthermore, treatment of rats with sex hormone steroids, that are known to alter smooth muscle contractivity, induced the expression of Rnd proteins in intestinal and aortic smooth muscle and decreased agonistinduced contraction.16 Interestingly, RhoA induced calcium sensitization was completely inhibited when Rnd1 was added together with RhoA, but Rnd1 could not reverse the tension induced by addition of RhoA alone for 15 minutes. Thus, on this short time scale, when RhoA has been activated and engaged in the interaction with its partners, Rnd1 is no longer able to inhibit, suggesting that Rnd1 directly inhibits RhoA activation, or competes for the interaction with a subset of RhoA partners. Although these functional studies in smooth muscle were performed with Rnd1, it is possible that the protein involved in-vivo is Rnd3, that has similar biological effects. Interestingly, Rnd3 expression increases in myometrium during pregnancy, when smooth muscle contraction needs to be repressed, and decreases close to delivery, before contraction can occur.17 These results confirm that Rnd proteins can inhibit Rho pathways in several physiological situations.
Proteins Interacting with Rnds The effects of Rnds suggest that they might compete for the interaction with some Rho effectors, however, using the two-hybrid system, no interaction of Rnd1 with citron, rhotekin, the Rho binding domain of ROK, or PAK could be detected. Interestingly, the interactions with RhoGDI-3 and LyGDI were also negative. Positive controls with known interacting proteins were included in all cases (Gerard Zalcman and Jacques Camonis, unpublished). Surprisingly, a fragment of Rnd1 (61-144) was found in a two-hybrid screen with the Grb7 adaptor protein as bait. Full length Rnd1 also interacts with Grb7 in the two-hybrid system. Further mapping indicated that the SH2 domain of Grb7 is sufficient for the interaction with Rnd1, no interaction could be detected with a large variety of other SH2 domains. Direct binding was demonstrated in-vitro: Recombinant Rnd1 interacts with GST-Grb7, suggesting that tyrosine phosphorylation of Rnd1 is not required for its interaction with the SH2 domain of Grb7. Rnd1 expressed in mammalian cells is also able to bind Grb7, but no tyrosine phosphorylation of Rnd1 could be detected.18 Rnd1 and Grb7 are both expressed in liver and Grb7 appears to be involved in cell migration.19 A role for Grb7 interaction with phospho-caveolin1, near focal adhesions, in EGF-stimulated cell migration has recently been proposed.20 Since Rnd1 overexpression leads to the loss of focal adhesions, one could imagine that Rnd1 traps Grb7 away from these sites. Several groups have reported that the Rho antagonist effects of Rnds are due to the stimulation of RhoGAPs and inhibition of a Rho effector, these recent results are discussed in last paragraph.
Effects of Rnd1 in Neurons Rnd1 is expressed in specialized neurons and has major effects on the actin cytoskeleton in fibroblasts. Since Rho proteins have been involved in neurite retraction whereas Cdc42 and Rac promote neurite extension in PC12 cells it was tempting to look at Rnd1 effects in these cells. Aoki et al,21 found that Rnd1 expressed in PC12 cells localizes to the plasma membrane and induces the formation of long branched neuritic processes, as a control the inactive T27N mutant of Rnd1 had no effect. NGF induces long neurites having thick bundles of microtu-
Rnd Proteins: Intriguing Members of the Rho Family
103
bules and neurofilaments, and F-actin at their tips, in contast Rnd1 expression induced shorter neuritic processes containing microtubules but little neurofilaments and F-actin. Treatment of PC12 with cytochalasin D, that inhibits actin polymerization, induced processes similar to those seen with Rnd1, suggesting that the morphological effects of Rnd1 are mostly due to the collapse of peripheral actin filaments, with no active role of Rnd1 in the elongation of dendritic processes. Although Rnd1 induced processes seem to contain little F-actin, co-transfection of dominant negative Rac with Rnd1 inhibited the formation of these long processes and led to the formation of multiple thin and short processes.21 In the macrophage cell line Bac1.2F5 RhoE /Rnd3 also induces filopodial or pseudopodial extensions, but in this case they are actincontaining structures.2 Interestingly, Rnd1 was found to interact with PlexinA1, a trans-membrane protein with an intracellular domain showing some homology with R-RasGAP. Plexins are the signal transducing subunits associated with Neuropilin-1, the receptor for the axon guidance signal semaphorin 3A that induces growth cone collapse. A double mutant of PlexinA1 at two arginines likely to be involved in GAP activity no longer induces collapse in a model system, but still binds Rnd1, indicating that other properties than Rnd1 binding, possibly GAP activity, are required for the collapse induced by PlexinA1 (ref. 22). It is suggested that PlexinA1 could be a Rnd1 GAP, but this has not been tested experimentally. Rnd3/RhoE has first been isolated as a p190RhoGAP binding protein3 but is not sensitive to the GAP activity of p190. Alternatively, PlexinA1 could act simply by sequestering Rnd1.
Induced Expression of Rnd3 Participates in the Transformation of Epithelial Cells by Raf Rho family proteins play an important role in cell proliferation and their exchange factors are also involved in transformation and invasiveness26 (reviewed by Symons,27 see also Chapter 11). Cells microinjected with activated Ras rapidly spread, with increased ruffling and actin stress fibers,28,29,30 but display a completely different morphology at later times, with cell rounding and a fusiform appearance as seen in foci of Ras-transformed cells.27 Several events contribute to cell rounding: for instance activation of the Ras/raf/MAP Kinase pathway leads to the suppression of integrin activation, in the absence of de-novo protein synthesis.31 At later times, transformation by Ras also induces the expression and secretion of cathepsins D and L, matrix proteases involved in the acquisition of invasiveness. Decreases in α-actinin, vinculin, or tropomyosins, have also been proposed to explain the loss of stress fibers in transformed cells and more recently, oncogenic Ras has been shown to downregulate Rho-kinase.32 Activation of the Raf–MEK-ERK pathway in MDCK cells induces transformation, with characteristic morphological changes: loss of basal actin stress fibers, increased cortical actin and multilayering, with a loss of cell polarity.33 The increase in cortical actin correlates with Rac activation, but no change in active Rho could be detected. However, Raf activation induced a strong increase of Rnd3 protein expression that could be blocked by MEK inhibitors. This increased Rnd3 expression correlated with the decrease in actin stress fibers. Moreover, in MDCK cells expressing Rnd3 under the control of tetracyclin (Tet-off system), induction of Rnd3 expression results in a loss of actin stress fibers. To confirm the central role of the Rho pathway, it was shown that Raf induced multilayering could be abrogated by constitutive expression of activated RhoA, but surprisingly most stress fibers were lost, even in the activated RhoA expressing cells, indicating that the loss of basal actin stress fibers is not sufficient to induce multilayering.33 Since Rho-GTP levels do not seem to decrease when Rnd3 is induced, this suggests that Rnd does not interfere with Rho activation, but rather with its stimulation of downstream targets. One could imagine that Rnd3 traps some Rho effectors in membrane domains where they can not be active. Increased Rnd3 expression has also been found in pancreatic cancer.34 Furthermore, in keratinocytes, Rnd3 expression also increases 1-2 hours after the binding of activated Factor VIIa to Tissue Factor, a transmembrane glycoprotein.35 In this case, increased Rnd3 expression
104
Rho GTPases
together with transcription factors, growth factors, cytokines, and other proteins involved in cell migration, appears to be part of a wound-healing response. Interestingly, increased expression of Rnd3/RhoE has also been found after treatment of colon cancer cell lines by the nonsteroidal anti-inflammatory drug Sulindac that has an anti-proliferative effect. Although this last result does not seem to fit with the observed increase in Rnd3 expression in proliferating cells or wound-healing, it should be noted that Rnd3 expression was already quite high in the colon cancer cell lines before treatment, whereas expression of Rnd3 in normal colon cells is very low. Thus, overall, a higher expression of Rnd3 in cancer cells is frequently observed and it is clear that Rnd3 gene expression is modulated in response to a variety of different signals.
Rnds in Development Several proteins of the Rho family, as well as their regulators, are involved in developmental process such as dorsal closure or gastrulation and have also been involved in the establishment of cell polarity. Wünnenberg-Stapleton et al37 (1999) have studied the role of RhoA and Rnd1 in Xenopus development. XRnd1 was originally isolated from a cDNA library enriched in ventral mRNAs, and screened for inhibitors of secondary axis formation induced by a dominant negative receptor for the ventralizing factor BMP. However, XRnd1 does not seem to be involved in BMP signalling since it does not ventralize embryos when injected into the dorsal side. XRnd1 is expressed predominantly in tissues undergoing extensive morphogenic movements and reduces cell adhesion, whereas activated XRhoA has an opposite effect, increasing cell adhesion. In addition, XRnd1 is also mostly associated with the plasma membrane.37 Guasch et al,2 have also observed that Rnd3 increases MDCK cell migration in response to HGF (Scatter factor). In contrast, activated RhoA expression in MDCK cells leads to an increase in basal stress fibers that impairs locomotion, thus in epithelial cells too Rnd3 and RhoA have antagonistic effects. In testis, the differentiation of germ cells and maturation of spermatids is tightly coupled to their migration between the sertoli cells epithelium in seminiferous tubules. At places of germ cell/sertoli cell contacts, the rearrangements of cell junctions and associated cytoskeletal elements in sertoli cells controls germ cells differentiation. The expression of Rnd2 could contribute to the control of these rearrangements of cellular junctions. Rnd2 interacts and co-localizes with MgcRacGAP in male germ cells38 (spermatocytes and early spermatids) where it most likely controls the RhoGAP activity of MgcRacGAP.
Perspectives Expression of Rnd1, which is probably constitutively in the GTP form, inhibits the formation of actin stress fibers. These dramatic effects of Rnd1 on stress fiber formation could be due to the high level of expression, whereas at physiological levels the effects of Rnd1 on the actin cytoskeleton might be localized to more specific intracellular regions. Several groups have reported that the Rho antagonist effects of Rnds are due to the stimulation of RhoGAPs and inhibition of the Rho effector Rock. The group of Anne Ridley found an interaction of Rnd3/ RhoE with Rock, an observation that seemed to contradict ours, that Rnd3 does not bind the Rho Binding Domain (RBD) of Rock in the two-hybrid assay. In fact, it appears that Rnd3 does bind Rock, not in the RBD, but close to the kinase domain, inhibiting kinase activity.39 In addition, Steen Hansen’s group has shown that Rnd3 interacts with p190 RhoGAP, not in the GAP domain itself, as first assumed, but in the central domain of previously unknown structure and function. Membrane-associated Rnd3 most likely recruits p190-RhoGAP to the membrane where it can act on its substrate: membrane-associated Rho-GTP. At high levels of expression this leads to a massive inhibition of stress fiber formation, but in more physiological conditions it is likely that Rnds act at discrete places, such as adherens junctions, where other actin structures are formed. A protein named Socius is also proposed to participate in Rnd effects on the actin cytoskeleton,41 but at present it is not clear how it fits in the general picture. Since Socius is mostly expressed in testis, as Rnd2, they may interact to affect the cytoskeleton
Rnd Proteins: Intriguing Members of the Rho Family
105
in male germ cells. It has recently been shown that Cadherins, the main components of adherens junctions, recruit p190-RhoGAP to inactivate Rho.42 Since Rnd1 and 3 co-localize with cadherins,1 and interact with p190-RhoGAP,40 it is tempting to think that they are involved in p190-RhoGAP recruitment on cadherins, and local Rho inhibition. Until now, little was known on RhoGAPs regulation. These recent discoveries emphasize their importance and open new perspectives, suggesting other complex cross-talks between different small G proteins. Several recent results indicate that the membrane micro-domains where small GTP binding proteins get activated might be essential for their functions. Cdc42, Rac and Rho control dynamic rearrangements of the cytoskeleton that can occur in the time-scale of minutes. They can be rapidly activated by exchange factors and inactivated by GAPs, both being precisely localized and tightly coupled to regulatory signals. We suggest that Rnd proteins, which may constitutively be in the GTP-bound form, are regulated on a longer time-scale (hours). Their expression appears to be restricted to a few specialized cells in the adult. In these cells, Rnd proteins could be used to induce a local inhibition of actin stress fiber formation, at places of cell-cell contacts, for axon guidance and growth cone extension in neurons, for cell migration, or during cytokinesis.
References 1. Nobes CD, Lauritzen I, Mattei MG et al. A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J Cell Biol 1998; 141:187-97. 2. Guasch RM, Scambler P, Jones GE et al. RhoE regulates actin cytoskeleton organization and cell migration. Mol Cell Biol 1998; 18:4761-71. 3. Foster R, Hu K-Q, Lu Y et al. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in-vivo farnesylation. Mol Cell Biol 1996; 16:2689-2699. 4. Huber LA et al. Mapping of Ras-related GTP-binding proteins by GTP overlay following twodimensional gel electrophoresis. P N A S 1994; 91:7874-7878. 5. Prendergast GC et al. Farnesyltransferase inhibition causes morphological reversion of Ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol Cell Biol 1994; 14:4193-4202. 6. Smith TM, Lee MK, Szabo CI et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 1996; 6:1029-49. 7. Chardin P, Boquet P, Madaule P et al. The mammalian G protein RhoC is ADP-ribosylated by clostridium botulinum exoenzyme C3 and affects actin microfilaments in vero cells. The EMBO J 1989; 8:1087-1092. 8. Aktories K, Just I. In vitro ADP-ribosylation of Rho by bacterial ADP-ribosyl transferases. Methods in Enzymology 1995; 256 part B:184-195. Academic press. 9. Wilde C, Genth H, Aktories K et al. Recognition of RhoA by Clostridium botulinum C3 exoenzyme. J Biol Chem 2000; 275:16478-83. 10. Wilde C, Chhatwal GS, Schmalzing G et al. C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3. J Biol Chem 2001; 276:9537-42. 11. Nishi M, Takeshima H, Houtani T et al. RhoN, a novel small GTP-binding protein expressed predominantly in neurons and hepatic stellate cells. Mol Brain Res 1999; 67:74-81. 12. Hirata K, Kikuchi A, Sasaki T et al. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem May 5 1992; 267(13):8719-22. 13. Gong MC, Fujihara H, Somlyo AV et al. Translocation of rhoA associated with Ca2+ sensitization of smooth muscle. J Biol Chem 1997; 272:10704-9. 14. Uehata M, Ishizaki T, Satoh H et al. Calcium sensitization of smooth muscle mediated by a Rhoassociated protein kinase in hypertension. Nature 1997; 389:990-4. 15. Kimura et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase. Science 1996; 273:245-248. 16. Loirand G, Cario-Toumaniantz C, Chardin P et al. The Rho-related protein Rnd1 inhibits Ca2+ sensitization of rat smooth muscle. J Physiol 1999; 516:825-34. 17. Cario-Toumaniantz C, Reillaudoux G, Sauzeau V et al. Modulation of RhoA/Rho kinase-mediated Ca2+ sensitization of rabbit myometrium during pregnancy—Role of Rnd3. J Physiol 2003. 18. Vayssiere B, Zalcman G, Mahe Y et al. Interaction of the Grb7 adapter protein with Rnd1, a new member of the Rho family. FEBS Lett 2000; 467:91-6. 19. Han DC, Shen TL, Guan JL. Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration. J Biol Chem 2000; 275:28911-7.
106
Rho GTPases
20. Lee H, Woodman SE, Engelman JA et al. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase. J Biol Chem 2001. in press. 21. Aoki J, Katoh H, Mori K et al. Rnd1, a novel rho family GTPase, induces the formation of neuritic processes in PC12 cells. Biochem Biophys Res Commun 2000; 278:604-8. 22. Rohm B, Rahim B, Kleiber B et al. The semaphorin 3A receptor may directly regulate the activity of small GTPases. FEBS Lett 2000; 486:68-72. 23. Qiu R-G, Chen J, Kirn D et al. An essential role for rac in Ras transformation. Nature 1995; 374:457-459. 24. Qiu R-G, Chen J, McCormick F et al. A role for Rho in Ras transformation. P N A S 1995; 92:11781-11785. 25. Olson MF, Ashworth A, Hall A. An essential role for Rho, rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995; 269:1270-1272. 26. Habets GG, Scholtes EH, Zuydgeest D et al. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994; 77:537-49. 27. Symons, M. Rho family GTPases: The cytoskeleton and beyond. T I B S 1996; 21:178-181. 28. Bar-Sagi D, Feramisco JR. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by Ras proteins. Science 1986; 233:1061-1068. 29. Ridley AJ, Hall A. The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70:389-399. 30. Ridley AJ, Patterson HF, Johnston CL et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992; 70:401-410. 31. Hughes PE et al. Suppression of integrin activation: A novel function of a Ras/raf-initiated MAP Kinase pathway. Cell 1997; 88:521-530. 32. Sahai E, Olson MF, Marshall CJ. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J 2001; 20:755-66. 33. Hansen SH, Zegers MM, Woodrow M et al. Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway. Mol Cell Biol 2000; 20:9364-75. 34. Gress TM, Muller-Pillasch F, Geng M et al. A pancreatic cancer-specific expression profile. Oncogene 1996; 13:1819-30. 35. Camerer E, Gjernes E, Wiiger M et al. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 2000; 275:6580-5. 36. Akashi H, Han HJ, Iizaka M et al. Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac. Int J Cancer 2000; 88:873-80. 37. Wunnenberg-Stapleton K, Blitz IL, Hashimoto C et al. Involvement of the small GTPases XRhoA and XRnd1 in cell adhesion and head formation in early Xenopus development. Development 1999; 126:5339-51. 38. Naud N, Toure A, Liu J et al. Rho family GTPase Rnd2 interacts and co-localizes with MgcRacGAP in male germ cells. Biochem J 2003; 372(Pt 1):105-112. 39. Riento K, Guasch RM, Garg R et al. RhoE binds to ROCK I and inhibits downstream signalling. Mol Cell Biol 2003; 23(12):4219-4229. 40. Wennerberg K, Forget M-A, Ellerbroek S et al. Rnd proteins function as RhoA antagonists by activating p190-RhoGAP. Current Biol 2003; 13:1106-1115. 41. Katoh H, Harada A, Mori K et al. Socius is a novel Rnd GTPase-interacting protein involved in disassembly of actin stress fibers. Mol Cell Biol 2002; 22(9):2952-2964. 42. Noren NK, Arthur WT, Burridge K. Cadherin engagement inhibits RhoA via p190RhoGAP. J Biol Chem 2003; 278(16):13615-13618.
CHAPTER 7
Rho GTPases in the Organization of the Actin Cytoskeleton Ed Manser
Abstract
C
ells change their shape by altering their internal cytoskeleton. It has become apparent that in all eukaryotes Rho-family GTPases orchestrate changes to the actin cytoskeleton. In the last few years we have gained important insights into how these GTPases carry such processes via a variety of downstream ‘effectors’. These target proteins have a range of functions which can be under the direct control of the GTPase.
Introduction All organisms have cellular machinery dedicated to modulating cell shape, which is important in many biological processes, particularly for development, in the immune system and for plasticity in the central nervous system. Actin is an ancient protein that is able to form filaments that can be organized into a variety of structures, providing shape and allowing force generation within the cell. This abundant eukaryotic proteins, is a cytoskeletal component that assembles into paired filaments, and is conserved from yeast to humans.1 The ~43 kDa protein has an ATP binding domain with intrinsic ATPase activity and assembles primarily at the ‘barbed’ or ‘plus’ end of filaments when charged with ATP. This subsequently undergoes hydrolysis within the filament producing a phenomenon known as treadmilling, whereby monomers apparently move through the filament at steady-state. Proteins such as profilin and cofilin bind to monomeric or globular (G) actin, while many others actin binding proteins interact preferentially with filamentous (F) actin. Just recently proteins distantly related to actin have been discovered in prokaryotes such as Bacillus subtilis2 where they also regulate cell shape. Crystallization of the one such bacterial protein (MreB) indeed revealed a tertiary structure highly related to that of mammalian actin.3 Many dynamic actin structures are organized by a Rho family GTP-binding proteins. It is ten years since Alan Hall and colleagues first described4 how active versions of two such proteins, Rac1 and RhoA, can assemble distinct actin arrays in mammalian cells.5 Significantly, these studies found that external signals acting on transmembrane cell-surface receptors use these GTPases to initiate such changes in the actin cytoskeleton. Specifically, Rac1, acting downstream of receptor tyrosine kinases (RTKs), generates peripheral extensions known as membrane ruffles or lamellipodia while RhoA assembles more internally located actin stress fibres and associated adhesion complexes. The related GTPase called Cdc42, first described in budding yeast, was found to organize peripheral actin structures known as filopodia in mammalian cells.6,7 Work from many laboratories has since established that the Rho-GTPases family including Rho, Rac and Cdc42, alter the cytoskeleton by recruiting protein effectors. These, in turn, act in cascades that are responsible for changes to the actin cytoskeleton providing the basis for Rho GTPases, edited by Marc Symons. ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers.
Rho GTPases
108
Table 1. Effector proteins involved in actin organization Effector
GTPase Selectivity
Protein Type
Target
mDia1/2
Rho
adaptor
MRCK (α,β)
Cdc42
S/T kinase
MBS
PAK (α,β,γ)
Cdc42 Rac
S/T kinase
PAK4
Cdc42
S/T kinase
LIM-K MLCK LIM-K
PIP5kinase
Rac Rho
Lipid kinase
PIP2
ROK (α,β)
Rho
S/T kinase
N-WASP IRS-p53/58
Cdc42 Cdc42 Rac
adaptor adaptor
MBS vimentin Arp2/3 WAVE
Cytoskeletal Effect actin polymerization/ microtubule organization actin/myosin II/ focal adhesions actin polymerization/ inhibits actin/myosin II actin polymerization actin polymerization/ focal adhesions actin/myosin II IFs disassembly actin polymerization actin polymerization
both cell shape and adhesion. Thus, many signals that impinge on cells act via a common set of Rho switches. Here I discuss the established mechanisms by which three well-characterized GTPases — Rac, Cdc42 and Rho — use a variety of ‘effectors’ to alter the actin cytoskeleton. Lessons learned about these pathways tell us how cells coordinate complex internal reorganisation, as required for processes such as cell movement.
Different Actin Networks: Membrane Ruffles, Filopodia and Stress Fibres Reorganization of the actin cytoskeleton is most easily visualized in cultured cells responding to soluble factors or extracellular matrices, undergoing progression through the cell-cycle, or during invasion by pathogens. These systems have provided models which are the basis of most of our understanding of actin dynamics. Many studies have pointed to Rac playing a critical role in cell migration,8 a property of many cultured cells that can be directly observed and quantified. In migrating cells, the forward ‘leading’ edge consists of protruding flat lamellipodia in which there exists a dense array of actin. These filaments are orientated with their plus ends pointing towards the plasma membrane.9 The actin elements provide a ‘pushing’ force to expand the plasma membrane at the leading edge of the cell or, in combination with myosin, provide contractile ‘pulling’ forces between different cell attachment sites. Recent real-time imaging techniques have allowed the production of active Rac.GTP by growth factors to be visualized directly to the leading edge,10 confirming that the GTPase is activated in a polarized fashion. Cdc42 drives formation of filopodia and is important for cells to orientate correctly towards a chemotactic gradient11 or for fibroblasts to align themselves during wound healing.12 Recent evidence suggests that this involves organization of the microtubule network.13 Rho-dependent actin stress fibres are responsible for the contractile forces generated in cultured cells, both within leading-edge structures14 and between integrin-containing focal-adhesion complexes (FCs), particularly in the retracting ‘tail’ of migrating cells.15 It is in these central and rear areas that Rho promotes the formation of actin stress fibres. Rho, acting through its effector Rho kinase (ROK), plays a key role in producing these structures by organizing myosin II16 in combination with other Rho effectors (see next section). Several types of protein are needed to organize and regulate the actin cytoskeleton. Key among these are pro-
Rho GTPases in the Organization of the Actin Cytoskeleton
109
Figure 1. Pathways linking Rho GTPase effectors to actin/myosin II assembly. Phosphorylation events that have inhibitory effects are marked (-). Rho regulation of actin organization occurs through multiple effectors. The Rho-associated kinase (ROK) blocks the protein phosphatase delta (PP1δ), by phosphorylating the myosin binding subunit (MBS) p85 or p130 subunits. This prevents inactivation of phosphorylated MLC~P assembled into actin stress fibres. Myosin II driven assembly of stress fibres favours the formation of focal adhesion complexes. Myosin light chain kinase (MLCK) is a key enzyme for maintaining the myosin heavy–light chain complex in an active state, but is negatively regulated by Rac via the p21-activated kinase (PAK). Cdc42 regulates myotonin-related Cdc42-binding kinase (MRCK) and PAKs, which act via LIM-kinases (LIMKs) to inactivate cofilin. This stabilizes actin filaments because cofilin serves to accelerate actin dissociation.
teins that promote actin-filament assembly, treadmilling, crosslinking, branching, severing and linkage of actin filaments to the cell membrane. We now have some understanding of how a number of Rho effectors couple to these actin-related processes. The importance of Rho GTPases is exemplified by the way in which microbial pathogens have developed specific proteins that interact with Rho GTPases to turn them on or off, thus allowing pathogens to subvert actin function. This fascinating subject has recently been reviewed in some detail.17
Actin–Myosin II Contractility and Stress Fibre Formation In nonmuscle cells, actin is organized into functional motor units analogous to those found in muscle. This involves the assembly of actin filaments into higher-order structures bridged by myosin II. Such structures are readily observable as the actin stress fibres, which are often seen
110
Rho GTPases
Figure 2. Pathways linking Rho GTPase effectors to Arp2/3 mediated actin assembly. At peripheral locations Cdc42 interaction with N-WASP, or Rac1 interaction with IRS-p53/WAVE can recruit and activate the Arp2/3 complex. This protein complex thereby increases the number of actin filaments through branching onto existing filaments. The N-WASP can also be activated by PIP2, or through interactions of SH3 domain containing proteins such as WIP and Nck. PtdIns(4,5)P2 also binds to and activates N-WASP. It is suggested from dominant interfering experiments that N-WASP is required for actin assembly underlying filopodia formation: data using N-WASP knockout cells is required to confirm these findings. The IRS-p53/WAVE complex can also recruit the Arp2/3 complex to drive net actin polymerization - Arp2/3 is a key component of lamellipodia.
in cultured cells stained with phalloidin, and assemble under the control of Rho.4 Myosin II is primarily under the control of the calcium-dependent myosin light chain kinase (MLCK), whose activity is absolutely required to maintain stress fibres, however the kinase also functions at the leading edge of cells. For example in motile eosinophils, photolysis of caged inhibitory peptides directed to either calmodulin or MLCK results in a rapid block of forward motion of the leading lamellipod.18 The serine/threonine kinases ROK and the myotonin-related Cdc42-binding kinase (MRCK) cause MLC phosphorylation, but not by affecting MLCK. Rather these promote maintenance of the phosphorylated state of myosin light chain (P~MLC) (Fig. 1) by blocking the action of the key phosphatase in the cycle.4 Both ROK and MRCK target a single inhibitory threonine phosphorylation site on the p8519 or p13020 myosin-binding subunit (MBS) of protein phosphatase 1δ. This MBS phosphorylation directly blocks the activity of the phosphatase and causes acccumulation of P~MLC. Such activity occurs in the context of other Rho effectors, for example the mammalian Diaphanous (mDia) a formin which can generate F-actin in combination with the action of ROK.21
Controlling Actin Treadmilling The maximal forward movement of the leading edge of mammalian cells is of the order of 5–10 µm per minute. In vitro studies of the properties of actin have shown that disassembly is rate limiting for actin to cycle quickly enough to drive such rates of cell movement, therefore in vivo proteins must accelerate the intrinsic rate. ADF/cofilin fulfils this role (Fig. 1), by stimulating ‘treadmilling’ of actin.22 This increases net actin turnover in the cell and net loss of F- actin. However, cofilin is under tight negative regulation by LIM kinases phophorylation. While expressing a cofilin mutant that cannot be inactivated (S3A) does not block formation of filopodia, lamellipodia or actin stress fibres,23 cofilin inactivation facilitates the dynamics of assembly/disassembly. LIM-kinase is regulated by ROK16,24 and this is in part why Rho promotes net actin assembly (Fig. 1). LIM-kinase 1 is
Rho GTPases in the Organization of the Actin Cytoskeleton
111
also reported to be activated by the serine/threonine p21-activated kinase PAK1/αPAK,25 one of the first Cdc42/Rac effectors to be identified.26 It has recently been shown27 that the Cdc42 effector PAK4 is a potent in vivo activator of LIM-kinase 1.
Arp2/3-Mediated Actin Nucleation and Branching One of the key findings of the last few years is that Wiscott-Aldrich syndrome protein (WASP) and its ubiquitously expressed homologue N-WASP are important actin organizers downstream of Cdc42.28,29 Use of dominant-inhibitory constructs of N-WASP suggest it is required for the formation of filopodia, although Arp2/3 is not actually present in these structures.30 Structural studies have revealed how binding of Cdc42 releases the auto-inhibitory region from the WASP carboxy-terminal region31 (referred to as the VCA domain), allowing it to activate a multi-protein component called the Arp2/3 complex (Fig. 2). The VCA region of WASP contains a sequence homologous to the ActA protein of the pathogenic bacterium Listeria monocytogenes, which also recruits Arp2/3 to drive actin-based bacterial movement. The Arp2/3 complex is capable of branching actin filaments and thereby rapidly increasing the number of ends. N-WASP can apparently be recruited for this purpose by proteins other than Cdc42. For example, the enteropathogenic E. coli Tir protein binds the adaptor Nck, which in turn recruits N-WASP to assemble a pedestal below the bacterium.32 In lamellipodia, electron-microscopic analysis of the actin network has revealed an extensive branched network of actin filaments, where the barbed ends face the leading edge.9 Here, 70 Y junctions between actin filaments contain Arp2 and Arp3 in addition to five other subunits: this complex is enriched at the leading edge of crawling cells.33 Many studies have indicated the nucleation and crosslinking of actin filaments provides a force to push against the leading-edge membrane. But what organizes this behaviour downstream of Rac? Truncated versions of a WASP-related protein (WASP family Verprolin homologous), WAVE, can block formation of Rac-induced lamellipodia but not Cdc42-induced filopodia.34 WAVE has the same type of VCA domains as WASP, but does not seem to be regulated by an analogous interaction with Rac.35 Instead it might be brought into play through additional signalling proteins, such as the binding partner insulin receptor substrate protein IRSp53/58 (Fig. 2). IRSp53/58 is reported to bind Rac.GTP via an amino-terminal domain,36 and this adaptor clearly contains a distinct central Cdc42.GTP binding site resembling that in PAK and WASP.37 Thus Rac is which potently assembles leading edge actin, is biochemically linked to actin assembly—however why both Rac1 and Cdc42 bind the IRSp53 protein remains to be resolved
Stimulating Actin Assembly The polymerization of actin is controlled by actin-binding proteins that either promote new filament nucleation or stimulate elongation of existing structures. The role of Arps in creating new ends has been discussed. A different player is the actin-binding protein profilin, which can stimulate the rate of actin addition from sequestered pools to the barbed end of the filament.38 Profilin’s name derives from its affinity for proline-rich sequences, which are a feature of profilin-binding proteins such as vasodilator-stimulated phosphoprotein (VASP) and formins. Profilin can be recruited by bacterial pathogens that use actin polymerization for movement, indicating its central role in actin-based motility.29 Rho effectors are indeed linked to profilin: profilin is recruited by the Cdc42 effector WASP. Significantly, mutants of profilin that do not bind actin, block filopodia formation downstream of Cdc4239 and can suppresses N-WASP-induced actin reorganization in cells.34 The WAVE similarly requires profilin to promote the formation of lamellipodia.40 The ability of profilin to stimulate actin assembly is augmented by the binding of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) to profilin to release actin from the complex. Levels of cellular PtdIns(4,5)P2 are elevated by PtdIns 4-phosphate 5-kinases (PIPKs), which associate with both Rho and Rac41 and are stimulated by ROK.42 Thus, elevating the levels of PtdIns(4,5)P2 causes extensive actin polymerisation.43
112
Rho GTPases
Tethering Assembled Actin to Membranes In most cell types the plasma membrane is intimately associated with the underlying actin cytoskeleton. Rho GTPases, which coordinate changes in the plasma-membrane shape, are ideally placed to modulate this attachment - via ERM proteins. This acronym derives from the first three members to be identified - ezrin, radaxin and moesin, which all have an amino-terminal membrane-associated domain and a carboxy-terminal actin-binding region. Such proteins are known to be associated with plasma membrane structures such as microvilli, filopodia and membrane ruffles,44 but require phosphorylation in the C-terminal domain to become active.45 Activation of RhoA leads to phosphorylation of ERMs on a conserved regulatory threonine residue.45 Activated Cdc42 also drives such phosphorylation of ERMs but at the tips of filopodia, via the ROK-like kinase MRCK.46 Although ROK has been implicated in this process,47,48 other in vivo experiments showed that phosphorylation of ERMs is not suppressed by the ROK inhibitor Y-27632. Rather overexpression of the lipid kinase effector PIPKα, is capable of increasing levels of phosphorylated ERM sixfold and concomitant formation of microvilli.49 A lipid regulated protein kinase might mediate such ERM phosphorylation. Interestingly a nonphosphorylatable mutant of ezrin has been reported to block actin contractility, focal-adhesion formation and transformation downstream of Rho.50
The Focal Adhesion Complex-Actin Connection Introduction of active Cdc42, Rac and Rho drives the formation of integrin-containing focal complexes (FCs) in serum-starved fibroblasts.6 Formation of FCs is reinforced by intracellular tension between the integrins and underlying actin cytoskeleton, and is very sensitive to myosin II inhibitors.51 To sustain the structure of FCs in turn requires components that link actin filaments to the integrin complex, including vinculin, talin and α-actinin. Vinculin is directly regulated by PtdIns(4,5)P2, which disrupts intramolecular interactions to allow binding to talin and α-actinin52—key interactions in the assembly of FCs. Thus, injection of antibodies to PtdIns(4,5)P2 blocks the formation of FCs.52 Rho, ROK53 and Rac42 are known to increase cellular levels of PtdIns(4,5)P2 through the action of PIPKs. This promotes protein components to assemble with integrins into bona fide FCs. In spite of the close connection between Rho GTPases and FCs, the only identified effector that has been localized to FCs is PAK.54 Because assembly of new FCs leads to activation of Rac and Cdc42, PAK is probably locally activated in these fledgling structures.55 Much work is yet required to resolve the various connections between integrin containing complexes and Rho GTPases. This will continue to be a key area of focus because of the importance of integrin signalling for development, organogenesis and metastasis.
Conclusions and Future Directions We are beginning to build a more detailed picture of how Rho GTPases regulate the actin cytoskeleton, but much of our knowledge is derived from work using cultured cells. It will be a challenge to understand how these processes are coordinated in whole organisms. As we have seen, the pathways that control the actin cytoskeleton downstream of Rho GTPases are mainly controlled by phosphorylation but identification of their targets in vivo continues to remain a challenge. New methodologies such as sensitive mass spectrometry are anticipated to speed up the identification of protein modifications resulting from Rho signalling.
Acknowledgement The author is supported by the Glaxo-IMCB Research Fund.
Rho GTPases in the Organization of the Actin Cytoskeleton
113
References 1. Schmidt A, Hall MN. Signalling to the actin cytoskeleton. Annu Rev Cell Dev Biol 1998; 14:305-338. 2. Jones LJ, Carballido-Lopez R, Errington J. Control of cell shape in bacteria: Helical, actin-like filaments in Bacillus subtilis. Cell 2001; 104:913-922. 3. van Den Ent F, Amos LA, Lowe J. Prokaryotic origin of the actin cytoskeleton. Nature 2001; 413:39-44. 4. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70:389-399. 5. Ridley AJ, Paterson HF, Johnston Cl et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992; 70:401-410. 6. Nobes CD, Hall A. Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81:53-62. 7. Kozma R, Ahmed S, Best A et al. The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol Cell Biol 1995; 15:1942-1952. 8. Keely PJ, Westwick JK, Whitehead IP et al. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997; 390:632-636. 9. Svitkina TM, Borisy GG. Progress in protrusion: The tell-tale scar. Trends Biochem Sci 1999; 24:432-436. 10. Kraynov VS, Chamberlain C, Bokoch GM et al. Localized Rac activation dynamics visualized in living cells. Science 2000; 290:333-337. 11. Allen WE, Zicha D, Ridley AJ et al. A role for Cdc42 in macrophage chemotaxis. J Cell Biol 1998; 141:1147-1157. 12. Nobes CD, Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 1999; 144:1235-1244. 13. Etienne-Manneville S, Hall A. Integrin-Mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 2001; 106:489-498. 14. Pelham RJ, Wang Yl. High resolution detection of mechanical forces exerted by locomoting fibroblasts on the substrate. Mol Biol Cell 1999; 10:935-945. 15. Galbraith CG, Sheetz MP. A micromachined device provides a new bend on fibroblast traction forces. Proc Natl Acad Sci USA 1997; 94:9114-9118. 16. Maekawa M, Ishizaki T, Boku S et al. Signalling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999; 285:895-898. 17. Knodler LA, Celli J, Finlay BB. Pathogenic trickery: Deception of host cell processes. Nat Rev Mol Cell Biol 2001; 2:578-588. 18. Walker JW, Gilbert SH, Drummond RM et al. Signalling pathways underlying eosinophil cell motility revealed by using caged peptides. Proc Natl Acad Sci USA 1998; 95:1568-1573. 19. Tan I, Ng CH, Lim L et al. Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J Biol Chem 2001; 276:21209-21216. 20. Leung T, Chen XQ, Tan I et al. Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol Cell Biol 1998; 18:130-140. 21. Nakano K, Takaishi K, Kodama A et al. Distinct actions and cooperative roles of ROCK and mDia in Rho small G protein-induced reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells. Mol Biol Cell 1999; 10:2481-2491. 22. Carlier MF, Laurent V, Santolini J et al. Actin depolymerizing factor (ADF/cofilin) enhances the rate of filament turnover: Implication in actin-based motility. J Cell Biol 1997; 136:1307-1322. 23. Sumi T, Matsumoto K, Takai Y et al. Cofilin phosphorylation and actin cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2. J Cell Biol 1999; 147:1519-1532. 24. Amano T, Tanabe K, Eto T et al. LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505. Biochem J 2001; 354:149-159. 25. Edwards DC, Sanders LC, Bokoch GM et al. Activation of LIM-kinase by Pak1 couples Rac/ Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1999; 1:253-259. 26. Manser E, Leung T, Salihuddin H et al. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994; 367:40-46. 27. Dan C, Kelly A, Bernard O et al. Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin. J Biol Chem 2001; 276:32115-32121. 28. Mullins RD. How WASP-family proteins and the Arp2/3 complex convert intracellular signals into cytoskeletal structures. Curr Opin Cell Bio 2000; 12:91-96.
114
Rho GTPases
29. Cameron LA, Giardini PA, Soo FS et al. Secrets of actin-based motility revealed by a bacterial pathogen. Nature Reviews Mol Cell Biol 2001; 1:110-120. 30. Castellano F, Montcourrier P, Guillemot JC et al. Inducible recruitment of Cdc42 or WASP to a cell-surface receptor triggers actin polymerization and filopodium formation. Curr Biol 1999; 9:351-360. 31. Kim AS, Kakalis LT, Abdul-Manan N et al. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 2000; 404:151-8. 32. Gruenheid S, DeVinney R, Bladt F et al. Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells. Nat Cell Biol 2001; 3:856-859. 33. Machesky LM, Gould KL. The Arp2/3 complex: A multifunctional actin organizer. Curr Opin Cell Biol 1999; 11:117-121. 34. Miki H, Sasaki T, Takai Y et al. Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP. Nature 1998; 391:93-96. 35. Rohatgi R, Ma L, Miki H et al. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 1999; 97:221-231. 36. Miki H, Yamaguchi H, Suetsugu S et al. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature 2000; 408:732-735. 37. Govind S, Kozma R, Monfries C et al. Cdc42Hs facilitates cytoskeletal reorganization and neurite outgrowth by localizing the 58-kD insulin receptor substrate to filamentous actin. J Cell Biol 2001; 152:579-594. 38. Didry D, Carlier MF, Pantaloni D. Synergy between actin depolymerizing factor/cofilin and profilin in increasing actin filament turnover. J Biol Chem 1998; 273:25602-25611. 39. Suetsugu S, Miki H, Takenawa T. Identification of two human WAVE/SCAR homologues as general actin regulatory molecules which associate with the Arp2/3 complex. Biochem Biophys Res Commun 1999; 260:296-302. 40. Sasaki N, Miki H, Takenawa T. Arp2/3 complex-independent actin regulatory function of WAVE. Biochem Biophys Res Commun 2000; 272:386-390. 41. Ren XD, Bokoch GM, Traynor-Kaplan A et al. Physical association of the small GTPase rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in Swiss 3T3 cells. Mol Biol Cell 1996; 7:435-442. 42. Tolias KF, Hartwig JH, Ishihara H et al. Type Ialpha phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent actin assembly. Curr Biol 2000; 10:153-156. 43. Shibasaki Y, Ishihara H, Kizuki N et al. Massive actin polymerization induced by phosphatidylinositol4-phosphate 5-kinase in vivo. J Biol Chem 1997; 272:7578-7581. 44. Bretscher A. Regulation of cortical structure by the ezrin-radixin-moesin protein family. Curr Opin Cell Biol 1999; 11:109-116. 45. Hirao M, Sato N, Kondo T et al. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/ plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signalling pathway. J Cell Biol 1996; 135:37-51. 46. Nakamura N, Oshiro N, Fukata Y et al. Phosphorylation of ERM proteins at filopodia induced by Cdc42. Genes Cells 2000; 5:571-581. 47. Matsui T, Maeda M, Doi Y et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/ radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 1998; 140:647-657. 48. Shaw RJ, Henry M, Solomon F et al. RhoA-dependent phosphorylation and relocalization of ERM proteins into apical membrane/actin protrusions in fibroblasts. Mol Biol Cell 1998; 9:403-419. 49. Matsui T, Yonemura S, Tsukita S et al. Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases. Curr Biol 1999; 9:1259-1262. 50. Tran Quang C, Gautreau A, Arpin M et al. Ezrin function is required for ROCK-mediated fibroblast transformation by the net and dbl oncogenes. EMBO J 2000; 19:4565-4576. 51. Small JV, Rottner K, Kaverina I. Functional design in the actin cytoskeleton. Curr Opin Cell Biol 1999; 11:54-60. 52. Gilmore AP, Burridge K. Regulation of vinculin binding to talin and actin by phosphatidyl-inositol-4 -5-bisphosphate. Nature 1996; 381:531-535. 53. Oude Weernink PA, Schulte P, Guo Y et al. Stimulation of phosphatidylinositol-4-phosphate 5-kinase by Rho-kinase. J Biol Chem 2000; 275:10168-10174. 54. Manser E, Huang HY, Loo TH et al. Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 1997; 17:1129-1143. 55. Zhao ZS, Manser E, Loo TH et al. Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly. Mol Cell Biol 2000; 20:6354-6363.
CHAPTER 8
Cell-Cell Adhesion Vania M.M. Braga and Martha Betson
Introduction
C
ell-cell adhesion is an essential process for tissue architecture. During development and differentiation, intercellular adhesion provides a selective way for choosing like-neighbours and spatial cues for cell positioning within a tissue. In addition, by modulating the type and the surface levels of cell-cell adhesion receptors, cells can change not only their morphology but also their phenotypic properties (differentiation status, gene expression profile, proliferation and migration rates). As the above cellular processes are perturbed during tumorigenesis, much effort has been put into understanding how cell-cell contacts are regulated and how they can affect so many diverse signalling events. The role of cell-cell adhesion is particularly relevant for epithelium function. An epithelium is formed by a sheet of cells tightly attached to each other. The major functions are in secretion/ absorption and as a protective barrier. Although cell-cell adhesion is essential for the differentiation of epithelia, distinct epithelial types (simple or stratified) differ somewhat in the adhesive structures present and in the distribution of proteins at junctions (see below). In this chapter, we discuss the major cell-cell adhesive system found in epithelia (adherens junctions), its interaction with the cytoskeleton and the signalling pathways that have been implicated on its functional regulation.
Characteristics of Epithelial Cells Adhesive Structures The epithelial junction is a complex cellular structure cosisting of different adhesive components: adherens junctions, desmosomes and tight junctions. Adherens junctions and desmosomes contain members of the cadherin superfamily of transmembrane proteins, which mediate calcium-dependent cell-cell adhesion. Classical cadherins form the adherens junctions and are indirectly connected to the actin cytoskeleton. Other cadherin-family members, desmogleins and desmocollins, form the desmosomes and interact with the intermediate cytoskeleton (keratins) via a cytosolic plaque containing different proteins.1 The tight junction transmembrane proteins are claudins and occludins that, similarly to cadherins in adherens junctions, are indirectly connected to actin filaments. Adherens junctions and desmosomes give strength to the epithelial junction and their association with the cytoskeleton provides resistance to tension and friction. Tight junction formation yields impermeability to ions and solutes across the epithelial sheet, virtually sealing the space in between adjacent cells (paracellular permeability).
Epithelial Phenotype and Cytoskeleton Epithelial cells are characterised by a cuboidal morphology and differential distribution of surface and cytosolic proteins into specific domains (Fig. 1). This is known as the polarised Rho GTPases, edited by Marc Symons. ©2003 Eurekah.com and Kluwer Academic / Plenum Publishers.
116
Rho GTPases
Figure 1. Cell shape and cytoskeletal organization of epithelial and fibroblast cells. Actin bundles are shown as red lines; cadherin receptors are represented as green dots at the membrane. The main differences between these epithelia and fibroblasts are on the cell shape (flat versus tall; irregular versus cobblestone, respectively) and cytoskeletal organization (stress fibers versus circumferential bundles of actin). Distinct organization of the cytoskeleton is found in simple epithelial cell such as MDCK. Polarised MDCK cells have stress fibers at the base; adherens junctions and the circumferential actin ring are present as a single spot at the apex of the lateral domain.
epithelial phenotype and a cooperation between cell-cell adhesion and remodelling of the cytoskeleton is necessary to achieve it. Adherens junctions provide points of attachment for the actin cytoskeleton at the lateral domain. From these points, the actin cytoskeleton can generate contraction/tension to create the cuboidal cell morphology. This rearrangement programmes the sorting machinery to redirect membrane proteins to different domains (apical, basal or lateral), promoting the recruitment to the junctions of cytosolic and signalling proteins. The presence of tight junctions in simple epithelia prevents the mixing of proteins between apical and baso-lateral domains. The end point is the formation of dynamic structures across the whole length of the adhesive lateral domain, from which external clues are transmitted via the signalling proteins nearby and the cytoskeleton. The association with the cytoskeletal network is essential for the assembly and function of the junctional adhesive structures. Mutation or deletion of the junctional proteins that mediate the interaction with the actin cytoskeleton or intermediate filaments completely abolishes the appropriate assembly of adherens junctions, tight junctions and desmosomes, respectively (reviewed by ref. 2). The cytoskeleton organization in polarised epithelial cells is distinct from the one found in fibroblasts (Fig. 1),3,4 with differences in the composition and organization of actin bundles between these two cell types. In fibroblasts, filamentous actin is organised into thick bundles known as stress fibers. Stress fibers originate from points of attachment to the extracellular matrix and can traverse the whole length of a fibroblast cell. Epithelial cell lines grown in vitro show stress fibers at the base of the cell (i.e., MDCK cells derived from kidney epithelia). In
Cell-Cell Adhesion
117
contrast, in primary/normal epithelia, stress fibers are not prominent. Instead, thin actin cables can traverse the epithelial cell body, but the majority of actin cables are found in circumferential bundles adjacent to cell-cell junctions.5 Because of the functional interaction between adhesive receptors and the cytoskeletal network, understanding how this connection is established and maintained may provide insights into how cell-cell adhesion is regulated.
Cadherin Receptors Cadherins and Catenins Classical cadherin receptors found in epithelial tissues are E- and P-cadherin. Additional family members may be found to be expressed in epithelial cells, as new cadherin types are investigated in epithelia. However, E-cadherin seems to be the most important receptor for epithelia differentiation. First, while P-cadherin knockout mice are viable and fertile, embryos depleted of E-cadherin gene die very early (embryonic day E6.5), as the first epithelium, the trophectoderm, is not properly formed.6,7 Second, expression of E-cadherin gene in fibroblasts and tumour cell lines is sufficient to restore the cuboidal morphology and asymmetrical distribution of proteins typical of epithelial cells.8 Cadherin receptors interact with similar type of molecules from adjacent cells (homophilic binding). At the cytoplasmic side, the cadherin tail associates directly with proteins of the armadillo family (β-catenin, plakoglobin, δ-catenin, p120ctn, reviewed by ref. 9). Some of these proteins (β-catenin and plakoglobin) serve as a docking site for α-catenin, which can bind to and bundle actin filaments.10 These three components (cadherin, α-catenin and β-catenin) provide the core and essential unit of the cadherin complexes. Similar to the E-cadherin knockout phenotype, depletion of β-catenin in vivo is lethal due to impairment in epithelial differentiation.11 The catenins δ-catenin, ARVCF and p120ctn differ from the other armadillo family members, as they bind to a distinct region in the cadherin cytoplasmic tail.12-14 The role of δ-catenin in cadherin adhesion is less clear than for β-catenin as it seems to destabilise adhesive complexes.13 In addition, reports have described either a positive or negative role for p120ctn on cadherin-dependent adhesion.12,15-17 Most probably these discrepancies reflect the cellular context, the presence of multiple p120ctn isoforms and the modulation of p120ctn by phosphorylation (reviewed by ref. 18). Thus, while the roles that α-catenin, β-catenin and plakoglobin play on cadherin function are established, it has been more challenging to pin point the functional contribution of the other catenins.
Proposed Model for Cadherin-Dependent Adhesion Formation of cell-cell contacts is a dynamic process that results in complex changes both locally at the site of adhesion as well as in the overall cell morphology. Cadherin-mediated cell-cell adhesion is formed by sequential steps of increasing levels of complexity. While there is a predicted temporal sequence of events, in a given cell the different steps can overlap with each other considerably, as cell-cell contact formation does not occur synchronously along the lateral domain. Although the key steps in the cadherin adhesion have been known for the past fifteen years, the mechanisms via which they take place are still not completely understood. These steps are discussed below.
Homophilic Binding Cadherin receptors are found at the surface as lateral or cis dimers, which form the structural unit of the adhesive complexes (Fig. 2).19-24 Lateral dimerization is mediated by the extracellular domain (containing 5 calcium-binding repeats), and its stability is independent of the association with calcium ions.21,25 In the presence of calcium ions, the extracellular domain is stabilised as an elongated, rigid conformation, allowing the interaction with the same type of molecules on opposing cells (homophilic binding; Fig. 2).22,24 Although the formation of lat-
118
Rho GTPases
Figure 2. Homophilic binding, clustering and puncta formation after induction of cell-cell adhesion. (a) Homophilic binding. Cadherin molecules have 5 extracellular calcium-binding repeats and are found as lateral dimers at the surface. Association with β- and α-catenin form the cadherin complex. As calcium ions interact with the extracellular domain, it is rearranged in a rod-like structure and receptors become adhesive. These dimers interact with similar dimers from neighbouring cells, in a process known as homophilic binding. Two models have been proposed for how homophilic binding takes place. Model 1 predicts that only the first repeat of cadherin receptors interact with each the apposing dimers. Model 2 argues for a more extensive overlap of all 5 extracellular repeats. (b) Apposing membranes from two neighbour cells are shown with cadherin dimers represented in green. After homophilic binding, cadherins progressively cluster at sites of cell-cell contacts. These clusters are seen at the microscopic level as distinct punctum. As clustering progresses, each punctum is enlarged until a complete line of adhesive cadherin dimers is found at cell-cell contacts.
eral dimers is important for the adhesive interaction of cadherin receptors, it is not known whether these dimers can form before reaching the cell surface or if they are regulated in any way. Two models have been proposed for how the homophilic binding occurs (Fig. 2a). The two models differ in the amount of overlap between the dimers engaged in adhesion, and there is supportive experimental evidence for both models. One model predicts that only the first extracellular repeat of each dimer overlap with each other.20,22 This model is consistent with the identification of cadherin specificity domain at the first repeat.26 and the mapping of epitopes for inhibitory antibodies to this region.26,27 The second model proposes that a more extensive overlap may occur, with the participation of 3 to 5 extracellular repeats.28 The later model suggests that cadherin adhesiveness results from multivalent low affinity interactions between cadherin dimers. It is supported by (a) mutations of E-cadherin gene known to affect adhesion that do not lie in the first N-terminal repeat;29,30 (b) inhibitory antibodies binding to the repeat 5;30 (c) biophysical measurements of force between the adhesive dimers;31 and (d) direct in vitro binding of different combinations of the cadherin repeats.28
Clustering After the homophilic binding, the interacting receptors cluster at sites of cell-cell contacts, originating what are known as “puncta”.32,33 These structures are visible by immunofluorescence very quickly after induction of cell-cell contacts.33,34 Scattered along the lateral domain,
Cell-Cell Adhesion
119
multiple puncta enlarge as more receptors are engaged in adhesion and they then coalesce to form a contiguous line of E-cadherin staining at the lateral domain to form the junctions (Fig. 2B). It is not clear how the clustering events take place nor how pucta are formed and enlarged. Lateral mobility of the receptors in the plane of the membrane as well as recruitment of intracellular pools is thought to play a role. Because these structures are not stable if the actin cytoskeleton is disrupted, actin filament reorganization/polymerisation may participate in the process.33,35 In addition, myosin-dependent contractility also may play a role in the clustering process, as different myosin isoforms do localise at the junctions in epithelial cells.36-38 Yet, a functional link between the myosin localization and cadherin adhesion has not been addressed experimentally. It has been proposed that cells make transient contacts prior to stable cell-cell attachment using “finger-like” projections at their membrane.39-41 Upon cadherin homophilic binding, these projections are then stabilised and embedded into the neighbour’s cell body. Actin cytoskeletal rearrangement results in the formation of a cadherin zipper, which seals the lateral domains of adjacent cells from bottom to top. During junction formation of primary keratinocytes, Drosophila and C.elegans epidermis these finger-like projections are evident.39-41 However, in keratinocytes, the extent of interdigitation of the adhesive membranes is variable across the monolayer. Moreover, these structures are not observed in other epithelia such as MDCK cells.32,33 This may reflect a cell-type specific event and suggests that these “finger-like” projections are not essential for junction formation.
Stabilization via Association with the Actin Cytoskeleton The association of cadherin complexes with the actin cytoskeleton results in the stabilization of the clustered receptors. One characteristic of the puncta is that these are sites for de novo actin polymerisation.33,34 A couple of minutes after induction of cell-cell adhesion, actin is already colocalised with cadherin receptors,34 suggesting that actin recruitment occurs concomitantly or shortly after homophilic binding. The mechanism via which clustered cadherin receptors can induce actin polymerisation is not known. Proteins such as VASP and Mena, which regulate actin polymerization, colocalise with cadherin receptors at junctions40 and are good candidates for participating in actin recruitment. Interestingly, around 50% of the cadherin molecules not engaged in adhesion already associate with actin filaments, and this interaction is important for the mobility of receptors in the plane of the membrane.42,43 However, as there are no reports of detectable actin incorporation at nonadhesive cadherin complexes, the latter association is qualitatively different from the interaction observed at junctions. Another characteristic of the puncta is that a proportion of its cadherin receptor content is detergent-insoluble.33,34 The detergent insolubility of cadherin receptors is interpreted as their immobilisation at the puncta via an interaction with the actin cytoskeleton.44,45 However, lipid association may also render proteins insoluble in detergents.
Remodelling of the Cytoskeleton After cell-cell contact formation, a combination of new polymerisation and remodelling of existing filaments may play a role in the reorganization of the epithelial cytoskeleton. However, it is not know how actin dynamics are altered to produce the cuboidal cell shape typical of epithelia (reviewed by ref. 46). Nor is it clear how the filaments are reorganised to form the circumferential ring of actin, which is connected to the puncta and provides support and contractility.5,33,47 Generation of tension and contraction is then coordinated to produce compaction between adjacent cells that ultimately leads to the cuboidal morphology. Concomitant with the cytoskeleton remodelling, other cytoskeletal and signalling molecules are recruited to sites of cadherin-dependent cell-cell contacts (see below). Among them are spectrin, ZO-1, vinculin and α-actinin that bind directly to α-catenin.48-53 Although these
120
Rho GTPases
interactions are thought to reinforce the binding of cadherin complexes to the actin cytoskeleton, this has not been formally proven. Alternatively, these proteins may help to cross-link and bundle actin filaments at the subcortical cytoskeleton, contributing to the reorganization of cell shape.
Polarised Epithelial Phenotype In addition to cytoskeletal proteins, many other transmembrane and cytosolic molecules are relocalised to junctions. Among the transmembrane proteins, some are involved in cell-cell adhesion, but others are clearly not, such as growth factor receptors, ion pumps, etc. (reviewed ref. 9). Signalling proteins are also localised at cell-cell contacts, presumably by assembly of multi-molecular complexes at the tail of transmembrane receptors. It is not clear how cadherin-dependent adhesion triggers the differential distribution of proteins to the baso-lateral and apical domains of epithelia. The formation of other adhesive structures also contributes to the stabilization of junctions, remodelling of the cytoskeleton and the recruitment of additional signalling complexes.
Maturation of Junctions The maturation of junctions is a poorly characterised process. It derives from the observation that with time after junction formation and after confluence, the biochemical properties of cadherin complexes change. There is an enhanced stability of the complexes at junctions that can be evaluated as an increased detergent-insolubility, inability of mature contacts to be disassembled by cytochalasin D (a drug interfering with actin polymerization), and insensitivity of desmosomes to withdrawal of calcium.33,44,45,54 The molecular mechanisms underlying these processes are not known.
Experimental Models to Investigate Cell-Cell Adhesion Regulation Different models for studying the regulation of cadherin adhesion are available. They allow investigation of junction regulation from different angles: the establishment of new cell-cell contacts or the stability of previously formed junctions (mature junctions). The formation of cell-cell contacts assay investigates which elements are important for the initial events during the establishment of cadherin-dependent adhesion. The mature junction assay studies the relevant events for the maintenance of cadherin complexes at junctions. This can be done by analysing the stability of the complexes under steady state conditions or after stimuli that interfere with cadherin-dependent adhesion such as oncogene expression and treatment with growth factors or HGF/scatter factor.55-59 Interpretation of the published results should take into account the experimental model system, cell type and methodology used. These different settings can account for some of the discrepancies reported in the literature. For instance, it is not known whether the same signalling pathways participate in the formation of new cell-cell contacts and in the maintenance of mature junctions (steady state). It is possible that they are somewhat different, as the stability of cadherin complexes at junctions is clearly increased during maturation.60 Similarly, it is not yet clear whether the same regulatory mechanisms operate after a destabilising stimulus is applied to epithelial cells containing mature junctions. Growth factors and oncogenes are known to activate multiple signalling pathways. Thus, under these conditions, regulation of cadherin adhesion occurs in a different setting, in which additional signalling events and increased phosphorylation levels are triggered by growth factor treatment/oncogene expression. The same applies for the use of established transformed epithelial cell lines. Another cautionary note applies to results obtained with fibroblasts expressing different cadherin constructs. First, although an epithelial morphology is achieved after full length cadherin expression in fibroblasts, the junctions formed are different as no other epithelial adhesive
Cell-Cell Adhesion
121
Figure 3. Working model of how Rho small GTPases participate on the stabilization of cadherin-dependent cell-cell contacts. Homophilic binding is represented as model 1. After clustering of cadherin dimers at the cell surface, Rho proteins are activated. Rho and Rac are independently activated; it is not known whether Cdc42 activation is required for Rac activation. Each GTPase interact and activate their specific targets. These targets may play a role in cellular processes that may be distinct or overlap (see Fig. 4). The cooperation between these multiple activities leads to the development of the epithelial phenotype: tight cell-cell adhesion, cytoskeletal rearrangement to produce a cuboidal cell shape and the asymmetric distribution of membrane proteins. Some of these activated pathways form a feed back loop to stabilise clustered cadherin receptors (dashed curved arrows).
structures are present (i.e., desmosomes). Second, as mentioned above, the cytoskeletal network of these two cell types is distinct. This concerns both the actin filaments organization and intermediate filament composition (vimentin instead of keratin expression). Finally, and importantly, the same stimuli can activate different signalling pathways in fibroblasts and epithelial cells.61,62 In particular, the regulation of cadherin-adhesion by small GTPases is affected by the cell type in which the receptors are expressed.60
122
Rho GTPases
Regulation of Cadherin Function Small GTPases The Rho family of small GTPases plays a role in cytoskeletal reorganization in a variety of cellular processes. As many of these processes are covered in other chapters, only a detailed discussion on the role of small GTPases in the regulation of cadherin adhesion is found below. Small GTPases are activated when associated with GTP (guanine nucleotide triphosphate). This is the form competent to interact with downstream targets and activate distinct signalling pathways. Inactivation occurs by hydrolysis and elimination of the phosphate, a step that is facilitated by GAPs (GTPase Activating Proteins). When a new activation cycle starts, GDP is released and replaced by GTP. This step is regulated by molecules that promote the GDP-GTP exchange (GEF or Guanine nucleotide Exchange Factors). Thus, signalling pathways that impinge on the small GTPase activity can operate at two different levels, by regulating the function of either GAP or GEF proteins (inactivation and activation of small GTPases, respectively). There are many members in the Rho family, but in epithelia the function of 3 members has been investigated in detail: RhoA, Rac1 and Cdc42 (thereafter referred to as Rho, Rac and Cdc42). In fibroblasts, activated Rho induces bundling of actin filaments in the cytoplasm known as stress fibers.63 Following stimulation by different growth factors, Rac form large protusions rich in polymerised actin at the cell periphery (lamellipodia) or on top of the cell (ruffles).64 Cdc42 can be activated by a distinct set of growth factors and can induce the formation of finger-like projections containing bundles of actin filaments (filopodia).65,66
Working Model for the Participation of Small GTPases in Junction Regulation Studies in vivo all reveal the important role of Rho proteins in junction regulation and epithelial differentiation.41,67-71 Similar to what has been described in fibroblasts, expression of activated forms of Rho, Rac and Cdc42 in epithelial cells in vitro leads to the formation of stress fibers, lamellipodia and filopodia, respectively. However, it is not clear how these specific cytoskeletal rearrangements play a role in cadherin function or the development of epithelial cell shape. The working model of how the small GTPases may participate in the regulation of cadherin adhesion is shown in Figure 3; specific steps are discussed below. Upon induction of new cell-cell contacts, activation of the small GTPases occurs. This has been demonstrated for Rho, Rac and Cdc42 (see below).72-74 Experimental data also suggest that, following cell-cell contact formation, Rho and Rac pathways are activated independently.75,76 This is in contrast to migration in fibroblasts, where the activation levels of Rho and Rac are interrelated.77-80 The activated small GTPases then bind to different effectors and trigger distinct signalling pathways (Fig. 3). These pathways collaborate with each other to produce the cytoskeletal rearrangements and originate the epithelial phenotype. Some of these pathways provide a feedback loop for the maintenance of stable cadherin-dependent cell-cell contacts. The ability of small GTPases to regulate cadherin adhesion depends on the maturation status of the junctions and the cell type.60 For example, in endothelial cells blocking Rho or Rac function does not affect VE-cadherin localization at junctions. However, in CHO cells expressing VE-cadherin, this receptor is readily removed by Rho or Rac inhibition. Thus, the current evidence indicates that Rho and Rac activities are important for cadherin-dependent adhesion, while Cdc42 function is relevant for the development of the polarized phenotype. An attractive possibility is that, in addition to the morphological changes, the small GTPases may participate in other signalling activities important for epithelia differentiation (see below).
Cell-Cell Adhesion
123
Activation of Small GTPases Recently, it was demonstrated that the activation of small GTPases can be induced by cadherin-dependent adhesion in epithelial cells.72-74 When expressed in MDCK cells, wild type, activated and dominant negative forms of Rac and Cdc42 localise at the junctions.73,76,81-83 It is not clear why all these mutants localise at the same place and no reports on the localization of endogenous proteins at junctions have been published. In contrast, no such localization has been reported for Rho.82 The functional significance of the distinct localization of each Rho family member is not known. Nevertheless, the localization of exogenous Rho molecules seems specific and dependent on cadherin adhesion: clustering of cadherin receptors with antibodies results in the recruitment of Rac (activated and dominant negative).73
Rac and Cdc42 The pattern observed for Rac and Cdc42 activation following cell-cell contact formation is similar in many cell types.72-74 First, activation of Rac and Cdc42 occurs very quickly, although depending on the study the time when activation is first detected varied (5 to 30 minutes). Second, this process requires cadherin adhesion, as inhibitory antibodies against cadherins can block activation of both GTPases. Third, PI3 kinase appears to be involved in Rac and Cdc42 activation following junction assembly.72,73 Regarding the role of PI3 kinase in increasing levels of Rac.GTP and Cdc42.GTP, it is noteworthy that PI3 kinases are themselves activated by induction of cell-cell adhesion.72,84 However, in MDCK cells, PI3 kinase inhibition can not interfere with junction assembly nor with Rac localization at these sites.73 One possible explanation is that PI 3-kinase activity is not essential for cadherin function and Rac recruitment to junctions, but may participate in subsequent steps (i.e., Rac activation; junction maintenance).73 Nevertheless, as during junction assembly PI3 kinase inhibition did not abolish completely the levels of active Rac in MDCK,73 it is conceivable that, in addition to PI3 kinase, alternative mechanisms exist to promote Rac activation. Although activation of Rac and Cdc42 during junction formation in epithelia has many similarities, it has not yet been demonstrated whether their activation is linked as described in fibroblasts (i.e., Cdc42 activates Rac; Fig. 3).66 While the above studies demonstrated that E-cadherin function is necessary for the activation of Rac and Cdc42 small GTPases, the question of whether cadherin adhesion is sufficient to drive their activation has not yet been addressed.
Rho Regarding Rho activation, conflicting results using MDCK cells are available. In one study, no upregulation of Rho activity was detected after new cell-cell contacts formation.73 In another study, Rho is activated following 5 minutes of induction of cell-cell adhesion, but measurement of Rho activity in other cells lines also gave conflicting data.74 A possible explanation for these discrepancies is that different levels of endogenous Rho in the distinct MDCK strains that would make it more difficult to detect variations in the activity levels. The above results led the authors to propose that Rho activity was due to calcium signalling, and not cadherin-mediated adhesion.74 However, no controls to pin point the contribution of calcium signalling versus cadherin adhesion for the process are provided (i.e., using anti-cadherin blocking antibodies). In addition, the use of different cell lines such as CHO and fibroblasts poses additional complications, due to the distinct cellular context in which Rho operates.60 These cell lines also express different members of the cadherin family, and at the moment, it is not known whether all the family members are regulated in a similar way by the small GTPases. Thus, Rho activation following junction formation is controversial and requires additional experiments to demonstrate its specificity by cadherin-mediated adhesion. Nevertheless, irrespective of how Rho is activated, its function is clearly necessary for the stability of the cadherin complexes at junctions (see below).60,75,82
124
Rho GTPases
How Are Small GTPases Activated Following Cell-Cell Adhesion? It is also not known how the GTPases activation takes place, but presumably it involves the recruitment of GEFs to these sites. Alternatively, formation of cell-cell contacts may inactivate specific GAPs, allowing increased levels of activated Rho proteins. At the moment, no candidate GEF or GAP has been put forward to fulfill this task. Vav-2, an exchange factor for Rac and Cdc42, is not activated by phosphorylation following induction of cell-cell adhesion in MDCK cells.74 Thus, Vav-2 has been excluded to participate on the cadherin-dependent activation of the small GTPases.74 Interestingly, Vav-2 is able to interact with the catenin p120ctn, but this association occurs mostly with the p120ctn cytoplasmic pool (see section Regulation of Cadherin Function/Cross-Talk between Small GTPase, Cadherin- and Integrin-Dependent Adhesion).74 Future studies will investigate the mechanisms via which cadherin receptors can signal to activate the small GTPases.
Regulation by Rho Many of the reported cellular functions of Rho have a component of contractility and generation of tension. These include the Rho functions in the formation of stress fibers, phagocytosis and cytokinesis (reviewed by ref. 85). However, it is not clear whether generation of tension plays a role in other Rho activities such as gene transcription, growth control and in cadherin adhesion. Inhibition of Rho by C3 transferase destabilises cadherin receptors from both newly formed and mature junctions.60,75,82 Rho activity play also a role in tight junction function.86 In two studies, transfection of the N19RhoA mutant to block endogenous Rho function was unable to disturb the presence of cadherins or actin at the junctions.76,87 One possibility is that expression of the N19Rho mutant was not high enough to completely block Rho function. A complete inhibition of Rho function by transfection is not achievable, as the cells would round up and detach during the selection procedure. On the other hand, in addition to RhoA, C3 is also able to inhibit RhoB and RhoC, and it is feasible that these other members may play a role on cadherin adhesion. However, a contribution of RhoB- and RhoC-specific signalling pathways seems unlikely: coexpression of a RhoA molecule insensitive to C3 inhibition can completely rescue the inhibitory phenotype induced by C3 alone.88 One current model argues that Rho activities are relevant for the cytoskeletal organization of epithelia, and that this effect indirectly stabilises cadherin receptors at junctions.89 Another model predicts that Rho function is important for both cell shape changes and events more proximal to the cadherin receptors.88 Both models agree on the participation of Rho in cytoskeletal organization. Because there are profound cell shape changes as the epithelial morphology develops, Rho-dependent contractility may be important for this process. The main difference between the two models is whether Rho can participate in events more proximal to the receptors, such as cadherin clustering. In support of the second model, when Rho is inhibited, cadherins are removed from junctions before other adhesion receptors, implying a certain degree of specificity in this process.75 Cells are still touching each other when cadherins are removed, suggesting that there is not a major disorganization of the cytoskeleton at this time. In addition, Rho is known to modulate myosin function, and different myosin molecules are found at the subcortical actin cytoskeleton and junctions.36-38 In endothelial cells, Rho mediates clustering of adhesion receptors such as ICAM-1 and VCAM-1.90,91 Based on the above evidence, it is possible that pathways activated by Rho may impinge on the cadherin clustering process in the following steps (see below): (a) lateral mobility of the receptors; (b) clustering to form the punctum; or (c) coalescence of the different puncta to form the adherens junctions. However, direct experimental evidence for an involvement in these processes are not available at the moment.
Cell-Cell Adhesion
125
Rho Targets One of Rho targets that has been investigated in epithelial cell-cell adhesion is ROCK (also known as Rho kinase or Rok).92,93 ROCK is a key target in the induction of stress fibers and generation of contractility.93-95 Transfection of a dominant negative version of ROCK (ROCK-KD-IA) can partially perturb the localization of cadherins at the MDCK junctions.89 However, expression of the same construct in breast epithelial cells do not disturb the recruitment of cadherins or actin to cell-cell contacts.87 In addition, inhibition of ROCK function by treatment with the compound Y27632 in keratinocytes cannot prevent establishment of new cell-cell contacts (ref. 88 and data not shown). These discrepancies may reflect different methodology and cellular context used in these studies. ROCK is able to regulate myosin II function and induce contraction.95-97 As blocking ROCK activity in certain epithelial types does not prevent cadherin clustering, these results imply that ROCK is not necessary for this process. One possible role for ROCK is in the development of epithelial cell shape. Indeed, by using the compound Y27632 during induction of cell-cell contacts in keratinocytes, the cells were unable to shape up and become tall and polarised (ref. 88 and data not shown). As the compound is not effective in cells containing mature junctions, it is possible that the ROCK inhibitory effects require the remodelling of the cytoskeleton. Thus, these results can dissociate between cadherin adhesiveness and cell compaction, and suggest that ROCK operates downstream of cadherin receptor clustering.
Regulation by Rac In different cell types, Rac has an important role in the regulation of lamellipodia formation, cell spreading and actin polymerisation. Recent evidence suggests that induction of lamellipodia is not relevant for cadherin-mediated adhesion.88 Indeed in epithelial cells, there is an inverse correlation between the presence of junctions and lamellipodia, suggesting an antagonism between these structures.47,88 Interestingly, Rac regulates the clustering of acetylcholine receptors in myotubes and integrins in T-lymphocytes and fibroblasts.64,91,98 Thus, it is conceivable that Rac may also play a role in cadherin clustering. In epithelial cells, Rac plays a role on the structural and functional organization of tight junctions.86 During cell-cell contacts formation, the subcortical cytoskeleton needs to be relaxed locally to allow formation of protusions which probe neighbouring cells for adhesion and polarization. Similar relaxation of the cell cortex is seen during spreading, a process regulated by Rac.77,91,99,100 Based on these results, Rac may contribute to cadherin adhesion on three fronts: clustering of the receptors, relaxation of cell cortex and receptor stabilization via actin recruitment and remodelling (Fig. 4b). However, the hypothesis that Rac participates in the clustering of cadherin receptors and in cell cortex relaxation has not yet been tested during junction assembly in epithelia. Experimental evidence suggests that Rac-dependent actin polymerisation plays a role in cadherin adhesion. Inhibition of endogenous Rac function in keratinocytes and MDCK cells removes cadherin receptors from both newly formed and mature junctions.60,75,82 Actin recruitment to junctions and to clustered cadherin receptors is also inhibited by blocking endogenous Rac function.75,82 On the other hand, expression of activated Rac results in (a) enhanced staining of cadherins and actin at the junctions and (b) more intermingled cell-cell contacts.38,82,83 As mentioned earlier, it is not know how actin dynamic changes and cytoskeletal reorganization takes place following junction assembly. Actin polymerization at cell-cell contacts strictly requires the presence of adhesive cadherin receptors. Interestingly, activation of Rac in the absence of cell-cell adhesion in keratinocytes does not lead to actin polymerisation at the cell borders.60 The results suggest the Rac activation per se cannot bypass the requirement for cadherin adhesion. It is possible that clustering of cadherin receptors provides spatial clues for a localised, Rac-dependent actin polymerisation in epithelia. Taken together, the data indicate that a tri-partite process takes place, in which cadherin-dependent adhesion, Rac activation and actin recruitment cooperate with and depend on each other for the formation of stable cell-cell contacts.
126
Rho GTPases
Figure 4. Possible cellular processes triggered by the small GTPases Rho (a) and Rac (b) during establishment of cadherin-dependent cell-cell adhesion. Dashed arrows and question marks denote possible activities based on data from other cell types; no direct evidence from epithelia and cadherin-based adhesion. Possible cellular processes triggered by the small GTPase Cdc42 (c) during establishment of cadherin-dependent cell-cell adhesion. Dashed arrows and question marks denote possible activities based on data from other cell types; no direct evidence from epithelia and cadherin-based adhesion. See text for details.
Cell-Cell Adhesion
127
Regulation by Cdc42 In addition to formation of filopodia, Cdc42 has also been implicated in actin polymerisation.101-103 In other cell types, Cdc42 regulates polarity during cell migration and bud formation in yeast, as well as chemotactic responses.79,104-106 Similarly in epithelial cells, Cdc42 contributes to the development of polarity, as it regulates the fidelity of the transport of secretory vesicles, and thus promotes the asymmetric distribution of proteins at the membrane (see section Regulation of Cadherin Function/Rac and Cdc42 Binding Proteins/Cell Polarity).107,108 In Drosophila, after blocking Cdc42 function two main effects are observed: (a) inhibition of the apicobasal elongation of epithelial cells,67,109 and (b) perturbation of dorsal closure (embryonic ectodermal epithelium; Jacinto et al, 2000). However, in the latter case it is difficult to distinguish between defects in migration of the leading edges and a failure in junction formation per se when the wound is closed. Nevertheless, the staining for junctional components is not substantially perturbed in these studies.41,67,109 While the above evidence suggests that Cdc42 is important for the development of the epithelial phenotype, the specific role of Cdc42 in cadherin-mediated adhesion per se is not clear (Fig. 4c). Inhibition of Cdc42 has no effect on the levels of cadherin staining at junctions in MDCK cells.83,107,110 However, upon expression of dominant negative Cdc42, a reduction in cadherin-mediated adhesion (aggregation assays) is observed in E-cadherin transfected fibroblasts.111 These data might reflect an inefficient inhibition of endogenous Cdc42 by the dominant negative approach. Further experiments using alternative tools to inhibit Cdc42 are necessary to confirm this phenotype. In epithelial cells, activated Cdc42 produces similar effects to activated Rac: it can promote more intermingled cell-cell contacts and accumulation of F-actin at junctions38,83 These results suggest that Cdc42 may cooperate with Rac in actin recruitment at junctions. However, there are many transmembrane proteins at junctions in addition to cadherin receptors that may act as recipients for recruited actin. As opposed to Rac,75 direct recruitment of actin to clustered cadherin receptors has not yet been show for Cdc42. Another step in which Cdc42 may pay a role is on the induction of the finger-like structures observed during new cell-cell contacts formation in keratinocytes, Drosophila or C. elegans.39-41 These projections appear similar to filopodia, and, after establishment of cell-cell adhesion in keratinocytes, bundles of actin filaments are seen inside.40 However, it is not clear whether before cell-cell adhesion these projections already contain actin bundles. During dorsal and ventral closure, typical filopodia are clearly seen, but the epithelial sheets are actively migrating towards each other.39,41 While these morphological considerations needs further investigation, the question is whether these finger-like projections are dependent on Cdc42 activity. Direct evidence for a role for Cdc42 on this process using a confluent epithelial monolayer (where no migration is involved) is still lacking. The fact that at present Cdc42 inhibition cannot abolish the localization of cadherins at junctions would argue against a participation of these small GTPase in this process. Alternatively, these finger-like structures are not essential for junction assembly as discussed previously.
Rac and Cdc42 Binding Proteins In different cell types, Rac has a clear effect on actin organization via activation of different targets such as PI4,5P kinase and LIM kinase.112-114 In epithelial cells, no Rac target has yet been identified that mediates Rac-dependent actin recruitment at junctions. IQGAP, a Rac and Cdc42 target, is detected at cell-cell contacts in epithelial cells.110 This molecule has homology with RasGAP, but no detectable GAP activity.110,115,116 IQGAP1 interacts with the cadherin tail and β-catenin. The latter interaction occurs in the same region as α-catenin, and therefore IQGAP competes with α-catenin for binding to β-catenin.117 The displacement of α-catenin from cadherin complexes is supposed to weaken the interaction with the actin cytoskeleton. However, IQGAP is also able to bind and bundle actin filaments,116 and may partially substitute for α-catenin in the cytoskeletal interactions. Nevertheless, the
128
Rho GTPases
presence of “less adhesive” cadherin receptors at the membrane may contribute to the dynamics of cell-cell adhesion in different cellular processes. Expression of IQGAP in fibroblasts expressing E-cadherin can reduce their aggregation levels in a quantitative assay for cell-cell adhesion.117 Consistent with that, activated Cdc42 and Rac bind to IQGAP and prevent it from associating with β-catenin, thereby inhibiting disassembly of cell-cell contacts.111,117 Nevertheless, IQGAP expression does not abolish E-cadherin staining at junctions.117 Another level of regulation is via calmodulin, which interacts with IQGAP1 and competes with E-cadherin for IQGAP1 binding. Inhibition of calmodulin function increases junctional localization of IQGAP1 and negatively modulates E-cadherin adhesion in MCF-7 cells.118 The physiological role of IQGAP in junction regulation is unclear at present. Similarly to α-catenin, IQGAP can bind to actin bundles, and it could therefore mediate attachment of cadherin complexes to the actin cytoskeleton.116,119 A putative dominant negative truncation of IQGAP1 prevents HGF- and TPA-induced disruption of cell-cell contacts in MDCK cells,120 suggesting that IQGAP1 may play a role on cell scattering. Mice with a targeted disruption of the IQGAP1 gene show no defects in cadherin-dependent adhesion and develop normally, although there is an increased incidence of late-onset gastric hyperplasia.118 IQGAP2 is a close homologue of IQGAP1 (62% identical) and it may functionally compensate for the lack of this protein.119 Arguing against this, IQGAP2 has a much more restricted expression than IQGAP1 and there is no obvious increase in IQGAP2 expression upon loss of IQGAP1.118,119 Tiam-1 is an exchange factor for Rac that localises at cell-cell contacts in epithelia and has been connected to components of cadherin complexes. When expressed in fibroblasts and transformed MDCK cells, Tiam-1 induces an “epithelial-like” phenotype with an increased localization of cadherin and actin at the cell-cell borders.80,121 The enhanced actin staining at junctions may result from an increased localization of Rac at these sites, a process that is mediated by Tiam-1. Although in transformed MDCK Tiam-1 activity appears to promote cell-cell adhesion, Tiam-1 can induce invasion and migration in T-lymphocytes and breast tumour cells.122-124 Thus, it seems that Tiam-1 may play a role in migration as well as cell-cell adhesion, depending on the cell type in which it is expressed. Nevertheless, it is not know whether Tiam-1 function is essential for cadherin-mediated adhesion as no dominant negative experiments have yet been reported. The Cdc42 effector MRCKα localises at cell-cell contact sites, but its role in the regulation of junctions has not yet been determined.125 A new family of Cdc42 effector proteins, CEPs has been implicated in regulation of cell-cell contacts.126 However, since the CRIB domain (Cdc42/Rac Binding Domain) of CEP is necessary for this response, it is possible that CEP perturb junctions by titrating out endogenous Cdc42.
Cell Polarity Cdc42 plays a role in epithelial polarity (asymmetric distribution of proteins in distinct domains) as well as in the polarity of cell migration. A Cdc42 target that may play a role on these processes is PAR-6.127-129 PAR-6 forms a complex with activated Rac/Cdc42, PAR-3 and PKCζ.127-129 In Drosophila and C.elegans, this complex participates in the establishment of epithelial polarity.130 In mammalian cells, PAR-6/PAR-3/PKCζ complex localizes at tight junctions via a direct interaction of PAR-3 with JAM, a member of the immunoglobulin family.131,132 This association is important, as overexpression of PAR-6 or the N-terminal domain of PAR-3 disrupts tight junctions.129 In contrast, localization of cadherin at adherens junctions is not perturbed. As JAM localises at tight junctions through an interaction with ZO-1, it is likely that JAM recruits the complex to tight junctions. Thus, Cdc42 and the PAR-6/PAR-3/ PKCζ complex appear to be involved in the establishment of epithelial polarity, but not specifically on the localization of cadherin receptors at junctions. Moreover, this Cdc42 function has been conserved in evolution from worm to man.
Cell-Cell Adhesion
129
Regulation by Other Small GTPases Additional members of small GTPase superfamily may also play a role on the organization of cadherin-based junctions, in particular, members of the ARF and Rab subfamilies that play a role in vesicular transport. The recycling of endocytosed cadherin receptors is clearly important for the establishment of new cell-cell contacts in MDCK cells.133 Dominant negative versions of Arf6 and Rab5 can block the HGF-induced disruption of cell-cell contacts.134,135 Consistent with these results, Arf6 activation can induce disassembly of cell-cell adhesion and cell scattering in MDCK cells.135,136 The mechanisms via which cadherin-based adhesion is disrupted are not clear, but it may involve activation of both Rac and phospolipase D.136 Rnd proteins (Rnd1, Rnd2 and Rnd3/RhoE) may exist in a constitutively activated form, as they show very low intrinsic levels of GTP hydrolysis.137 Endogenous Rnd 1 colocalizes with cadherin receptors at cell-cell contacts in epithelia and fibroblasts. Expression of wild type Rnd1 or Rnd3 leads to disassembly of actin filaments and loss of cell-matrix adhesion.137-139 However, no major effect is seen on the organization of actin at cell-cell adhesion sites when Rnd1 is expressed in MDCK cells.137,138 Thus, it appears that even though Rnd1 localises at junctions, so far its biological effect has been primarily described at sites of adhesion to substratum and stress fibers. Further experiments are necessary to define a putative function for Rnd proteins on cadherin-dependent cell-cell contacts. Another example is the Ras target, AF-6 or Afadin, which has been shown to localise at adherens and/or tight junctions.140-142 While a direct interaction between AF-6 and ZO-1 and AF-6 and JAM have been demonstrated, no functional implication for these interactions has been described.140,143 Interestingly, deficiency of AF-6/afadin causes embryonic lethality and both adherens and tight junctions are not properly organised in the ectoderm.141 However, these results need to be reconciled with the fact that Ras activity is not apparently necessary for formation of cadherin dependent cell-cell contacts.144
Cross-Talk between Small GTPases Cadherin and Integrin-Dependent Adhesion For many years, different reports have described a cross-talk between cadherin and integrin adhesion. This cross-talk is observed in different systems such as keratinocyte and muscle differentiation,145,146 migration of neural crest cells,147 MDCK polarization,148,149 regulation of receptor expression levels150 and determination of malignant phenotype.151,152 This cross-talk is apparently a two-way street, in which a reciprocal relationship is observed between the adhesiveness of both types of adhesion receptors. This phenomenon is interpreted as the need to coordinate cell-cell and cell-extracellular matrix adhesion in different cellular processes, and ultimately determine a sessile or migratory phenotype. However, the mechanism via which such coordination is achieved is poorly understood. Rho small GTPases regulate both cadherin- and integrin-mediated adhesion, and they are likely candidates to participate in a cross-talk between the two receptors. Recent results suggest that adhesion to different extracellular matrices can influence the manner in which Rac interferes with cadherin-dependent cell-cell contacts.80 Depending on the substratum to which the cells are attached, either a positive or negative effect is observed on junctions following Rac activation. These results suggest that the engagement of different types of integrin receptors can have a profound effect on the signalling pathways activated by Rho small GTPases. Interestingly, expression of β1 integrin in epithelial GE11 null cells (β1-/-) leads to a disruption of cadherin-based adhesion, decrease in cadherin and α-catenin levels and rearrangement of focal adhesions.78 Expression of β1 integrin in these null cells activates Rac and Rho, but not Cdc42. The morphological and scattering phenotype can be reversed by expression of dominant negative versions of the small GTPases.78 In contrast, reports in other cell types point out to a balance between the activity levels for Rho and Rac to determine cell-cell adhesion or migratory behaviour.99,153
130
Rho GTPases
Similarly, the presence of cadherin-dependent adhesion can modify the migratory behaviour of cells, by reducing the speed and motility rate. This balance between motility and cell-cell adhesion is perturbed by treatment with specific growth factors/scatter factors. HGF/scatter factor, TGF-β and Ras can all induce disruption of cell-cell adhesion, scattering and enhanced motility via activation of Rho small GTPases.87,144,154,155 However, these effects are dependent on the cell type, substratum and the levels of growth factor receptors expressed.80,156 In cells containing normal levels of growth factor receptors, cadherin-dependent cell-cell contacts are not easily disrupted: addition of inhibitory antibodies against cadherins is necessary to induce the migratory phenotype.157,158 A candidate player for the coordination between cell adhesion and migration is the nonreceptor tyrosine kinase Fer.159 This molecule associates with the juxta-membrane domain of N-cadherin, and has been shown to participate in the cross-talk between N-cadherin and integrins.160,161 Indeed, the juxta-membrane region of E-cadherin cytoplasmic tail is also involved in the regulation of cell adhesion and cell motility.162 Another possible point of cross-talk between cadherins, integrins and small GTPases is the catenin p120ctn. Recent results suggest that p120ctn can modulate the activation status of Rho proteins as overexpression of this catenin induces branching protusions.163-165 This phenotype is dependent on Rho inhibition and upregulation of Rac and Cdc42. Only p120ctn molecules not associated with the cadherin receptors (cytosolic pools) regulate the activity of small GTPases. Expression of E-cadherin can titrate out p120ctn and inhibit these effects.163-165 It is predicted that disruption of cadherin-based junctions would free up p120ctn in the cytoplasm, which would then be able to modulate the activity of RHO small GTPases to an appropriate setting for migration (Rho inhibition and activation of Rac/Cdc42). Although p120ctn can interact with Vav-2, an exchange factor for Rho, Rac and Cdc42,166 overexpression of Vav-2 cannot reproduce the same phenotype as p120ctn overexpression.164 On the other hand, using purified proteins, it has been shown that p120ctn can inhibit the intrinsic GDP/GTP exchange activity of Rho.163 However, a direct interaction between these two proteins has been unsuccessful. Thus, the mechanisms via which p120ctn may regulate the activity of Rho small GTPases is an open issue. Taken together, these results reflect the ability of cells to coordinate when is necessary to move and when to stop and adhere to each other. The coordination between these two decisions observed in vitro represent glimpses of a biological process that occurs often during tissue morphogenesis. During developmental processes such as migration of neural crest cells, kidney epithelial tubular formation and muscle differentiation, the precise spatial and temporal control of migration to specific regions in the embryo is essential. Here cells become sessile, adhere to their neighbours and differentiate. It will be important to confirm whether the molecular players identified in the cross-talk between cadherins and integrins in vitro may also play a role on the differentiation processes in vivo.
Signalling from Cadherin Receptors Because addition of extracellular calcium ions is required for cadherin function, there is a concern about the role of calcium signalling in the cellular processes that are triggered following cell-cell contact formation. An important role for calcium signalling seems unlikely because: (a) an increase in intracellular calcium ions is readily buffered; (b) the time course for calcium signalling is usually very short, and does not match the time course for cytoskeletal rearrangement triggered by cell-cell adhesion (1 – 2 hours); (c) inhibition of cadherin function has so far blocked the relevant cellular processes (formation of other adhesive structures and cell shape change).73-75,145,167,168 Thus, calcium signalling may contribute to some cellular processes after cadherin-dependent adhesion.169 However, this pathway is by no means essential or sufficient for the development of the epithelial phenotype. Although it was originally thought that cadherin receptors play a purely mechanical role in mediating attachment of adjacent cells, it is now becoming apparent that cadherin-mediated adhesion can also activate intracellular signalling pathways. The pathways activated in a
Cell-Cell Adhesion
131
cadherin-dependent manner participate in different cellular processes such as gene expression, differentiation, growth control, apoptosis and phosphorylation/activation of specific signalling cascades. The small GTPases of the Rho family have also been implicated in these processes in different cell types.85 One interesting question is to whether in epithelial cells small GTPases can participate in these processes in a cadherin-dependent manner. Some studies give insights particularly when the specificity of the signalling output depends on a particular type of cadherin expressed. For example, in keratinoctytes, cell-cell contact formation induces expression of differentiation markers in an E-cadherin- and P-cadherin-dependent manner.170,171 Reexpression of E-cadherin in embryonic stem cells derived form E-cadherin -/- mice triggers epithelial differentiation in vitro (Larue et al, 1996). In contrast, expression of N-cadherin induces chondrogenic, skeletal and cardiac muscle differentiation.6,172-174 However, E-cadherin can functionally substitute for N-cadherin when expressed in cardiomyocytes null for N-cadherin expression.175 These results imply that some functions of different cadherin receptors are interchangeable, but not all of them. A role for cadherins in the contact-inhibition of growth of normal cells has long been speculated. This involvement has now been shown for both E- and N-cadherin, although the mechanisms are somewhat different.110,176 In addition, there is some evidence suggesting that E-cadherin may function as a tumor suppressor, as it can slow the proliferation rate of some cell lines.176-179 A participation of E-cadherin-, N-cadherin- and VE-cadherin-mediated adhesion in suppression of apoptosis has also been demonstrated.175,180,181 Moreover, cell-cell adhesion mediated by cadherin receptors can trigger the transcription of specific genes.146,182-184 Cell-cell contacts mediated by cadherins in fibroblasts can activate stretch-sensitive calcium permeable channels, which induces a transient actin polymerisation at contact sites.169 Finally, in addition to the activation of Rho proteins, cell-cell contact formation in epithelial cells can activate PI3 kinase, Akt/PKB and MAPK.84,185 Establishment of junctions induces phosphorylation of the docking protein Gab1 in an E-cadherin-dependent manner.186 As phosphorylation of Gab1 can negatively regulate HGF receptor signalling,187 it will be interesting to determine if these phosphorylated residues are similar to the residues modified after cell-cell adhesion formation. In many of the studies described above, particularly the long-term differentiation studies, it is not clear whether the activation of signalling pathways is a direct consequence of cadherin association or results from the assembly of other junctional complexes or recruitment of signalling molecules to the junction. This issue has been addressed in some instances, where clustering of cadherin receptors using specific antibodies or antibody-coated beads can mimic the ability of cadherin-mediated adhesion to activate distinct pathways.171,173,188 However, in two of these studies, cell-cell contact assembly is also enhanced by incubation with antibody-coated beads. Therefore, this increase in junction formation, rather than the bead-treatment per se, may be responsible for the activation of signalling cascades.173,188
Possible Mechanisms for Signalling Following Cell-Cell Contact Formation Since the cadherins have no intrinsic catalytic activity, the manner in which they may activate signalling cascades is unclear at present. One possibility is by the association with scaffolding proteins or proteins with enzymatic activity. Indeed, an association between a number of growth factor receptors (NGFR, EGFR, VEGFR) and cadherin-adhesion complexes has been demonstrated in different cell types.180,185,189-191 Shc has also been shown to coprecipitate with cadherin receptors.192 However, it is conceivable that Shc was present in the cadherin precipitates via association with a growth factor receptor, an established partner for Shc. A current hypothesis is that clustering of cadherins and growth factors receptors at sites of cell-cell contact may be sufficient to activate the receptors and thus downstream signalling pathways. Alternatively, cadherin receptors may associate with kinases and phosphatases that can then mediate some of the reported effects. These interactions have been demonstrated for N-cadherin and the tyrosine phosphatases PTPµ, PTP1B and LAR193-195 and nonreceptor tyrosine kinase Fer.159
132
Rho GTPases
It has long been demonstrated that the formation of desmosomes, gap junctions and tight junctions require the prior assembly of cadherin-dependent cell-cell contacts.8,167,168,196,197 Two possibilities have been suggested to explain these events: first, cadherin receptors form stronger cell-cell contacts and, by holding the two opposing membranes from neighbouring cells together, it would facilitate the formation of these other adhesive structures. Alternatively, cadherin-dependent adhesion would trigger signalling events that facilitate the assembly of desmosomes and tight junctions (see section Signalling from Cadherin Receptors). Some recent experiments indicate that PKC isoforms may play a role in these processes.198-202 The mechanism via which PKC can induce the localized assembly of tight junctions and desmosomes at cell borders in the absence of cadherin function is far from clear. Nevertheless, this data imply that a possible consequence of cadherin adhesion is the activation of PKC isoforms, which then participate in the assembly of tight junctions. One possible connection that has not yet been explored is via association of PKCζ with Par3/Par6 complexes. This complex can directly interact with JAM receptors present at tight junctions.131,132 Another example is the involvement of Src kinases (Src, Fyn and Yes). In keratinocytes, inhibition of Src activity in vitro leads to the stabilization of transient cadherin-dependent cell-cell contacts, even in the absence of calcium ions.203 This suggests that after cell-cell contact formation, cadherins might inactivate Src to enable stable junction formation. These results are consistent with early experiments in which expression of the oncogenic form v-Src can perturb cadherin-mediated cell-cell adhesion.55,57,204 In contrast, a recent report showed that fyn-/- keratinocytes are deficient in the formation of cell-cell junctions in vitro.205 Disruption of cell-cell contacts in the epidermis in vivo requires ablation of both src and fyn genes.205 These contradictions might reflect that, in addition to the catalytic domain, additional adaptor functions (i.e., SH2, SH3 domains) of the Src molecule are necessary for its effects on junctions.
Conclusions Exciting results in the past few years have highlighted the potential mechanisms for regulation of cell-cell contacts in epithelial cells. Cadherin receptors emerge as a key component for the activation of distinct signalling pathways during formation of new cell-cell adhesion. These pathways have been shown to participate in many different cellular processes relevant to epithelia function: assembly of adhesive structures, cell shape change, polarisation, differentiation, survival and growth control. Some of the activated pathways, particularly related to Rho and Rac small GTPases, participate in a feed back loop as they may be an important contribution to the stability of the cadherin receptors at junctions. The challenge now is to understand the signalling components and the molecular interactions that leads to the activation of these diverse signalling pathways following clustering of cadherin receptors.
References 1. Cowin PM, B B. Cytoskeleton-membrane interactions. Cur Op Cell Biol 1996; 8:56-65. 2. Gumbiner BM. Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 1996; 84:345-357. 3. Pepperbrock R, Bre MH, Davoust J et al. Microtubules are stabilized in confluent epithelial cells but not in fibroblasts. J Cell Biol 1990; 111:3003-3012. 4. Sanger JW, Sanger JM, Jockusch BM. Differences in the stress fibers between fibroblasts and epithelial cells. J Cell Biol 1983; 96:961-969. 5. Owaribe K, Kodama R, Eguchi G. Demonstration of contractility of circunferential actin bundles and its morphogenetic significance in pigmented epithelium in vitro and in vivo. J Cell Biol 1981; 90:507-514. 6. Larue L, Oshugi M, Hirchenhain J et al. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 1994; 91:8263-8267. 7. Radice GL, Ferreira-Cornwell MC, Robinson SD et al. Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 1997; 139:1025-1032. 8. Mege R-M, Matsuzaki F, Gallin WJ et al. Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules. Proc Natl Acad Sci USA 1988; 85:7274-7278.
Cell-Cell Adhesion
133
9. Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Ann Rev Cell Dev Biol 1997; 13:119-146. 10. Rimm DL, Koslov ER, Kebriaei P et al. Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci USA 1995; 92:8813-7. 11. Haegel H, Larue L, Ohsugi M et al. Lack of β-catenin affects mouse development at gastrulation. Development 1995; 121:3529-3537. 12. Ohkubo T, Ozawa M. P120ctn binds to the membrane-proximal region of the E-cadherin cytoplasmic domain and is involved in modulation of adhesion activity. J Biol Chem 1999; 274:21409-21415. 13. Lu Q, Paredes M, Medina M et al. δ-catenin, an adhesive junction-associated protein which promotes cell scattering. J Cell Biol 1999; 144:519-532. 14. Mariner DJ, Wang J, Reynolds AB. ARVCF localizes to the nucleus and adherens junctions and is mutually exclusive with p120ctn in E-cadherin complexes. J Cell Sci 2000; 113:1481-1490. 15. Thoreson MA, Anastasiadis PZ, Daniel JM et al. Selective uncoupling of p120ctn from E-cadherin disrupts strong adhesion. J Cell Biol 2000; 148:189-201. 16. Ozawa M, Kemler R. The membrane-proximal region of the E-cadherin cytoplasmic domain prevents dimerization and negatively regulates adhesion activity. J Cell Biol 1998; 142:1605-1613. 17. Aono S, Nakagawa S, Reynolds AB et al. P120ctn acts as an inhibitory regulator of cadherin function in colon carcinoma cells. J Cell Biol 1999; 145:551-562. 18. Anastasiadis PZ, Reynolds AB. The p120 catenin family: Complex roles in adhesion, signalling and cancer. J Cell Sci 2000; 113:1319-1334. 19. Pertz O, Bozic D, Koch AW et al. A new crystal structure, Ca2+, dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J 1999; 18:1738-1747. 20. Shapiro L, Fannon AM, Kwong PD et al. Structural basis of cell-cell adhesion by cadherins. Nature 1995; 374:327-337. 21. Chitaev NA, Troyanovsky SM. Adhesive but not lateral E-cadherin complexes require calcium and catenins for their formation. J Cell Biol 1998; 142:837-846. 22. Nagar B, Overduin M, Ikura M et al. Structural basis of calcium-induced E-cadherin rigidification and dimerization. Nature 1996; 380:360-364. 23. Shan W-S, Tanaka H, Phillips GR et al. Functional cis-heterodimers of N- and R-cadherins. J Cell Biol 2000; 148:579-590. 24. Tamura K, Shan WS, Hendrickson WA et al. Structure function analysis of cell adhesion by neural (N-)cadherin. Neuron 1998; 20:1153-1163. 25. Brieher WM, Yap AS, Gumbiner BM. Lateral dimerization is required for the homophilic binding activity of C-cadherin. J Cell Biol 1996; 135:487-496. 26. Nose A, Tsuji K, Takeichi M. Localization of specificity determining sites in cadherin cell adhesion molecules. Cell 1990; 61:147-155. 27. Amagai M, Karpati S, Prussick R et al. Autoantibodies against the aminoterminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992; 90:919-926. 28. Chappuis-Flament S, Wong E, Hicks LD et al. Multiple cadherin extracellular repeats mediate homophilic binding and adhesion. J Cell Biol 2001; 154:231-243. 29. Berx G, Nollet F, van Roy F. Dysregulation of E-cadherin/catenin complex by irreversible mutations in himan carcinomas. Cell Adhesion Com 1998; 6:171-184. 30. Ozawa M, Hoschutsky H, Herrenknecht K et al. A possible new adhesive site in the cell-cell adhesion molecule uvomorulin. Mechanisms Dev 1990; 33:49-56. 31. Sivasankar S, Brieher W, Lavrik N et al. Direct molecular force measurements of multiple adhesive interactions between cadherin ectodomains. Proc Natl Acad Sci USA 1999; 96:11820-11824. 32. Adams CL, Nelson WJ, Smith SJ. Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion. J Cell Biol 1996; 135:1899-1911. 33. Adams CL, Chen Y-T, Smith SJ et al. Mechanisms of epithelial cell-cell adhesion and cell compaction revealed by high-resolution tracking of E-cadherin-green fluorescent protein. J Cell Biol 1998; 142:1105-1119. 34. Braga VMM, Najabagheri N, Watt FM. Calcium-induced intercellular adhesion of keratinocytes does not involve accumulation of β1 integrins at cell-cell contact sites and does not involve changes in the levels or phosphorylation of the catenins. Cell Ad Com 1998; 5:137-149. 35. Angres B, Barth A, Nelson WJ. Mechanism for transition from initial to stable cell-cell adhesion: Kinetic analysis of E-cadherin-mediated adhesion using a quantitative adhesion assay. J Cell Biol 1996; 134:549-557. 36. Sobel JS. Myosin rings and spreading in mouse blastomeres. J Cell Biol 1984; 99:1145-1150. 37. Philip NJ, Nachmias VT. Components of the cytoskeleton in the retinal pigmented epithelium of the chick. J Cell Biol 1985; 101:358-362.
134
Rho GTPases
38. Stoffler HE, Honnert U, Bauer CA et al. Targeting of the myosin-I to intercellular adherens type junctions induced by dominant active Cdc42 in HeLa cells. J Cell Sci 1998; 111:2779-2788. 39. Raich WB, Agbunag C, Hardin J. Rapid epithelial-sheet sealing in the Caenorhabditis elegans embryo requires cadherin-dependent filopodial priming. Curr Biol 1999; 9:1139-1146. 40. Vasioukhin V, Bauer C, Yin M et al. Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 2000; 100:209-219. 41. Jacinto A, Wood W, Balayo T et al. Dynamic actin-based epithelial adhesion and cell matching during Drosophila dorsal closure. Curr Biol 2000; 10:1420-1426. 42. Kusumi A, Sako Y. Cell surface organization by the membrane skeleton. Cur Op Cell Biol 1996; 8:566-574. 43. Sako Y, Nagafuchi N, Tsukita S et al. Cytoplasmic regulation of the movement of E-cadherin on the free cell surface as studied by op